
<html lang="en"     class="pb-page"  data-request-id="a018033c-3128-47a5-9146-3c3bff5ef999"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-9;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.8b00067"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne" /></meta><meta name="dc.Creator" content="Jean-François  Fournier" /></meta><meta name="dc.Creator" content="Laurence  Clary" /></meta><meta name="dc.Creator" content="Sandrine  Chambon" /></meta><meta name="dc.Creator" content="Laurence  Dumais" /></meta><meta name="dc.Creator" content="Craig Steven  Harris" /></meta><meta name="dc.Creator" content="Corinne  Millois" /></meta><meta name="dc.Creator" content="Romain  Pierre" /></meta><meta name="dc.Creator" content="Sandrine  Talano" /></meta><meta name="dc.Creator" content="Étienne  Thoreau" /></meta><meta name="dc.Creator" content="Jérome  Aubert" /></meta><meta name="dc.Creator" content="Michèle  Aurelly" /></meta><meta name="dc.Creator" content="Claire  Bouix-Peter" /></meta><meta name="dc.Creator" content="Anne  Brethon" /></meta><meta name="dc.Creator" content="Laurent  Chantalat" /></meta><meta name="dc.Creator" content="Olivier  Christin" /></meta><meta name="dc.Creator" content="Catherine  Comino" /></meta><meta name="dc.Creator" content="Ghizlane  El-Bazbouz" /></meta><meta name="dc.Creator" content="Anne-Laurence  Ghilini" /></meta><meta name="dc.Creator" content="Tatiana  Isabet" /></meta><meta name="dc.Creator" content="Claude  Lardy" /></meta><meta name="dc.Creator" content="Anne-Pascale  Luzy" /></meta><meta name="dc.Creator" content="Céline  Mathieu" /></meta><meta name="dc.Creator" content="Kenny  Mebrouk" /></meta><meta name="dc.Creator" content="Danielle  Orfila" /></meta><meta name="dc.Creator" content="Jonathan  Pascau" /></meta><meta name="dc.Creator" content="Kevin  Reverse" /></meta><meta name="dc.Creator" content="Didier  Roche" /></meta><meta name="dc.Creator" content="Vincent  Rodeschini" /></meta><meta name="dc.Creator" content="Laurent François  Hennequin" /></meta><meta name="dc.Description" content="The use of an interleukin β antibody is currently being investigated in the clinic for the treatment of acne, a dermatological disorder affecting 650M persons globally. Inhibiting the protease resp..." /></meta><meta name="Description" content="The use of an interleukin β antibody is currently being investigated in the clinic for the treatment of acne, a dermatological disorder affecting 650M persons globally. Inhibiting the protease resp..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 12, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00067" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00067" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00067" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00067" /></link>
        
    
    

<title>Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00067" /></meta><meta property="og:title" content="Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0018.jpeg" /></meta><meta property="og:description" content="The use of an interleukin β antibody is currently being investigated in the clinic for the treatment of acne, a dermatological disorder affecting 650M persons globally. Inhibiting the protease responsible for the cleavage of inactive pro-IL1β into active IL-1β, caspase-1, could be an alternative small molecule approach. This report describes the discovery of uracil 20, a potent (38 nM in THP1 cells assay) caspase-1 inhibitor for the topical treatment of inflammatory acne. The uracil series was designed according to a published caspase-1 pharmacophore model involving a reactive warhead in P1 for covalent reversible inhibition and an aryl moiety in P4 for selectivity against the apoptotic caspases. Reversibility was assessed in an enzymatic dilution assay or by using different substrate concentrations. In addition to classical structure–activity-relationship exploration, topical administration challenges such as phototoxicity, organic and aqueous solubility, chemical stability in solution, and skin metabolic stability are discussed and successfully resolved." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00067"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00067">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00067&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00067&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00067&amp;href=/doi/10.1021/acs.jmedchem.8b00067" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 4030-4051</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00041" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00082" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jean-François Fournier</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean-François Fournier</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +33 4 92 38 68 84. E-mail: <a href="/cdn-cgi/l/email-protection#3d57585c53105b4f5c535e52544e135b52484f5354584f7d48505253494f585c51135e5c"><span class="__cf_email__" data-cfemail="89e3ece8e7a4effbe8e7eae6e0faa7efe6fcfbe7e0ecfbc9fce4e6e7fdfbece8e5a7eae8">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Fran%C3%A7ois++Fournier">Jean-François Fournier</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4958-1478" title="Orcid link">http://orcid.org/0000-0003-4958-1478</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laurence Clary</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laurence Clary</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laurence++Clary">Laurence Clary</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sandrine Chambon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandrine Chambon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandrine++Chambon">Sandrine Chambon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laurence Dumais</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laurence Dumais</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laurence++Dumais">Laurence Dumais</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Craig Steven Harris</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Craig Steven Harris</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Craig+Steven++Harris">Craig Steven Harris</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Corinne Millois</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Corinne Millois</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Corinne++Millois">Corinne Millois</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Romain Pierre</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Romain Pierre</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Romain++Pierre">Romain Pierre</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sandrine Talano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandrine Talano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandrine++Talano">Sandrine Talano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Étienne Thoreau</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Étienne Thoreau</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=%C3%89tienne++Thoreau">Étienne Thoreau</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jérome Aubert</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jérome Aubert</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%A9rome++Aubert">Jérome Aubert</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michèle Aurelly</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michèle Aurelly</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mich%C3%A8le++Aurelly">Michèle Aurelly</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claire Bouix-Peter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claire Bouix-Peter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claire++Bouix-Peter">Claire Bouix-Peter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anne Brethon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anne Brethon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Edelris, 115 Avenue Lacassagne, 69003 Lyon, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anne++Brethon">Anne Brethon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laurent Chantalat</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laurent Chantalat</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laurent++Chantalat">Laurent Chantalat</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Olivier Christin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Olivier Christin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Olivier++Christin">Olivier Christin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Catherine Comino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Catherine Comino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Comino">Catherine Comino</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ghizlane El-Bazbouz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ghizlane El-Bazbouz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ghizlane++El-Bazbouz">Ghizlane El-Bazbouz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anne-Laurence Ghilini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anne-Laurence Ghilini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anne-Laurence++Ghilini">Anne-Laurence Ghilini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tatiana Isabet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tatiana Isabet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Synchrotron Soleil, L’Orme des Merisiers, Saint-Aubin, BP 48, 91192 Gif-sur-Yvette Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tatiana++Isabet">Tatiana Isabet</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claude Lardy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claude Lardy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Edelris, 115 Avenue Lacassagne, 69003 Lyon, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claude++Lardy">Claude Lardy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anne-Pascale Luzy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anne-Pascale Luzy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anne-Pascale++Luzy">Anne-Pascale Luzy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Céline Mathieu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Céline Mathieu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9line++Mathieu">Céline Mathieu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kenny Mebrouk</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kenny Mebrouk</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kenny++Mebrouk">Kenny Mebrouk</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Danielle Orfila</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Danielle Orfila</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Danielle++Orfila">Danielle Orfila</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonathan Pascau</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathan Pascau</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Pascau">Jonathan Pascau</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin Reverse</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin Reverse</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Reverse">Kevin Reverse</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Didier Roche</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Didier Roche</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Edelris, 115 Avenue Lacassagne, 69003 Lyon, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Didier++Roche">Didier Roche</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vincent Rodeschini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vincent Rodeschini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Edelris, 115 Avenue Lacassagne, 69003 Lyon, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vincent++Rodeschini">Vincent Rodeschini</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4758-5021" title="Orcid link">http://orcid.org/0000-0002-4758-5021</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Laurent François Hennequin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laurent François Hennequin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Nestlé Skin Health R&D, 2400 Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laurent+Fran%C3%A7ois++Hennequin">Laurent François Hennequin</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00067&amp;href=/doi/10.1021%2Facs.jmedchem.8b00067" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 4030–4051</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 12, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 January 2018</li><li><span class="item_label"><b>Published</b> online</span>12 April 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 May 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00067" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00067</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4030%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJean-Fran%25C3%25A7ois%2BFournier%252C%2BLaurence%2BClary%252C%2BSandrine%2BChambon%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D9%26contentID%3Dacs.jmedchem.8b00067%26title%3DRational%2BDrug%2BDesign%2Bof%2BTopically%2BAdministered%2BCaspase%2B1%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BInflammatory%2BAcne%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4051%26publicationDate%3DMay%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00067"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2201</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00067" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jean-François&quot;,&quot;last_name&quot;:&quot;Fournier&quot;},{&quot;first_name&quot;:&quot;Laurence&quot;,&quot;last_name&quot;:&quot;Clary&quot;},{&quot;first_name&quot;:&quot;Sandrine&quot;,&quot;last_name&quot;:&quot;Chambon&quot;},{&quot;first_name&quot;:&quot;Laurence&quot;,&quot;last_name&quot;:&quot;Dumais&quot;},{&quot;first_name&quot;:&quot;Craig&quot;,&quot;last_name&quot;:&quot;Steven Harris&quot;},{&quot;first_name&quot;:&quot;Corinne&quot;,&quot;last_name&quot;:&quot;Millois&quot;},{&quot;first_name&quot;:&quot;Romain&quot;,&quot;last_name&quot;:&quot;Pierre&quot;},{&quot;first_name&quot;:&quot;Sandrine&quot;,&quot;last_name&quot;:&quot;Talano&quot;},{&quot;first_name&quot;:&quot;Étienne&quot;,&quot;last_name&quot;:&quot;Thoreau&quot;},{&quot;first_name&quot;:&quot;Jérome&quot;,&quot;last_name&quot;:&quot;Aubert&quot;},{&quot;first_name&quot;:&quot;Michèle&quot;,&quot;last_name&quot;:&quot;Aurelly&quot;},{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;Bouix-Peter&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;Brethon&quot;},{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;Chantalat&quot;},{&quot;first_name&quot;:&quot;Olivier&quot;,&quot;last_name&quot;:&quot;Christin&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Comino&quot;},{&quot;first_name&quot;:&quot;Ghizlane&quot;,&quot;last_name&quot;:&quot;El-Bazbouz&quot;},{&quot;first_name&quot;:&quot;Anne-Laurence&quot;,&quot;last_name&quot;:&quot;Ghilini&quot;},{&quot;first_name&quot;:&quot;Tatiana&quot;,&quot;last_name&quot;:&quot;Isabet&quot;},{&quot;first_name&quot;:&quot;Claude&quot;,&quot;last_name&quot;:&quot;Lardy&quot;},{&quot;first_name&quot;:&quot;Anne-Pascale&quot;,&quot;last_name&quot;:&quot;Luzy&quot;},{&quot;first_name&quot;:&quot;Céline&quot;,&quot;last_name&quot;:&quot;Mathieu&quot;},{&quot;first_name&quot;:&quot;Kenny&quot;,&quot;last_name&quot;:&quot;Mebrouk&quot;},{&quot;first_name&quot;:&quot;Danielle&quot;,&quot;last_name&quot;:&quot;Orfila&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Pascau&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Reverse&quot;},{&quot;first_name&quot;:&quot;Didier&quot;,&quot;last_name&quot;:&quot;Roche&quot;},{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;Rodeschini&quot;},{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;François Hennequin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;4030-4051&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00067&quot;},&quot;abstract&quot;:&quot;The use of an interleukin β antibody is currently being investigated in the clinic for the treatment of acne, a dermatological disorder affecting 650M persons globally. Inhibiting the protease responsible for the cleavage of inactive pro-IL1β into active IL-1β, caspase-1, could be an alternative small molecule approach. This report describes the discovery of uracil 20, a potent (38 nM in THP1 cells assay) caspase-1 inhibitor for the topical treatment of inflammatory acne. The uracil series was designed according to a published caspase-1 pharmacophore model involving a reactive warhead in P1 for covalent reversible inhibition and an aryl moiety in P4 for selectivity against the apoptotic caspases. Reversibility was assessed in an enzymatic dilution assay or by using different substrate concentrations. In addition to classical structure–activity-relationship exploration, topical administration challenges such as phototoxicity, organic and aqueous solubility, chemical stability in solution, and skin metabolic st&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00067&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00067" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00067&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00067" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00067&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00067" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00067&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00067&amp;href=/doi/10.1021/acs.jmedchem.8b00067" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00067" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00067" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00067%26sid%3Dliteratum%253Aachs%26pmid%3D29648825%26genre%3Darticle%26aulast%3DFournier%26date%3D2018%26atitle%3DRational%2BDrug%2BDesign%2Bof%2BTopically%2BAdministered%2BCaspase%2B1%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BInflammatory%2BAcne%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D9%26spage%3D4030%26epage%3D4051%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292176" title="Uracil">Uracil</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/jmcmar.2018.61.issue-9/20180510/jmcmar.2018.61.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The use of an interleukin β antibody is currently being investigated in the clinic for the treatment of acne, a dermatological disorder affecting 650M persons globally. Inhibiting the protease responsible for the cleavage of inactive pro-IL1β into active IL-1β, caspase-1, could be an alternative small molecule approach. This report describes the discovery of uracil <b>20</b>, a potent (38 nM in THP1 cells assay) caspase-1 inhibitor for the topical treatment of inflammatory acne. The uracil series was designed according to a published caspase-1 pharmacophore model involving a reactive warhead in P1 for covalent reversible inhibition and an aryl moiety in P4 for selectivity against the apoptotic caspases. Reversibility was assessed in an enzymatic dilution assay or by using different substrate concentrations. In addition to classical structure–activity-relationship exploration, topical administration challenges such as phototoxicity, organic and aqueous solubility, chemical stability in solution, and skin metabolic stability are discussed and successfully resolved.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23611" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23611" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Acne is a dermatological disorder affecting 40–50 million Americans and 650 million globally.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Lesions typically appear in the face, upper back, and chest area and can lead to permanent scarring as well as low self-esteem. Current treatment consists of the use teratogenic retinoids such as Roaccutane. Therefore, drugs with novel mechanisms of action and improved safety profiles would benefit patients.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">The pathogenesis of acne can be divided in different steps: (1) (over)production of sebum by the sebaceous gland; (2) colonization of the hair follicle by <i>P. acnes</i>; (3) hyperkeratinization of the follicle; (4) the release of inflammatory mediators into the skin.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Proinflammatory cytokines including TNFα, IL-1α, and IL-1β are considered to be involved for follicular hyperkeratinization and the inflammatory lesions characteristic of acne. This cytokine usually exists in its proform which is cleaved to its active form by the aspartic cysteine protease caspase-1 upon inflammatory stimulus.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Recently, French and co-workers have demonstrated that the active form of IL-1β is abundant in human acne lesions.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Moreover, they demonstrated that the production induced by <i>P. acnes</i> of active IL-1β in monocytic lineage and in mice is dependent on the NLRP3/caspase-1 inflammasome by <i>P. acnes</i> exposed cells. These data indicate that IL-1β is a novel potential therapeutic target in acne, and therefore, we postulate that inhibiting caspase-1 could have a beneficial effect in inflammatory acne.</div><div class="NLM_p">Most dermatological diseases such as acne are non-life-threatening, and as such, treatments are subject to a very low tolerance to risk. Thus, a common strategy employed is ensuring the concentration of drug in the target organ, skin, is significantly higher than that in blood. Because the free drug hypothesis precludes accomplishing this via the systemic route,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> a local topical administration of drugs showing high systemic clearance is often favored (soft drug<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a>). Furthermore, with dermatological diseases that affect only a small portion of the body surface area (BSA), this can also lead to dose minimization and therefore to a reduced risk. This could be of particular interest in the case of targets that are typically treated with covalent drugs.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Caspase-1 is a well-documented target for which a few clinical candidates have already been evaluated, including Vertex’ belnacasan and pralnacasan.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> However, previously disclosed inhibitors have been optimized for the systemic rather than the topical route and are not necessarily appropriate for use in dermatology.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> We have therefore initiated a chemistry program to identify a caspase-1 inhibitor better suited to the topical treatment of inflammatory acne.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0019.gif" alt="" id="fx1" /></img></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Hit Generation and Reversibility Issues</h3><div class="NLM_p">Most published structures of caspase-1 inhibitors follow a few general rules derived from the elucidation of the protein’s tertiary structure by crystallography and from the key binding elements of the tetrapeptide Ac-YVAD-CHO, an early tool compound.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a, a reactive warhead and (<span class="smallcaps smallerCapital">l</span>)-aspartic acid mimic in P1 are key for potency and selectivity vs other cysteine proteases, key H-bond donors and acceptors in P2 and P3, and an aromatic residue in P4 for selectivity vs the apoptotic caspases.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Consequently, about a dozen different new scaffolds were designed in accordance with these guidelines and were evaluated in an enzymatic assay using two different concentrations (<i>K</i><sub>M</sub> and 20<i>K</i><sub>M</sub>) of substrate, a fluorescent pro-IL-1β analog (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b). The aim was for these peptidomimetic scaffolds to present a chemical topology that would allow the formation of the same H-bonds with caspase-1 in P2 and P3 as depicted in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a, namely, the two NHs flanking R<sub>1</sub> and R<sub>4</sub> and, between these, one acceptor (carbonyl or pyridine). In addition, the outgoing vectors for R<sub>1</sub> and R<sub>4</sub> should be consistent with those from ZVAD-CHO to provide the other binding elements: the covalent bond and salt bridge in P1 and the π-stacking in P4. To standardize this phase, each synthesized scaffold was combined at the very least with the ubiquitous aspartyl aldehyde warhead in P1 and a 2-naphthyl (similar to pralnacasan’s 1-isoquinolyl) group in P4.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) ZVAD-CHO bound to caspase-1 shows the key binding elements that need to be reproduced in novel scaffolds: covalent bond with CYS285, ionic interactions with ARG179, GLN283, and ARG341, H-bonds with SER339’s carbonyl and ARG341’s carbonyl and NH. (b) Some examples of novel scaffolds designed to reproduce key binding elements with caspase-1 and tested for inhibitory activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In principle, the IC<sub>50</sub> values of competitive inhibitors following Michaelis–Menten kinetics should be right shifted about 10-fold at the higher substrate concentration (<i>K</i><sub>i</sub> = IC<sub>50</sub>/(<i>S</i>/<i>K</i><sub>M</sub> + 1)).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> By testing at two different substrate concentrations, we were able to get a first crude idea of the binding kinetics of our inhibitors. Indeed, since our inhibitors contained a reactive warhead which after an initial precomplexation step makes a covalent-reversible bond with the protein’s catalytic cysteine,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> we anticipated that some of our inhibitors would not reach equilibrium under our assay conditions (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0020.gif" alt="" id="GRAPHIC-d142e541-autogenerated" /></img></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Correlation between the pIC<sub>50</sub> measured at <i>K</i><sub>M</sub> vs 20<i>K</i><sub>M</sub> substrate concentration for early compounds. For competitive inhibition following Michaelis–Menten kinetics, a 1 log unit difference in pIC<sub>50</sub> values would be expected (green line). (b) Reversibility profiles as evaluated by the recovery of enzymatic reaction rate in a kinetic dilution experiment. Results from both graphs suggest that reversibility of the inhibition (under the condition of the assay) can be quickly evaluated using the ratio of IC<sub>50</sub> values: fully reversible inhibitors (green line/bars) have a 10-fold difference, whereas pseudoirreversible inhibitors (red line/bars) have equal IC<sub>50</sub> values irrespective of the substrate concentration. Under this assumption, uracil compound <b>8</b> is fully reversible.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">For a few selected compounds displaying various profiles, a kinetic experiment was done to assess the reversibility of the inhibitors (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In this assay, the enzyme is preincubated with inhibitors at 10× their IC<sub>50</sub> values before being diluted 100-fold with the substrate. Recovery of the enzymatic activity is then monitored, and the extent of reaction speed recovery (from the slope of the curve) indicates whether the inhibitor is displaying a fully reversible profile, a pseudoirreversible (irreversible in the time scale of the assay), or partially reversible profile.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Since the results fully corroborated the ratio of the IC<sub>50</sub> values with substrate concentrations at 20<i>K</i><sub>M</sub> vs <i>K</i><sub>M</sub>, this higher throughput method was thereafter used to monitor the reversibility of the covalent bond formation with the catalytic cysteine.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Consequently, this methodology gave us confidence that we could properly rank our compounds and conduct a normal SAR.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> From Hit to Lead</h3><div class="NLM_p">This article focuses on the work around the uracil hit <b>8</b>, but other scaffolds were also investigated in parallel.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Analogs with varying substituents in the P2 to P4 subpockets were prepared in a few SAR iteration cycles with most of the focus on R4, identifying lead compound <b>10</b> (pIC<sub>50Km</sub> = 8.3; pIC<sub>50 20Km</sub> = 7.5) bearing Sunesis’ quinoxaline in P4 and which was isolated as a yellow solid.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Conducting a retrospective binding efficiency index (BEI)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> analysis as proposed by Hajduck showed that although the BEI slowly crept up during the hit to lead (H2L) phase for the new “concept compounds”, a linear relationship between Mw and pIC<sub>50</sub> could be found with a slope of 48 amu/pIC<sub>50</sub> unit (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> These findings are in line with Hajduk’s retroanalysis across 15 Abbott projects and point toward the same conclusion: when adding new atoms on a hit or lead, if only the optimal ones are retained, then the molecular weight and potency of the starting point (hit) should be projectable to those of the end point (candidate). This analysis thus strengthened our belief the uracil series could be optimized to deliver a candidate.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0021.gif" alt="" id="GRAPHIC-d142e642-autogenerated" /></img></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding efficiency index plot of the H2L phase of the uracil series. Starting from hit <b>8</b>, a 10-fold improvement in potency can be achieved by the addition of 48 amu. Potency gains that come at the cost of larger molecular weight contributions should be rejected.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">However, the lead uracil compounds were subject to a number of liabilities specific to topical drug development, namely, color of the drug substance, solvent solubility, phototoxicity, and chemical stability in solution. These were, therefore, the parameters chosen as the main focus of the lead optimization phase.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Lead Optimization</h3><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Solvent Solubility</h4><div class="NLM_p">In the case of orally administered drugs, good aqueous solubility (>20–400 μM for compounds with medium permeabilities) is necessary to achieve good absorption in the gut.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> As per Yalkowsky’s general solubility equation (GSE), this can be achieved by decreasing the melting point (approximation of the crystalline lattice energy) or the log <i>D</i> of compounds.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, in the case of topically administered drugs, it is often necessary to achieve orders of higher magnitude solubilities (>20 mM) for formulation purposes.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This is usually achieved by the use of nonaqueous solvents such as ethanol, which means that the main driver for solubility will be its crystallinity/Mp (the log <i>D</i> component in the GSE serves to “account for the difference between an ideal solution and an aqueous solution”; it is, therefore, specific to aqueous solubility).<a onclick="showRef(event, 'ref22 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref24">(22,24)</a> Considerable efforts were therefore invested in getting meaningful solubility measurements: semistandardized crystallization processes were elaborated, crystallinity and melting points were assessed by DSCs with large enthalpies (>50 J/g), and thermodynamic solubilities were measured in a routine assay directly from crystalline material after 24 h in a 30/70 mixture of PG/EtOH. In the case of the uracil series, compounds with high solubility had lower melting points and higher (not lower!) ChromLogD (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Solubility in PG/EtOH is a function of the melting point in the uracil series with no positive impact from lowering ChromLogD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We surmised we might disrupt the crystalline lattice of our uracils by increasing their sp<sup>3</sup> fraction<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and more specifically by increasing the substitution pattern of the carbon atoms directly connected to the uracil core. This strategy proved fruitful as the isopropyl substituted uracil <b>11</b> showed a 10-fold improvement on PG/EtOH solubility while maintaining aqueous solubility vs <b>10</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Inversely, removing the methyl substituent at R<sub>2</sub> resulted in a compound with decreased solubilities (<b>12</b> vs <b>11</b>) despite the small drop in lipophilicity. Finally, switching the quinoxaline ring for a naphthyl ring also led to significant improvements in both types of solubility (<b>12</b> vs <b>13</b>). The fact that the aqueous solubility increased 6-fold, in spite of the ΔChromLogD, confirms the importance of this structural elements on crystallinity and solubility.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Moreover, this switch also resulted in colorless compounds as opposed to the yellow quinoxaline analogs.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Unfortunately, the LipE took a double hit as the potency decreased at the same time the ChromLogD increased. This behavior was generally observed across many matched pairs.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Optimization of PG/EtOH 30/70 Solubility; Replacing the Quinoxaline for a Naphthalene Group (<b>13</b>) and Steric Perturbation of the H-bond Donors/Acceptors (<b>14</b>) Give Rise to Solubility Improvements</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0014.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">Next we thought the addition of a second substituent α to the aliphatic amide might further improve solubility as well as stereochemical stability. Furthermore, inspection of the X-ray structure of <b>10</b> in caspase-1 revealed that the pocket formed by Val338 and Trp340 might accommodate a small substituent, and we hoped we could improve potency at the same time Indeed, the overlay of the docking of cyclopropyl <b>14</b> over the X-ray structure of <b>10</b> shows that the cyclopropyl group fits nicely in the shallow S2 lipophilic pocket with no perturbation of the surrounding side chain, while the three essential backbone H-bonds of the ligand are also maintained (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Cyclopropane <b>14</b> was therefore synthesized, and we were rewarded with small but reproducible improvements in solubility, cellular potency, and LipE vs <b>11</b>. <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> shows the potency boost was specific to the cyclopropyl moiety and reproducible across many matched pairs.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking studies of <b>14</b> (brown) vs X-ray structure of <b>10</b> (green; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F6R">6F6R</a>) suggest the cyclopropyl moiety in S2 optimally fits a small lipophilic pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Molecular matched pairs on the R1 substituents (connected dots) vs celluar potency: cyclopropyl unit gives a consistent increase in potency vs nonsubstituted, monomethyl, monoethyl, and <i>gem</i>-dimethyl substituents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Phototoxicity</h4><div class="NLM_p">Following its topical application, a drug substance is typically found in much higher concentration in skin than what occurs after oral administration. Furthermore, following UV irradiation by the sun, some benign compounds may become irritant or even toxic. This phenomenon is called phototoxicity. Because skin irritation is often incompatible with the desired therapeutic effect, phototoxicity can be a liability and needs to be screened early in the development. Photocytotoxicity potential is assessed by evaluating cell viability after 24 h exposure with caspase-1 inhibitors in the presence and absence of UV light. A phototoxicity irritation factor (PIF) value is determined by the ratio of LC<sub>50</sub> values, and compounds are classified as follows: PIF < 2 is nonphototoxic, 2 < PIF < 5 has low phototoxic potential, and PIF > 5 is phototoxic.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> A good practice when evaluating phototoxicity SPR is to keep an eye on the specific LC<sub>50</sub> values for more subtle effects (provided in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_001.pdf" class="ext-link">Supporting Information, Table 1S</a>). In the case of the present discussion, we find that simply taking into account the overall conclusion suffices.</div><div class="NLM_p">When we initially switched our focus from the quinoxaline to naphthalene substituents in P4 pocket, we observed a higher proportion of phototoxic products. For example, <b>13</b> was phototoxic whereas <b>12</b> was not. A more detailed analysis revealed a clear dependency on lipophilicity (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) which gave an upper limit of ChromLogD of about 3.5–4 for the design of new inhibitors.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Because of their better suited physical properties and despite their inherent higher lipophilicity, the naphthalene subseries was pursued since a design window remained and other strategies to mitigate the phototoxicity risk, for instance breaking conjugation between π-systems, remained (see below).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0007.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Phototoxicity in the uracil series is highly dependent on ChromLogD: 100% of the compounds with ChromLogD lower than 2 were photosafe vs only 18% when it was higher than 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For example, structural elements such as the addition of an ortho-methyl on the phenyl ring of phototoxic <b>13</b> resulted in an inhibitor with only a low risk of phototoxicity (<b>15</b>) along with an improvement in solubility and potency (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The likely explanation is that the ortho-substituent twists the acyl moiety out of plane and breaks the conjugation with the phenyl ring, an important factor in light absorption.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Final Optimization: Cyclopropane <b>20</b> Combines All the Beneficial Chemical Features That Translate into a Compound with the Required Profile in Terms of Solubility, Potency, Safety, and Stability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0015.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Solubility in mM.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Solubility in μM.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Potency in nM.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">In percent of recovered parent compound.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">S9 CL<sub>int</sub> in (μL/min)/mg of protein. For numbers in parentheses, CL<sub>int</sub> values measured in NHEK cells in (μL/min)/10<sup>6</sup> cells.</p></div></div><div></div></div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Chemical and Skin Metabolic<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Stability</h4><div class="NLM_p">The chemical stability of drug substances is paramount in topical delivery medicinal chemistry projects as APIs are not formulated in solid forms but rather dissolved in various excipients and need to have a shelf life stability of at least a year. From the start of the project, this parameter was judged to be at high risk due to the electrophilic nature of the aspartyl aldehyde warhead and was, therefore, constantly monitored.</div><div class="NLM_p">To this effect, stability of compounds with the aspartyl aldehyde warhead was evaluated in 96% ethanol at 23 °C for 12 weeks,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> but SPR information could be used after 4 weeks by projecting stability results to 12 weeks using the appropriate (best fit) kinetic order equations.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> It was found that a significant proportion of our inhibitors were not stable at 23 °C for more than 3 months. Consequently, significant efforts went into the synthesis of novel and hopefully more stable electrophilic warheads.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">These novel warheads should feature an electrophilic moiety susceptible to thiolate attack by caspase-1’s CYS285 as well as an acidic residue for the ionic interactions with caspase-1’s ARG179, GLN283, and ARG341. Herein lies the challenge: to be reactive, yet stable in solution despite the combination of an electrophile with an acid. Different acids, electrophiles, linker length, and masking groups were evaluated. The results, however, were quite disappointing as Free–Wilson analysis of the contributions of many warheads on chemical stability and potency showed that most were much weaker binders in the enzymatic assay (2 log units loss) and/or did not offer improvements in stability (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Most of the remaining warheads were shifted in the cellular assay to even lower potencies,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> leaving the homoaspartyl aldehyde warhead as the sole candidate for further exploration.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0008.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (a) Stability<sup>a</sup> vs potency<sup>b</sup> of various electrophilic warheads. <sup>a</sup>Numbers in boxes represent the Free–Wilson contribution on chemical stability in ethanol at 23 °C after 3 months as compared to the standard aspartyl aldehyde warhead <b>A</b>. For example, molecular matched pairs with warhead <b>J</b> give, on average, analogs with 33% less parent product after 3 months. Gray boxes: no stability measurements were made. <sup>b</sup>The <i>y</i>-coordinate of boxes represent the binned Free–Wilson contribution on enzymatic pIC<sub>50</sub> (at <i>K</i><sub>M</sub> concentration of substrate) as compared to the standard aspartyl aldehyde warhead <b>A</b>. For example, molecular matched pairs with warheads <b>F</b> through <b>H</b> give, on average, analogs that are 10- to 30-fold less potent compounds (−1 to −1.5 log unit). (b) Structures of warheads used in Free–Wilson plot. Aspartylaldehyde warhead <b>A</b> is the optimal warhead when taking into account both potency and chemical stability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Indeed, homoaspartyl aldehyde <b>18</b> showed a modest increase in 3-month stability vs the related aspartyl aldehyde <b>16</b> (84% vs 72%) with minimal drop in potency (IC<sub>50</sub> THP1 210 nM vs 76 nM); however skin metabolism was also almost 3-fold higher (13 vs 4.9 (μL/min)/mg protein in normal human epidermal keratinocytes). Furthermore, whereas the increase in the skin S9 fraction or NHEK clearance was observed across many molecular match pairs, the increase in chemical stability was not (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p">Surprisingly, we observed that pyridine <b>17</b> was much more chemically stable than the analogous phenyl <b>16</b> (100% vs 72%). The role of this pyridine in the compound’s stability was unclear as the only degradation products observed for this chemical series involved the warhead. However, the pyridine analogs also displayed increased skin clearance and lipophilicity<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> along with lower potency. This approach was therefore not pursued.</div><div class="NLM_p last">Fortunately, cyclopropane <b>19</b> displayed a good mix of solubility, potency, chemical, and skin metabolic stability,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> albeit with a low phototoxicity potential. As described previously, addition of the ortho-methyl to break π-conjugation gave <b>20</b>, a nonphototoxic compound that retained all the qualities of <b>19</b>. This compound was therefore selected for further evaluation.</div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Synthesis</h3><div class="NLM_p">The general strategy toward our novel P2/P3 peptidomimetic uracil fragment relied upon selective N-3-protection of 5-nitrouracil with the benzhydryl group followed by N-1 alkylation to prepare <b>23</b> in acceptable yield.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Subsequent deprotection of the benzhydryl group under hydrolytic conditions<a onclick="showRef(event, 'cit43b'); return false;" href="javascript:void(0);" class="ref cit43b">(43b)</a> gave access to <b>24</b> for exploration from the N-3 vector (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis Strategy Employed for Our Uracil-Based P2/P3 Peptidomimetic Fragments Building Blocks Exemplified by the Synthesis of <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Ph<sub>2</sub>CHBr, <i>N</i>,<i>O</i>-bis(trimethylsilyl)acetamide, cat. I<sub>2</sub>, acetonitrile, reflux, yield 85%; (b) K<sub>2</sub>CO<sub>3</sub>, acetonitrile, 23 °C, yield 64%; (c) TFA–TfOH (1:1), 23 °C, yield 98%.</p></p></figure><div class="NLM_p">For analogs bearing a quaternary C centers at N-1, we were obliged to develop a novel 3MCR (multicomponent reaction) to prepare the <i>gem</i>-dimethyl and cyclopropyl analogs (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Briefly, aminocarbonylation of the amino acid residues followed by protection of the carboxylic acid residue afforded primary urea precursors <b>26</b>. Condensation of <b>26</b> with ethyl nitroacetate in the presence of triethyl orthoformate afforded a 6:4 <i>E</i>/<i>Z</i> ratio of ene-urea intermediates <b>27</b>. Finally cyclization to the urea scaffolds was carried out in the presence of a 2-fold excess of cesium carbonate to afford <b>28</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of P2/P3 Uracil Peptidomimetic Fragments Building Blocks with Quaternary C Centers at N-1<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) KOCN, water, reflux, yield 78%; (b) allyl bromide, DIPEA, THF/H<sub>2</sub>O (10:1), 60 °C, 18 h, yield 80%; (c) ethyl nitroacetate, triethyl orthoformate, toluene, reflux, yield 92%; (d) Cs<sub>2</sub>CO<sub>3</sub>, MeCN, reflux, yield 81%.</p></p></figure><div class="NLM_p">Intermediates <b>24</b> and <b>28</b> were then converted to caspase-1 inhibitors following one of the three strategies enumerated below. The most common approach was to begin by alkylation at N-3 to afford intermediate <b>41</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>b). Then, installation of the P4 fragment was carried out by reduction of the nitro group under dissolving metal conditions<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and subsequent amide bond formation using COMU (1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylaminomorpholinocarbenium hexafluorophosphate)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> as the coupling agent and acid <b>40</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>a) as the coupling partner to give <b>43</b>. After saponification of ester <b>43</b> to acid <b>44</b>,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> final compound assembly was terminated by coupling the warhead <b>33</b> or <b>38</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>a)<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> after in situ deprotection of the Alloc group with the preactivated Pfp (pentafluorophenol) ester of <b>44</b> followed by hydrolysis of the acetal <b>45</b> or <b>46</b> to the hemiacetal <b>20</b> or <b>21</b>, respectively.</div><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. General Synthesis Strategy Employed for Our Uracil-Based Caspase-1 Inhibitors: (a) P1 and P4 Building Blocks and (b) Final Assembly<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaHCO<sub>3</sub>, allyl chloroformate, THF/H<sub>2</sub>O (1:3), 23 °C, yield 80%; (b) MeONHMe·HCl, NMM, EDCI, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, yield 86%; (c) LiAlH<sub>4</sub>, THF, −78 °C, yield 83%; (d) (EtO)<sub>3</sub>CH, 3 Å molecular sieves, <i>p</i>-TsOH, EtOH, 23 °C, yield 92%; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, yield 71%; (f) MeONHMe·HCl, NMM, EDCI, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, yield quantitative; (g) DBU, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, yield 68%; (h) NaHCO<sub>3</sub>, allyl chloroformate, THF/H<sub>2</sub>O (1:3), 23 °C, yield 88%; (i) LiAlH<sub>4</sub>, THF, −78 °C, yield 95%; (j) (EtO)<sub>3</sub>CH, 3 Å molecular sieves, <i>p</i>-TsOH, EtOH, 23 °C, yield 81%; (k) 2-aminonaphthalene, Pd(OAc)<sub>2</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, μwave 120 °C, yield 89%; (l) LiOH<sub>(aq)</sub>, MeOH, 50 °C, yield 92%; (m) 2-iodopropane, K<sub>2</sub>CO<sub>3</sub>, DMF, 23 °C, yield 46%; (n) Fe(s), NH<sub>4</sub>Cl, THF/EtOH/H<sub>2</sub>O (1:1:1), 70 °C, yield 98%; (o) <b>40</b>, COMU, NMM, DMF, 23 °C, yield 90%; (p) Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,3-dimethylbarbituric acid, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, yield 60%; (q) (i) HATU, CH<sub>2</sub>Cl<sub>2</sub>/DMF (1:1), 23 °C; (ii) <b>33</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,3-dimethylbarbituric acid, CH<sub>2</sub>Cl<sub>2</sub>/DMF (1.4:1), 23 °C, yield quantitative; (r) HCl<sub>(aq)</sub>, acetonitrile, 23 °C, yield 65%; (s) (i) HATU, CH<sub>2</sub>Cl<sub>2</sub>/DMF (0.7:1), 23 °C; (ii) <b>38</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,3-dimethylbarbituric acid, CH<sub>2</sub>Cl<sub>2</sub>/DMF (1.4:1), 23 °C, yield 95%; (t) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0–23 °C, yield 80%.</p></p></figure><div class="NLM_p">The second strategy was developed to permit N-3 alkylation at the end of the sequence in order to probe SAR at this position. Reduction of <b>47</b> (obtained using the methodology developed for <b>28</b>) by hydrogenation afforded amine <b>48</b> in poor yield (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Coupling of the P4 fragment using COMU followed by deprotection of the <i>tert</i>-butyl ester afforded <b>50</b>. The precyclized hemiacetal warhead <b>33</b> was next deprotected and coupled in situ using T3P as the coupling agent to afford <b>51</b>.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Finally, exploration at N-3 was best achieved through Mitsunobu alkylation chemistry, and hydrolysis of the acetal prodrug to the hemiacetal drug molecules was achieved using aqueous HCl to afford <b>20</b>.</div><figure id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Strategy Employed for N-3 Alkylation Exploration Based on a Late-Stage Mitsunobu Alkylation<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>, Pd–C, EtOAc, 23 °C, yield 32%; (b) <b>40</b>, COMU, NMM, DMF, 80 °C, yield 79%; (c) 4 M HCl in dioxane, 23 °C, yield 78%; (d) (i) DIPEA, T3P, DMF, 23 °C; (ii) <b>33</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,3-dimethylbarbituric acid, CH<sub>2</sub>Cl<sub>2</sub>/DMF (1:1), 23 °C, yield 73%; (e) <i>i</i>-PrOH, DIAD, PPh<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0–23 °C, yield 11%; (f) 1 M HCl (aq), MeCN, 23 °C, 65%.</p></p></figure><div class="NLM_p">Finally, we also developed an efficient library route to probe the P4 region (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Alkylation of <b>24</b> followed by saponification of ester <b>52</b> afforded the acid <b>53</b>. Unfortunately, <b>53</b> underwent partial epimerization during the saponification step, but we decided to continue with this route to build up our SAR knowledge of this key selectivity pocket. Coupling of <b>53</b> with the precyclized warhead <b>33</b> via the Pfp ester methodology followed by reduction afforded the key library synthon <b>55</b>. Final amide coupling through Schotten–Baumann conditions or using COMU followed by hydrolysis of the warhead acetal <b>56</b> afforded hemiacetal final compounds <b>57</b> in moderate to good yields.</div><figure id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Strategy Employed for the P4 Region Exploration Based on a Late-Stage Amide Coupling Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Me-I, K<sub>2</sub>CO<sub>3</sub>, DMF, 23 °C, yield 88%; (b) LiOH, THF/MeOH (10:1), 50 °C, yield 92% (<i>S</i>/<i>R</i>, 86:14); (c) (i) Pfp-OH, EDCI, CH<sub>2</sub>Cl<sub>2</sub>/DMF (4:1), 23 °C; (ii) <b>33</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,3-dimethylbarbituric acid, CH<sub>2</sub>Cl<sub>2</sub>/DMF (2:1), 23 °C, yield 60%; (d) H<sub>2</sub>, Pd–C, EtOAc, 23 °C, yield 80%; (e) RCOCl, DIEA, THF or RCOOH, HATU, NMM, THF, 23 °C or RCOOH, COMU, NMM, DMF, 80 °C, yield 34–95%; (f) AcOH/H<sub>2</sub>O (1:1), 40 °C or 1 M HCl<sub>(aq)</sub>, acetonitrile, 23 °C, yield >70%.</p></p></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Pharmacological Profiling</h3><div class="NLM_p">Our lead compound cyclopropyl analog <b>20</b> was evaluated in a caspase selectivity panel, and we were pleased by the results indicating complete (>1000-fold) selectivity vs the apoptotic caspases 3, 6, 7, and 8 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In addition, selectivity vs inflammatory caspase 5 was 300-fold.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Cellular Potency and Biochemical Selectivity vs Apoptotic and Inflammatory Caspases of Uracil <b>20</b> Shows the Compound Is Potent and Selective</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0016.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Biochemical IC<sub>50</sub> evaluated in nM at <i>K</i><sub>M</sub> concentration of substrate.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Cellular IC<sub>50</sub> evaluated in nM.</p></div></div><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Ex Vivo and in Vitro Pharmacokinetics</h3><div class="NLM_p">Next we wanted to evaluate the pharmacokinetic profile of <b>20</b>. Topical drugs should provide high tissue exposure in the target skin layer, the dermis in this case, with minimal plasma exposure to provide a high safety margin. A high skin flux is needed to achieve high exposure in the deeper skin layers such as the dermis (in our experience, at the very least 1 (μmol/cm<sup>2</sup>)/h, but 10–100 (μmol/cm<sup>2</sup>)/h is a safer range), but since this is vascularized, high hepatic clearance is also needed to keep plasmatic exposure low.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Skin exposure was measured at micromolar levels in dermis after a single topical application both in mice PK and in a cryogenically preserved human skin explant (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Furthermore, the maximum systemic exposure in mice following topical administration was only 1 nM and the intrinsic clearance in human hepatocytes is 9.8 (μL/min)/10<sup>6</sup> cells, thus minimizing risk of adverse effects.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Skin Penetration Profile of <b>20</b>: >3000-Fold Tissue Selectivity between Dermis and Plasma</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0017.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Flux in (μmol/cm<sup>2</sup>)/h calculated using Fick’s law and Potts and Guy <i>K</i><sub>p</sub>.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last"><i>C</i><sub>max</sub> in μM after topical (0.1 μmol/cm<sup>2</sup> applied using a 10 mM PG/EtOH 3/7 solution) mouse PK.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Concentration in μM after topical (0.2 μmol/cm<sup>2</sup> applied using a 40 mM PG/EtOH 3/7 solution) on a cryogenically preserved human skin explant.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Intrinsic clearance in (μL/min)/10<sup>6</sup> cells.</p></div></div><div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11284" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11284" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Acne is a skin disease affecting the quality of life of 650 million people globally.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Inhibition of cysteine-aspartic protease caspase-1 was identified as a potential new approach to treat inflammatory acne due to its role in the formation of IL-1β. Structure-based drug design was therefore used to identify several novel scaffolds with an electrophilic warhead. The uracil series was thus identified and optimized to deliver <b>20</b> as a potent, soluble, and stable inhibitor of caspase-1. Key structural improvements included (a) the addition of cyclopropyl substituent in P2, which boosted cellular potency, solubility, and chemical stability, and (b) the use of an <i>o</i>-tolyl derivative in P4 to break π-conjugation and eliminate the risk of phototoxicity. Further profiling of <b>20</b> revealed it was selective vs apoptotic caspases, was able to expose the mouse and human dermis at micromolar levels after topical administration, and yet did not give rise to a systemic exposure.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88010" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88010" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Caspase-1 Enzymatic Assay</h3><div class="NLM_p last">Human recombinant caspase-1, assay buffer (50 mM HEPES pH = 7.4, 100 mM NaCl, 0.1% CHAPS, 1 mM EDTA, 10% glycerol, 10 mM DTT) and profluorescent peptidic substrate (AC-WEHD-AMC) were purchased from Enzo Life Sciences. 4 μL of 200 μM or 10 μM final concentration of substrate (corresponding to its <i>K</i><sub>M</sub>) was dispensed in a 384-well microplate together with 4 μL of appropriate dilutions of the evaluated compounds (10 000–0.04 nM, 1% DMSO). 2 μL of enzyme was then added at a final concentration allowing for the conversion of less than 20% of substrate after 20 min at room temperature. Free AMC was measured by fluorescence detection (λ<sub>ex</sub> = 340 nm, λ<sub>em</sub> = 450 nm). Percent inhibition was calculated from the averaged values of the uninhibited and the uncatalyzed controls, and IC<sub>50</sub> values were determined by fitting the concentration–response data with a four-parameter logistic equation.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Caspase Panel Enzymatic Assays</h3><div class="NLM_p last">Human recombinant caspase proteins (i.e., caspase-3, caspase-5, caspase-6, caspase-7, and caspase-8), assay buffer (50 mM HEPES pH = 7.4, 100 mM NaCl, 0.1% CHAPS, 1 mM EDTA, 10% glycerol, 10 mM DTT), and profluorescent peptidic substrates (AC-WEHD-AMC for caspase-1/-5, Ac-DEVD-AMC for caspase-3/-7, Ac-VEID-AMC for caspase-6 and Ac-IETD-AMC for caspase-8) were purchased from Enzo Life Sciences. 4 μL of caspase-specific substrate (with a final concentration corresponding to its <i>K</i><sub>M</sub>) was dispensed in a 384-well microplate together with 4 μL of appropriate dilutions of the evaluated compounds (10 000–0.04 nM, 1% DMSO). 2 μL of enzyme was then added at a final concentration allowing for the conversion of less than 20% of substrate after 20 min (or 2 h depending on enzymatic activity) at room temperature. Free AMC was measured by fluorescence detection (λ<sub>ex</sub> = 340 nm, λ<sub>em</sub> = 450 nm). Percent inhibition was calculated from the averaged values of the uninhibited and the uncatalyzed controls, and IC<sub>50</sub> values were determined by fitting the concentration–response data with a four-parameter logistic equation.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Jump Dilution Method</h3><div class="NLM_p last">A simple test to discriminate between reversible and pseudoirreversible inhibition is provided by the jump dilution method previously described by Copeland.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The overall procedure and the reagents were the same as the one used for caspase-1 enzymatic assay. 12 μL of 100× concentrated enzyme solution were preincubated with 8 μL of the evaluated inhibitor at a concentration corresponding to its IC<sub>90</sub> (1% DMSO) for 1 h. 10 μL of the latter solution was then diluted with 990 μL of substrate (diluted to the concentration corresponding to the <i>K</i><sub>M</sub>) to start the enzymatic reaction. An amount of 10 μL of the reaction mixture was immediately dispensed in a 384-well microplate, and the free AMC production was continuously recorded for 2 h. The slope of the progress curve (i.e., a plot of activity as a function of time) was calculated and normalized to the DMSO control. For a rapidly reversible compound, the resulting progress curve is expected to be linear and to display a slope value that is approximately 90% that of the solvent control. For a pseudoirreversible inhibitor, the slope should be only approximately 10% that of the control.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> IL-1β Release on Monocytic Cell Line (THP1)</h3><div class="NLM_p">This assay is designed to measure the inhibition of the IL-1β secretion from PMA differenciated monocytic cells (THP1) after activation of the two signals leading to the formation of the inflammasome (LPS activation of the pro-IL-1β synthesis and ATP activation of the pro-caspase-1). IL-1β levels were measured using HTRF human IL-1β kit (Cisbio no. 62IL1PEC) which is a rapid and quantitative sandwich immunoassay based on TR-FRET technology.</div><div class="NLM_p">THP1 cells were seeded in 96-well plates (10 000 cells/well) in culture medium (RPMI 10% FBS 400 ng/mL PMA). After 24 h of incubation at 37 °C, serial dilutions of tested inhibitors (10 000–0.04 nM, 0.1% DMSO) and 1 μg/mL of LPS (lipopolysaccharides from <i>Escherichia coli</i>) and 5 mM ATP were added to the cells. After overnight incubation at 37 °C, an amount of 10 μL of cell supernatant was mixed with 5 μL of each tagged anti-IL-1β specific antibody as recommended by the supplier. After 2 h of incubation at room temperature, the HTRF signals were measured using a microplate reader (wavelengths: excitation = 337 nm, first emission = 620 nm, second emission = 665 nm).</div><div class="NLM_p last">The ratios of the measured signals (665/620) were normalized using the average of positive controls (ATP/LPS-activated with no inhibitor) and negative controls (not activated). IC<sub>50</sub> values were determined by fitting the concentration–response data with a four-parameter logistic equation.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> IL-1β Release on Human Monocyte-Derived Macrophages<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></h3><div class="NLM_p">Cryopreserved human peripheral blood monocytes (STEMCELL Technologies) were seeded in 48-well plates (300 000 cells/well) in culture medium (RPMI, 10% heat inactivated FBS) and 100 ng/mL recombinant human GM-CSF to induce M1 macrophages polarization.</div><div class="NLM_p last">After 10 days of culture at 37 °C, monocyte-derived macrophages were stimulated with LPS (10 μg/mL) and INFy (20 ng/mL) to activate the formation of the inflammasome and treated by serial dilutions of tested compounds (10000–0.04 nM, 0.1% DMSO). IL-1β levels were measured after 24 h using HTRF human IL-1β kit (Cisbio no. 62IL1PEC) which is a rapid and quantitative sandwich immunoassay based on TR-FRET technology.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Methods</h3><div class="NLM_p"><sup>1</sup>H NMR spectra were recorded on a BRUKER Biospin AVANCE 400 spectrometer unless otherwise stated. Chemical shifts are reported as δ values downfield from internal TMS in appropriate organic solutions. The abbreviations used for explaining the multiplicities were as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. High resolution mass (ESI HRMS) was recorded on a Thermofisher Q Exactive hybrid quadrupole-Orbitrap mass spectrometer.</div><div class="NLM_p">The relative purity ≥95% and the mass of the products were confirmed by LC/MS (220–420 nm) on a Waters acquity UPLC photodiode array detector system using the following conditions: column, BEH C18 50 mm × 2.1 mm; 1.8 μm; solvent A, water 0.1% formic acid or water ammonium carbonate 2 g/L; solvent B, CH3CN; flow rate, 0.8 mL/min; run time, 2.2 min; gradient, from 5 to 95% solvent B; mass detector, Waters SQ detector. All compounds were purified by LC/MS on a waters autopurification system using the following conditions: column, Xbridge C18 150 mm × 30 mm, 5 μm; solvent A, water 0.1% formic acid or water ammonium carbonate 2 g/L; solvent B, CH3CN; flow rate, 50 mL/min; run time, 10 or 15 min; with adapted isocratic elution mode; mass detector, Waters ZQ detector.</div><div class="NLM_p last">All experimental activities involving animals were carried out in accordance with Galderma/Nestlé Skin Health animal welfare protocols which are consistent with the American Chemical Society publications rules and ethical guidelines and were approved by the Galderma animal welfare ethics committee.</div></div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-(3-(1-(((3<i>S</i>)-2-Hydroxy-5-oxotetrahydrofuran-3-yl)amino)-1-oxopropan-2-yl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-naphthamide (<b>8</b>)</h3><div class="NLM_p last">To a stirred solution of <i>N</i>-(3-(1-(((3<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-yl)amino)-1-oxopropan-2-yl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-naphthamide (70.0 mg, 0.14 mmol, 1.00 equiv) obtained following the procedures described for <b>24</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and <b>20</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) in MeCN (2.00 mL) at rt was added HCl (aq) (1.0 M, 2.00 mL, 2.00 mmol, 14 equiv), and the reaction mixture is stirred for 4 h at rt. A saturated solution of NaHCO<sub>3</sub> was added adjusting the pH to 7. The product was extracted in AcOEt (3 × 30 mL). The organic phases were combined, dried over MgSO<sub>4</sub>, and concentrated to afford a beige solid. The solid was triturated with diethyl ether, recuperated by filtration, and dried to a constant weight under vacuum to afford <i>N</i>-(3-(1-(((3<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-yl)amino)-1-oxopropan-2-yl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-naphthamide (50 mg, 74%) as an off-white solid: LCMS <i>t</i><sub>R</sub> = 1.02 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 467 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.51 (d, <i>J</i> = 8.2 Hz, 1H), 8.58 (s, 1H), 8.39 (d, <i>J</i> = 6.7 Hz, 1H), 8.23 (s, 1H), 7.91–8.15 (m, 5H), 7.51–7.76 (m, 2H), 5.53 (s, 1H), 5.32 (q, <i>J</i> = 6.7 Hz, 1H), 4.17 (s, 1H), 3.40 (d, <i>J</i> = 1.7 Hz, 3H), 2.27–2.49 (m, 2H), 1.46 (dd, <i>J</i> = 6.9, 3.1 Hz, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.2, 165.55, 159.62, 149.67, 134.43, 132.13, 130.97, 129.08, 128.21, 128.06, 127.71, 126.96, 124.19, 112.11, 50.05, 46.21, 36.83, 13.86.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(3-(1-(((3<i>S</i>)-2-Hydroxy-5-oxotetrahydrofuran-3-yl)amino)-1-oxopropan-2-yl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4-((5-methylpyrazin-2-yl)amino)benzamide (<b>9</b>)</h3><div class="NLM_p last">To a stirred solution of <i>N</i>-{3-[(<i>S</i>)-1 ((<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-ylcarbamoyl)ethyl]-1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-4-(5-methylpyrazin-2-ylamino)benzamide (80.0 mg, 0.15 mmol, 1.00 equiv) obtained following the procedures described for <b>24</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and <b>20</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) in formic acid (1.60 mL, 42.4 mmol; 20.0 V) was added water (1.60 mL). The reaction mixture was stirred for 5 h at rt, concentrated to dryness, and the residue was suspended in EtOAc (20 mL), and the suspension was stirred at rt overnight. The precipitate was collected by filtration and dried to a constant weight at 40 °C in a vacuum oven to afford <i>N</i>-(3-(1-(((3<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-yl)amino)-1-oxopropan-2-yl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4-((5-methylpyrazin-2-yl)amino)benzamide (56.0 mg, 74%) as a pale orange solid: LCMS <i>t</i><sub>R</sub> = 0.80 min, purity = 85%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 524.16 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.72 (s, 1H), 9.06 (d, <i>J</i> = 7.5 Hz, 1H), 8.34 (d, <i>J</i> = 6.8 Hz, 1H), 8.23 (s, 1H), 8.11 (s, 1H), 7.89 (d, <i>J</i> = 8.5 Hz, 2H), 7.78 (d, <i>J</i> = 8.7 Hz, 2H), 5.30 (d, <i>J</i> = 7.1 Hz, 1H), 4.13 (s, 1H), 3.38 (s, 3H), 2.3- 2.7 (m, 2H), 2.39 (s, 3H), 1.43 (d, <i>J</i> = 6.9 Hz, 3H).</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(3-(1-(((3<i>S</i>)-2-Hydroxy-5-oxotetrahydrofuran-3-yl)amino)-1-oxopropan-2-yl)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4-(quinoxalin-2-ylamino)benzamide (<b>10</b>)</h3><div class="NLM_p last">To a stirred solution of formic acid (15.0 mL, 398 mmol) and water (15.0 mL) was added <i>N</i>-{3-[1-((<i>S</i>)-2-ethoxy-5-oxo-tetrahydrofuran-3-ylcarbamoyl)ethyl]-1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-4-(quinoxalin-2-ylamino)benzamide (750 mg, 1.28 mmol, 1.00 equiv) obtained following the procedures described for <b>24</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and <b>20</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The reaction mixture was stirred at room temperature overnight, concentrated to dryness and dissolved in EtOAc. The solution was triturated with heptane and the precipitate was collected by filtration and dried to a constant weight to afford <i>N</i>-{3-[(S)-1-((<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-ylcarbamoyl)ethyl]-1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-4-(quinoxalin-2-ylamino)benzamide (620 mg, 87%) as a pale yellow solid: LCMS <i>t</i><sub>R</sub> = 0.94 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 560.14 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.30 (s, 1H), 9.17 (d, <i>J</i> = 8.9 Hz, 1H), 8.63 (s, 1H), 8.36 (d, <i>J</i> = 7.4 Hz, 1H), 8.16–8.26 (m, 1H), 8.13 (d, <i>J</i> = 8.5 Hz, 2H), 7.99 (d, <i>J</i> = 8.6 Hz, 2H), 7.91 (d, <i>J</i> = 8.1 Hz, 1H), 7.82 (d, <i>J</i> = 8.3 Hz, 1H), 7.71 (t, <i>J</i> = 7.4 Hz, 1H), 7.54 (t, <i>J</i> = 7.5 Hz, 1H), 5.32 (m, 1H), 4.25 (m, 1H), 3.39 (d, <i>J</i> = 1.7 Hz, 3H), 2,3–2,6 (m, 2H), 1.45 (m, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.89, 159.68, 149.62, 149.36, 143.79, 140.64, 140.37, 137.21, 136.50, 136.24, 136.10, 130.30, 128.70, 128.59, 126.74, 126.47, 125.64, 117.81, 112.29, 109.92, 54.98, 48.67, 38.47, 36.81, 13.88; HRMS (ESI) calculated for C<sub>27</sub>H<sub>25</sub>N<sub>7</sub>O<sub>7</sub> [M + H]+ 560.18154, found 560.18829.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(3-(1-(((3<i>S</i>)-2-Hydroxy-5-oxotetrahydrofuran-3-yl)amino)-1-oxopropan-2-yl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4-(quinoxalin-2-ylamino)benzamide (<b>11</b>)</h3><div class="NLM_p last">To a stirred solution of <i>N</i>-{3-[(<i>S</i>)-1-((<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-ylcarbamoyl)ethyl]-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-4-(quinoxalin-2-ylamino)benzamide (155 mg, 0.25 mmol, 1.00 equiv) obtained following the procedures described for <b>24</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and <b>20</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) in formic acid (3.10 mL) at rt was added water (3.10 mL). The reaction mixture was stirred at rt for 5 h. The volatiles were removed under vacuum and the crude product was triturated in a mixture of AcOEt and heptane to afford a yellow solid. The solid was suspended in AcOEt and stirred overnight at rt, collected by filtration, washed with cold AcOEt, and dried to a constant weight in a vacuum oven at 40 °C to afford <i>N</i>-{3-[(<i>S</i>)-1-((<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-ylcarbamoyl)ethyl]-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-4-(quinoxalin-2-ylamino)benzamide (100 mg, 67%) as a pale yellow solid: LCMS <i>t</i><sub>R</sub> = 1.03 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 588.12 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.33 (s, 1H), 9.23 (d, <i>J</i> = 8.6 Hz, 1H), 8.64 (s, 1H), 8.38 (d, <i>J</i> = 9.3 Hz, 1H), 8.14 (d, <i>J</i> = 8.6 Hz, 2H), 8.00 (dd, <i>J</i> = 8.8, 1.6 Hz, 2H), 7.91 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 7.83 (dd, <i>J</i> = 8.3, 1.4 Hz, 1H), 7.71 (ddd, <i>J</i> = 8.4, 7.0, 1.5 Hz, 1H), 7.54 (ddd, <i>J</i> = 8.3, 6.9, 1.4 Hz, 1H), 5.33 (q, <i>J</i> = 6.8 Hz, 1H), 4.68–4.84 (m, 1H), 4.17 (s, 1H), 1.45 (d, <i>J</i> = 6.9 Hz, 3H), 1.27–1.39 (m, 6H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.89; 159.68, 149.62, 149.36, 143.79, 140.64, 140.37, 137.21, 136.50, 136.24, 136.10, 130.30, 128.70, 128.59, 126.74, 126.47, 125.64, 117.81, 112.29, 109.92, 54.98, 48.67, 38.47, 36.81, 13.88; HRMS (ESI) calculated for C<sub>27</sub>H<sub>25</sub>N<sub>5</sub>O<sub>7</sub> [M + H]<sup>+</sup> 560.1815, found 560.1882.</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(3-(2-(((3<i>S</i>)-2-Hydroxy-5-oxotetrahydrofuran-3-yl)amino)-2-oxoethyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4-(quinoxalin-2-ylamino)benzamide (<b>12</b>)</h3><div class="NLM_p last">To a stirred solution <i>N</i>-{3-[((<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-ylcarbamoyl)methyl]-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-4-(quinoxalin-2-ylamino)benzamide (58.0 mg, 0.10 mmol, 1.00 equiv) obtained following the procedures described for <b>24</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and <b>20</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) in MeCN (1.16 mL) at rt, was added 2 N HCl (aq) (0.48 mL, 0.96 mmol, 10.0 equiv), and the reaction mixture was stirred at rt for 7 h. The precipitate was collected by filtration, washed with diethyl ether, and dried to a constant weight in a vacuum oven at 45 °C to afford <i>N</i>-{3-[((<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-ylcarbamoyl)methyl]-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-4-(quinoxalin-2-ylamino)benzamide (50.0 mg, 87%) as an orange crystalline solid: LCMS <i>t</i><sub>R</sub> = 1.00 min, purity = 96.5%, MS ES+ <i>m</i>/<i>z</i> 574.22 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.34 (s, 1H), 9.30 (d, <i>J</i> = 7.5 Hz, 1H), 8.72 (d, <i>J</i> = 6.8 Hz, 1H), 8.64 (s, 1H), 8.31 (d, <i>J</i> = 2.6 Hz, 1H), 8.13 (d, <i>J</i> = 8.8 Hz, 2H), 8.00 (d, <i>J</i> = 8.8 Hz, 2H), 7.90 (dd, <i>J</i> = 8.2–1.2 Hz, 1H), 7.82 (dd, <i>J</i> = 8.3–1.0 Hz, 1H), 7.70 (td, <i>J</i> = 7.0, 1.4 Hz, 1H), 7.52 (td, <i>J</i> = 7.0, 1.4 Hz, 1H), 5.48 (s, 1H), 4.77 (q, <i>J</i> = 6.8 Hz, 1H), 4.49–4.61 (m, 3H), 2.98–3.05 (m, 1H), 2.45–2.48 (m, 1H), 2.32–2.37 (m, 1H), 1.33 (d, <i>J</i> = 6.8 Hz, 6H).</div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(3-(2-(((3<i>S</i>)-2-Hydroxy-5-oxotetrahydrofuran-3-yl)amino)-2-oxoethyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4-(naphthalen-2-ylamino)benzamide (<b>13</b>)</h3><div class="NLM_p last">A stirred solution <i>N</i>-(3-(2-(((3<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-yl)amino)-2-oxoethyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4-(naphthalen-2-ylamino)benzamide (0.024 mmol) which can be obtained following the procedures described for <b>24</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and <b>20</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) was dissolved in MeCN (1.65 mL), and HCl (aq) (2.0 M, 1.65 mL) was added, and the reaction mixture was stirred at rt for 2 h. The reaction mixture was poured into a mixture of ice and a saturated solution of NaHCO<sub>3</sub> (aq) and diluted with EtOAc (20 mL). The pH was decreased to 5 with AcOH and the product extracted with EtOAc (3 × 20 mL). The organic phases were combined, washed with water (2 × 10 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The residue was purified by mass-triggered Prep LCMS (formic acid buffer) to afford <i>N</i>-{3-[((<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-ylcarbamoyl)methyl]-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-4-(naphthalen-2-ylamino)benzamide/S-SCM-001646.001 (65.0 mg, 45%) as a beige solid: LCMS <i>t</i><sub>R</sub> = 1.22 min, purity = 97%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 572.08 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.13 (s, 1H), 8.91 (s, 1H), 8.30 (s, 1H), 8.00–7.72 (m, 6H), 7.64 (d, m, 1H), 7.44 (m, 1H), 7.39–7.29 (m, 2H), 7.30–7.16 (m, 2H), 4.77 (m, 1H), 4.52 (m, 2H), 4.08 (m, 1H), 3.81 (s, 0H), 2.71–2.55 (m, 1H), 2.45–2.24 (m, 1H), 1.33 (d, <i>J</i> = 6.8 Hz, 6H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.14, 159.37, 158.07, 152.00, 149.49, 147.01, 139.63, 134.19, 132.11, 129.31, 129.06, 128.96, 127.53, 126.64, 126.45, 125.70, 123.86, 123.72, 122.87, 120.82, 102.50, 97.23, 65.74, 48.43, 43.33, 33.21, 20.77; HRMS (ESI) calculated for C<sub>30</sub>H<sub>29</sub>N<sub>5</sub>O<sub>7</sub> [M + H]<sup>+</sup> 572.2067, found 572.2135.</div></div><div id="sec4_6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(3-(1-(((3<i>S</i>)-2-Hydroxy-5-oxotetrahydrofuran-3-yl)carbamoyl)cyclopropyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4-(quinoxalin-2-ylamino)benzamide (<b>14</b>)</h3><div class="NLM_p last">To a stirred solution of <i>N</i>-{3-[1-((<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-ylcarbamoyl)cyclopropyl]-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-4-(quinoxalin-2-ylamino)benzamide (191 mg, 0.22 mmol, 1.00 equiv) obtained following the procedures described for <b>28</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) and <b>57</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>) in MeCN (2.71 mL) at rt, was added HCl (aq) (2.00 M, 1.08 mL, 2.16 mmol, 10.0 equiv), and the reaction mixture was stirred at rt for 18 h. The volatiles were eliminated under a flow of nitrogen and the residue was treated with a saturated aqueous solution of NaHCO<sub>3</sub> (pH 8) and then diluted with EtOAc. The organic phase was discarded, and the pH of the aqueous phase was adjusted to 5 with AcOH. The product was extracted in EtOAc (3 × 20 mL), the organic phases were combined, washed with water (3 × 5 mL), dried over MgSO<sub>4</sub>, and concentrated. The product crystallized during evaporation and was recuperated by filtration, washed with cold EtOAc, and dried to a constant weight in a vacuum oven at 40 °C to afford <i>N</i>-(3-(1-(((3<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-yl)carbamoyl)cyclopropyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4-(quinoxalin-2-ylamino)benzamide (76 mg, 58%) as a pale yellow solid: LCMS <i>t</i><sub>R</sub> = 1.03 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 600.10 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.30 (s, 1H), 9.2 (s, 1H), 8.62 (s, 1H), 8.40 (s, 1H), 8.11–8.14 (d, <i>J</i> = 8.9 Hz, 2H), 7.99–8.01 (d, <i>J</i> = 8.8 Hz, 2H), 7.89–7.92 (dd, <i>J</i> = 8.2–1.2 Hz, 1H), 7.80–7.83 (dd, <i>J</i> = 8.3–1.0 Hz, 1H), 7.68–7.73 (td, <i>J</i> = 7.0–1.4 Hz, 2H), 7.51–7.55 (td, <i>J</i> = 7.0–1.4 Hz, 1H), 5.40 (m, 1H), 4.74–4.81 (m, 1H), 4.13 (m, 1H), 2.52–2.53 (m, 1H), 2.32–2.37 (m, 1H), 1.66–1.68 (s, 2H), 1.30–1.35 (m, 6H), 1.18 (s, 2H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.77, 160.33, 149.96, 149.34, 143.77, 140.61, 140.35, 137.20, 135.26, 132.83, 132.09, 130.28, 128.66, 128.57, 126.71, 126.52, 125.62, 117.80, 113.45, 99.57, 59.79, 48.03, 37.29, 32.70, 20.81, 14.14; HRMS (ESI) calculated for C<sub>30</sub>H<sub>29</sub>N<sub>7</sub>O<sub>7</sub> [M + H]<sup>+</sup> 600.2128, found 600.2195.</div></div><div id="sec4_6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(3-(2-(((3<i>S</i>)-2-Hydroxy-5-oxotetrahydrofuran-3-yl)amino)-2-oxoethyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-methyl-4-(naphthalen-2-ylamino)benzamide (<b>15</b>)</h3><div class="NLM_p last">To a stirred solution of <i>N</i>-{3-[((<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-ylcarbamoyl)methyl]-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-2-methyl-4-(naphthalen-2-ylamino)benzamide (280 mg, 0.46 mmol, 1.00 equiv) obtained following the procedures described for <b>24</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and <b>20</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) in MeCN (5.60 mL) at rt, was added 2 N HCl (aq) (2.28 mL, 4.56 mmol, 10.0 equiv), and the solution was stirred at rt for 4 h. The volatiles were eliminated through sparging with nitrogen, and the reaction mixture was suspended in a saturated solution of NaHCO<sub>3</sub>(aq) and extracted with EtOAc (5 mL). The organic layer was discarded, and the pH of the aqueous phase was lowered to 5–5.5 with 1 N AcOH (aq). The product was extracted with EtOAc (3 × 10 mL). The organic phases were combined, dried over MgSO<sub>4</sub>, and concentrated to dryness. The residue was recrystallized from a EtOAc heptane mixture to afford <i>N</i>-(3-(2-(((3<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-yl)amino)-2-oxoethyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-methyl-4-(naphthalen-2-ylamino)benzamide (180 mg, 67%) as an off-white solid: LCMS <i>t</i><sub>R</sub> = 1.16 min, purity = 97.0%, MS ES+ <i>m</i>/<i>z</i> 586.13 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.00 (s, 1H), 8.69 (s, 1H), 8.33 (s, 1H), 7.71–7.84 (m, 3H), 7.53–7.59 (m, 1H), 7.50 (d, <i>J</i> = 8.4 Hz, 1H), 7.42 (t, <i>J</i> = 7.6 Hz, 1H), 7.26–7.37 (m, 2H), 7.02–7.09 (m, 1H), 7.02 (s, 1H), 5.48 (s, 1H), 4.76 (q, <i>J</i> = 6.7 Hz, 1H), 4.50 (s, 2H), 4.12 (s, 1H), 2.98 (s, 1H), 2.43 (s, 3H), 2.37 (m, 1H), 1.32 (d, <i>J</i> = 6.9 Hz, 6H).</div></div><div id="sec4_6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(3-(1-(((3<i>S</i>)-2-Hydroxy-5-oxotetrahydrofuran-3-yl)amino)-1-oxobutan-2-yl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-methyl-4-(naphthalen-2-ylamino)benzamide (<b>16</b>)</h3><div class="NLM_p last">To a stirred solution of <i>N</i>-{3-[1-((<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-ylcarbamoyl)-propyl]-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-2-methyl-4-(naphthalen-2-ylamino)benzamide (210 mg, 0.33 mmol, 1.00 equiv) obtained following the procedures described for <b>24</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and <b>20</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) in MeCN (4.2 mL), was added HCl (aq) (2M, 1.64 mL, 3/27 mmol, 10.0 equiv), and the reaction mixture was stirred for 2 h. The volatiles were eliminated using nitrogen purging. The concentrate was treated with a saturated solution of NaHCO<sub>3</sub> (aq) and diluted with EtOAc (10 mL). The phases were separated, and the aqueous phase was retained, and the pH was lowered to 5 through the addition of AcOH. The product was extracted with EtOAc (3 × 50 mL). The organic phases were combined, washed with water (3 × 10 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness, triturated with a mixture of EtOAc/Et<sub>2</sub>O, and the solid was collected and dried to a constant weight to afford <i>N</i>-{3-[1-((<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-ylcarbamoyl)propyl]-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-2-methyl-4-(naphthalen-2-ylamino)benzamide (75.0 mg, 35%) as a beige solid: LCMS <i>t</i><sub>R</sub> = 1.23 min, purity = 93%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 614.16 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.92 (d, <i>J</i> = 7.1 Hz, 1H), 8.71 (s, 1H), 8.44 (d, <i>J</i> = 6.2 Hz, 1H), 8.10–8.30 (br s, 1H), 7.70–7.90 (m, 3H), 7.58 (s, 1H), 7.50 (d, <i>J</i> = 8.2 Hz, 1H), 7.43 (t, <i>J</i> = 7,12 Hz, 1H), 7.30–7.40 (m, 2H), 7.00–7.10 (m, 2H), 5.20 (m, 1H), 4.75 (m, 1H), 4.15 (m, 1H), 2.45 (s, 3H), 2.30–2.50 (m, 2H), 1.85–2.25 (br m, 2H), 1.25–1.40 (m, 6H), 0.78 (t, <i>J</i> = 6.6 Hz, 3H).</div></div><div id="sec4_6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-(3-(1-(((3<i>S</i>)-2-Hydroxy-5-oxotetrahydrofuran-3-yl)amino)-1-oxobutan-2-yl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3-methyl-5-(naphthalen-2-ylamino)picolinamide (<b>17</b>)</h3><div class="NLM_p last">To a stirred solution of <i>N</i>-(3-(1-(((3<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-yl)amino)-1-oxobutan-2-yl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3-methyl-5-(naphthalen-2-ylamino)picolinamide (120 mg, 0.19 mmol, 1.00 equiv) obtained following the procedures described for <b>24</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and <b>20</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) in MeCN (2.40 mL) at rt, was added 2 M HCl(aq) (934 μL, 1.87 mmol, 10.0 equiv), and the reaction mixture was stirred for 3 h at rt, neutralized with a saturated solution of NaHCO<sub>3</sub>(aq), and EtOAc (5 mL) was added. The phases were separated and the organic phase was discarded. The pH was lowered to 5 with 1 N AcOH (aq) and the product extracted with AcOEt (3 × 5 mL). The organic phases were combined, washed with water (5 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The residue was triturated in EtOAc and the solid was recuperated by filtration and dried to a constant weight in a vacuum oven at 40 °C to afford <i>N</i>-(3-(1-(((3<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-yl)amino)-1-oxobutan-2-yl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3-methyl-5-(naphthalen-2-ylamino)picolinamide (95.0 mg, 82%) as a yellow crystalline solid: LCMS <i>t</i><sub>R</sub> = 1.29 min, purity = 99%, MS ES+ <i>m</i>/<i>z</i> 615.19 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.19 (s, 1H), 9.18 (s, 1H), 8.70 (s, 1H), 8.37 (d, <i>J</i> = 2.6 Hz, 1H), 7.90 (d, <i>J</i> = 8.8 Hz, 1H), 7.85 (dd, <i>J</i> = 8.1, 3.9 Hz, 3H), 7.72 (d, <i>J</i> = 2.3 Hz, 2H), 7.44–7.51 (m, 2H), 7.29–7.43 (m, 2H), 5.50 (s, 1H), 5.22 (s, 1H), 4.77 (p, <i>J</i> = 6.7 Hz, 1H), 4.12 (s, 1H), 2.89 (m, 1H), 2.68 (s, 3H), 2.07–2.27 (m, 1H), 1.83 (s, 1H), 1.36 (d, <i>J</i> = 6.8 Hz, 3H), 1.31 (d, <i>J</i> = 6.8 Hz, 3H), 0.77 (td, <i>J</i> = 7.5, 2.5 Hz, 3H).</div></div><div id="sec4_6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-(3-(1-(((4<i>R</i>)-2-Hydroxy-6-oxotetrahydro-2<i>H</i>-pyran-4-yl)amino)-1-oxobutan-2-yl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-methyl-4-(naphthalen-2-ylamino)benzamide (<b>18</b>)</h3><div class="NLM_p last">To a stirred solution of (<i>R</i>)-5,5-diethoxy-3-(2-{3-isopropyl-5-[2-methyl-4-(naphthalen-2-ylamino)benzoylamino]-2,6-dioxo-3,6-dihydro-2<i>H</i>-pyrimidin-1-yl}butyrylamino)pentanoic acid <i>tert</i>-butyl ester (440 mg, 0.58 mmol, 1.00 equiv) obtained following the procedures described for <b>24</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and <b>21</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) in DCM (13.2 mL) was added dropwise TFA (13.2 mL, 0.17 mmol) at 0 °C. The reaction mixture was allowed to warm to room temperature and stirred for 3 h. LCMS confirmed the presence of the cyclized OEt warhead intermediate. The reaction mixture was carefully added to a mixture of ice and a saturated solution of NaHCO<sub>3</sub> (aq). The pH of the reaction mixture was lowered to 5 with AcOH and the product extracted with DCM (3 × 10 mL). The organic extracts were combined, washed with water (2 × 5 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The residue was purified by flash chromatography (silica gel, gradient of 2–10% MeOH in DCM) to afford <i>N</i>-(3-(1-(((4<i>R</i>)-2-hydroxy-6-oxotetrahydro-2<i>H</i>-pyran-4-yl)amino)-1-oxobutan-2-yl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-methyl-4-(naphthalen-2-ylamino)benzamide (300 mg, 81%) as a beige solid: LCMS <i>t</i><sub>R</sub> = 1.23 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 628.20 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.72 (m, 1H), 8.76 (d, <i>J</i> = 6.8 Hz, 1H), 8.09 (s, 1H), 7.81 (t, <i>J</i> = 7.8 Hz, 2H), 7.73 (d, <i>J</i> = 8.2 Hz, 1H), 7.56 (d, <i>J</i> = 2.2 Hz, 1H); 7.43–7.52 (m, 2H), 7.38 (t, <i>J</i> = 7.5 Hz, 1H), 7.31 (m, 2H), 6.96 (m, 2H), 6.75 (d, <i>J</i> = 8.8 Hz, 1H), 5.40 (m, 1H), 4.92 (m, 1H), 4.67 (m, 1H), 2.65–3.02 (m, 4H), 2.53 (s, 3H), 2.17 (m, 2H), 1.35–1.48 (m, 6H), 0.91 (t, <i>J</i> = 7.4 Hz, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.00, 167.93, 167.41, 161.93, 159.43, 145.40, 140.14, 138.40, 134.28, 133.56, 130.98, 129.60, 129.02, 128.73, 127.53, 126.43, 126.11, 123.49, 122.03, 120.62, 118.20, 113.40, 112.80, 111.54, 59.82, 56.29, 54.99, 48.67, 47.37, 20.95, 20.63, 14.16, 10.73; HRMS (ESI) calculated for C<sub>34</sub>H<sub>37</sub>N<sub>5</sub>O<sub>7</sub> [M + H]<sup>+</sup> 628.26930, found 628.27612.</div></div><div id="sec4_6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-(3-(1-(((3<i>S</i>)-2-Hydroxy-5-oxotetrahydrofuran-3-yl)carbamoyl)cyclopropyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-4-(naphthalen-2-ylamino)benzamide (<b>19</b>)</h3><div class="NLM_p last">To a stirred solution of <i>N</i>-{3-[1-((<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-ylcarbamoyl)cyclopropyl]-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-4-(naphthalen-2-ylamino)benzamide (170 mg, 0.20 mmol, 1.00 equiv) obtained following the procedures described for <b>28</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) and <b>57</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>) in MeCN (2.48 mL) at rt, was added HCl (aq) (2.00 M, 0.99 mL, 10.0 equiv), and the reaction mixture was agitated for 4 h at rt. The volatiles were eliminated under a flow of nitrogen, and the residue was treated with a saturated aqueous solution of NaHCO<sub>3</sub> (pH 8) and then diluted with EtOAc. The organic phase was discarded and the pH of the aqueous phase was adjusted to 5 with AcOH. The product was extracted in EtOAc (3 × 20 mL), the organic phases were combined, washed with water (3 × 5 mL), dried over MgSO<sub>4</sub>, and concentrated to afford a gum. The gum was crystallized from by dissolution in mixture of toluene and EtOAc at 60 °C, and the solution was allowed to cool slowly to rt and stirred overnight. The solid formed was recuperated by filtration washed with cold EtOAc and dried to a constant weight in a vacuum oven at 40 °C to afford <i>N</i>-{3-[1-((<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-ylcarbamoyl)cyclopropyl]-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-4-(naphthalen-2-ylamino)benzamide (60.0 mg, 50%) as an off-white solid: LCMS <i>t</i><sub>R</sub> = 1.16 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 598.12 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.02 (s, 1H), 8.92 (s, 1H), 8.39 (s, 1H), 7.85–7.87 (t, 2H), 7.77–7.82 (q, 2H), 7.63–7.64 (d, <i>J</i> = 2.0 Hz, 1H), 7.42–7.46 (td, <i>J</i> = 8.0–1.1 Hz, 1H), 7.32–7.38 (m, 2H), 7.22–7.27 (m, 2H), 7.13–7.19 (m, 2H), 5.4 (m, 1H), 4.74–4.76 (m, 1H), 4.10 (s, 1H), 2.30 (s, 2H), 1.65–1.67 (m, 2H), 1.29–1.34 (m, 6H), 1.16–1.19 (s, 2H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 186.48, 178.94, 164.68, 160.34, 147.08, 139.59, 137.99, 149.89, 134.17, 129.23, 129.07, 128.98, 128.95, 128.25, 127.53, 126.63, 126.46, 125.36, 123.79, 120.83, 123.74, 114.92, 113.66, 112.43, 65.94, 48.00, 47.03, 39.06, 38.01, 37.28, 21.09, 20.93; HRMS (ESI) calculated for C<sub>32</sub>H<sub>31</sub>N<sub>5</sub>O<sub>7</sub> [M + H]+ 598.2223, found 598.22986.</div></div><div id="sec4_6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-(3-(1-(((3<i>S</i>)-2-Hydroxy-5-oxotetrahydrofuran-3-yl)carbamoyl)cyclopropyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-methyl-4-(naphthalen-2-ylamino)benzamide (<b>20</b>)</h3><div class="NLM_p last">To a stirred solution of <b>45</b> (1.72 g, 2.69 mmol, 1.00 equiv) in MeCN (34.40 mL) was added HCl (aq) (2 M, 13.44 mL, 26.89 mmol, 10.00 equiv), and the reaction mixture was stirred at room temperature for 5 h. The volatiles were eliminated under a flow of nitrogen, and the residue was treated with a saturated aqueous solution of NaHCO<sub>3</sub> (pH 8) and then diluted with EtOAc. The organic phase was discarded, and the pH of the aqueous phase was adjusted to 5 with AcOH. The product was extracted in EtOAc (3 × 20 mL), and the organic phases were combined, dried over MgSO<sub>4</sub>, and concentrated to dryness. The resulting beige solid was crystallized from a mixture of EtOAc/toluene and the solid was recuperated by filtration and dried to a constant weight in a vacuum oven at 40 °C to afford <i>N</i>-(3-(1-(((3<i>S</i>)-2-hydroxy-5-oxotetrahydrofuran-3-yl)carbamoyl)cyclopropyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-methyl-4-(naphthalen-2-ylamino)benzamide (1.07 g, 65%) as an off-white solid: LCMS <i>t</i><sub>R</sub> = 1.19 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 612.21 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.34 (s, 1H), 9.29–9.31 (d, <i>J</i> = 7.5 Hz, 1H), 8.72–8.73 (d, <i>J</i> = 6.8 Hz, 1H), 8.64 (s, 1H), 8.31 (d, <i>J</i> = 2.6 Hz, 1H), 8.12–8.14 (d, <i>J</i> = 8.8 Hz, 2H), 7.99–8.01 (d, <i>J</i> = 8.8 Hz, 2H), 7.89–7.91 (dd, <i>J</i> = 8.2–1.2 Hz, 1H), 7.81–7.84 (dd, <i>J</i> = 8.3–1.0, 1H), 7.68–7.72 (td, <i>J</i> = 7.0–1.4 Hz, 1H), 7.51–7.55 (td, <i>J</i> = 7.0–1.4 Hz, 1H), 5.48 (s, 1H), 4.75–4.80 (q, <i>J</i> = 6.8 Hz, 1H), 4.49–4.61 (m, 3H), 2.98–3.05 (m, 1H), 2.45–2.48 (m, 1H), 2.32–2.37 (m, 1H), 1.32–1.34 (d, <i>J</i> = 6.8 Hz, 6H); <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.31, 160.22, 149.87, 145.41, 140.15, 138.33, 134.28, 129.53, 129.02, 128.75, 128.48, 127.53, 126.53, 126.44, 126.14, 123.50, 120.61, 118.24, 113.99, 112.86, 111.55, 48.09, 39.07, 37.32, 20.98, 20.84, 20.60, 19.38. HRMS (ESI) calculated for C<sub>33</sub>H<sub>34</sub>N<sub>5</sub>O<sub>7</sub> [M + H]<sup>+</sup> 612.2458, found 612.2452.</div></div><div id="sec4_6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(3-(1-(((4<i>R</i>)-2-Hydroxy-6-oxotetrahydro-2<i>H</i>-pyran-4-yl)carbamoyl)cyclopropyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-methyl-4-(naphthalen-2-ylamino)benzamide (<b>21</b>)</h3><div class="NLM_p last">To a stirred solution of <b>46</b> (200 mg, 0.26 mmol, 1.00 equiv) in DCM (6.00 mL) at 0 °C, was added TFA (6.00 mL, 78.4 mmol) dropwise over 2 min. The reaction mixture was stirred at rt for 2 h. The reaction mixture was carefully added to a mixture of ice and a saturated solution of NaHCO<sub>3</sub> (aq). The pH of the reaction mixture was brought up to 8 with 1 M NaOH (aq) and then lowered to 5 with AcOH and the product extracted with DCM (2 × 10 mL). The organic extracts were combined, washed with water (2 × 2 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The residue was purified by flash chromatography (silica gel, gradient of 2–10% MeOH in DCM) to afford a yellow solid. The solid was triturated with heptane and stirred overnight, recuperated by filtration, and dried to a constant weight to afford <i>N</i>-(3-(1-(((4<i>S</i>)-2-hydroxy-6-oxotetrahydro-2<i>H</i>-pyran-4-yl)carbamoyl)cyclopropyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-methyl-4-(naphthalen-2-ylamino)benzamide (134 mg, 80%) as an off-white solid: LCMS <i>t</i><sub>R</sub> = 1.22 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 626.25 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.52 (s, 1H), 8.84 (s, 1H), 8.72 (s, 1H), 8.41 (s, 1H), 7.99 (s, 1H), 7.71–7.88 (m, 3H), 7.58 (d, <i>J</i> = 2.4 Hz, 1H), 7.50 (d, <i>J</i> = 8.6 Hz, 1H), 7.43 (ddd, <i>J</i> = 8.2, 6.8, 1.3 Hz, 1H), 7.26–7.37 (m, 2H), 6.94–7.03 (m, 2H), 4.76 (s, 1H), 4.46 (s, 1H), 2.30–2.50 (m, 2H), 2.44 (s, 3H), 2.38 (d, <i>J</i> = 10.9 Hz, 2H), 1.61 (m, 2H), 1.28–1.38 (m, 6H), 1.11 (s, 2H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.04, 167.23, 160.07, 149.74, 148.66, 145.39, 140.14, 138.32, 135.06, 134.26, 129.48, 128.99, 128.72, 128.33, 127.51, 126.51, 126.40, 126.10, 123.46, 120.60, 118.24, 113.92, 112.85, 111.52, 48.08, 42.61, 37.37, 31.30, 28.41, 22.14, 20.59, 14.00; HRMS (ESI) calculated for C<sub>34</sub>H<sub>35</sub>N<sub>5</sub>O<sub>7</sub> [M + H]<sup>+</sup> 626.2536, found 626.2605.</div></div><div id="sec4_6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-Benzhydryl-5-nitropyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>22</b>)</h3><div class="NLM_p last"><i>N</i>,<i>O</i>-Bis(trimethylsilyl)acetamide (97.5 mL, 0.40 mol, 2.50 equiv) was added dropwise to a stirred suspension of 5-nitrouracil (25.0 g, 0.16 mol, 1.00 equiv) in acetonitrile (500 mL). The reaction mixture is stirred until a clear solution was obtained, and then bromodiphenylmethane (62.1 g, 0.24 mol, 1.50 equiv) and iodine (4.04 g, 0.02 mol, 0.10 equiv) were added. The reaction mixture was heated at reflux for 3 h 30 min, allowed to cool to room temperature, and the reaction mixture was stirred overnight. The product partially precipitated (20 g) and was collected by filtration and washed with cold MeCN (3 × 10 mL). The filtrate was concenterd to dryness, and the residue was dissolved in EtOAc (500 mL) and washed with water (3 × 50 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The residue was triturated in EtOAc and the resulting precipitate was collected by filtration combined with the previous precipitate and dried to constant weight in a vacuum oven to afford 1-benzhydryl-5-nitropyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (43.5 g, 84.5%) as a beige solid: LCMS <i>t</i><sub>R</sub> = 0.87 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 322.0 (M – H)<sup>−</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.12 (s, 1H), 8.32 (s, 1H), 7.51–7.29 (m, 7H), 7.29–7.14 (m, 4H), 6.88 (s, 1H).</div></div><div id="sec4_6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Ethyl (<i>S</i>)-2-(3-Benzhydryl-5-nitro-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)propanoate (<b>23</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>22</b> (14.8 g, 45.9 mmol, 1.00 equiv) and potassium carbonate (6.66 g, 48.2 mmol, 1.05 equiv) in MeCN (115 mL) at rt, was added (<i>R</i>)-2-trifluoromethanesulfonyloxypropionic acid ethyl ester (9.00 mL, 48.2 mmol, 1.05 equiv) over 10 min, and the reaction mixture was agitated at room temperature for a further 2 h. The reaction mixture was diluted with EtOAc (500 mL) and washed with water (3 × 50 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The residue was purified by chromatography (silica gel, gradient of 0–30% EtOAc in heptane) to afford (<i>S</i>)-2-(3-benzhydryl-5-nitro-2,6-dioxo-3,6-dihydro-2<i>H</i>-pyrimidin-1-yl)propionic acid ethyl ester (12.50 g, 64.31%): LCMS <i>t</i><sub>R</sub> = 1.14 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 424.0 (M + H)<sup>+</sup>, 446 (M + Na)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.49 (s, 1H), 7.56–7.24 (m, 11H), 7.00 (s, 1H), 5.43 (q, <i>J</i> = 6.9 Hz, 1H), 4.01–3.83 (m, 2H), 1.44 (d, <i>J</i> = 6.9 Hz, 3H), 0.92 (t, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.82, 153.41, 148.61, 145.80, 136.56, 136.18, 129.18, 129.12, 128.98, 128.94, 128.60, 128.40, 125.10, 65.59, 60.85, 50.01, 13.63, 13.50; HRMS (ESI) calculated for C<sub>22</sub>H<sub>21</sub>N<sub>3</sub>O<sub>6</sub> [M + H]<sup>+</sup> 424.14303; found, 424.1498, 446.1319 [M + Na]<sup>+</sup>.</div></div><div id="sec4_6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Ethyl (<i>S</i>)-2-(5-Nitro-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)propanoate (<b>24</b>)</h3><div class="NLM_p last"><b>23</b> (12.4 g, 29.3 mmol, 1.00 equiv) was dissolved in a mixture trifluoroacetic acid (124 mL) and methanesulfonic acid (124 mL) and stirred for 2 days at rt. The reaction mixture was added to a mixture of NaOH (1 N) and ice until pH of 6 was achieved. The reaction mixture was extracted with EtOAc (200 mL) and washed with water (3 × 20 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness to afford (<i>S</i>)-2-(5-nitro-2,6-dioxo-3,6-dihydro-2<i>H</i>-pyrimidin-1-yl)propionic acid ethyl ester (7.40 g, 98%) as a yellow residue: LCMS <i>t</i><sub>R</sub> = 0.82 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 256.1 (M – H)<sup>−</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.2–12.5 (br s, 1H), 8.97 (s, 1H), 5.38 (q, <i>J</i> = 6.9 Hz, 1H), 4.29–3.88 (m, 2H), 1.44 (d, <i>J</i> = 6.9 Hz, 3H), 1.14 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-Ureidocyclopropane-1-carboxylic Acid (<b>25</b>)</h3><div class="NLM_p last">To a stirred suspension of the 1-aminocyclopropanecarboxylic acid (120 g, 1.18 mol) (1 equiv) in water (500 mL) was added potassium isocyanate (150 g, 1.85 mol), and the reaction mixture was heated to reflux for 3 h, cooled to 0–5 °C, and the pH was adjusted to 2 with the addition of concentrated HCl [CARE: vigorous evolution of carbon dioxide]. The resulting white precipitate was collected by filtration, washed with ice cold water (250 mL), acetone (3 × 250 mL), and dried to a constant weight to afford the desired urea intermediate (134 g, 78%) as a white solid without the need for further purification: LCMS <i>t</i><sub>R</sub> = 0.22 min, MS ES<sup>+</sup><i>m</i>/<i>z</i> 144.94 (M + H)<sup>+</sup>, 166.99 (M + Na)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.61 (s, 1H), 5.55 (s, 2H), 1.26 (q, <i>J</i> = 4.2 Hz, 2H), 0.93 (q, <i>J</i> = 4.2 Hz, 2H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.80, 158.71, 51.96, 17.47.</div></div><div id="sec4_6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Allyl 1-Ureidocyclopropane-1-carboxylate (<b>26</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>25</b> (10 g, 69 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (14.3 mL, 83 mmol) in THF–H<sub>2</sub>O (10:1; 110 mL) was added allyl bromide (7.2 mL, 83 mmol). The reaction mixture was heated to 60 °C, stirred overnight, and concentrated to about 35 mL. A few drops of NH<sub>4</sub>Cl were added followed by water to dissolve solids. The aqueous phase is extracted with EtOAc (100 mL). The aqueous phase is further acidified to pH 2–3 with HCl 37% and again extracted with EtOAc (3 × 100 mL). The combined organic layers are dried (MgSO<sub>4</sub>) and concentrated to dryness to afford the title compound (10.2 g, 79.6% yield) as a white powder containing 6 wt % DIPEA salts: MS ES+ <i>m</i>/<i>z</i> 184.98 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.66 (s, 1H), 5.88 (ddt, <i>J</i> = 17.3, 10.3, 5.0 Hz, 1H), 5.58 (s, 2H), 5.39–5.11 (m, 2H), 4.53 (dt, <i>J</i> = 5.0, 1.7 Hz, 2H), 1.33 (q, <i>J</i> = 4.3 Hz, 2H), 1.02 (q, <i>J</i> = 4.4 Hz, 2H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.97, 158.73, 132.65, 117.10, 64.66, 33.49, 17.51; HRMS (ESI) calculated for C<sub>8</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 185.0848, found 185.0921.</div></div><div id="sec4_6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Allyl (<i>E</i>/<i>Z</i>)-1-(3-(3-Ethoxy-2-nitro-3-oxoprop-1-en-1-yl)ureido)cyclopropane-1-carboxylate (<b>27</b>)</h3><div class="NLM_p last">To a stirred solution of <b>26</b> (14.2 g, 0.07 mol) in toluene (140 mL) at rt, was added ethyl nitroacetate (11.8 mL, 0.11 mol) and triethyl orthoformate (17.7 mL, 0.11 mol). The resulting suspension was heated at 95 °C to reflux for 16 h. The solution was concentrated to dryness triturated with Et<sub>2</sub>O–heptane (1:1, 100 mL) and the resulting precipitate was collected by filtration, washed with Et<sub>2</sub>O, and dried to constant weight to afford allyl (<i>E</i>/<i>Z</i>) 1-(3-(3-ethoxy-2-nitro-3-oxoprop-1-en-1-yl)ureido)cyclopropane-1-carboxylate (22.3 g, 92%) as yellow solid in a <i>E</i>/<i>Z</i> ratio of ∼7/3: MS ES<sup>+</sup><i>m</i>/<i>z</i> 344.14 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.78 (d, <i>J</i> = 13.4 Hz, 0.7 H), 10.26 (d, <i>J</i> = 13.1 Hz, 0.3 H), 8.88 (d, <i>J</i> = 13.1 Hz, 0.3H), 8.80 (s, 0.3H), 8.64 (s, 0.7H), 8.51 (d, <i>J</i> = 13.4 Hz, 0.7 H), 4.33 (q, <i>J</i> = 7.1 Hz, 0.6H), 4.23 (q, <i>J</i> = 7.1 Hz, 1.4H), 1.38 (s, 9H), 1.33–1.18 (overlapping t, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.24, 159.93, 152.08, 141.43, 132.42, 119.58, 117.53, 65.24, 61.21, 33.60, 17.11, 14.07; HRMS (ESI) calculated for C<sub>13</sub>H<sub>17</sub>N<sub>3</sub>O<sub>7</sub> [M + H]<sup>+</sup> 328.1066, found 328.1137.</div></div><div id="sec4_6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Allyl 1-(5-Nitro-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylate (<b>28</b>)</h3><div class="NLM_p last">To a stirred solution of <b>27</b> (1.0 g, 3.06 mmol) in acetonitrile (10 mL) at rt was added Cs<sub>2</sub>CO<sub>3</sub> (2.19 g; 6.72 mmol) and the reaction mixture was heated at reflux for 1 h, cooled to rt, concentrated to dryness, and the residue was dissolved in water (10 mL). The aqueous solution was washed with TBME (10 mL), cooled and the pH reduced to 2 with concentrated HCl (aq) [CARE: vigorous evolution of CO<sub>2</sub>(g)], and the product was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 25 mL). The organic phase was dried (MgSO<sub>4</sub>) and concentrated to dryness to afford allyl 1-(5-nitro-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylate (0.70 g, 81%) without the need for further purification: MS ES<sup>+</sup><i>m</i>/<i>z</i> 282.02 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.65 (s, 1H), 8.97 (s, 1H), 5.85 (m, 1H), 5.28–5.13 (m, 2H), 4.58 (m, 2H), 1.83–1.72 (m, 2H), 1.41 (m, 2H).</div></div><div id="sec4_6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>S</i>)-2-(((Allyloxy)carbonyl)amino)-4-(<i>tert</i>-butoxy)-4-oxobutanoic Acid (<b>29</b>)</h3><div class="NLM_p last">To a cooled (4 °C) solution of <span class="smallcaps smallerCapital">l</span>-aspartic acid 4-<i>tert</i>-butyl ester (25.0 g, 132.1 mmol) in THF/H<sub>2</sub>O (80 mL/240 mL) were added sodium bicarbonate (44.4 g, 528.5 mmol) and allyl chloroformate (25.28 mL, 237.8 mmol). After 2 h 30 min of stirring at room temperature, the medium was extracted with EtOAc (three times). The aqueous layer was acidified with aqueous HCl (6 N) until obtaining pH 2. The aqueous layer was extracted (EtOAc, three times). The combined organic layer was dried over sodium sulfate, filtered, and concentrated in vacuo to afford the title compound (29.2 g, 80%, as pale yellow oil): MS <i>m</i>/<i>z</i> (ES<sup>–</sup>) 272.4; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.87–5.96 (m, 1H). 5.74 (bd, <i>J</i> = 8.5 Hz, 1H), 5.31 (m, 1H), 5.22 (m, 1H), 4.55–4.65 (m, 3H), 2.97 (dd, <i>J</i> = 17.0 and 4.0 Hz, 1H), 2.76 (dd, <i>J</i> = 17.0 and 5.0 Hz, 1H), 1.44 (s, 9H).</div></div><div id="sec4_6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>tert</i>-Butyl (<i>S</i>)-3-(((Allyloxy)carbonyl)amino)-4-(methoxy(methyl)amino)-4-oxobutanoate (<b>30</b>)</h3><div class="NLM_p last">To a cooled (4 °C) solution of <b>29</b> (29.1 g, 106.4 mmol) in DCM (600 mL) were added <i>N</i>,<i>O</i>-dimethylhydroxylamine hydrochloride (12.4 g, 127.8 mmol), 4-methylmorpholine (14.05 mL, 127.8 mmol), and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (24.5 g, 127.8 mmol). After 3 h of stirring at room temperature, the medium was washed with aqueous HCl (0.2 N), with water, with brine, dried over sodium sulfate, filtered, and concentrated in vacuo to afford the title compound (29.2 g, 86%, as yellow oil): MS, <i>m</i>/<i>z</i> (ES+) 317.3; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.85–5.93 (m, 1H). 5.59 (bd, <i>J</i> = 8.5 Hz, 1H), 5.30 (m, 1H), 5.19 (m, 1H), 5.00 (m, 1H), 4.56 (m, 2H), 3.78 (s, 3H), 3.21 (s, 3H), 2.70 (dd, <i>J</i> = 15.0 and 5.5 Hz, 1H), 2.54 (dd, <i>J</i> = 15.0 and 6.5 Hz, 1H), 1.43 (s, 9H).</div></div><div id="sec4_6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>tert</i>-Butyl (<i>S</i>)-3-(((Allyloxy)carbonyl)amino)-4-oxobutanoate (<b>31</b>)</h3><div class="NLM_p last">A solution of lithium aluminum hydride (2 N in THF, 5.93 mL, 11.8 mmol) was added dropwise to a cooled (−78 °C) solution of <b>30</b> (5.0 g, 15.8 mmol) in anhydrous THF (65 mL). The mixture was stirred at −78 °C for 2 h, then aqueous HCl (1 N) was slowly added to the medium and the temperature was allowed to warm to 0 °C. The mixture was diluted with EtOAc. The aqueous layer was extracted (EtOAc, two times). The combined organic layer was washed with aqueous HCl (0.5 N), with brine, dried over sodium sulfate, filtered, and concentrated in vacuo to afford the title compound (3.4 g, 83%, as pale pink oil): <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.66 (s, 1H), 5.83 (br d, 1H), 5.82–5.99 (m, 1H), 5.33 (m, 1H), 5.24 (m, 1H), 4.61 (m, 2H), 4.36 (m, 1H), 2.96 (dd, <i>J</i> = 17.2 and 4.5 Hz, 1H), 2.76 (dd, <i>J</i> = 17.2 and 5.1 Hz, 1H), 1.43 (s, 9H).</div></div><div id="sec4_6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>tert</i>-Butyl (<i>S</i>)-3-(((Allyloxy)carbonyl)amino)-4,4-diethoxybutanoate (<b>32</b>)</h3><div class="NLM_p last">To a freshly prepared solution of <b>31</b> (3.40 g, 13.23 mmol) in absolute ethanol (11 mL) were added, under argon atmosphere, triethyl orthoformate (5.62 mL, 33.09 mmol), <i>p</i>-toluenesulfonic acid (45 mg, 0.26 mmol), and 3 Å molecular sieves. After stirring at room temperature overnight, the mixture was filtered over a pad of Celite and rinsed with EtOH. The filtrate was concentrated under reduced pressure and coevaporated with toluene (three times). Purification of the residue by flash chromatography on silica gel (cHx–EtOAc 9/1 to 8/2) afforded the title compound (4.05 g, 92%, colorless oil): <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.83–6.00 (m, 1H), 5.30 (d, <i>J</i> = 17.4 Hz, 1H), 5.23 (bd, <i>J</i> = 8.5 Hz, 1H), 5.21 (m, 1H), 4.56 (m, 2H), 4.49 (m, 1H), 4.11–4.22 (m, 1H), 3.65–3.78 (m, 2H), 3.48–3.61 (m, 2H), 2.56 (dd, <i>J</i> = 15.6 and 5.7 Hz, 1H), 2.45 (dd, <i>J</i> = 15.6 and 7.2 Hz, 1H), 1.44 (s, 9H), 1.21 (m, 6H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.12, 155.44, 133.78, 116.66, 102.57, 79.66, 64.16, 63.39, 62.22, 50.44, 36.09, 27.69, 15.15; [α]<sub>D</sub><sup>20</sup> = −18.3° (<i>c</i> = 16 g/L, MeCN); HRMS (ESI) calculated for C<sub>16</sub>H<sub>29</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 331.1995, found 354.1886 [M + Na]<sup>+</sup>.</div></div><div id="sec4_6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Allyl ((3<i>S</i>)-2-Ethoxy-5-oxotetrahydrofuran-3-yl)carbamate (<b>33</b>)</h3><div class="NLM_p last">To a cooled (4 °C) solution of <b>32</b> (5.0 g, 15.1 mmol) in DCM (20 mL) was added trifluoroacetic acid (11.6 mL, 151 mmol). After 30 min of stirring at room temperature, the mixture was concentrated under vacuum, then coevaporated with EtOAc. Purification of the residue by flash chromatography on silica gel (cHx–EtOAc 95/5 to 6/4) afforded the title compound (2.45 g, 71%, as pink oil, two diastereoisomers, 1/1.2), <i>m</i>/<i>z</i> (ES+), 229.9; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.85–5.97 (m, 1H) 5.44 (d, <i>J</i> = 5.0 Hz, 0.5 H), 5.40 (bs, 0.5 H), 5.22–5.36 (m, 2.5H), 5.00 (br s, 0.5 H), 4.57–4.62 (m, 2H), 4.52–4.57 (br s, 0.5H), 4.20 (br t, <i>J</i> = 6.5 Hz, 0.5H), 3.83–3.95 (m, 1H), 3.62–3.69 (m, 1H), 3.01 (dd, <i>J</i> = 18.0 and 7.5 Hz, 0.5H), 2.84 (dd, <i>J</i> = 17.0 and 8.5 Hz, 0.5H), 2.46 (dd, <i>J</i> = 17.0 and 10.5 Hz, 0.5H), 2.39 (dd, <i>J</i> = 18.0 and 1.4 Hz, 0.5H), 1.26 (t, <i>J</i> = 7.0 Hz, 1.5H), 1.24 (t, <i>J</i> = 7.0 Hz, 1.5H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 174.71,173.78, 155.73, 155.56, 133.58, 117.00, 107.23, 102.14, 65.16, 64.60, 52.85, 49.47, 32.89, 31.30, 14.90; HRMS (ESI) calculated for C<sub>10</sub>H<sub>15</sub>NO<sub>5</sub> [M + H]<sup>+</sup> 229.0950, found 230.1023.</div></div><div id="sec4_6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>tert</i>-Butyl (<i>R</i>)-3-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(methoxy(methyl)amino)-5-oxopentanoate (<b>34</b>)</h3><div class="NLM_p last">To a cooled solution of Fmoc-β-homoaspartic acid (O<sup><i>t</i></sup>Bu) (20.0 g, 47.0 mmol) in DCM (268 mL) were added <i>N</i>,<i>O</i>-dimethylhydroxylamine hydrochloride (5.50 g, 56.4 mmol), 4-methylmorpholine (6.2 mL, 56.4 mmol), and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (10.8 g, 56.4 mmol). After 2 h of stirring at room temperature, the medium was washed with aqueous HCl (1 N, two times), with brine, dried over sodium sulfate, filtered, and concentrated in vacuo. Purification of the residue by chromatography on silica gel (cHx–EtOAc 8/2 to 6/4) afforded the title compound (22.6 g, quantitative): <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.75 (d, <i>J</i> = 7.5 Hz, 2H), 7.57–7.60 (m, 2H), 7.39 (t, <i>J</i> = 7.5 Hz, 2H), 7.30 (td, <i>J</i> = 7.5 and 1.0 Hz, 2H), 5.95 (d, <i>J</i> = 7.8 Hz, 1H), 4.35–4.40 (m, 3H), 4.21 (m, 1H), 3.70 (s, 3H), 3.21 (s, 3H), 2.94–2.97 (m, 1H), 2.68–2.73 (m, 2H), 2.61 (dd, <i>J</i> = 15.7 and 7.0 Hz, 1H), 1.44 (s, 9H).</div></div><div id="sec4_6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>tert</i>-Butyl (<i>R</i>)-3-Amino-5-(methoxy(methyl)amino)-5-oxopentanoate (<b>35</b>)</h3><div class="NLM_p last">To a cooled (0 °C) solution of <b>34</b> (22.6 g, 48.2 mmmol) in DCM (377 mL) was added dropwise DBU (7.92 mL, 5.0 mmol). After 1 h 30 min of stirring at room temperature, the medium was concentrated under vacuum. Purification of the residue by chromatography on silica gel (DCM–MeOH/NH<sub>3</sub> (7 N), 97/3 to 95/5) afforded the title compound (8.11g, 68%) as a yellow oil): <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 3.63–3.70 (m, 1H), 3.68 (s, 3H), 3.17 (s, 3H), 2.60–2.64 (m, 1H), 2.52–2.57 (m, 1H), 2.45 (dd, <i>J</i> = 15.8 and 5.0 Hz, 1H), 2.39 (dd, <i>J</i> = 15.8 and 8.0 Hz, 1H), 1.45 (s, 9H).</div></div><div id="sec4_6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>tert</i>-Butyl (<i>R</i>)-3-(((Allyloxy)carbonyl)amino)-5-(methoxy(methyl)amino)-5-oxopentanoate (<b>36</b>)</h3><div class="NLM_p last">To a cooled (4 °C) solution of <b>35</b> (8.11 g, 32.9 mmol) in THF/H<sub>2</sub>O (20 mL/60 mL) were added sodium bicarbonate (41.1 g, 131.6 mmol) and allyl chloroformate (6.30 mL, 59.2 mmol). After 1 h 30 min of stirring at room temperature, the medium was extracted with EtOAc (three times). The combined organic layer was dried over sodium sulfate, filtered, and concentrated in vacuo. Purification of the residue by chromatography on silica gel (cHx–EtOAc 8/2 to 6/4) afforded the title compound (9.58 g, 88%, as colorless oil): <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.83–5.93 (m, 2H), 5.29 (d, <i>J</i> = 17.3 Hz, 1H), 5.18 (m, 1H), 4.54 (m, 2H), 4.32–4.36 (m, 1H), 3.67 (s, 3H), 3.17 (s, 3H), 2.86–2.91 (m, 1H), 2.65–2.72 (m, 2H), 2.59 (dd, <i>J</i> = 15.8 and 6.9 Hz, 1H), 1.44 (s, 9H).</div></div><div id="sec4_6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>tert</i>-Butyl (<i>R</i>)-3-(((Allyloxy)carbonyl)amino)-5-oxopentanoate (<b>37</b>)</h3><div class="NLM_p last">A solution of lithium aluminum hydride (2 N in THF, 5.90 mL, 11.8 mmol) was added dropwise to a cooled (−78 °C) solution of <b>36</b> (6.0 g, 18.1 mmol) in anhydrous THF (80 mL). The mixture was stirred at −78 °C for 2 h 30 min, then aqueous HCl (1 N) was slowly added to the medium, and the temperature was allowed to warm to 0 °C. The mixture was diluted with EtOAc. The aqueous layer was extracted (EtOAc, two times). The combined organic layer was washed with aqueous HCl (1 N), with brine, dried over sodium sulfate, filtered, and concentrated in vacuo to afford the title compound (4.7 g, 95%, as pale yellow oil): <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.75 (t, <i>J</i> = 1.4 Hz, 1H), 5.86–5.94 (m, 1H), 5.48 (br s, 1H), 5.29 (m, 1H), 5.20 (m, 1H), 4.54 (d, <i>J</i> = 4.9 Hz, 2H), 4.37–4.40 (m, 1H), 2.83 (dd, <i>J</i> = 17.5 and 5.5 Hz, 1H), 2.74 (ddd, <i>J</i> = 17.5 Hz, 6.0 and 1.4 Hz, 1H), 2.58 (d, <i>J</i> = 5.8 Hz, 2H), 1.44 (s, 9H).</div></div><div id="sec4_6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>tert</i>-Butyl (<i>R</i>)-3-(((Allyloxy)carbonyl)amino)-5,5-diethoxypentanoate (<b>38</b>)</h3><div class="NLM_p last">To a freshly prepared solution of <b>37</b> (4.7 g, 17.3 mmol) in absolute ethanol (20 mL) were added, under argon atmosphere, triethyl orthoformate (11.53 mL, 69.3 mmol), <i>p</i>-toluenesulfonic acid (90 mg, 0.52 mmol), and 3 Å molecular sieves. After stirring at room temperature overnight, the mixture was filtered over a pad of Celite and rinsed with EtOH. The filtrate was concentrated under reduced pressure and coevaporated with toluene (three times). Purification of the residue by flash chromatography on silica gel (cHx–EtOAc 9/1 to 8/2) afforded the title compound (4.85 g, 81%, as pale yellow oil): <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.13 (d, <i>J</i> = 8.8 Hz, 1H), 5.85–5.92 (m, 1H), 5.24–5.27 (m, 1H), 5.14–5.17 (m, 1H), 4.44–4.47 (m, 3H), 3.84–3.90 (m, 1H), 3.50–3.59 (m, 2H), 3.37–3.43 (m, 2H), 2.28–2.36 (m, 2H), 1.65 (m, 2H), 1.37 (s, 9H), 1.09 (m, 6H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.97, 155.13, 133.83, 116.63, 100.06, 79.73, 64.09, 61.11, 60.48, 45.22, 41.12, 38.26, 27.67, 15.29; [α]<sub>D</sub><sup>20</sup> +13.4° (<i>c</i> 10 g/L, EtOH); HRMS (ESI) calculated for C<sub>17</sub>H<sub>31</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 345.2151, found 368.2083 [M + Na]<sup>+</sup>.</div></div><div id="sec4_6_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Methyl 2-Methyl-4-(naphthalen-2-ylamino)benzoate (<b>39</b>)</h3><div class="NLM_p last">A stirred solution of 2-aminonaphthalene (2.38 g, 16.63 mmol, 1.00 equiv), 4-bromo-2-methylbenzoic acid methyl ester (4.00 g, 17.5 mmol, 1.05 equiv), palladium(II) acetate (373 mg; 1.66 mmol, 0.10 equiv), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (1.92 g, 3.33 mmol, 0.20 equiv), and cesium carbonate (7.04 g, 21.6 mmol, 1.30 equiv) in 1,4-dioxanne (38.10 mL) was degassed and purged with nitrogen then heated at 120 °C under microwave irradiation for 30 min. The reaction was concentrated to dryness and partitioned between DCM (50 mL) and water (5 mL). The organic phase was retained, and the aqueous phase was washed with DCM (3 × 5 mL). The organic phases were combined, washed with water (10 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness to afford a pale yellow residue. The residue was triturated with a mixture of DCM and heptane to afford a solid that was collected by filtration and dried to a constant weight to afford 2-methyl-4-(naphthalen-2-ylamino)benzoic acid methyl ester (4.30 g, 89%) as a pale brown solid: LCMS <i>t</i><sub>R</sub> = 1.35 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 292.01 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.89 (s, 1H), 7.93–7.75 (m, 5H), 7.63 (d, <i>J</i> = 2.2 Hz, 1H), 7.44 (ddd, <i>J</i> = 8.2, 6.8, 1.3 Hz, 1H), 7.40–7.29 (m, 2H), 7.05 (dd, <i>J</i> = 8.6, 2.4 Hz, 1H), 7.00 (d, <i>J</i> = 2.3 Hz, 1H), 3.78 (s, 3H), 2.50 (s, 3H expected under DMSO signal).</div></div><div id="sec4_6_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-Methyl-4-(naphthalen-2-ylamino)benzoic Acid (<b>40</b>)</h3><div class="NLM_p last">To a stirred solution of <b>39</b> (4.00 g, 13.7 mmol, 1.00 equiv) in a mixture of THF (80.0 mL) and MeOH (20.0 mL), was added lithium hydroxide (1.0 M, 41.2 mL, 41.2 mmol, 3.00 equiv). The reaction mixture was stirred at 50 °C overnight, concentrated to a minimum volume, and the residue was partitioned between DCM (30 mL) and water (5 mL). The pH of the aqueous phase was adjusted to 1 by the addition of HCl (aq) (1.0 M) resulting in a thick precipitate that was collected by filtration and dried to a constant weight to afford 2-methyl-4-(naphthalen-2-ylamino)benzoic acid (3.50 g, 92%) as a beige solid: LCMS <i>t</i><sub>R</sub> = 1.20 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 278.02 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.19 (br s, 1H), 8.82 (s, 1H), 7.98–7.72 (m, 4H), 7.61 (d, <i>J</i> = 2.3 Hz, 1H), 7.50–7.25 (m, 3H), 7.10–6.90 (m, 2H), 2.51 (s, 3H hidden by DMSO signal); <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.07, 146.95, 141.82, 139.60, 134.19, 132.88, 129.01, 127.51, 128.96, 126.66, 126.43, 123.72, 120.93, 120.18, 117.95, 112.68, 112.31, 40.07, 22.25; HRMS (ESI) calculated for C<sub>18</sub>H<sub>15</sub>NO<sub>2</sub> [M + H]<sup>+</sup> 278.1102, found 278.1172.</div></div><div id="sec4_6_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Allyl 1-(3-Isopropyl-5-nitro-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylate (<b>41</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>28</b> (4.58 g, 16.3 mmol, 1.00 equiv) and K<sub>2</sub>CO<sub>3</sub> (3.38 g, 0.02 mol, 1.50 equiv) in DMF (91.6 mL) at rt, was added 2-iodopropane (8.15 mL; 81.5 mmol; 5.00 equiv). The reaction mixture was slowly added to water and the product was extracted in EtOAc (3 × 100 mL). The organic phases were combined, washed with water (3 × 50 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The residue was purified by flash chromatography (silica gel, gradient 0–20% EtOAc in heptane) to afford 1-(3-isopropyl-5-nitro-2,6-dioxo-3,6-dihydro-2<i>H</i>-pyrimidin-1-yl)cyclopropanecarboxylic acid allyl ester (2.41 g, 46%) as a white solid: LCMS <i>t</i><sub>R</sub> = 1.03 min, purity = 100%, ES<sup>+</sup><i>m</i>/<i>z</i> 324.06 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.13 (s, 1H), 5.97–5.69 (m, 1H), 5.31–5.05 (m, 2H), 4.79–4.68 (m, 1H), 4.58 (ddt, <i>J</i> = 8.5, 4.9, 1.7 Hz, 2H), 1.91–1.59 (m, 2H), 1.50–1.10 (m, 8H); <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.51, 165.59, 149.39, 141.42, 132.32, 124.69, 116.63, 64.86, 47.04, 39.05, 35.46, 20.92, 20.48, 19.53, 19.33.</div></div><div id="sec4_6_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Allyl 1-(5-Amino-3-isopropyl-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylate (<b>42</b>)</h3><div class="NLM_p last">A stirred suspension of <b>41</b> (2.41 g, 7.45 mmol, 1.00 equiv), ammonium chloride (0.20 g, 3.73 mmol, 0.50 equiv), iron (1.67 g, 29.8 mmol, 4.00 equiv) in a mixture of EtOH (14.5 mL), THF (14.5 mL), and water (14.5 mL) was heated at 70 °C for 1 h. The reaction mixture was cooled to rt, filtered through a pad of Celite, and the pad of Celite was washed with EtOH (5 × 5 mL). The filtrate was concentrated to dryness to afford 1-(5-amino-3-isopropyl-2,6-dioxo-3,6-dihydro-2<i>H</i>-pyrimidin-1-yl)-cyclopropanecarboxylic acid allyl ester (2.31 g, 98%) as an orange gum: LCMS <i>t</i><sub>R</sub> = 0.85 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 294.11 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.97 (s, 1H), 5.83 (ddt, <i>J</i> = 17.3, 10.7, 4.7 Hz, 1H), 5.28–5.03 (m, 2H), 4.69 (hept, <i>J</i> = 6.8 Hz, 1H), 4.63–4.44 (m, 2H), 4.28–3.89 (br s, 2H), 1.71 (m, 2H), 1.26–1.08 (m, 8H); <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.51, 160.39, 149.39, 132.32, 122.42, 116.63, 115.19, 64.86, 47.04, 39.05, 35.46, 20.92, 20.48, 19.53, 19.33; HRMS (ESI) calculated for C<sub>14</sub>H<sub>19</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup> 293.1375, found 294.1448.</div></div><div id="sec4_6_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Allyl 1-(3-Isopropyl-5-(2-methyl-4-(naphthalen-2-ylamino)benzamido)-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylate (<b>43</b>)</h3><div class="NLM_p last">To a stirred solution of <b>40</b> (520 mg, 1.88 mmol, 1.10 equiv) and <i>N</i>-methylmorpholine (375 μL, 3.41 mmol; 2.00 equiv) in DMF (10.0 mL) at rt, was added COMU ({[1-cyano-1-ethoxycarbonylmeth-(<i>Z</i>)-ylideneaminooxy]morpholin-4-ylmethylene}dimethylammonium hexafluorophosphate) (876 mg, 2.05 mmol, 1.20 equiv), and the reaction mixture was stirred at rt for 30 min. <b>42</b> (500 mg, 1.70 mmol, 1.00 equiv) in DMF (5.00 mL) was added, and the reaction mixture was heated at 50 °C for 48 h. The reaction mixture was treated with a saturated solution of NaHCO<sub>3</sub>(aq) and the product extracted with EtOAc (3 × 30 mL). The organic phases were combined and washed with water (3 × 10 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The crude product was purified by flash chromatography (silica gel, gradient of 0–100% EtOAc in heptane) to afford 1-{3-isopropyl-5-[2-methyl-4-(naphthalen-2-ylamino)benzoylamino]-2,6-dioxo-3,6-dihydro-2<i>H</i>-pyrimidin-1-yl}cyclopropanecarboxylic acid allyl ester (850 mg, 90%) as a pale yellow solid: LCMS <i>t</i><sub>R</sub> = 1.43 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 533.22 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.98 (s, 1H), 8.69 (s, 1H), 8.30 (s, 1H), 7.93–7.68 (m, 4H), 7.57 (d, <i>J</i> = 2.2 Hz, 1H), 7.51 (d, <i>J</i> = 8.4 Hz, 1H), 7.42 (ddd, <i>J</i> = 8.2, 6.8, 1.4 Hz, 1H), 7.37–7.28 (m, 2H), 7.10–6.99 (m, 2H), 5.85 (ddt, <i>J</i> = 17.3, 10.7, 4.8 Hz, 1H), 5.33–5.01 (m, 2H), 4.77 (h, <i>J</i> = 6.7 Hz, 1H), 4.70–4.43 (m, 2H), 2.43 (s, 3H), 1.84–1.64 (m, 2H), 1.55–1.20 (m, 8H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 170.24, 159.94, 149.89, 145.30, 140.18, 138.35, 134.26, 132.27, 131.18, 129.61, 128.98, 128.70, 127.50, 126.50, 126.40, 126.19, 123.44, 120.58, 118.16, 116.88, 113.03, 112.76, 111.48, 65.04, 54.95, 48.38, 35.67, 20.93, 20.58, 19.48, 19.22; HRMS (ESI) calculated for C<sub>32</sub>H<sub>32</sub>N<sub>4</sub>O<sub>5</sub> [M + H]<sup>+</sup> 553.2372, found, 553.2443.</div></div><div id="sec4_6_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-(3-Isopropyl-5-(2-methyl-4-(naphthalen-2-ylamino)benzamido)-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylic Acid (<b>44</b>)</h3><div class="NLM_p last">A stirred solution of <b>43</b> (840 mg, 1.52 mmol, 1.00 equiv), 1,3-dimethylbarbituric acid (380 mg, 2.43 mmol, 1.60 equiv) in DCM (42 mL) was degassed and purged with nitrogen, and tetrakis(triphenylphosphine)palladium(0) (70.3 mg, 0.06 mmol, 0.04 equiv) was added. The reaction mixture was stirred at rt for 45 min, concentrated, and purified by flash chromatography (silica gel, gradient of 0–10% MeOH in DCM) to afford 1-{3-isopropyl-5-[2-methyl-4-(naphthalen-2-ylamino)benzoylamino]-2,6-dioxo-3,6-dihydro-2<i>H</i>-pyrimidin-1-yl}cyclopropanecarboxylic acid (470 mg, 60%) as a beige solid: LCMS <i>t</i><sub>R</sub> = 1.28 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 513.28 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.6 (br s, 1H), 8.93 (s, 1H), 8.69 (s, 1H), 8.28 (s, 1H), 7.92–7.70 (m, 3H), 7.57 (d, <i>J</i> = 2.2 Hz, 1H), 7.51 (d, <i>J</i> = 8.3 Hz, 1H), 7.42 (ddd, <i>J</i> = 8.2, 6.8, 1.3 Hz, 1H), 7.37–7.28 (m, 2H), 7.09–7.00 (m, 2H), 4.96–4.49 (m, 1H), 2.44 (s, 3H), 1.67 (m, 2H), 1.45–1.20 (m, 8H).</div></div><div id="sec4_6_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>N</i>-(3-(1-(((3<i>S</i>)-2-Ethoxy-5-oxotetrahydrofuran-3-yl)carbamoyl)cyclopropyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-methyl-4-(naphthalen-2-ylamino)benzamide (<b>45</b>)</h3><div class="NLM_p"><i>Step 1</i>: To a stirred solution of <b>44</b>, (1.39 g, 2.71 mmol, 1.00 equiv) and <i>N</i>-methylmorpholine (358 μL, 3.25 mmol, 1.20 equiv) in a mixture of DCM (13.90 mL) and DMF (13.90 mL), HATU (1.24 g, 3.25 mmol, 1.20 equiv) was added, and the reaction mixture was stirred at rt for 40 min.</div><div class="NLM_p"><i>Step 2</i>: In parallel, a solution of <b>33</b>, (870 mg, 3.80 mmol, 1.40 equiv) and 1,3-dimethylbarbituric acid (593 mg, 3.80 mmol, 1.40 equiv) in a mixture of DCM (9.73 mL) and DMF (6.95 mL) at rt was degassed and purged with nitrogen, and then tetrakis(triphenylphosphine)palladium(0) (125 mg, 0.11 mmol; 0.04 equiv) was added. The reaction mixture was stirred at room temperature for 1 h.</div><div class="NLM_p last"><i>Step 3</i>: The product, (4<i>S</i>)-4-amino-5-ethoxydihydrofuran-2(3<i>H</i>)-one, from the Alloc deprotection step was added to the preactivated ester for the first step, and the reaction mixture was stirred at room temperature overnight. The reaction mixture was treated with a saturated solution of NaHCO<sub>3</sub>(aq) and the product extracted with EtOAc (2 × 50 mL). The organic phases were combined and washed with water (3 × 10 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The crude product was purified by flash chromatography (silica gel, gradient of 0–5% MeOH in DCM) to afford <i>N</i>-{3-[1-((<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-ylcarbamoyl)cyclopropyl]-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl}-2-methyl-4-(naphthalen-2-ylamino)benzamide (1.80 g, quant.) as an orange solid (mixture of diastereoisomers): LCMS <i>t</i><sub>R</sub> = 1.34 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 640.20 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.03–8.75 (m, 1H), 8.71 (s, 1H), 8.42 (s, 1H), 7.87–7.72 (m, 3H), 7.68–7.53 (m, 3H), 7.52–7.39 (m, 1H), 7.37–7.28 (m, 1H), 7.12–7.01 (m, 1H), 5.50 (d, <i>J</i> = 6.0 Hz, 0.5H), 5.22 (d, <i>J</i> = 6.0 Hz, 0.5H), 4.77 (m, 0.5H), 4.29–4.07 (m, 0.5H), 3.83–3.65 (m, 0.5H), 3.61 (overlapping signals, 1H), 2.55 (m, 1H), 2.44 (s, 3H), 2.41–2.29 (m, 1H), 1.67 (m, 2H), 1.33–1.16 (overlapping signals, 11H).</div></div><div id="sec4_6_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>tert</i>-Butyl (<i>R</i>)-5,5-Diethoxy-3-(1-(3-isopropyl-5-(2-methyl-4-(naphthalen-2-ylamino)benzamido)-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxamido)pentanoate (<b>46</b>)</h3><div class="NLM_p"><i>Step 1:</i> To a stirred solution <b>44</b> (100 mg, 0.20 mmol, 1.00 equiv) and <i>N</i>-methylmorpholine (25.7 μL, 0.23 mmol, 1.20 equiv) in a mixture of DCM (700 μL) and DMF (1.00 mL), was added HATU (89.0 mg, 0.23 mmol, 1.20 equiv), and the reaction mixture was stirred at room temperature for 30 min.</div><div class="NLM_p"><i>Step 2</i>: In a separate flask, a solution of <b>38</b> (101 mg, 0.29 mmol, 1.50 equiv) and 1,3-dimethylbarbituric acid (45.7 mg, 0.29 mmol, 1.50 equiv) in a mixture of DCM (700 μL) and DMF (500 μL) was degassed and purged with nitrogen, and then tetrakis(triphenylphosphine)palladium(0) (9.02 mg, 0.01 mmol, 0.04 equiv) was added. The reaction mixture was stirred at rt for 30 min.</div><div class="NLM_p last"><i>Step 3</i>: The solution from the Alloc deprotection containing <i>tert</i>-butyl (<i>R</i>)-3-amino-5,5-diethoxypentanoate was added dropwise to the activated ester formed in step 1, and the resulting solution was stirred for 2 h at rt. The reaction mixture was diluted with EtOAc (30 mL) and washed with a saturated aqueous solution of NaHCO<sub>3</sub>. The aqueous phase was washed with EtOAc (2 × 10 mL). The organic phases were combined, dried over MgSO<sub>4</sub>, and concentrated to dryness. The residue was purified by flash chromatography (silica gel, gradient of 0–100% EtOAc in heptane) to afford <i>tert</i>-butyl (<i>R</i>)-5,5-diethoxy-3-(1-(3-isopropyl-5-(2-methyl-4-(naphthalen-2-ylamino)benzamido)-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxamido)pentanoate (140 mg, 95%) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 1.44 min, purity = 100%, MS ES<sup>–</sup><i>m</i>/<i>z</i> 754.48 (M-H)<sup>−</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.83 (d, <i>J</i> = 6.3 Hz, 1H), 8.72 (s, 1H), 8.42 (d, <i>J</i> = 6.3 Hz, 1H), 7.89–7.71 (m, 3H), 7.69–7.55 (m, 2H), 7.53–7.38 (m, 2H), 7.38–7.28 (m, 2H), 7.13–6.99 (m, 2H), 4.77 (p, <i>J</i> = 6.7 Hz, 1H), 4.46 (dd, <i>J</i> = 8.1, 3.1 Hz, 1H), 3.49 (overlapping m, 4H), 2.65–2.53 (m, 1H), 2.44 (s, 3H), 2.39–2.17 (m, 1H), 1.81–1.50 (m, 2H), 1.47–1.18 (overlapping signals, 17H), 1.10 (m, 6H).</div></div><div id="sec4_6_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>tert</i>-Butyl 1-(5-Nitro-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylate (<b>47</b>)</h3><div class="NLM_p last">To a stirred solution of 1-[3-((<i>E</i>)-2-ethoxycarbonyl-2-nitrovinyl)ureido]cyclopropanecarboxylic acid <i>tert</i>-butyl ester (22.3 g, 0.06 mol, 1.00 equiv) obtained following the procedures described for <b>27</b> in MeCN (223 mL), was added cesium carbonate (42.3 g, 0.13 mol, 2.00 equiv) at rt. The resulting bright yellow suspension was heated at 120 °C for 1 h 20 min, cooled to rt, and the precipitate was removed by filtration and discarded. The filtrate was concentrated to dryness, and the residue was partitioned between DCM (200 mL) and water (20 mL). The pH was adjusted to 3 with a saturated aqueous solution of NaHSO<sub>4</sub>, and the organic phase was retained. The aqueous phase was washed with DCM (3 × 20 mL), and the organic phases were combined, washed with water (2 × 20 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness to afford <i>tert</i>-butyl 1-(5-nitro-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylate (19.2 g, 99%) as a yellow solid: LCMS <i>t</i><sub>R</sub> = 0.86 min, purity = 100%, MS ES<sup>–</sup><i>m</i>/<i>z</i> 296.26 (M – H)<sup>−</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.56 (s, 1H), 8.97 (s, 1H), 1.82–1.53 (m, 1H), 1.34 (s, 9H), 1.33–1.23 (m, 2H); 13C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.11, 155.02, 149.96, 146.58, 124.93, 81.26, 35.67, 27.51, 18.47, 18.23; HRMS (ESI) calculated for C<sub>12</sub>H<sub>15</sub>N<sub>3</sub>O<sub>6</sub> [M – H]<sup>−</sup> 296.0960, found 296.0884.</div></div><div id="sec4_6_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>tert</i>-Butyl 1-(5-Amino-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylate (<b>48</b>)</h3><div class="NLM_p last">To a stirred solution of <b>47</b> (18.1 g, 61 mmol, 1.00 equiv) in AcOEt (181 mL) was added 10% Pd–C (3.89 g, 1.83 mmol, 0.03 equiv). The stirred suspension was degassed and put under 1.5 bar of hydrogen for 22 h. The reaction mixture was filtered through a pad of Celite and concentrated to dryness. The residue was purified by flash chromatography (silica gel, gradient of 2–5% MeOH in DCM) to afford <i>tert</i>-butyl 1-(5-amino-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylate (5.23 g, 32%) as a beige solid: LCMS <i>t</i><sub>R</sub> = 0.69 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 266.17 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.20 (br s, 1H), 6.63 (d, <i>J</i> = 4.4 Hz, 1H), 3.98 (s, 2H), 1.75–1.45 (m, 2H), 1.35 (overlapping signals, 11H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.81, 161.51, 150.01, 121.61, 115.69, 80.65, 35.33, 27.69, 27.56, 18.48; HRMS (ESI) calculated for C<sub>12</sub>H<sub>17</sub>N<sub>3</sub>O<sub>4</sub> [M – H]<sup>−</sup> 266.1219, found 266.1144.</div></div><div id="sec4_6_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>tert</i>-Butyl 1-(5-(2-Methyl-4-(naphthalen-2-ylamino)benzamido)-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylate (<b>49</b>)</h3><div class="NLM_p">To a stirred solution of <b>40</b> (2.59 g, 9.35 mmol, 1.00 equiv) and <i>N</i>-methylmorpholine (1.23 mL, 11.2 mmol, 1.20 equiv) in DMF (25.0 mL) at rt, was added COMU {[1-cyano-1-ethoxycarbonylmeth-(<i>Z</i>)-ylideneaminooxy]morpholin-4-yl-methylene}dimethylammonium hexafluorophosphate (4.81 g, 11.2 mmol, 1.20 equiv), and the reaction mixture was stirred for 15 min. The resulting solution was added to <b>48</b> (2.50 g, 9.35 mmol, 1.00 equiv) in DMF (50 mL), and the reaction mixture was heated at 80 °C for 6 h then at rt overnight.</div><div class="NLM_p last">To the resulting orange solution, was added a saturated aqueous solution of NaHCO<sub>3</sub> (20 mL) followed by water (500 mL). The precipitate was recuperated by filtration, suspended in EtOAc (20 mL), and refiltered to afford <i>tert</i>-butyl 1-(5-(2-methyl-4-(naphthalen-2-ylamino)benzamido)-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylate (3.88 g, 79%) as a pale yellow solid: LCMS <i>t</i><sub>R</sub> = 1.34 min, purity = 97%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 527.33 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.60 (s, 1H), 8.20 (s, 1H), 8.00 (s, 1H), 7.88–7.66 (m, 3H), 7.54 (m, 1H), 7.48–7.22 (m, 3H), 7.12–6.94 (m, 2H), 2.41 (s, 3H), 1.64–1.50 (m, 2H), 1.33 (s, 9H), 1.11 (s, 2H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.53, 160.93, 150.17, 145.24, 140.21, 138.24, 134.27, 129.48, 128.99, 128.69, 127.51, 126.50, 126.40, 126.30, 123.43, 120.57, 118.22, 112.84, 112.48, 111.40, 80.95, 35.53, 27.55, 20.50, 18.34; HRMS (ESI) calculated for C<sub>30</sub>H<sub>30</sub>N<sub>4</sub>O<sub>5</sub> [M + H]<sup>+</sup> 527.2216; found, 527.2286.</div></div><div id="sec4_6_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 1-(5-(2-Methyl-4-(naphthalen-2-ylamino)benzamido)-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylic Acid (<b>50</b>)</h3><div class="NLM_p last"><b>49</b> (2.00 g, 3.80 mmol, 1.00 equiv) was suspended in a 4.0 M solution of HCl in 1,4-dioxane (40.0 mL) and stirred at rt for 5 h. The volatiles were removed under nitrogen, and the remaining residue was suspended in EtOAc and evaporated to dryness. The gum obtained was triturated with EtOAc, stirred at rt overnight and the resulting solid was collected by filtration and dried to a constant weight in a vacuum oven to afford 1-(5-(2-methyl-4-(naphthalen-2-ylamino)benzamido)-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)cyclopropane-1-carboxylic acid (1.40 g, 78%) as a pale yellow solid that was used without further purification: LCMS <i>t</i><sub>R</sub> = 1.14 min, purity = 95%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 471.21 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.6 (br s, 1H) 8.55 (s, 1H), 8.19 (s, 1H), 8.02 (s, 1H), 7.85–7.64 (m, 3H), 7.55 (m, 1H), 7.48–7.22 (m, 3H), 7.14–6.98 (m, 2H), 2.45 (s, 3H), 1.62–1.44 (m, 2H), 1.13 (s, 2H).</div></div><div id="sec4_6_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>N</i>-(3-(1-(((3<i>S</i>)-2-Ethoxy-5-oxotetrahydrofuran-3-yl)carbamoyl)cyclopropyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-methyl-4-(naphthalen-2-ylamino)benzamide (<b>51</b>)</h3><div class="NLM_p"><i>Step 1</i>: To a stirred solution of <b>50</b> (1.95 g, 4.14 mmol, 1.00 equiv) and DIPEA (1.43 mL, 8.29 mmol, 2.00 equiv) in DMF (40 mL), was added 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane-2,4,6-trioxide 50% in DMF (3.63 mL, 6.22 mmol, 1.50 equiv), and the reaction mixture was stirred at rt for 1 h.</div><div class="NLM_p"><i>Step 2</i>: In parallel, a solution of <b>33</b> (1.52 g, 6.63 mmol, 1.60 equiv) and 1,3-dimethylbarbituric acid (1.04 g, 6.63 mmol, 1.60 equiv) in a mixture of DCM (19.5 mL) and DMF (19.5 mL) at rt was degassed and purged with nitrogen, and then tetrakis(triphenylphosphine)palladium(0) (192 mg, 0.17 mmol; 0.04 equiv) was added. The reaction mixture was stirred at room temperature for 1 h.</div><div class="NLM_p last"><i>Step 3</i>: The product, (4<i>S</i>)-4-amino-5-ethoxydihydrofuran-2(3<i>H</i>)-one, from the Alloc deprotection step was added to the preactivated ester from the first step, and the reaction mixture was stirred at room temperature overnight. The reaction mixture was treated with a saturated solution of NaHCO<sub>3</sub>(aq) and the product extracted with EtOAc (2 × 100 mL). The organic phases were combined and washed with water (3 × 20 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness. The crude product was purified by flash chromatography (silica gel, gradient of 0–5% MeOH in DCM) to afford <i>N</i>-(3-(1-(((3<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-yl)carbamoyl)cyclopropyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2-methyl-4-(naphthalen-2-ylamino)benzamide (1.82 g, 73%) as an off-white solid (mixture of diastereoisomers): LCMS <i>t</i><sub>R</sub> = 1.18 min, purity = 98%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 598.27 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.93 (s, 1H), 6.89–8.95 (m, 14H), 5.50 (d, <i>J</i> = 5.3 Hz, 0.4H), 5.21 (d, <i>J</i> = 5.3 Hz, 0.6H), 4.54–4.69 (m, 0.4H), 4.13–4.28 (m, 0.6H), 3.51–3.81 (m, 2H), 2.42 (s, 3H), 2.31–3.07 (m, 2H), 1.64 (m, 2H), 1.10–1.30 (m, 5H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 175.12, 174.04, 170.09, 161.23, 150.22, 145.32, 143.74, 141.87, 140.14, 138.21, 134.26, 129.41, 128.99, 128.71, 127.51, 126.51, 126.40, 123.46, 120.58, 118.24, 113.53, 112.88, 111.47, 107.43, 102.15, 65.47, 64.60, 51.81, 36.37, 32.68, 20.51, 14.88; HRMS (ESI) calculated for C<sub>32</sub>H<sub>31</sub>N<sub>5</sub>O<sub>7</sub> [M + H]+ 598.2223; found, 598.2297.</div></div><div id="sec4_6_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> (<i>S</i>)-2-(3-Methyl-5-nitro-2,6-dioxo-3,6-dihydro-2<i>H</i>-pyrimidin-1-yl)propionic Acid Ethyl Ester (<b>52</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>24</b> (7.54 g, 29.3 mmol, 1.00 equiv) and potassium carbonate (4.46 g, 0.03 mol, 1.10 equiv) in DMF (75.4 mL), was added iodomethane (2.01 mL, 0.03 mol, 1.10 equiv), and the reaction mixture was stirred at rt for 4 h. The reaction mixture was partitioned between EtOAc (200 mL) and water (20 mL). The organic phase was retained, and the aqueous phase was extracted with EtOAc (3 × 50 mL). The organic phases were combined, washed with water (3 × 50 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness to afford a yellow residue that was purified by flash chromatography (silica gel, gradient of 30–60% EtOAc in heptane) to afford (<i>S</i>)-2-(3-methyl-5-nitro-2,6-dioxo-3,6-dihydro-2<i>H</i>-pyrimidin-1-yl)propionic acid ethyl ester as a white foam: LCMS <i>t</i><sub>R</sub> = 0.87 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 272.1 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.42 (s, 1H), 5.42 (q, <i>J</i> = 6.4 Hz, 1H), 4.10 (q, <i>J</i> = 7.1 Hz, 2H), 3.50 (s, 3H), 1.44 (d, <i>J</i> = 6.4 H, 3H), 1.14 (t, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.95, 153.81, 150.55, 149.30, 124.13, 60.94, 50.02, 13.97, 13.61; HRMS (ESI) calculated for C<sub>10</sub>H<sub>13</sub>N<sub>3</sub>O<sub>6</sub> [M + H]<sup>+</sup> 272.0804, found 272.0877.</div></div><div id="sec4_6_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (<i>S</i>)-2-(3-Methyl-5-nitro-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)propanoic Acid (<b>53</b>)</h3><div class="NLM_p last">To a stirred solution of <b>52</b> (2.43 g, 8.96 mmol, 1.00 equiv) in a mixture of THF (50 mL) and MeOH (5 mL), was added lithium hydroxide monohydrate (1.00 M, 18 mL, 18 mmol, 2.00 equiv). The reaction mixture was heated at 50 °C for 1 h 30 min. The reaction mixture was partitioned between EtOAc (20 mL) and water (20 mL). The aqueous phase was retained and the pH adjusted to 1–2 with HCl(aq), and the aqueous phase was extracted with EtOAc (3 × 50 mL). The organic phases were combined, washed with water (3 × 10 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness to afford 2-(3-methyl-5-nitro-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)propanoic acid (2.0 g, 92%) as a pale yellow solid: LCMS <i>t</i><sub>R</sub> = 0.37 min, purity = 100%, MS ES<sup>–</sup><i>m</i>/<i>z</i> 242.1 (M – H)<sup>−</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.4 (br s, 1H), 9.46 (s, 1H) 5.42 (q, <i>J</i> = 6.3 Hz, 1H), 3.48 (s, 3H), 1.44 (d, <i>J</i> = 6.3 H, 3H); HRMS (ESI) calculated for C<sub>8</sub>H<sub>9</sub>N<sub>3</sub>O<sub>6</sub> [M + H]<sup>+</sup> 244.04913, found 244.0563.</div></div><div id="sec4_6_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>N</i>-((3<i>S</i>)-2-Ethoxy-5-oxotetrahydrofuran-3-yl)-2-(3-methyl-5-nitro-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)propanamide (<b>54</b>)</h3><div class="NLM_p"><i>Step 1:</i> To a stirred solution of <b>53</b> (2.00 g, 8.22 mmol, 1.00 equiv) and pentafluorophenol (1.67 g, 9.05 mmol, 1.10 equiv) in a mixture of DCM (40.0 mL) and DMF (10.0 mL), was added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI) (1.73 g, 9.05 mmol, 1.10 equiv), and the reaction mixture was agitated at rt for 1 h.</div><div class="NLM_p last"><i>Step 2:</i> A stirred solution of <b>33</b> (2.55 g, 10.7 mmol, 1.30 equiv) and 1,3-dimethylbarbituric acid (835 mg, 5.35 mmol, 0.65 equiv) in a mixture of DCM (40.0 mL) and DMF (20.0 mL) was degassed and purged with nitrogen, and then tetrakis(triphenylphosphine)palladium(0) (190 mg, 0.16 mmol, 0.02 equiv) was added, and the reaction mixture was stirred for 1 h. The resulting solution containing (4<i>S</i>)-4-amino-5-ethoxydihydrofuran-2(3<i>H</i>)-one was added dropwise to the activated ester formed in step 1 over 5 min. The reaction mixture was stirred overnight, diluted with DCM (50 mL), and washed with water (5 mL), a saturated solution of NaHCO<sub>3</sub>(aq) (5 mL), and water (3 × 5 mL), dried over MgSO<sub>4</sub>, and concentrated to dryness to afford the crude product as a pale orange oil. The crude product was purified by flash chromatography (silica gel, gradient of 0–3% MeOH in DCM) to afford (<i>S</i>)-<i>N</i>-((S)-2-ethoxy-5-oxotetrahydrofuran-3-yl)-2-(3-methyl-5-nitro-2,6-dioxo-3,6-dihydro-2<i>H</i>-pyrimidin-1-yl)propionamide (1.83 g, 60%) as a beige solid and as a complex mixture of diastereoisomers: LCMS <i>t</i><sub>R</sub> = 0.76 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 371.1 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.43 (s, 0.6H), 9.40 (s, 0.4H), 5.55 (d, <i>J</i> = 5.2 Hz, 0.4H), 5.44 (d, <i>J</i> = 5.2 Hz, 0.2H), 5.34 (d, <i>J</i> = 1.2 Hz, 0.4H), 5.30–5.10 (m, 1H), 4.59 (m, 1H), 4.23–3.94 (m, 1H), 3.81–3.54 (overlapping m, 2H), 3.48 (s, 3H), 2.97 (m, 1H), 2.70–2.55 (m, 1H), 2.33 (m, 1H), 1.44–1.33 (overlapping d, <i>J</i> = 6.3 H, 3H), 1.22–1.04 (overlapping m, 3H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.50, 153.89, 150.45, 149.35, 124.18, 49.96, 37.77, 13.70; HRMS (ESI) calculated for C<sub>8</sub>H<sub>9</sub>N<sub>3</sub>O<sub>6</sub> [M + H]<sup>+</sup> 244.0491, found 244.0563.</div></div><div id="sec4_6_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 2-(5-Amino-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)-<i>N</i>-((3<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-yl)propanamide (<b>55</b>)</h3><div class="NLM_p last">To a stirred solution of <b>54</b> (2.18 g, 5.89 mmol, 1.00 equiv) in AcOEt (22 mL) at rt, was added 10% Pd–C (440 mg, 0.21 mmol, 0.04 equiv), and the resulting suspension was degassed, put under 3 bar of hydrogen, and stirred overnight. The reaction mixture was filtered through a pad of Celite and concentrated to dryness to afford a beige foam. The foam was triturated with diethyl ether and the solid collected by filtration and dried to a constant weight under vacuum to afford 2-(5-amino-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2<i>H</i>)-yl)-<i>N</i>-((3<i>S</i>)-2-ethoxy-5-oxotetrahydrofuran-3-yl)propanamide (1.61 g, 80%) as a very complex diastereoisomeric mixture that was used without further purification and stored at −19 °C: LCMS <i>t</i><sub>R</sub> = 0.48 min, 0.54 min, purity = 100%, MS ES<sup>+</sup><i>m</i>/<i>z</i> 341.2 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (complex mixture of diastereoisomers) 8.27–7.88 (m, 1H), 6.89 (m, <i>J</i> = 7.1 Hz, 1H), 5.65–5.35 (m, 1H), 5.33–5.24 (m, 1H), 5.22–4.51 (m, 1H), 4.22 (m, 2H), 3.91–3.45 (m, 2H), 3.37 (s, 3H), 3.01–2.60 (m, 2H), 1.51–1.37 (m, 3H), 1.27–1.11 (m, 3H).</div></div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> General Library Procedure for P4 Pocket Exploration. Ethyl Acetal <b>56</b></h3><div class="NLM_p last">To a stirred solution of <b>55</b> (1 equiv) and DIPEA (1.20 equiv) in THF (5 vol) was added either the heteroarylcarbonyl chloride (1.2 equiv) or the preactivated ester (prepared by adding HATU (1.2 equiv) to a stirred solution of heteroarylcarboxylic acid (1.2 equiv) in THF (5 vol) and <i>N</i>-methylmorpholine (1.2 equiv) at rt and agitating for 30 min prior to addition to the amine). The reaction mixture was stirred for 1–16 h, partitioned between water and EtOAc (20 mL). The organic layer was retained and the aqueous layer washed with EtOAc (2 × 5 mL). The organic phases were combined, washed with water (3 × 5 mL), dried over MgSO<sub>4</sub>, and concentrated. The crude product was purified by flash chromatography (silica gel, gradient 0–5% MeOH in DCM) to afford the desired compounds usually as solids.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Hemiacetal <b>57</b></h3><div class="NLM_p last">Hydrolysis of the ethyl acetal prodrugs was carried out in AcOH–H<sub>2</sub>O (1:1, 5 vol) at 40 °C overnight. The volatiles were removed by nitrogen sparging and the residues were triturated with diethyl ether to afford the desired hemiacetal drug molecules usually as solids in sufficient purity for in vitro evaluation.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00067" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00067" class="ext-link">10.1021/acs.jmedchem.8b00067</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional chemical and biological figures and tables (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Additional experimental information (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_001.pdf">jm8b00067_si_001.pdf (374.97 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_002.pdf">jm8b00067_si_002.pdf (1.4 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_003.csv">jm8b00067_si_003.csv (3.98 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">X-ray crystal structures have been deposited in the Protein Data Bank as follows: compound <b>6</b> bound to human caspase-1, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F6R">6F6R</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00067" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43155" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43155" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-François Fournier</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4958-1478" title="Orcid link">http://orcid.org/0000-0003-4958-1478</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#066c6367682b6074676865696f752860697374686f637446736b6968727463676a286567"><span class="__cf_email__" data-cfemail="dbb1bebab5f6bda9bab5b8b4b2a8f5bdb4aea9b5b2bea99baeb6b4b5afa9bebab7f5b8ba">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurence Clary</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandrine Chambon</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurence Dumais</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Craig Steven Harris</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Corinne Millois</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romain Pierre</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandrine Talano</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Étienne Thoreau</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jérome Aubert</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michèle Aurelly</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire Bouix-Peter</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne Brethon</span> - <span class="hlFld-Affiliation affiliation">Edelris, 115 Avenue Lacassagne, 69003 Lyon, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent Chantalat</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olivier Christin</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Comino</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ghizlane El-Bazbouz</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne-Laurence Ghilini</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatiana Isabet</span> - <span class="hlFld-Affiliation affiliation">Synchrotron Soleil, L’Orme des Merisiers, Saint-Aubin, BP 48, 91192 Gif-sur-Yvette Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claude Lardy</span> - <span class="hlFld-Affiliation affiliation">Edelris, 115 Avenue Lacassagne, 69003 Lyon, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne-Pascale Luzy</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Céline Mathieu</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenny Mebrouk</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Danielle Orfila</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Pascau</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Reverse</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Didier Roche</span> - <span class="hlFld-Affiliation affiliation">Edelris, 115 Avenue Lacassagne, 69003 Lyon, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent Rodeschini</span> - <span class="hlFld-Affiliation affiliation">Edelris, 115 Avenue Lacassagne, 69003 Lyon, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4758-5021" title="Orcid link">http://orcid.org/0000-0002-4758-5021</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent François Hennequin</span> - <span class="hlFld-Affiliation affiliation">Nestlé Skin
Health R&D, 2400
Route des Colles, BP 87, 06902 Sophia-Antipolis Cedex, France</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors were Nestle Skin Health, Edelris, or Synchrotron Soleil full-time employees at the time this work was carried out.<br /></br></div></li></ul></div><div class="ack" id="ACK-d142e5600-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge Yoko Takahashi and Professor André B. Charette for providing a synthetic intermediate in the macrocycle seen in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Ac-YVAD-CHO</td><td class="NLM_def"><p class="first last">acetyl-tyrosine-valine-alanine-aspartyl aldehyde peptide</p></td></tr><tr><td class="NLM_term">μM</td><td class="NLM_def"><p class="first last">micromolar</p></td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">Alloc</td><td class="NLM_def"><p class="first last">allyloxycarbonyl</p></td></tr><tr><td class="NLM_term">amu</td><td class="NLM_def"><p class="first last">atomic mass unit</p></td></tr><tr><td class="NLM_term">API</td><td class="NLM_def"><p class="first last">active pharmaceutical ingredient</p></td></tr><tr><td class="NLM_term">BEI</td><td class="NLM_def"><p class="first last">binding efficiency index</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">body surface area</p></td></tr><tr><td class="NLM_term">CDCl<sub>3</sub></td><td class="NLM_def"><p class="first last">deuterated chloroform</p></td></tr><tr><td class="NLM_term">ChromLogD</td><td class="NLM_def"><p class="first last">chromotographic octanol/water partition coefficient</p></td></tr><tr><td class="NLM_term">cHx</td><td class="NLM_def"><p class="first last">cyclohexane</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">COMU</td><td class="NLM_def"><p class="first last">1-cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylaminomorpholinocarbenium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">Cs<sub>2</sub>CO<sub>3</sub></td><td class="NLM_def"><p class="first last">cesium carbonate</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DSC</td><td class="NLM_def"><p class="first last">differential scanning calorimetry</p></td></tr><tr><td class="NLM_term">Et<sub>2</sub>O</td><td class="NLM_def"><p class="first last">diethyl ether</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">Fmoc</td><td class="NLM_def"><p class="first last">fluorenylmethyloxycarbonyl</p></td></tr><tr><td class="NLM_term"><i>gem</i></td><td class="NLM_def"><p class="first last">geminal</p></td></tr><tr><td class="NLM_term">GSE</td><td class="NLM_def"><p class="first last">general solubility equation</p></td></tr><tr><td class="NLM_term">H2L</td><td class="NLM_def"><p class="first last">hit to lead</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>O</td><td class="NLM_def"><p class="first last">water</p></td></tr><tr><td class="NLM_term">HCl</td><td class="NLM_def"><p class="first last">hydrochloric acid</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">concentration for 50% inhibition</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">inhibitory concentration for 50% of cells/enzymes</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">KOCN</td><td class="NLM_def"><p class="first last">potassium cyanate</p></td></tr><tr><td class="NLM_term">LC<sub>50</sub></td><td class="NLM_def"><p class="first last">lethal concentration for 50% of cells</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MgSO<sub>4</sub></td><td class="NLM_def"><p class="first last">magnesium sulfate</p></td></tr><tr><td class="NLM_term">Mo</td><td class="NLM_def"><p class="first last">month</p></td></tr><tr><td class="NLM_term">Mw</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">NHEK</td><td class="NLM_def"><p class="first last">normal human epidermal keratinocyte</p></td></tr><tr><td class="NLM_term">NLRP3</td><td class="NLM_def"><p class="first last">NOD-like receptor family, pyrin domain containing 3</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar</p></td></tr><tr><td class="NLM_term">Pfp</td><td class="NLM_def"><p class="first last">pentafluorophenol</p></td></tr><tr><td class="NLM_term">PG</td><td class="NLM_def"><p class="first last">propylene glycol</p></td></tr><tr><td class="NLM_term">PIF</td><td class="NLM_def"><p class="first last">phototoxicity irritation factor</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">Sol</td><td class="NLM_def"><p class="first last">solubility</p></td></tr><tr><td class="NLM_term">Stab</td><td class="NLM_def"><p class="first last">stability</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">property–activity relationship</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">propylphosphonic anhydride</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">UP-LCMS</td><td class="NLM_def"><p class="first last">ultraperfromance liquid chromatography–mass spectrometry</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20240" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20240" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, E.
B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimball, A. B.</span></span> <span> </span><span class="NLM_article-title">Meta-analysis comparing efficacy versus oral of antibiotics contraceptives in acne vulgaris</span>. <i>J. Am. Acad. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1016/j.jaad.2014.03.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.jaad.2014.03.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=24880665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFCjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=450-459&author=E.%0AB.+Kooauthor=T.+D.+Petersenauthor=A.+B.+Kimball&title=Meta-analysis+comparing+efficacy+versus+oral+of+antibiotics+contraceptives+in+acne+vulgaris&doi=10.1016%2Fj.jaad.2014.03.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris</span></div><div class="casAuthors">Koo, Eubee Baughn; Petersen, Tyler Daniel; Kimball, Alexandra Boer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Academy of Dermatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">450-459</span>CODEN:
                <span class="NLM_cas:coden">JAADDB</span>;
        ISSN:<span class="NLM_cas:issn">0190-9622</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Both antibiotics and oral contraceptive pills (OCPs) have been found to be effective in managing acne vulgaris.  Despite widespread use, few direct comparisons of efficacy between the 2 modalities have been published.We compared the efficacy of antibiotics and OCPs in managing acne.A meta-anal. was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Cochrane collaboration guidelines.A review of 226 publications yielded 32 randomized controlled trials that met our inclusion criteria.  At 3 and 6 mo, compared with placebo, both antibiotics and OCPs effected greater percent redn. in inflammatory, noninflammatory, and total lesions; the 2 modalities at each time point demonstrated statistical parity, except that antibiotics were superior to OCPs in percent redn. of total lesions at 3 mo (weighted mean inflammatory lesion redn.: 3-mo course of oral antibiotic treatment = 53.2%, 3-mo course of OCPs = 35.6%, 3-mo course of placebo treatment = 26.4%, 6-mo course of oral antibiotic treatment = 57.9%, 6-mo course of OCPs = 61.9%, 6-mo course of placebo treatment = 34.2%; weighted mean noninflammatory lesion redn.: 3-mo course of oral antibiotic treatment = 41.9%, 3-mo course of OCPs = 32.6%, 3-mo course of placebo treatment = 17.1%, 6-mo course of oral antibiotic treatment = 56.4%, 6-mo course of OCPs = 49.1%, 6-mo course of placebo treatment = 23.4%; weighted mean total lesion redn.: 3-mo course of oral antibiotic treatment = 48.0%, 3-mo course of OCPs = 37.3%, 3-mo course of placebo treatment = 24.5%, 6-mo course of oral antibiotic treatment = 52.8%, 6-mo course of OCPs = 55.0%, 6-mo course of placebo treatment = 28.6%).Investigative treatment heterogeneity and publication bias are limitations.Although antibiotics may be superior at 3 mo, OCPs are equiv. to antibiotics at 6 mo in reducing acne lesions and, thus, may be a better first-line alternative to systemic antibiotics for long-term acne management in women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqikbHL8QtvcbVg90H21EOLACvtfcHk0ljWomwWtPma4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFCjsL4%253D&md5=6e7b4c5fb1caf34fb2f7497e70637648</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2014.03.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2014.03.051%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DE.%2BB.%26aulast%3DPetersen%26aufirst%3DT.%2BD.%26aulast%3DKimball%26aufirst%3DA.%2BB.%26atitle%3DMeta-analysis%2520comparing%2520efficacy%2520versus%2520oral%2520of%2520antibiotics%2520contraceptives%2520in%2520acne%2520vulgaris%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2014%26volume%3D71%26spage%3D450%26epage%3D459%26doi%3D10.1016%2Fj.jaad.2014.03.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaxman, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naghavi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdalla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboyans, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">AlMazroa, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baddour, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahalim, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker-Collo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrero, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartels, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basáñez, M.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernabé, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhandari, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikbov, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulhak, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birbeck, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blencowe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blore, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blyth, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolliger, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boufous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boussinesq, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braithwaite, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brayne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridgett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brugha, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan-Hancock, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucello, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchbinder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budke, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabria, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canter, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carabin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carapetis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffeng, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colquhoun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corriere, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortinovis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vaccaro, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couser, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowie, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criqui, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabhadkar, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahodwala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damsere-Derry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danaei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Leo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degenhardt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellavalle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delossantos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derrett, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Des Jarlais, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmaratne, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dherani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Torne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driscoll, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duber, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmond, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erskine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erwin, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espindola, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewoigbokhan, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farzadfar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feigin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felson, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferri, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fèvre, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finucane, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaxman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flood, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foreman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forouzanfar, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowkes, F. G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fransen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabbe, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gakidou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganatra, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillum, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grainger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groeger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunnell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haagsma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halasa, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haring, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havmoeller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotez, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibeanusi, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasrasaria, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karthikeyan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassebaum, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoo, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowlton, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobusingye, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koranteng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalloo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laslett, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lathlean, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leasher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leigh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipnick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipshultz, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mabweijano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malekzadeh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manivannan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcenes, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolis, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzopoulos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayosi, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAnulty, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGill, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina-Mora, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meltzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memish, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mensah, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merriman, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miglioli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocumbi, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffitt, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokdad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monasta, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montico, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moradi-Lakeh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawska, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdoch, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mwaniki, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidoo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naldi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, K. M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevitt, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O'Donnell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O'Hanlon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olives, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omer, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortblad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozgediz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pahari, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandian, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivero, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patten, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Ruiz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perico, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesudovs, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pion, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polanczyk, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polinder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pope, C. A.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porrini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourmalek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullan, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranganathan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razavi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehm, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rein, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Leòn, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronfani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Room, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenfeld, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rushton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacco, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Riera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwebel, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segui-Gomez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahraz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepard, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivakoti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silberberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singleton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleet, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sliwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stapelberg, N. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolk, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stovner, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudfeld, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburlini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavakkoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurston, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tleyjeh, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towbin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truelsen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsilimbaris, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubeda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Undurraga, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Werf, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Os, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vavilala, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venketasubramanian, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weatherall, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisskopf, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteford, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiersma, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaidi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonies, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">AlMazroa, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memish, Z. A.</span></span> <span> </span><span class="NLM_article-title">Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the global burden of disease study 2010</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>380</i></span>,  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2196</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(12)61729-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2FS0140-6736%2812%2961729-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=23245607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A280%3ADC%252BC3s3isFCltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2012&pages=2163-2196&author=T.+Vosauthor=A.+D.+Flaxmanauthor=M.+Naghaviauthor=R.+Lozanoauthor=C.+Michaudauthor=M.+Ezzatiauthor=K.+Shibuyaauthor=J.+A.+Salomonauthor=S.+Abdallaauthor=V.+Aboyansauthor=J.+Abrahamauthor=I.+Ackermanauthor=R.+Aggarwalauthor=S.+Y.+Ahnauthor=M.+K.+Aliauthor=M.+A.+AlMazroaauthor=M.+Alvaradoauthor=H.+R.+Andersonauthor=L.+M.+Andersonauthor=K.+G.+Andrewsauthor=C.+Atkinsonauthor=L.+M.+Baddourauthor=A.+N.+Bahalimauthor=S.+Barker-Colloauthor=L.+H.+Barreroauthor=D.+H.+Bartelsauthor=M.-G.+Bas%C3%A1%C3%B1ezauthor=A.+Baxterauthor=M.+L.+Bellauthor=E.+J.+Benjaminauthor=D.+Bennettauthor=E.+Bernab%C3%A9author=K.+Bhallaauthor=B.+Bhandariauthor=B.+Bikbovauthor=A.+B.+Abdulhakauthor=G.+Birbeckauthor=J.+A.+Blackauthor=H.+Blencoweauthor=J.+D.+Bloreauthor=F.+Blythauthor=I.+Bolligerauthor=A.+Bonaventureauthor=S.+Boufousauthor=R.+Bourneauthor=M.+Boussinesqauthor=T.+Braithwaiteauthor=C.+Brayneauthor=L.+Bridgettauthor=S.+Brookerauthor=P.+Brooksauthor=T.+S.+Brughaauthor=C.+Bryan-Hancockauthor=C.+Bucelloauthor=R.+Buchbinderauthor=G.+Buckleauthor=C.+M.+Budkeauthor=M.+Burchauthor=P.+Burneyauthor=R.+Bursteinauthor=B.+Calabriaauthor=B.+Campbellauthor=C.+E.+Canterauthor=H.+Carabinauthor=J.+Carapetisauthor=L.+Carmonaauthor=C.+Cellaauthor=F.+Charlsonauthor=H.+Chenauthor=A.+T.+Chengauthor=D.+Chouauthor=S.+S.+Chughauthor=L.+E.+Coffengauthor=S.+D.+Colanauthor=S.+Colquhounauthor=K.+E.+Colsonauthor=J.+Condonauthor=M.+D.+Connorauthor=L.+T.+Cooperauthor=M.+Corriereauthor=M.+Cortinovisauthor=K.+C.+de+Vaccaroauthor=W.+Couserauthor=B.+C.+Cowieauthor=M.+H.+Criquiauthor=M.+Crossauthor=K.+C.+Dabhadkarauthor=M.+Dahiyaauthor=N.+Dahodwalaauthor=J.+Damsere-Derryauthor=G.+Danaeiauthor=A.+Davisauthor=D.+De+Leoauthor=L.+Degenhardtauthor=R.+Dellavalleauthor=A.+Delossantosauthor=J.+Denenbergauthor=S.+Derrettauthor=D.+C.+Des+Jarlaisauthor=S.+D.+Dharmaratneauthor=M.+Dheraniauthor=C.+Diaz-Torneauthor=H.+Dolkauthor=E.+R.+Dorseyauthor=T.+Driscollauthor=H.+Duberauthor=B.+Ebelauthor=K.+Edmondauthor=A.+Elbazauthor=S.+E.+Aliauthor=H.+Erskineauthor=P.+J.+Erwinauthor=P.+Espindolaauthor=S.+E.+Ewoigbokhanauthor=F.+Farzadfarauthor=V.+Feiginauthor=D.+T.+Felsonauthor=A.+Ferrariauthor=C.+P.+Ferriauthor=E.+M.+F%C3%A8vreauthor=M.+M.+Finucaneauthor=S.+Flaxmanauthor=L.+Floodauthor=K.+Foremanauthor=M.+H.+Forouzanfarauthor=F.+G.+R.+Fowkesauthor=R.+Franklinauthor=M.+Fransenauthor=M.+K.+Freemanauthor=B.+J.+Gabbeauthor=S.+E.+Gabrielauthor=E.+Gakidouauthor=H.+A.+Ganatraauthor=B.+Garciaauthor=F.+Gaspariauthor=R.+F.+Gillumauthor=G.+Gmelauthor=R.+Gosselinauthor=R.+Graingerauthor=J.+Groegerauthor=F.+Guilleminauthor=D.+Gunnellauthor=R.+Guptaauthor=J.+Haagsmaauthor=H.+Haganauthor=Y.+A.+Halasaauthor=W.+Hallauthor=D.+Haringauthor=J.+M.+Haroauthor=J.+E.+Harrisonauthor=R.+Havmoellerauthor=R.+J.+Hayauthor=H.+Higashiauthor=C.+Hillauthor=B.+Hoenauthor=H.+Hoffmanauthor=P.+J.+Hotezauthor=D.+Hoyauthor=J.+J.+Huangauthor=S.+E.+Ibeanusiauthor=K.+H.+Jacobsenauthor=S.+L.+Jamesauthor=D.+Jarvisauthor=R.+Jasrasariaauthor=S.+Jayaramanauthor=N.+Johnsauthor=J.+B.+Jonasauthor=G.+Karthikeyanauthor=N.+Kassebaumauthor=N.+Kawakamiauthor=A.+Kerenauthor=J.-P.+Khooauthor=C.+H.+Kingauthor=L.+M.+Knowltonauthor=O.+Kobusingyeauthor=A.+Korantengauthor=R.+Krishnamurthiauthor=R.+Lallooauthor=L.+L.+Laslettauthor=T.+Lathleanauthor=J.+L.+Leasherauthor=Y.+Y.+Leeauthor=J.+Leighauthor=S.+S.+Limauthor=E.+Limbauthor=J.+K.+Linauthor=M.+Lipnickauthor=S.+E.+Lipshultzauthor=W.+Liuauthor=M.+Loaneauthor=S.+L.+Ohnoauthor=R.+Lyonsauthor=J.+Maauthor=J.+Mabweijanoauthor=M.+F.+MacIntyreauthor=R.+Malekzadehauthor=L.+Mallingerauthor=S.+Manivannanauthor=W.+Marcenesauthor=L.+Marchauthor=D.+J.+Margolisauthor=G.+B.+Marksauthor=R.+Marksauthor=A.+Matsumoriauthor=R.+Matzopoulosauthor=B.+M.+Mayosiauthor=J.+H.+McAnultyauthor=M.+M.+McDermottauthor=N.+McGillauthor=J.+McGrathauthor=M.+E.+Medina-Moraauthor=M.+Meltzerauthor=Z.+A.+Memishauthor=G.+A.+Mensahauthor=T.+R.+Merrimanauthor=A.-C.+Meyerauthor=V.+Miglioliauthor=M.+Millerauthor=T.+R.+Millerauthor=P.+B.+Mitchellauthor=A.+O.+Mocumbiauthor=T.+E.+Moffittauthor=A.+A.+Mokdadauthor=L.+Monastaauthor=M.+Monticoauthor=M.+Moradi-Lakehauthor=A.+Moranauthor=L.+Morawskaauthor=R.+Moriauthor=M.+E.+Murdochauthor=M.+K.+Mwanikiauthor=K.+Naidooauthor=M.+N.+Nairauthor=L.+Naldiauthor=K.+M.+V.+Narayanauthor=P.+K.+Nelsonauthor=R.+G.+Nelsonauthor=M.+C.+Nevittauthor=C.+R.+Newtonauthor=S.+Nolteauthor=P.+Normanauthor=R.+Normanauthor=M.+O%27Donnellauthor=S.+O%27Hanlonauthor=C.+Olivesauthor=S.+B.+Omerauthor=K.+Ortbladauthor=R.+Osborneauthor=D.+Ozgedizauthor=A.+Pageauthor=B.+Pahariauthor=J.+D.+Pandianauthor=A.+P.+Riveroauthor=S.+B.+Pattenauthor=N.+Pearceauthor=R.+P.+Padillaauthor=F.+Perez-Ruizauthor=N.+Pericoauthor=K.+Pesudovsauthor=D.+Phillipsauthor=M.+R.+Phillipsauthor=K.+Pierceauthor=S.+Pionauthor=G.+V.+Polanczykauthor=S.+Polinderauthor=C.+A.+Popeauthor=S.+Popovaauthor=E.+Porriniauthor=F.+Pourmalekauthor=M.+Princeauthor=R.+L.+Pullanauthor=K.+D.+Ramaiahauthor=D.+Ranganathanauthor=H.+Razaviauthor=M.+Reganauthor=J.+T.+Rehmauthor=D.+B.+Reinauthor=G.+Remuzziauthor=K.+Richardsonauthor=F.+P.+Rivaraauthor=T.+Robertsauthor=C.+Robinsonauthor=F.+R.+De+Le%C3%B2nauthor=L.+Ronfaniauthor=R.+Roomauthor=L.+C.+Rosenfeldauthor=L.+Rushtonauthor=R.+L.+Saccoauthor=S.+Sahaauthor=U.+Sampsonauthor=L.+Sanchez-Rieraauthor=E.+Sanmanauthor=D.+C.+Schwebelauthor=J.+G.+Scottauthor=M.+Segui-Gomezauthor=S.+Shahrazauthor=D.+S.+Shepardauthor=H.+Shinauthor=R.+Shivakotiauthor=D.+Silberbergauthor=D.+Singhauthor=G.+M.+Singhauthor=J.+A.+Singhauthor=J.+Singletonauthor=D.+A.+Sleetauthor=K.+Sliwaauthor=E.+Smithauthor=J.+L.+Smithauthor=N.+J.+C.+Stapelbergauthor=A.+Steerauthor=T.+Steinerauthor=W.+A.+Stolkauthor=L.+J.+Stovnerauthor=C.+Sudfeldauthor=S.+Syedauthor=G.+Tamburliniauthor=M.+Tavakkoliauthor=H.+R.+Taylorauthor=J.+A.+Taylorauthor=W.+J.+Taylorauthor=B.+Thomasauthor=W.+M.+Thomsonauthor=G.+D.+Thurstonauthor=I.+M.+Tleyjehauthor=M.+Tonelliauthor=J.+A.+Towbinauthor=T.+Truelsenauthor=M.+K.+Tsilimbarisauthor=C.+Ubedaauthor=E.+A.+Undurragaauthor=M.+J.+van+der+Werfauthor=J.+van+Osauthor=M.+S.+Vavilalaauthor=N.+Venketasubramanianauthor=M.+Wangauthor=W.+Wangauthor=K.+Wattauthor=D.+J.+Weatherallauthor=M.+A.+Weinstockauthor=R.+Weintraubauthor=M.+G.+Weisskopfauthor=M.+M.+Weissmanauthor=R.+A.+Whiteauthor=H.+Whitefordauthor=S.+T.+Wiersmaauthor=J.+D.+Wilkinsonauthor=H.+C.+Williamsauthor=S.+R.+Williamsauthor=E.+Wittauthor=F.+Wolfeauthor=A.+D.+Woolfauthor=S.+Wulfauthor=P.-H.+Yehauthor=A.+K.+Zaidiauthor=Z.-J.+Zhengauthor=D.+Zoniesauthor=A.+D.+Lopezauthor=C.+J.+L.+Murrayauthor=M.+A.+AlMazroaauthor=Z.+A.+Memish&title=Years+lived+with+disability+%28YLDs%29+for+1160+sequelae+of+289+diseases+and+injuries+1990%E2%80%932010%3A+A+systematic+analysis+for+the+global+burden+of+disease+study+2010&doi=10.1016%2FS0140-6736%2812%2961729-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010</span></div><div class="casAuthors">Vos Theo; Flaxman Abraham D; Naghavi Mohsen; Lozano Rafael; Michaud Catherine; Ezzati Majid; Shibuya Kenji; Salomon Joshua A; Abdalla Safa; Aboyans Victor; Abraham Jerry; Ackerman Ilana; Aggarwal Rakesh; Ahn Stephanie Y; Ali Mohammed K; Alvarado Miriam; Anderson H Ross; Anderson Laurie M; Andrews Kathryn G; Atkinson Charles; Baddour Larry M; Bahalim Adil N; Barker-Collo Suzanne; Barrero Lope H; Bartels David H; Basanez Maria-Gloria; Baxter Amanda; Bell Michelle L; Benjamin Emelia J; Bennett Derrick; Bernabe Eduardo; Bhalla Kavi; Bhandari Bishal; Bikbov Boris; Bin Abdulhak Aref; Birbeck Gretchen; Black James A; Blencowe Hannah; Blore Jed D; Blyth Fiona; Bolliger Ian; Bonaventure Audrey; Boufous Soufiane; Bourne Rupert; Boussinesq Michel; Braithwaite Tasanee; Brayne Carol; Bridgett Lisa; Brooker Simon; Brooks Peter; Brugha Traolach S; Bryan-Hancock Claire; Bucello Chiara; Buchbinder Rachelle; Buckle Geoffrey; Budke Christine M; Burch Michael; Burney Peter; Burstein Roy; Calabria Bianca; Campbell Benjamin; Canter Charles E; Carabin Helene; Carapetis Jonathan; Carmona Loreto; Cella Claudia; Charlson Fiona; Chen Honglei; Cheng Andrew Tai-Ann; Chou David; Chugh Sumeet S; Coffeng Luc E; Colan Steven D; Colquhoun Samantha; Colson K Ellicott; Condon John; Connor Myles D; Cooper Leslie T; Corriere Matthew; Cortinovis Monica; de Vaccaro Karen Courville; Couser William; Cowie Benjamin C; Criqui Michael H; Cross Marita; Dabhadkar Kaustubh C; Dahiya Manu; Dahodwala Nabila; Damsere-Derry James; Danaei Goodarz; Davis Adrian; De Leo Diego; Degenhardt Louisa; Dellavalle Robert; Delossantos Allyne; Denenberg Julie; Derrett Sarah; Des Jarlais Don C; Dharmaratne Samath D; Dherani Mukesh; Diaz-Torne Cesar; Dolk Helen; Dorsey E Ray; Driscoll Tim; Duber Herbert; Ebel Beth; Edmond Karen; Elbaz Alexis; Ali Suad Eltahir; Erskine Holly; Erwin Patricia J; Espindola Patricia; Ewoigbokhan Stalin E; Farzadfar Farshad; Feigin Valery; Felson David T; Ferrari Alize; Ferri Cleusa P; Fevre Eric M; Finucane Mariel M; Flaxman Seth; Flood Louise; Foreman Kyle; Forouzanfar Mohammad H; Fowkes Francis Gerry R; Franklin Richard; Fransen Marlene; Freeman Michael K; Gabbe Belinda J; Gabriel Sherine E; Gakidou Emmanuela; Ganatra Hammad A; Garcia Bianca; Gaspari Flavio; Gillum Richard F; Gmel Gerhard; Gosselin Richard; Grainger Rebecca; Groeger Justina; Guillemin Francis; Gunnell David; Gupta Ramyani; Haagsma Juanita; Hagan Holly; Halasa Yara A; Hall Wayne; Haring Diana; Haro Josep Maria; Harrison James E; Havmoeller Rasmus; Hay Roderick J; Higashi Hideki; Hill Catherine; Hoen Bruno; Hoffman Howard; Hotez Peter J; Hoy Damian; Huang John J; Ibeanusi Sydney E; Jacobsen Kathryn H; James Spencer L; Jarvis Deborah; Jasrasaria Rashmi; Jayaraman Sudha; Johns Nicole; Jonas Jost B; Karthikeyan Ganesan; Kassebaum Nicholas; Kawakami Norito; Keren Andre; Khoo Jon-Paul; King Charles H; Knowlton Lisa Marie; Kobusingye Olive; Koranteng Adofo; Krishnamurthi Rita; Lalloo Ratilal; Laslett Laura L; Lathlean Tim; Leasher Janet L; Lee Yong Yi; Leigh James; Lim Stephen S; Limb Elizabeth; Lin John Kent; Lipnick Michael; Lipshultz Steven E; Liu Wei; Loane Maria; Ohno Summer Lockett; Lyons Ronan; Ma Jixiang; Mabweijano Jacqueline; MacIntyre Michael F; Malekzadeh Reza; Mallinger Leslie; Manivannan Sivabalan; Marcenes Wagner; March Lyn; Margolis David J; Marks Guy B; Marks Robin; Matsumori Akira; Matzopoulos Richard; Mayosi Bongani M; McAnulty John H; McDermott Mary M; McGill Neil; McGrath John; Medina-Mora Maria Elena; Meltzer Michele; Mensah George A; Merriman Tony R; Meyer Ana-Claire; Miglioli Valeria; Miller Matthew; Miller Ted R; Mitchell Philip B; Mocumbi Ana Olga; Moffitt Terrie E; Mokdad Ali A; Monasta Lorenzo; Montico Marcella; Moradi-Lakeh Maziar; Moran Andrew; Morawska Lidia; Mori Rintaro; Murdoch Michele E; Mwaniki Michael K; Naidoo Kovin; Nair M Nathan; Naldi Luigi; Narayan K M Venkat; Nelson Paul K; Nelson Robert G; Nevitt Michael C; Newton Charles R; Nolte Sandra; Norman Paul; Norman Rosana; O'Donnell Martin; O'Hanlon Simon; Olives Casey; Omer Saad B; Ortblad Katrina; Osborne Richard; Ozgediz Doruk; Page Andrew; Pahari Bishnu; Pandian Jeyaraj Durai; Rivero Andrea Panozo; Patten Scott B; Pearce Neil; Padilla Rogelio Perez; Perez-Ruiz Fernando; Perico Norberto; Pesudovs Konrad; Phillips David; Phillips Michael R; Pierce Kelsey; Pion Sebastien; Polanczyk Guilherme V; Polinder Suzanne; Pope C Arden 3rd; Popova Svetlana; Porrini Esteban; Pourmalek Farshad; Prince Martin; Pullan Rachel L; Ramaiah Kapa D; Ranganathan Dharani; Razavi Homie; Regan Mathilda; Rehm Jurgen T; Rein David B; Remuzzi Guiseppe; Richardson Kathryn; Rivara Frederick P; Roberts Thomas; Robinson Carolyn; De Leon Felipe Rodriguez; Ronfani Luca; Room Robin; Rosenfeld Lisa C; Rushton Lesley; Sacco Ralph L; Saha Sukanta; Sampson Uchechukwu; Sanchez-Riera Lidia; Sanman Ella; Schwebel David C; Scott James Graham; Segui-Gomez Maria; Shahraz Saeid; Shepard Donald S; Shin Hwashin; Shivakoti Rupak; Singh David; Singh Gitanjali M; Singh Jasvinder A; Singleton Jessica; Sleet David A; Sliwa Karen; Smith Emma; Smith Jennifer L; Stapelberg Nicolas J C; Steer Andrew; Steiner Timothy; Stolk Wilma A; Stovner Lars Jacob; Sudfeld Christopher; Syed Sana; Tamburlini Giorgio; Tavakkoli Mohammad; Taylor Hugh R; Taylor Jennifer A; Taylor William J; Thomas Bernadette; Thomson W Murray; Thurston George D; Tleyjeh Imad M; Tonelli Marcello; Towbin Jeffrey A; Truelsen Thomas; Tsilimbaris Miltiadis K; Ubeda Clotilde; Undurraga Eduardo A; van der Werf Marieke J; van Os Jim; Vavilala Monica S; Venketasubramanian N; Wang Mengru; Wang Wenzhi; Watt Kerrianne; Weatherall David J; Weinstock Martin A; Weintraub Robert; Weisskopf Marc G; Weissman Myrna M; White Richard A; Whiteford Harvey; Wiersma Steven T; Wilkinson James D; Williams Hywel C; Williams Sean R M; Witt Emma; Wolfe Frederick; Woolf Anthony D; Wulf Sarah; Yeh Pon-Hsiu; Zaidi Anita K M; Zheng Zhi-Jie; Zonies David; Lopez Alan D; Murray Christopher J L; AlMazroa Mohammad A; Memish Ziad A</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">9859</span>),
    <span class="NLM_cas:pages">2163-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Non-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health.  The Global Burden of Disease (GBD) studies done in 1990 and 2000 have been the only studies to quantify non-fatal health outcomes across an exhaustive set of disorders at the global and regional level.  Neither effort quantified uncertainty in prevalence or years lived with disability (YLDs).  METHODS:  Of the 291 diseases and injuries in the GBD cause list, 289 cause disability.  For 1160 sequelae of the 289 diseases and injuries, we undertook a systematic analysis of prevalence, incidence, remission, duration, and excess mortality.  Sources included published studies, case notification, population-based cancer registries, other disease registries, antenatal clinic serosurveillance, hospital discharge data, ambulatory care data, household surveys, other surveys, and cohort studies.  For most sequelae, we used a Bayesian meta-regression method, DisMod-MR, designed to address key limitations in descriptive epidemiological data, including missing data, inconsistency, and large methodological variation between data sources.  For some disorders, we used natural history models, geospatial models, back-calculation models (models calculating incidence from population mortality rates and case fatality), or registration completeness models (models adjusting for incomplete registration with health-system access and other covariates).  Disability weights for 220 unique health states were used to capture the severity of health loss.  YLDs by cause at age, sex, country, and year levels were adjusted for comorbidity with simulation methods.  We included uncertainty estimates at all stages of the analysis.  FINDINGS:  Global prevalence for all ages combined in 2010 across the 1160 sequelae ranged from fewer than one case per 1 million people to 350,000 cases per 1 million people.  Prevalence and severity of health loss were weakly correlated (correlation coefficient -0·37).  In 2010, there were 777 million YLDs from all causes, up from 583 million in 1990.  The main contributors to global YLDs were mental and behavioural disorders, musculoskeletal disorders, and diabetes or endocrine diseases.  The leading specific causes of YLDs were much the same in 2010 as they were in 1990: low back pain, major depressive disorder, iron-deficiency anaemia, neck pain, chronic obstructive pulmonary disease, anxiety disorders, migraine, diabetes, and falls.  Age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010.  Regional patterns of the leading causes of YLDs were more similar compared with years of life lost due to premature mortality.  Neglected tropical diseases, HIV/AIDS, tuberculosis, malaria, and anaemia were important causes of YLDs in sub-Saharan Africa.  INTERPRETATION:  Rates of YLDs per 100,000 people have remained largely constant over time but rise steadily with age.  Population growth and ageing have increased YLD numbers and crude rates over the past two decades.  Prevalences of the most common causes of YLDs, such as mental and behavioural disorders and musculoskeletal disorders, have not decreased.  Health systems will need to address the needs of the rising numbers of individuals with a range of disorders that largely cause disability but not mortality.  Quantification of the burden of non-fatal health outcomes will be crucial to understand how well health systems are responding to these challenges.  Effective and affordable strategies to deal with this rising burden are an urgent priority for health systems in most parts of the world.  FUNDING:  Bill & Melinda Gates Foundation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqOG_wjVrF_5NiNltV31zlfW6udTcc2eZU6mOZcVk9Pbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3isFCltA%253D%253D&md5=e23ef644cc0998b536d2d988807654a1</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2812%2961729-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252812%252961729-2%26sid%3Dliteratum%253Aachs%26aulast%3DVos%26aufirst%3DT.%26aulast%3DFlaxman%26aufirst%3DA.%2BD.%26aulast%3DNaghavi%26aufirst%3DM.%26aulast%3DLozano%26aufirst%3DR.%26aulast%3DMichaud%26aufirst%3DC.%26aulast%3DEzzati%26aufirst%3DM.%26aulast%3DShibuya%26aufirst%3DK.%26aulast%3DSalomon%26aufirst%3DJ.%2BA.%26aulast%3DAbdalla%26aufirst%3DS.%26aulast%3DAboyans%26aufirst%3DV.%26aulast%3DAbraham%26aufirst%3DJ.%26aulast%3DAckerman%26aufirst%3DI.%26aulast%3DAggarwal%26aufirst%3DR.%26aulast%3DAhn%26aufirst%3DS.%2BY.%26aulast%3DAli%26aufirst%3DM.%2BK.%26aulast%3DAlMazroa%26aufirst%3DM.%2BA.%26aulast%3DAlvarado%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DH.%2BR.%26aulast%3DAnderson%26aufirst%3DL.%2BM.%26aulast%3DAndrews%26aufirst%3DK.%2BG.%26aulast%3DAtkinson%26aufirst%3DC.%26aulast%3DBaddour%26aufirst%3DL.%2BM.%26aulast%3DBahalim%26aufirst%3DA.%2BN.%26aulast%3DBarker-Collo%26aufirst%3DS.%26aulast%3DBarrero%26aufirst%3DL.%2BH.%26aulast%3DBartels%26aufirst%3DD.%2BH.%26aulast%3DBas%25C3%25A1%25C3%25B1ez%26aufirst%3DM.-G.%26aulast%3DBaxter%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DM.%2BL.%26aulast%3DBenjamin%26aufirst%3DE.%2BJ.%26aulast%3DBennett%26aufirst%3DD.%26aulast%3DBernab%25C3%25A9%26aufirst%3DE.%26aulast%3DBhalla%26aufirst%3DK.%26aulast%3DBhandari%26aufirst%3DB.%26aulast%3DBikbov%26aufirst%3DB.%26aulast%3DAbdulhak%26aufirst%3DA.%2BB.%26aulast%3DBirbeck%26aufirst%3DG.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DBlencowe%26aufirst%3DH.%26aulast%3DBlore%26aufirst%3DJ.%2BD.%26aulast%3DBlyth%26aufirst%3DF.%26aulast%3DBolliger%26aufirst%3DI.%26aulast%3DBonaventure%26aufirst%3DA.%26aulast%3DBoufous%26aufirst%3DS.%26aulast%3DBourne%26aufirst%3DR.%26aulast%3DBoussinesq%26aufirst%3DM.%26aulast%3DBraithwaite%26aufirst%3DT.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DBridgett%26aufirst%3DL.%26aulast%3DBrooker%26aufirst%3DS.%26aulast%3DBrooks%26aufirst%3DP.%26aulast%3DBrugha%26aufirst%3DT.%2BS.%26aulast%3DBryan-Hancock%26aufirst%3DC.%26aulast%3DBucello%26aufirst%3DC.%26aulast%3DBuchbinder%26aufirst%3DR.%26aulast%3DBuckle%26aufirst%3DG.%26aulast%3DBudke%26aufirst%3DC.%2BM.%26aulast%3DBurch%26aufirst%3DM.%26aulast%3DBurney%26aufirst%3DP.%26aulast%3DBurstein%26aufirst%3DR.%26aulast%3DCalabria%26aufirst%3DB.%26aulast%3DCampbell%26aufirst%3DB.%26aulast%3DCanter%26aufirst%3DC.%2BE.%26aulast%3DCarabin%26aufirst%3DH.%26aulast%3DCarapetis%26aufirst%3DJ.%26aulast%3DCarmona%26aufirst%3DL.%26aulast%3DCella%26aufirst%3DC.%26aulast%3DCharlson%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DA.%2BT.%26aulast%3DChou%26aufirst%3DD.%26aulast%3DChugh%26aufirst%3DS.%2BS.%26aulast%3DCoffeng%26aufirst%3DL.%2BE.%26aulast%3DColan%26aufirst%3DS.%2BD.%26aulast%3DColquhoun%26aufirst%3DS.%26aulast%3DColson%26aufirst%3DK.%2BE.%26aulast%3DCondon%26aufirst%3DJ.%26aulast%3DConnor%26aufirst%3DM.%2BD.%26aulast%3DCooper%26aufirst%3DL.%2BT.%26aulast%3DCorriere%26aufirst%3DM.%26aulast%3DCortinovis%26aufirst%3DM.%26aulast%3Dde%2BVaccaro%26aufirst%3DK.%2BC.%26aulast%3DCouser%26aufirst%3DW.%26aulast%3DCowie%26aufirst%3DB.%2BC.%26aulast%3DCriqui%26aufirst%3DM.%2BH.%26aulast%3DCross%26aufirst%3DM.%26aulast%3DDabhadkar%26aufirst%3DK.%2BC.%26aulast%3DDahiya%26aufirst%3DM.%26aulast%3DDahodwala%26aufirst%3DN.%26aulast%3DDamsere-Derry%26aufirst%3DJ.%26aulast%3DDanaei%26aufirst%3DG.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DDe%2BLeo%26aufirst%3DD.%26aulast%3DDegenhardt%26aufirst%3DL.%26aulast%3DDellavalle%26aufirst%3DR.%26aulast%3DDelossantos%26aufirst%3DA.%26aulast%3DDenenberg%26aufirst%3DJ.%26aulast%3DDerrett%26aufirst%3DS.%26aulast%3DDes%2BJarlais%26aufirst%3DD.%2BC.%26aulast%3DDharmaratne%26aufirst%3DS.%2BD.%26aulast%3DDherani%26aufirst%3DM.%26aulast%3DDiaz-Torne%26aufirst%3DC.%26aulast%3DDolk%26aufirst%3DH.%26aulast%3DDorsey%26aufirst%3DE.%2BR.%26aulast%3DDriscoll%26aufirst%3DT.%26aulast%3DDuber%26aufirst%3DH.%26aulast%3DEbel%26aufirst%3DB.%26aulast%3DEdmond%26aufirst%3DK.%26aulast%3DElbaz%26aufirst%3DA.%26aulast%3DAli%26aufirst%3DS.%2BE.%26aulast%3DErskine%26aufirst%3DH.%26aulast%3DErwin%26aufirst%3DP.%2BJ.%26aulast%3DEspindola%26aufirst%3DP.%26aulast%3DEwoigbokhan%26aufirst%3DS.%2BE.%26aulast%3DFarzadfar%26aufirst%3DF.%26aulast%3DFeigin%26aufirst%3DV.%26aulast%3DFelson%26aufirst%3DD.%2BT.%26aulast%3DFerrari%26aufirst%3DA.%26aulast%3DFerri%26aufirst%3DC.%2BP.%26aulast%3DF%25C3%25A8vre%26aufirst%3DE.%2BM.%26aulast%3DFinucane%26aufirst%3DM.%2BM.%26aulast%3DFlaxman%26aufirst%3DS.%26aulast%3DFlood%26aufirst%3DL.%26aulast%3DForeman%26aufirst%3DK.%26aulast%3DForouzanfar%26aufirst%3DM.%2BH.%26aulast%3DFowkes%26aufirst%3DF.%2BG.%2BR.%26aulast%3DFranklin%26aufirst%3DR.%26aulast%3DFransen%26aufirst%3DM.%26aulast%3DFreeman%26aufirst%3DM.%2BK.%26aulast%3DGabbe%26aufirst%3DB.%2BJ.%26aulast%3DGabriel%26aufirst%3DS.%2BE.%26aulast%3DGakidou%26aufirst%3DE.%26aulast%3DGanatra%26aufirst%3DH.%2BA.%26aulast%3DGarcia%26aufirst%3DB.%26aulast%3DGaspari%26aufirst%3DF.%26aulast%3DGillum%26aufirst%3DR.%2BF.%26aulast%3DGmel%26aufirst%3DG.%26aulast%3DGosselin%26aufirst%3DR.%26aulast%3DGrainger%26aufirst%3DR.%26aulast%3DGroeger%26aufirst%3DJ.%26aulast%3DGuillemin%26aufirst%3DF.%26aulast%3DGunnell%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DHaagsma%26aufirst%3DJ.%26aulast%3DHagan%26aufirst%3DH.%26aulast%3DHalasa%26aufirst%3DY.%2BA.%26aulast%3DHall%26aufirst%3DW.%26aulast%3DHaring%26aufirst%3DD.%26aulast%3DHaro%26aufirst%3DJ.%2BM.%26aulast%3DHarrison%26aufirst%3DJ.%2BE.%26aulast%3DHavmoeller%26aufirst%3DR.%26aulast%3DHay%26aufirst%3DR.%2BJ.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DHill%26aufirst%3DC.%26aulast%3DHoen%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DH.%26aulast%3DHotez%26aufirst%3DP.%2BJ.%26aulast%3DHoy%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DJ.%2BJ.%26aulast%3DIbeanusi%26aufirst%3DS.%2BE.%26aulast%3DJacobsen%26aufirst%3DK.%2BH.%26aulast%3DJames%26aufirst%3DS.%2BL.%26aulast%3DJarvis%26aufirst%3DD.%26aulast%3DJasrasaria%26aufirst%3DR.%26aulast%3DJayaraman%26aufirst%3DS.%26aulast%3DJohns%26aufirst%3DN.%26aulast%3DJonas%26aufirst%3DJ.%2BB.%26aulast%3DKarthikeyan%26aufirst%3DG.%26aulast%3DKassebaum%26aufirst%3DN.%26aulast%3DKawakami%26aufirst%3DN.%26aulast%3DKeren%26aufirst%3DA.%26aulast%3DKhoo%26aufirst%3DJ.-P.%26aulast%3DKing%26aufirst%3DC.%2BH.%26aulast%3DKnowlton%26aufirst%3DL.%2BM.%26aulast%3DKobusingye%26aufirst%3DO.%26aulast%3DKoranteng%26aufirst%3DA.%26aulast%3DKrishnamurthi%26aufirst%3DR.%26aulast%3DLalloo%26aufirst%3DR.%26aulast%3DLaslett%26aufirst%3DL.%2BL.%26aulast%3DLathlean%26aufirst%3DT.%26aulast%3DLeasher%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DY.%2BY.%26aulast%3DLeigh%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BS.%26aulast%3DLimb%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DJ.%2BK.%26aulast%3DLipnick%26aufirst%3DM.%26aulast%3DLipshultz%26aufirst%3DS.%2BE.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLoane%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DS.%2BL.%26aulast%3DLyons%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DMabweijano%26aufirst%3DJ.%26aulast%3DMacIntyre%26aufirst%3DM.%2BF.%26aulast%3DMalekzadeh%26aufirst%3DR.%26aulast%3DMallinger%26aufirst%3DL.%26aulast%3DManivannan%26aufirst%3DS.%26aulast%3DMarcenes%26aufirst%3DW.%26aulast%3DMarch%26aufirst%3DL.%26aulast%3DMargolis%26aufirst%3DD.%2BJ.%26aulast%3DMarks%26aufirst%3DG.%2BB.%26aulast%3DMarks%26aufirst%3DR.%26aulast%3DMatsumori%26aufirst%3DA.%26aulast%3DMatzopoulos%26aufirst%3DR.%26aulast%3DMayosi%26aufirst%3DB.%2BM.%26aulast%3DMcAnulty%26aufirst%3DJ.%2BH.%26aulast%3DMcDermott%26aufirst%3DM.%2BM.%26aulast%3DMcGill%26aufirst%3DN.%26aulast%3DMcGrath%26aufirst%3DJ.%26aulast%3DMedina-Mora%26aufirst%3DM.%2BE.%26aulast%3DMeltzer%26aufirst%3DM.%26aulast%3DMemish%26aufirst%3DZ.%2BA.%26aulast%3DMensah%26aufirst%3DG.%2BA.%26aulast%3DMerriman%26aufirst%3DT.%2BR.%26aulast%3DMeyer%26aufirst%3DA.-C.%26aulast%3DMiglioli%26aufirst%3DV.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DT.%2BR.%26aulast%3DMitchell%26aufirst%3DP.%2BB.%26aulast%3DMocumbi%26aufirst%3DA.%2BO.%26aulast%3DMoffitt%26aufirst%3DT.%2BE.%26aulast%3DMokdad%26aufirst%3DA.%2BA.%26aulast%3DMonasta%26aufirst%3DL.%26aulast%3DMontico%26aufirst%3DM.%26aulast%3DMoradi-Lakeh%26aufirst%3DM.%26aulast%3DMoran%26aufirst%3DA.%26aulast%3DMorawska%26aufirst%3DL.%26aulast%3DMori%26aufirst%3DR.%26aulast%3DMurdoch%26aufirst%3DM.%2BE.%26aulast%3DMwaniki%26aufirst%3DM.%2BK.%26aulast%3DNaidoo%26aufirst%3DK.%26aulast%3DNair%26aufirst%3DM.%2BN.%26aulast%3DNaldi%26aufirst%3DL.%26aulast%3DNarayan%26aufirst%3DK.%2BM.%2BV.%26aulast%3DNelson%26aufirst%3DP.%2BK.%26aulast%3DNelson%26aufirst%3DR.%2BG.%26aulast%3DNevitt%26aufirst%3DM.%2BC.%26aulast%3DNewton%26aufirst%3DC.%2BR.%26aulast%3DNolte%26aufirst%3DS.%26aulast%3DNorman%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DR.%26aulast%3DO%2527Donnell%26aufirst%3DM.%26aulast%3DO%2527Hanlon%26aufirst%3DS.%26aulast%3DOlives%26aufirst%3DC.%26aulast%3DOmer%26aufirst%3DS.%2BB.%26aulast%3DOrtblad%26aufirst%3DK.%26aulast%3DOsborne%26aufirst%3DR.%26aulast%3DOzgediz%26aufirst%3DD.%26aulast%3DPage%26aufirst%3DA.%26aulast%3DPahari%26aufirst%3DB.%26aulast%3DPandian%26aufirst%3DJ.%2BD.%26aulast%3DRivero%26aufirst%3DA.%2BP.%26aulast%3DPatten%26aufirst%3DS.%2BB.%26aulast%3DPearce%26aufirst%3DN.%26aulast%3DPadilla%26aufirst%3DR.%2BP.%26aulast%3DPerez-Ruiz%26aufirst%3DF.%26aulast%3DPerico%26aufirst%3DN.%26aulast%3DPesudovs%26aufirst%3DK.%26aulast%3DPhillips%26aufirst%3DD.%26aulast%3DPhillips%26aufirst%3DM.%2BR.%26aulast%3DPierce%26aufirst%3DK.%26aulast%3DPion%26aufirst%3DS.%26aulast%3DPolanczyk%26aufirst%3DG.%2BV.%26aulast%3DPolinder%26aufirst%3DS.%26aulast%3DPope%26aufirst%3DC.%2BA.%26aulast%3DPopova%26aufirst%3DS.%26aulast%3DPorrini%26aufirst%3DE.%26aulast%3DPourmalek%26aufirst%3DF.%26aulast%3DPrince%26aufirst%3DM.%26aulast%3DPullan%26aufirst%3DR.%2BL.%26aulast%3DRamaiah%26aufirst%3DK.%2BD.%26aulast%3DRanganathan%26aufirst%3DD.%26aulast%3DRazavi%26aufirst%3DH.%26aulast%3DRegan%26aufirst%3DM.%26aulast%3DRehm%26aufirst%3DJ.%2BT.%26aulast%3DRein%26aufirst%3DD.%2BB.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DRichardson%26aufirst%3DK.%26aulast%3DRivara%26aufirst%3DF.%2BP.%26aulast%3DRoberts%26aufirst%3DT.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DDe%2BLe%25C3%25B2n%26aufirst%3DF.%2BR.%26aulast%3DRonfani%26aufirst%3DL.%26aulast%3DRoom%26aufirst%3DR.%26aulast%3DRosenfeld%26aufirst%3DL.%2BC.%26aulast%3DRushton%26aufirst%3DL.%26aulast%3DSacco%26aufirst%3DR.%2BL.%26aulast%3DSaha%26aufirst%3DS.%26aulast%3DSampson%26aufirst%3DU.%26aulast%3DSanchez-Riera%26aufirst%3DL.%26aulast%3DSanman%26aufirst%3DE.%26aulast%3DSchwebel%26aufirst%3DD.%2BC.%26aulast%3DScott%26aufirst%3DJ.%2BG.%26aulast%3DSegui-Gomez%26aufirst%3DM.%26aulast%3DShahraz%26aufirst%3DS.%26aulast%3DShepard%26aufirst%3DD.%2BS.%26aulast%3DShin%26aufirst%3DH.%26aulast%3DShivakoti%26aufirst%3DR.%26aulast%3DSilberberg%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DG.%2BM.%26aulast%3DSingh%26aufirst%3DJ.%2BA.%26aulast%3DSingleton%26aufirst%3DJ.%26aulast%3DSleet%26aufirst%3DD.%2BA.%26aulast%3DSliwa%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DStapelberg%26aufirst%3DN.%2BJ.%2BC.%26aulast%3DSteer%26aufirst%3DA.%26aulast%3DSteiner%26aufirst%3DT.%26aulast%3DStolk%26aufirst%3DW.%2BA.%26aulast%3DStovner%26aufirst%3DL.%2BJ.%26aulast%3DSudfeld%26aufirst%3DC.%26aulast%3DSyed%26aufirst%3DS.%26aulast%3DTamburlini%26aufirst%3DG.%26aulast%3DTavakkoli%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DH.%2BR.%26aulast%3DTaylor%26aufirst%3DJ.%2BA.%26aulast%3DTaylor%26aufirst%3DW.%2BJ.%26aulast%3DThomas%26aufirst%3DB.%26aulast%3DThomson%26aufirst%3DW.%2BM.%26aulast%3DThurston%26aufirst%3DG.%2BD.%26aulast%3DTleyjeh%26aufirst%3DI.%2BM.%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DTowbin%26aufirst%3DJ.%2BA.%26aulast%3DTruelsen%26aufirst%3DT.%26aulast%3DTsilimbaris%26aufirst%3DM.%2BK.%26aulast%3DUbeda%26aufirst%3DC.%26aulast%3DUndurraga%26aufirst%3DE.%2BA.%26aulast%3Dvan%2Bder%2BWerf%26aufirst%3DM.%2BJ.%26aulast%3Dvan%2BOs%26aufirst%3DJ.%26aulast%3DVavilala%26aufirst%3DM.%2BS.%26aulast%3DVenketasubramanian%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWatt%26aufirst%3DK.%26aulast%3DWeatherall%26aufirst%3DD.%2BJ.%26aulast%3DWeinstock%26aufirst%3DM.%2BA.%26aulast%3DWeintraub%26aufirst%3DR.%26aulast%3DWeisskopf%26aufirst%3DM.%2BG.%26aulast%3DWeissman%26aufirst%3DM.%2BM.%26aulast%3DWhite%26aufirst%3DR.%2BA.%26aulast%3DWhiteford%26aufirst%3DH.%26aulast%3DWiersma%26aufirst%3DS.%2BT.%26aulast%3DWilkinson%26aufirst%3DJ.%2BD.%26aulast%3DWilliams%26aufirst%3DH.%2BC.%26aulast%3DWilliams%26aufirst%3DS.%2BR.%26aulast%3DWitt%26aufirst%3DE.%26aulast%3DWolfe%26aufirst%3DF.%26aulast%3DWoolf%26aufirst%3DA.%2BD.%26aulast%3DWulf%26aufirst%3DS.%26aulast%3DYeh%26aufirst%3DP.-H.%26aulast%3DZaidi%26aufirst%3DA.%2BK.%26aulast%3DZheng%26aufirst%3DZ.-J.%26aulast%3DZonies%26aufirst%3DD.%26aulast%3DLopez%26aufirst%3DA.%2BD.%26aulast%3DMurray%26aufirst%3DC.%2BJ.%2BL.%26aulast%3DAlMazroa%26aufirst%3DM.%2BA.%26aulast%3DMemish%26aufirst%3DZ.%2BA.%26atitle%3DYears%2520lived%2520with%2520disability%2520%2528YLDs%2529%2520for%25201160%2520sequelae%2520of%2520289%2520diseases%2520and%2520injuries%25201990%25E2%2580%25932010%253A%2520A%2520systematic%2520analysis%2520for%2520the%2520global%2520burden%2520of%2520disease%2520study%25202010%26jtitle%3DLancet%26date%3D2012%26volume%3D380%26spage%3D2163%26epage%3D2196%26doi%3D10.1016%2FS0140-6736%2812%2961729-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thiboutot, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dréno, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abanmi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexis, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araviiskaia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barona Cabal, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettoli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casintahan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Costa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Ouazzani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollnick, H. P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herane, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honeyman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemeny, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubba, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyden, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Estebaranz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noppakun, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochsendorf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprica, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piquero-Martin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozada, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troielli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, L. F.</span></span> <span> </span><span class="NLM_article-title">Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne</span>. <i>J. Am. Acad. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">S1</span>– <span class="NLM_lpage">S23</span>, <span class="refDoi"> DOI: 10.1016/j.jaad.2017.09.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.jaad.2017.09.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=29127053" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=S1-S23&author=D.+M.+Thiboutotauthor=B.+Dr%C3%A9noauthor=A.+Abanmiauthor=A.+F.+Alexisauthor=E.+Araviiskaiaauthor=M.+I.+Barona+Cabalauthor=V.+Bettoliauthor=F.+Casintahanauthor=S.+Chowauthor=A.+da+Costaauthor=T.+El+Ouazzaniauthor=C.+L.+Gohauthor=H.+P.+M.+Gollnickauthor=M.+Gomezauthor=N.+Hayashiauthor=M.+I.+Heraneauthor=J.+Honeymanauthor=S.+Kangauthor=L.+Kemenyauthor=R.+Kubbaauthor=J.+Lambertauthor=A.+M.+Laytonauthor=J.+J.+Leydenauthor=J.+L.+L%C3%B3pez-Estebaranzauthor=N.+Noppakunauthor=F.+Ochsendorfauthor=C.+Opricaauthor=B.+Orozcoauthor=M.+Perezauthor=J.+Piquero-Martinauthor=J.+A.+Seeauthor=D.+H.+Suhauthor=J.+Tanauthor=V.+T.+Lozadaauthor=P.+Troielliauthor=L.+F.+Xiang&title=Practical+management+of+acne+for+clinicians%3A+An+international+consensus+from+the+Global+Alliance+to+Improve+Outcomes+in+Acne&doi=10.1016%2Fj.jaad.2017.09.078"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2017.09.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2017.09.078%26sid%3Dliteratum%253Aachs%26aulast%3DThiboutot%26aufirst%3DD.%2BM.%26aulast%3DDr%25C3%25A9no%26aufirst%3DB.%26aulast%3DAbanmi%26aufirst%3DA.%26aulast%3DAlexis%26aufirst%3DA.%2BF.%26aulast%3DAraviiskaia%26aufirst%3DE.%26aulast%3DBarona%2BCabal%26aufirst%3DM.%2BI.%26aulast%3DBettoli%26aufirst%3DV.%26aulast%3DCasintahan%26aufirst%3DF.%26aulast%3DChow%26aufirst%3DS.%26aulast%3Dda%2BCosta%26aufirst%3DA.%26aulast%3DEl%2BOuazzani%26aufirst%3DT.%26aulast%3DGoh%26aufirst%3DC.%2BL.%26aulast%3DGollnick%26aufirst%3DH.%2BP.%2BM.%26aulast%3DGomez%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DN.%26aulast%3DHerane%26aufirst%3DM.%2BI.%26aulast%3DHoneyman%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DKemeny%26aufirst%3DL.%26aulast%3DKubba%26aufirst%3DR.%26aulast%3DLambert%26aufirst%3DJ.%26aulast%3DLayton%26aufirst%3DA.%2BM.%26aulast%3DLeyden%26aufirst%3DJ.%2BJ.%26aulast%3DL%25C3%25B3pez-Estebaranz%26aufirst%3DJ.%2BL.%26aulast%3DNoppakun%26aufirst%3DN.%26aulast%3DOchsendorf%26aufirst%3DF.%26aulast%3DOprica%26aufirst%3DC.%26aulast%3DOrozco%26aufirst%3DB.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DPiquero-Martin%26aufirst%3DJ.%26aulast%3DSee%26aufirst%3DJ.%2BA.%26aulast%3DSuh%26aufirst%3DD.%2BH.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DLozada%26aufirst%3DV.%2BT.%26aulast%3DTroielli%26aufirst%3DP.%26aulast%3DXiang%26aufirst%3DL.%2BF.%26atitle%3DPractical%2520management%2520of%2520acne%2520for%2520clinicians%253A%2520An%2520international%2520consensus%2520from%2520the%2520Global%2520Alliance%2520to%2520Improve%2520Outcomes%2520in%2520Acne%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2018%26volume%3D78%26spage%3DS1%26epage%3DS23%26doi%3D10.1016%2Fj.jaad.2017.09.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dréno, B.</span></span> <span> </span><span class="NLM_article-title">What is new in the pathophysiology of acne, an overview</span>. <i>J. Eur. Acad. Dermatol. Venereol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1111/jdv.14374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1111%2Fjdv.14374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=28805938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlakt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=8-12&author=B.+Dr%C3%A9no&title=What+is+new+in+the+pathophysiology+of+acne%2C+an+overview&doi=10.1111%2Fjdv.14374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">What is new in the pathophysiology of acne, an overview</span></div><div class="casAuthors">Dreno, B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the European Academy of Dermatology and Venereology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">S5</span>),
    <span class="NLM_cas:pages">8-12</span>CODEN:
                <span class="NLM_cas:coden">JEAVEQ</span>;
        ISSN:<span class="NLM_cas:issn">1468-3083</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Acne is a chronic inflammatory disease of the pilosebaceous unit.  Its pathophysiol. includes hyperseborrhoea, abnormal follicular keratinization and Propionibacterium acnes proliferation in the pilosebaceous unit.  Recent research has shed some new light on the involvement of the sebaceous gland, as well as on the pro-inflammatory activity of the cutaneous microbiome.  During puberty, alteration of the sebaceous lipid profile, called dysseborrhoea, stress, irritation, cosmetics and potential dietary factors lead to inflammation and formation of different types of acne lesions.  Dysbiosis, the process leading to a disturbed skin barrier and disequil. of the cutaneous microbiome, resulting in the proliferation of P. acnes strains, is another important process that triggers acne.  P. acnes activates the innate immunity via the expression of protease activated receptors (PARs), tumor necrosis factor (TNF) α and toll-like receptors (TLRs), and the prodn. of interferon (INF) γ, interleukins (IL-8, IL12, IL-1), TNF, and matrix metalloproteinases (MMPs) by keratinocytes, resulting in the hyperkeratinization of the pilosebaceous unit.  Rebalancing the natural microbiome of the skin by restoring the natural skin barrier, limiting the proliferation of P. acnes on the skin by using topical antibacterials which do not cause resistance and regulating quantity and quality of sebum will be the main acne treatment challenges in the future.  The aim of this article to provide an update on the involvement of the sebaceous gland, the innate immunity and the cutaneous microbiome, how all of these factors promote acne and to illustrate their links with current and future treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotFmLmMfcPMbVg90H21EOLACvtfcHk0lgkqNvCPJdATA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlakt73P&md5=a0175785c47fea2f7f7f621847381fd5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fjdv.14374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjdv.14374%26sid%3Dliteratum%253Aachs%26aulast%3DDr%25C3%25A9no%26aufirst%3DB.%26atitle%3DWhat%2520is%2520new%2520in%2520the%2520pathophysiology%2520of%2520acne%252C%2520an%2520overview%26jtitle%3DJ.%2520Eur.%2520Acad.%2520Dermatol.%2520Venereol.%26date%3D2017%26volume%3D31%26spage%3D8%26epage%3D12%26doi%3D10.1111%2Fjdv.14374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moecking, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, S. L.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of NLRP1-mediated autoinflammatory disease in humans and mice</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>430</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2017.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.jmb.2017.07.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2018&pages=142-152&author=C.+H.+Yuauthor=J.+Moeckingauthor=M.+Geyerauthor=S.+L.+Masters&title=Mechanisms+of+NLRP1-mediated+autoinflammatory+disease+in+humans+and+mice&doi=10.1016%2Fj.jmb.2017.07.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2017.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2017.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DC.%2BH.%26aulast%3DMoecking%26aufirst%3DJ.%26aulast%3DGeyer%26aufirst%3DM.%26aulast%3DMasters%26aufirst%3DS.%2BL.%26atitle%3DMechanisms%2520of%2520NLRP1-mediated%2520autoinflammatory%2520disease%2520in%2520humans%2520and%2520mice%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D430%26spage%3D142%26epage%3D152%26doi%3D10.1016%2Fj.jmb.2017.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kistowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehrke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jankovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fettelschoss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmeyer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolios, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganceviciene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schauber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contassot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, L. E.</span></span> <span> </span><span class="NLM_article-title">IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1038/jid.2013.438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1038%2Fjid.2013.438" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=677-685&author=M.+Kistowskaauthor=S.+Gehrkeauthor=D.+Jankovicauthor=K.+Kerlauthor=A.+Fettelschossauthor=L.+Feldmeyerauthor=G.+Feniniauthor=A.+Koliosauthor=A.+Navariniauthor=R.+Gancevicieneauthor=J.+Schauberauthor=E.+Contassotauthor=L.+E.+French&title=IL-1%CE%B2+drives+inflammatory+responses+to+propionibacterium+acnes+in+vitro+and+in+vivo&doi=10.1038%2Fjid.2013.438"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fjid.2013.438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjid.2013.438%26sid%3Dliteratum%253Aachs%26aulast%3DKistowska%26aufirst%3DM.%26aulast%3DGehrke%26aufirst%3DS.%26aulast%3DJankovic%26aufirst%3DD.%26aulast%3DKerl%26aufirst%3DK.%26aulast%3DFettelschoss%26aufirst%3DA.%26aulast%3DFeldmeyer%26aufirst%3DL.%26aulast%3DFenini%26aufirst%3DG.%26aulast%3DKolios%26aufirst%3DA.%26aulast%3DNavarini%26aufirst%3DA.%26aulast%3DGanceviciene%26aufirst%3DR.%26aulast%3DSchauber%26aufirst%3DJ.%26aulast%3DContassot%26aufirst%3DE.%26aulast%3DFrench%26aufirst%3DL.%2BE.%26atitle%3DIL-1%25CE%25B2%2520drives%2520inflammatory%2520responses%2520to%2520propionibacterium%2520acnes%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2014%26volume%3D134%26spage%3D677%26epage%3D685%26doi%3D10.1038%2Fjid.2013.438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span> Assuming
equilibrium can be reached, then the free drug concentration in skin
should be comparable to that in blood at steady state. For a more
detailed explanation, see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span> <span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1038/nrd3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery&doi=10.1038%2Fnrd3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0ljcqmVe1u4DqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D929%26epage%3D939%26doi%3D10.1038%2Fnrd3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, P.</span></span> <span> </span><span class="NLM_article-title">Soft drug design: general principles and recent applications</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10608921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFWqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=58-101&author=N.+Bodorauthor=P.+Buchwald&title=Soft+drug+design%3A+general+principles+and+recent+applications&doi=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drug design: general principles and recent applications</span></div><div class="casAuthors">Bodor, Nicholas; Buchwald, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-101</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 208 refs.  Soft drug design represents a new approach aimed to design safer drugs with an increased therapeutic index by integrating metab. considerations into the drug design process.  Soft drugs are new therapeutic agents that undergo predictable metab. to inactive metabolites after exerting their therapeutic effect.  Hence, they are obtained by building into the mol., in addn. to the activity, the most desired way in which the mol. is to be deactivated and detoxified.  In an attempt to systematize and summarize the related work done in a no. of labs., including ours, the present review presents an overview of the general soft drug design principles and provides a variety of specific examples to illustrate the concepts.  A no. of already marketed drugs, such as esmolol, remifentanil, or loteprednol etabonate, resulted from the successful application of such design principles.  Many other promising drug candidates are currently under investigation in a variety of fields including possible soft antimicrobials, anticholinergics, corticosteroids, β-blockers, analgetics, ACE inhibitors, antiarrhythmics, and others.  Whenever possible, pharmacokinetic and pharmacodynamic properties are briefly summarized and compared to those of other compds. used in the same field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphV1vhXwTl8LVg90H21EOLACvtfcHk0ljcqmVe1u4DqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFWqsg%253D%253D&md5=e0ca493ba31d001e62a759be0fc4bcc8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528200001%252920%253A1%253C58%253A%253AAID-MED3%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DBodor%26aufirst%3DN.%26aulast%3DBuchwald%26aufirst%3DP.%26atitle%3DSoft%2520drug%2520design%253A%2520general%2520principles%2520and%2520recent%2520applications%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2000%26volume%3D20%26spage%3D58%26epage%3D101%26doi%3D10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsumi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakusa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, O.</span></span> <span> </span><span class="NLM_article-title">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1977</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.027797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1124%2Fdmd.109.027797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=19487250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1970-1977&author=S.+Nakayamaauthor=R.+Atsumiauthor=H.+Takakusaauthor=Y.+Kobayashiauthor=A.+Kuriharaauthor=Y.+Nagaiauthor=D.+Nakaiauthor=O.+Okazaki&title=A+zone+classification+system+for+risk+assessment+of+idiosyncratic+drug+toxicity+using+daily+dose+and+covalent+binding&doi=10.1124%2Fdmd.109.027797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span></div><div class="casAuthors">Nakayama, Shintaro; Atsumi, Ryo; Takakusa, Hideo; Kobayashi, Yoshimasa; Kurihara, Atsushi; Nagai, Yoko; Nakai, Daisuke; Okazaki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1970-1977</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The risk of idiosyncratic drug toxicity (IDT) is of great concern to the pharmaceutical industry.  Current hypotheses based on retrospective studies suggest that the occurrence of IDT is related to covalent binding and daily dose.  The authors detd. the covalent binding of 42 radiolabeled drugs in three test systems (human liver microsomes and hepatocytes in vitro and rat liver in vivo) to assess the risk of IDT.  On the basis of safety profiles given in official documentation, tested drugs were classified into the safety categories of safe, warning, black box warning, and withdrawn.  The covalent binding in each of the three test systems did not distinguish the safety categories clearly.  However, when the log-normalized covalent binding was plotted against the log-normalized daily dose, the distribution of the plot in the safety categories became clear.  An ordinal logistic regression anal. indicated that both covalent binding and daily dose were significantly correlated with safety category and that covalent binding in hepatocytes was the best predictor among the three systems.  When two sepn. lines were drawn on the correlation graph between covalent binding in human hepatocytes and daily dose by a regression anal. to create three zones, 30 of 37 tested drugs were located in zones corresponding to their resp. classified safety categories.  In conclusion, the authors established a zone classification system using covalent binding in human hepatocytes and daily dose for the risk assessment of IDTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtahZPkNJ3JbVg90H21EOLACvtfcHk0ljiMwqa53_GGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO&md5=425119e0451fc50ec6ca95d5e3fe5fd3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.027797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.027797%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DAtsumi%26aufirst%3DR.%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DA.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DNakai%26aufirst%3DD.%26aulast%3DOkazaki%26aufirst%3DO.%26atitle%3DA%2520zone%2520classification%2520system%2520for%2520risk%2520assessment%2520of%2520idiosyncratic%2520drug%2520toxicity%2520using%2520daily%2520dose%2520and%2520covalent%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1970%26epage%3D1977%26doi%3D10.1124%2Fdmd.109.027797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Howley, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearnhead, H. O.</span></span> <span> </span><span class="NLM_article-title">Caspases as therapeutic targets</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1502</span>– <span class="NLM_lpage">1516</span>, <span class="refDoi"> DOI: 10.1111/j.1582-4934.2008.00292.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1111%2Fj.1582-4934.2008.00292.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=18298652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVarsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1502-1516&author=B.+Howleyauthor=H.+O.+Fearnhead&title=Caspases+as+therapeutic+targets&doi=10.1111%2Fj.1582-4934.2008.00292.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Caspases as therapeutic targets</span></div><div class="casAuthors">Howley, B.; Fearnhead, H. O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5A</span>),
    <span class="NLM_cas:pages">1502-1516</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The development of small mols. to modulate caspase activity offers a novel therapeutic strategy in the treatment of apoptosis-related and inflammatory diseases.  Caspases are key mediators of apoptosis and inflammation; deregulation of their activation or expression can lead to the development of conditions such as neurodegenerative and autoinflammatory disorders.  This review details the different caspase-assocd. disorders while focusing on caspase-1 inhibition as a potential therapeutic strategy.  Problems facing the development of effective and safe caspase therapeutics will also be addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocysVbrR7n4bVg90H21EOLACvtfcHk0ljiMwqa53_GGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVarsbbI&md5=f439705c22843fdc973a71e3218ec3ad</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00292.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00292.x%26sid%3Dliteratum%253Aachs%26aulast%3DHowley%26aufirst%3DB.%26aulast%3DFearnhead%26aufirst%3DH.%2BO.%26atitle%3DCaspases%2520as%2520therapeutic%2520targets%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2008%26volume%3D12%26spage%3D1502%26epage%3D1516%26doi%3D10.1111%2Fj.1582-4934.2008.00292.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schipper, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. C.</span></span> <span> </span><span class="NLM_article-title">The potential for caspases in drug discovery</span>. <i>Curr. Opin. Drug Discovery Devel.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=568-576&author=S.+H.+MacKenzieauthor=J.+L.+Schipperauthor=A.+C.+Clark&title=The+potential+for+caspases+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DS.%2BH.%26aulast%3DSchipper%26aufirst%3DJ.%2BL.%26aulast%3DClark%26aufirst%3DA.%2BC.%26atitle%3DThe%2520potential%2520for%2520caspases%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Devel.%26date%3D2010%26volume%3D13%26spage%3D568%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="note"><p class="first last">In our experience, the hepatic stability of compounds designed for the systemic route often leads to difficulties in development.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T.</span>; <span class="NLM_string-name">Linton, S. D.</span></span> <i>Design of Caspase Inhibitors as Potential Clinical Agents</i>; <span class="NLM_publisher-name">CRC Press/Taylor & Francis Group</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>, <span class="NLM_year">2009</span>; pp  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">132</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=82-132&author=T.+O%E2%80%99Brien&author=S.+D.+Linton&title=Design+of+Caspase+Inhibitors+as+Potential+Clinical+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26btitle%3DDesign%2520of%2520Caspase%2520Inhibitors%2520as%2520Potential%2520Clinical%2520Agents%26pub%3DCRC%2520Press%252FTaylor%2520%2526%2520Francis%2520Group%26date%3D2009%26spage%3D82%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <i>Evaluation of Enzyme Inhibition in Drug Discovery: A Guide to Medicinal Chemists and Pharmacologists</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Wiley-Interscience</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2013</span>; 294 pp.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1002%2F9781118540398" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibition+in+Drug+Discovery%3A+A+Guide+to+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2F9781118540398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118540398%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibition%2520in%2520Drug%2520Discovery%253A%2520A%2520Guide%2520to%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DWiley-Interscience%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">General mechanism of reversible covalent bond formation between catalytic cysteine and reactive warhead occurs through general base catalysis via histidine 237 and concomitant attack of cysteine 285 on an electrophilic center, usually a carbonyl.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_001.pdf" class="ext-link">Scheme 1S in Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">PGE-3935199 (<b>5</b>):</p></div><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Soper, D. L.</span>; <span class="NLM_string-name">O’Neil, S. V.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Oppong, K. A.</span>; <span class="NLM_string-name">Ellis, C. D.</span>; <span class="NLM_string-name">Laufersweiler, M. C.</span>; <span class="NLM_string-name">Demuth, T. P.</span>; <span class="NLM_string-name">Fancher, A. N.</span>; <span class="NLM_string-name">Lu, W.</span>; <span class="NLM_string-name">Wang, R. L.</span>; <span class="NLM_string-name">Schwecke, W. P.</span>; <span class="NLM_string-name">Cruze, C. A.</span>; <span class="NLM_string-name">Buchalova, M.</span>; <span class="NLM_string-name">Belkin, M.</span>; <span class="NLM_string-name">Wos, J. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and discovery of PGE-527667, an orally bioavailable caspase-1 inhibitor</span>.  <i>Abstracts of Papers</i>, 228th National Meeting of the American Chemical Society, Philadelphia, PA, U.S., 2004; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2004</span>; MEDI-268.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=D.+L.+Soper&author=S.+V.+O%E2%80%99Neil&author=Y.+Wang&author=K.+A.+Oppong&author=C.+D.+Ellis&author=M.+C.+Laufersweiler&author=T.+P.+Demuth&author=A.+N.+Fancher&author=W.+Lu&author=R.+L.+Wang&author=W.+P.+Schwecke&author=C.+A.+Cruze&author=M.+Buchalova&author=M.+Belkin&author=J.+A.+Wos&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSoper%26aufirst%3DD.%2BL.%26atitle%3DSynthesis%2520and%2520discovery%2520of%2520PGE-527667%252C%2520an%2520orally%2520bioavailable%2520caspase-1%2520inhibitor%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Soper, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheville, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufersweiler, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppong, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baize, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fancher, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suchanek, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwecke, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruze, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchalova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belkin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wireko, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, T. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of novel 8,5-fused bicyclic peptidomimetic compounds as interleukin-1β converting enzyme (ICE) inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7880</span>– <span class="NLM_lpage">7892</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.07.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.bmc.2006.07.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=7880-7892&author=D.+L.+Soperauthor=J.+X.+Shevilleauthor=S.+V.+O%E2%80%99Neilauthor=Y.+Wangauthor=M.+C.+Laufersweilerauthor=K.+A.+Oppongauthor=J.+A.+Wosauthor=C.+D.+Ellisauthor=M.+W.+Baizeauthor=J.+J.+Chenauthor=A.+N.+Fancherauthor=W.+Luauthor=M.+K.+Suchanekauthor=R.+L.+Wangauthor=W.+P.+Schweckeauthor=C.+A.+Cruzeauthor=M.+Buchalovaauthor=M.+Belkinauthor=F.+Wirekoauthor=A.+Ritterauthor=B.+Deauthor=D.+Wangauthor=T.+P.+Demuth&title=Synthesis+and+evaluation+of+novel+8%2C5-fused+bicyclic+peptidomimetic+compounds+as+interleukin-1%CE%B2+converting+enzyme+%28ICE%29+inhibitors&doi=10.1016%2Fj.bmc.2006.07.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.07.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.07.056%26sid%3Dliteratum%253Aachs%26aulast%3DSoper%26aufirst%3DD.%2BL.%26aulast%3DSheville%26aufirst%3DJ.%2BX.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLaufersweiler%26aufirst%3DM.%2BC.%26aulast%3DOppong%26aufirst%3DK.%2BA.%26aulast%3DWos%26aufirst%3DJ.%2BA.%26aulast%3DEllis%26aufirst%3DC.%2BD.%26aulast%3DBaize%26aufirst%3DM.%2BW.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DFancher%26aufirst%3DA.%2BN.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DSuchanek%26aufirst%3DM.%2BK.%26aulast%3DWang%26aufirst%3DR.%2BL.%26aulast%3DSchwecke%26aufirst%3DW.%2BP.%26aulast%3DCruze%26aufirst%3DC.%2BA.%26aulast%3DBuchalova%26aufirst%3DM.%26aulast%3DBelkin%26aufirst%3DM.%26aulast%3DWireko%26aufirst%3DF.%26aulast%3DRitter%26aufirst%3DA.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DDemuth%26aufirst%3DT.%2BP.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%25208%252C5-fused%2520bicyclic%2520peptidomimetic%2520compounds%2520as%2520interleukin-1%25CE%25B2%2520converting%2520enzyme%2520%2528ICE%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D7880%26epage%3D7892%26doi%3D10.1016%2Fj.bmc.2006.07.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14c.0"><span>ZYVAD-FMK (<b>7</b>):</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ZYVAD-FMK+%287%29%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c.0&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochevar, I. E.</span></span> <span> </span><span class="NLM_article-title">Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 Cells</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>250</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1006/excr.1999.4501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1006%2Fexcr.1999.4501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10388534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADyaK1MXktV2ksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=1999&pages=203-212&author=S.+Zhuangauthor=M.+C.+Lynchauthor=I.+E.+Kochevar&title=Caspase-8+mediates+caspase-3+activation+and+cytochrome+c+release+during+singlet+oxygen-induced+apoptosis+of+HL-60+Cells&doi=10.1006%2Fexcr.1999.4501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-8 Mediates Caspase-3 Activation and Cytochrome c Release during Singlet Oxygen-Induced Apoptosis of HL-60 Cells</span></div><div class="casAuthors">Zhuang, Shougang; Lynch, Mary C.; Kochevar, Irene E.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">250</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">203-212</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">We reported previously that singlet oxygen, generated by irradn. of rose bengal with visible light, induced apoptosis in human promyelocytic leukemia HL-60 cells.  However, the mechanism of apoptosis caused by this reactive oxygen species is unclear.  In this study, we demonstrate that singlet oxygen induced caspase-3 activation and Z-DEVD-FMK, a caspase-3 inhibitor, blocked apoptosis induction, while caspase-1 activity was not detectable and the caspase-1 inhibitor Z-YVAD-FMK had a very limited effect on apoptosis.  This suggests that the activation of caspase-3 by singlet oxygen is essential for the commitment of cells to undergo apoptosis.  Further studies showed that singlet oxygen induced an increase in caspase-8 activity and a redn. in mitochondrial cytochrome c.  Time course anal. indicated that the cleavage of caspase-8 precedes that of caspase-3.  In addn., blockade of caspase-8 by Z-IETD-FMK inhibited cleavage of pro-caspase-3 and prevented loss of mitochondrial cytochrome c.  These results suggest that caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis in HL-60 cells.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXafrd6x_Y97Vg90H21EOLACvtfcHk0lhwTuLtqby_nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktV2ksbg%253D&md5=9826a2faf5c8dd9b78eb8753acfa1a50</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1999.4501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1999.4501%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DS.%26aulast%3DLynch%26aufirst%3DM.%2BC.%26aulast%3DKochevar%26aufirst%3DI.%2BE.%26atitle%3DCaspase-8%2520mediates%2520caspase-3%2520activation%2520and%2520cytochrome%2520c%2520release%2520during%2520singlet%2520oxygen-induced%2520apoptosis%2520of%2520HL-60%2520Cells%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D250%26spage%3D203%26epage%3D212%26doi%3D10.1006%2Fexcr.1999.4501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">This is also corroborated by preincubating caspase-1 with the inhibitors before the addition of substrate to allow slow equilibrium to take place. Indeed, a linear relationship was found between the log ratios of the IC<sub>50</sub> values measured with the two incubation periods (0 and 1 h) vs the two substrate concentrations. Thus, these two different sets of two experimental conditions are affected in a similar fashion by compounds that are slow to reach Michaelis–Menten equilibrium. See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_001.pdf" class="ext-link">Figure 1S in Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">Because the half-life of caspase-1 was shown to be below 10 min, we did not attempt to optimize this variable as a longer residence time would not translate into prolonged efficacy. See, for example, the following:</p></div><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logue, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lüthi, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. J.</span></span> <span> </span><span class="NLM_article-title">Caspase-1 promiscuity is counterbalanced by rapid inactivation of processed enzyme</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">32513</span>– <span class="NLM_lpage">32524</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.225862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1074%2Fjbc.M111.225862" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=32513-32524&author=J.+G.+Walshauthor=S.+E.+Logueauthor=A.+U.+L%C3%BCthiauthor=S.+J.+Martin&title=Caspase-1+promiscuity+is+counterbalanced+by+rapid+inactivation+of+processed+enzyme&doi=10.1074%2Fjbc.M111.225862"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.225862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.225862%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DJ.%2BG.%26aulast%3DLogue%26aufirst%3DS.%2BE.%26aulast%3DL%25C3%25BCthi%26aufirst%3DA.%2BU.%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26atitle%3DCaspase-1%2520promiscuity%2520is%2520counterbalanced%2520by%2520rapid%2520inactivation%2520of%2520processed%2520enzyme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D32513%26epage%3D32524%26doi%3D10.1074%2Fjbc.M111.225862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venhorst, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, C. G.</span></span> <span> </span><span class="NLM_article-title">Target-drug interactions: first principles and their application to drug discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.drudis.2011.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=21777691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns12gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=10-22&author=S.+N%C3%BA%C3%B1ezauthor=J.+Venhorstauthor=C.+G.+Kruse&title=Target-drug+interactions%3A+first+principles+and+their+application+to+drug+discovery&doi=10.1016%2Fj.drudis.2011.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Target-drug interactions: first principles and their application to drug discovery</span></div><div class="casAuthors">Nunez, Sara; Venhorst, Jennifer; Kruse, Chris G.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">10-22</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this review, we begin by introducing the basic principles of kinetics and thermodn. of target-drug binding within the context of drug discovery.  In addn., we present a meta-anal. of the recent literature describing the kinetic and thermodn. resoln. of successful clin. candidates with diverse mechanisms of action.  We finish by discussing the best practices in the triage and chem. optimization towards clin. candidates with maximal in vivo efficacy devoid of adverse events.  The utilization of the kinetic and thermodn. signatures of preclin. leads is proving pivotal in their triage and rational optimization towards clin. candidates with maximal in vivo efficacy devoid of adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-KD3TmQ_PbbVg90H21EOLACvtfcHk0lhwTuLtqby_nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns12gsQ%253D%253D&md5=9656faef61159898077def9fbe502360</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DS.%26aulast%3DVenhorst%26aufirst%3DJ.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26atitle%3DTarget-drug%2520interactions%253A%2520first%2520principles%2520and%2520their%2520application%2520to%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D10%26epage%3D22%26doi%3D10.1016%2Fj.drudis.2011.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span> The azabicyclooctane
is the object of another communication; see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Rodeschini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brethon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantalat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clary, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastreich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isabet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreau, E.</span></span> <span> </span><span class="NLM_article-title">New Caspase-1 inhibitor by scaffold hopping into bio-inspired 3D-fragment space</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5373</span>– <span class="NLM_lpage">5377</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.bmcl.2017.11.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5373-5377&author=V.+Rodeschiniauthor=A.+Brethonauthor=L.+Chantalatauthor=O.+Christinauthor=L.+Claryauthor=J.-F.+Fournierauthor=M.+Gastreichauthor=C.+S.+Harrisauthor=T.+Isabetauthor=D.+Rocheauthor=J.+Pascauauthor=E.+Thoreau&title=New+Caspase-1+inhibitor+by+scaffold+hopping+into+bio-inspired+3D-fragment+space&doi=10.1016%2Fj.bmcl.2017.11.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DRodeschini%26aufirst%3DV.%26aulast%3DBrethon%26aufirst%3DA.%26aulast%3DChantalat%26aufirst%3DL.%26aulast%3DChristin%26aufirst%3DO.%26aulast%3DClary%26aufirst%3DL.%26aulast%3DFournier%26aufirst%3DJ.-F.%26aulast%3DGastreich%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DIsabet%26aufirst%3DT.%26aulast%3DRoche%26aufirst%3DD.%26aulast%3DPascau%26aufirst%3DJ.%26aulast%3DThoreau%26aufirst%3DE.%26atitle%3DNew%2520Caspase-1%2520inhibitor%2520by%2520scaffold%2520hopping%2520into%2520bio-inspired%25203D-fragment%2520space%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5373%26epage%3D5377%26doi%3D10.1016%2Fj.bmcl.2017.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahr, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopko, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waal, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimundo, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanowski, M.</span></span> <span> </span><span class="NLM_article-title">Structural analysis of caspase-1 inhibitors derived from Tethering</span>. <i>Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">451</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1107/S1744309105010109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1107%2FS1744309105010109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=16511067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=451-458&author=T.+O%E2%80%99Brienauthor=B.+T.+Fahrauthor=M.+M.+Sopkoauthor=J.+W.+Lamauthor=N.+D.+Waalauthor=B.+C.+Raimundoauthor=H.+E.+Purkeyauthor=P.+Phamauthor=M.+Romanowski&title=Structural+analysis+of+caspase-1+inhibitors+derived+from+Tethering&doi=10.1107%2FS1744309105010109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analysis of caspase-1 inhibitors derived from tethering</span></div><div class="casAuthors">O'Brien, Tom; Fahr, Bruce T.; Sopko, Michelle M.; Lam, Joni W.; Waal, Nathan D.; Raimundo, Brian C.; Purkey, Hans E.; Pham, Phuongly; Romanowski, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">451-458</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Caspase-1 is a key endopeptidase responsible for the post-translational processing of the IL-1β and IL-18 cytokines and small-mol. inhibitors that modulate the activity of this enzyme are predicted to be important therapeutic treatments for many inflammatory diseases.  A fragment-assembly approach, accompanied by structural anal., was employed to generate caspase-1 inhibitors.  With the aid of Tethering with extenders (small mols. that bind to the active-site cysteine and contain a free thiol), two novel fragments that bound to the active site and made a disulfide bond with the extender were identified by mass spectrometry.  Direct linking of each fragment to the extender generated submicromolar reversible inhibitors that significantly reduced secretion of IL-1β but not IL-6 from human peripheral blood mononuclear cells.  Thus, Tethering with extenders facilitated rapid identification and synthesis of caspase-1 inhibitors with cell-based activity and subsequent structural analyses provided insights into the enzyme's ability to accommodate different inhibitor-binding modes in the active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMkYqntJ_HZLVg90H21EOLACvtfcHk0lhEP2cxPmwAyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVehsb8%253D&md5=2fa16fde66c84a35d8fe97c8a0931af6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1107%2FS1744309105010109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309105010109%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26aulast%3DFahr%26aufirst%3DB.%2BT.%26aulast%3DSopko%26aufirst%3DM.%2BM.%26aulast%3DLam%26aufirst%3DJ.%2BW.%26aulast%3DWaal%26aufirst%3DN.%2BD.%26aulast%3DRaimundo%26aufirst%3DB.%2BC.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DPham%26aufirst%3DP.%26aulast%3DRomanowski%26aufirst%3DM.%26atitle%3DStructural%2520analysis%2520of%2520caspase-1%2520inhibitors%2520derived%2520from%2520Tethering%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2005%26volume%3D61%26spage%3D451%26epage%3D458%26doi%3D10.1107%2FS1744309105010109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, J. T.</span></span> <span> </span><span class="NLM_article-title">Ligand efficiency indices as guideposts for drug discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(05)03386-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2FS1359-6446%2805%2903386-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=15809192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=464-469&author=C.+Abad-Zapateroauthor=J.+T.+Metz&title=Ligand+efficiency+indices+as+guideposts+for+drug+discovery&doi=10.1016%2FS1359-6446%2805%2903386-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices as guideposts for drug discovery</span></div><div class="casAuthors">Abad-Zapatero Cele; Metz James T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">464-9</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHqVfZXUq224qdXsLcGTEUfW6udTcc2eYFfXBT2NPr9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D&md5=1720f263a306122c86a57463e5a39287</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903386-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903386-6%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DMetz%26aufirst%3DJ.%2BT.%26atitle%3DLigand%2520efficiency%2520indices%2520as%2520guideposts%2520for%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D464%26epage%3D469%26doi%3D10.1016%2FS1359-6446%2805%2903386-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span> <span> </span><span class="NLM_article-title">Fragment-based drug design: How big is too big?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6972</span>– <span class="NLM_lpage">6976</span>, <span class="refDoi"> DOI: 10.1021/jm060511h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060511h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6972-6976&author=P.+J.+Hajduk&title=Fragment-based+drug+design%3A+How+big+is+too+big%3F&doi=10.1021%2Fjm060511h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Design: How Big Is Too Big?</span></div><div class="casAuthors">Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6972-6976</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Much has been discussed about the proper physicochem. properties (e.g., mol. wt., hydrophobicity, etc.) that should be considered when utilizing fragment leads in drug design.  However, little has been reported as to what emphasis, if any, should be placed on the potency of the resulting fragment leads.  In this report, a retrospective anal. of 18 highly optimized inhibitors is described in which the compds. were systematically deconstructed until the minimal binding elements could be identified.  An anal. of the potency changes that were obsd. as the leads were reduced in size indicate that a nearly linear relationship exists between mol. wt. and binding affinity over the entire range of sizes and potencies represented in the dataset.  On the basis of these observations, prediction maps can be constructed that enable crit. and quant. assessments of the process of lead identification and optimization.  These data place well-defined limits on the ideal size and potency of fragment leads that are being considered for use in fragment-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfCz9NMtBgNrVg90H21EOLACvtfcHk0liDXwpJDh9JRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLbJ&md5=b27d4ca6446a033b82e0ea223da5e6de</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm060511h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060511h%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DFragment-based%2520drug%2520design%253A%2520How%2520big%2520is%2520too%2520big%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6972%26epage%3D6976%26doi%3D10.1021%2Fjm060511h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span> <span> </span><span class="NLM_article-title">Drug-like properties and the causes of poor solubility and poor permeability</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/S1056-8719(00)00107-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2FS1056-8719%2800%2900107-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=11274893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=235-249&author=C.+A.+Lipinski&title=Drug-like+properties+and+the+causes+of+poor+solubility+and+poor+permeability&doi=10.1016%2FS1056-8719%2800%2900107-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like properties and the causes of poor solubility and poor permeability</span></div><div class="casAuthors">Lipinski C A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-49</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">There are currently about 10000 drug-like compounds.  These are sparsely, rather than uniformly, distributed through chemistry space.  True diversity does not exist in experimental combinatorial chemistry screening libraries.  Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics and exobiotics.  ADME is hard to predict for large data sets because current ADME experimental screens are multi-mechanisms, and predictions get worse as more data accumulates.  Currently, screening for biological receptor activity precedes or is concurrent with screening for properties related to "drugability." In the future, "drugability" screening may precede biological receptor activity screening.  The level of permeability or solubility needed for oral absorption is related to potency.  The relative importance of poor solubility and poor permeability towards the problem of poor oral absorption depends on the research approach used for lead generation.  A "rational drug design" approach as exemplified by Merck advanced clinical candidates leads to time-dependent higher molecular weight, higher H-bonding properties, unchanged lipophilicity, and, hence, poorer permeability.  A high throughput screening (HTS)-based approach as exemplified by unpublished data on Pfizer (Groton, CT) early candidates leads to higher molecular weight, unchanged H-bonding properties, higher lipophilicity, and, hence, poorer aqueous solubility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmUcEou3dTa_EeosoOnpOLfW6udTcc2easjfJX-zH5kbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D&md5=aeb705afe1eccaceaf441c7a19f13ecc</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2800%2900107-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252800%252900107-6%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DDrug-like%2520properties%2520and%2520the%2520causes%2520of%2520poor%2520solubility%2520and%2520poor%2520permeability%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2000%26volume%3D44%26spage%3D235%26epage%3D249%26doi%3D10.1016%2FS1056-8719%2800%2900107-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalkowsky, S. H.</span></span> <span> </span><span class="NLM_article-title">Estimation of the aqueous solubility i: application to organic nonelectrolytes</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1002/1520-6017(200102)90:2<234::AID-JPS14>3.0.CO;2-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1002%2F1520-6017%28200102%2990%3A2%3C234%3A%3AAID-JPS14%3E3.0.CO%3B2-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=11169540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1yktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2001&pages=234-252&author=N.+Jainauthor=S.+H.+Yalkowsky&title=Estimation+of+the+aqueous+solubility+i%3A+application+to+organic+nonelectrolytes&doi=10.1002%2F1520-6017%28200102%2990%3A2%3C234%3A%3AAID-JPS14%3E3.0.CO%3B2-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of the aqueous solubility I: Application to organic nonelectrolytes</span></div><div class="casAuthors">Jain, Neera; Yalkowsky, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">234-252</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The estn. of aq. solubilities of org. nonelectrolytes by the General Soly. Equation (GSE) as proposed by Valvani and Yalkowsky (1980) is used.  The data and assumptions on which the GSE are based are reevaluated, and the equation is revised.  The revised GSE is validated on a set of 580 pharmaceutically, environmentally, and industrially relevant nonelectrolytes.  The revised equation has a stronger theor. background and provides a more accurate estn. of aq. soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokht7kvEZSF7Vg90H21EOLACvtfcHk0liDXwpJDh9JRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1yktbo%253D&md5=d0ff887aeb74953499706b49598277f4</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1002%2F1520-6017%28200102%2990%3A2%3C234%3A%3AAID-JPS14%3E3.0.CO%3B2-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1520-6017%2528200102%252990%253A2%253C234%253A%253AAID-JPS14%253E3.0.CO%253B2-V%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DN.%26aulast%3DYalkowsky%26aufirst%3DS.%2BH.%26atitle%3DEstimation%2520of%2520the%2520aqueous%2520solubility%2520i%253A%2520application%2520to%2520organic%2520nonelectrolytes%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2001%26volume%3D90%26spage%3D234%26epage%3D252%26doi%3D10.1002%2F1520-6017%28200102%2990%3A2%3C234%3A%3AAID-JPS14%3E3.0.CO%3B2-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalkowsky, S. H.</span></span> <span> </span><span class="NLM_article-title">Prediction of drug solubility by the general solubility equation (GSE)</span>. <i>J. Chem. Inf. Comput. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">354</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1021/ci000338c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci000338c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislKntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=354-357&author=Y.+Ranauthor=S.+H.+Yalkowsky&title=Prediction+of+drug+solubility+by+the+general+solubility+equation+%28GSE%29&doi=10.1021%2Fci000338c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Drug Solubility by the General Solubility Equation (GSE)</span></div><div class="casAuthors">Ran, Yingqing; Yalkowsky, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">354-357</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The revised GSE proposed by Jain and Yalkowsky is used to est. the aq. soly. of a set of org. nonelectrolytes studied by Jorgensen and Duffy.  The only inputs used in the GSE are the Celsius m.p. (MP) and the octanol water partition coeff. (Kow).  These are generally known, easily measured, or easily calcd.  The GSE does not utilize any fitted parameters.  The av. abs. error for the 150 compds. is 0.43 compared to 0.56 with Jorgensen and Duffy's computational method, which utilizes 5 fitted parameters.  Thus, the revised GSE is simpler and provides a more accurate estn. of aq. soly. of the same set of org. compds.  It is also more accurate than the original version of the GSE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC0cl3QciSf7Vg90H21EOLACvtfcHk0liDXwpJDh9JRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislKntA%253D%253D&md5=c15ffefdf6aacf5fdafd95e5adad7017</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fci000338c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci000338c%26sid%3Dliteratum%253Aachs%26aulast%3DRan%26aufirst%3DY.%26aulast%3DYalkowsky%26aufirst%3DS.%2BH.%26atitle%3DPrediction%2520of%2520drug%2520solubility%2520by%2520the%2520general%2520solubility%2520equation%2520%2528GSE%2529%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2001%26volume%3D41%26spage%3D354%26epage%3D357%26doi%3D10.1021%2Fci000338c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span>Furthermore,
the importance of good organic and aqueous solubility for skin permeation
has been demonstrated by Sloan and co-workers.<span class="NLM_contrib-group"><span class="NLM_string-name">Sloan, K. B.</span>; <span class="NLM_string-name">Wasdo, S. C.</span></span> In  <i>Prodrugs: Challenges and Rewards Part 1</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, V. J.</span>, <span class="NLM_string-name">Borchardt, R. T.</span>, <span class="NLM_string-name">Hageman, M. J.</span>, <span class="NLM_string-name">Oliyai, R.</span>, <span class="NLM_string-name">Maag, H.</span>; <span class="NLM_string-name">Tilley, J. W.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">123</span> and references cited therein..</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=86-123&author=K.+B.+Sloan&author=S.+C.+Wasdoauthor=V.+J.+Stella&author=R.+T.+Borchardt&author=M.+J.+Hageman&author=R.+Oliyai&author=H.+Maag&author=J.+W.+Tilley&title=Prodrugs%3A+Challenges+and+Rewards+Part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSloan%26aufirst%3DK.%2BB.%26btitle%3DProdrugs%253A%2520Challenges%2520and%2520Rewards%2520Part%25201%26aulast%3DStella%26aufirst%3DV.%2BJ.%26pub%3DSpringer%26date%3D2007%26spage%3D86%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sepassi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalkowsky, S. H.</span></span> <span> </span><span class="NLM_article-title">Solubility prediction in octanol: A technical note</span>. <i>AAPS PharmSciTech</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">E184</span>– <span class="NLM_lpage">E191</span>, <span class="refDoi"> DOI: 10.1208/pt070126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1208%2Fpt070126" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=E184-E191&issue=1&author=K.+Sepassiauthor=S.+H.+Yalkowsky&title=Solubility+prediction+in+octanol%3A+A+technical+note&doi=10.1208%2Fpt070126"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1208%2Fpt070126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fpt070126%26sid%3Dliteratum%253Aachs%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DYalkowsky%26aufirst%3DS.%2BH.%26atitle%3DSolubility%2520prediction%2520in%2520octanol%253A%2520A%2520technical%2520note%26jtitle%3DAAPS%2520PharmSciTech%26date%3D2006%26volume%3D7%26issue%3D1%26spage%3DE184%26epage%3DE191%26doi%3D10.1208%2Fpt070126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">Compound lipophilicity is evaluated at pH 6.5 by the chromatographic method described by Valko and then expressed as ChromLogD using the equation described by Young: ChromLogD = CHI × 0.0857 – 2.</p></div><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Valko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, D.</span></span> <span> </span><span class="NLM_article-title">Chromatographic hydrophobicity index by fast-gradient RP-HPLC: A high-throughput alternative to logP/logD</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">2022</span>– <span class="NLM_lpage">2029</span>, <span class="refDoi"> DOI: 10.1021/ac961242d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac961242d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1997&pages=2022-2029&author=K.+Valkoauthor=C.+Bevanauthor=D.+Reynolds&title=Chromatographic+hydrophobicity+index+by+fast-gradient+RP-HPLC%3A+A+high-throughput+alternative+to+logP%2FlogD&doi=10.1021%2Fac961242d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Fac961242d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac961242d%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%26aulast%3DBevan%26aufirst%3DC.%26aulast%3DReynolds%26aufirst%3DD.%26atitle%3DChromatographic%2520hydrophobicity%2520index%2520by%2520fast-gradient%2520RP-HPLC%253A%2520A%2520high-throughput%2520alternative%2520to%2520logP%252FlogD%26jtitle%3DAnal.%2520Chem.%26date%3D1997%26volume%3D69%26spage%3D2022%26epage%3D2029%26doi%3D10.1021%2Fac961242d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span> <span> </span><span class="NLM_article-title">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">822</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.drudis.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=21704184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=822-830&author=R.+J.+Youngauthor=D.+V.+S.+Greenauthor=C.+N.+Luscombeauthor=A.+P.+Hill&title=Getting+physical+in+drug+discovery+II%3A+the+impact+of+chromatographic+hydrophobicity+measurements+and+aromaticity&doi=10.1016%2Fj.drudis.2011.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span></div><div class="casAuthors">Young, Robert J.; Green, Darren V. S.; Luscombe, Christopher N.; Hill, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17/18</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here, we review the performance of chromatog. hydrophobicity measurements in a data set of 100 000 GlaxoSmithKline compds., demonstrating the advantages of the method over octanol-water partitioning and highlighting new insights for drug discovery.  The value of chromatog. measurements, vs. other hydrophobicity ests., was supported by improved relationships with soly., permeation, cytochrome P450s, intrinsic clearance, hERG binding and promiscuity.  We also obsd. marked differentiation of the relative influence of intrinsic and effective hydrophobicity.  The summing of hydrophobicity values plus arom. ring count [log D pH7.4 (or log P) + #Ar], indicated a wide relevance for simplistic property forecast indexes' in developability assays, clearly enhanced by chromatog. values; therefore establishing new foundations for enriching property-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmIJyWi-DBW7Vg90H21EOLACvtfcHk0lj3uFnBEH_lGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF&md5=22788603a45aa77537e8666433473d14</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DGreen%26aufirst%3DD.%2BV.%2BS.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DHill%26aufirst%3DA.%2BP.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%2520II%253A%2520the%2520impact%2520of%2520chromatographic%2520hydrophobicity%2520measurements%2520and%2520aromaticity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D822%26epage%3D830%26doi%3D10.1016%2Fj.drudis.2011.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schultes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haaksma, E. E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krämer, O.</span></span> <span> </span><span class="NLM_article-title">A medicinal chemistry perspective on melting point: matched molecular pair analysis of the effects of simple descriptors on the melting point of drug-like compounds</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">584</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1039/c2md00313a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1039%2Fc2md00313a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFart7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=584-591&author=S.+Schultesauthor=C.+de+Graafauthor=H.+Bergerauthor=M.+Mayerauthor=A.+Steffenauthor=E.+E.+J.+Haaksmaauthor=I.+J.+P.+de+Eschauthor=R.+Leursauthor=O.+Kr%C3%A4mer&title=A+medicinal+chemistry+perspective+on+melting+point%3A+matched+molecular+pair+analysis+of+the+effects+of+simple+descriptors+on+the+melting+point+of+drug-like+compounds&doi=10.1039%2Fc2md00313a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">A medicinal chemistry perspective on melting point: matched molecular pair analysis of the effects of simple descriptors on the melting point of drug-like compounds</span></div><div class="casAuthors">Schultes, Sabine; de Graaf, Chris; Berger, Helmut; Mayer, Moriz; Steffen, Andreas; Haaksma, Eric E. J.; de Esch, Iwan J. P.; Leurs, Rob; Kraemer, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">584-591</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The influence of simple mol. descriptors on the m.p. temp. (Tm) was studied using a matched mol. pair (MMP) anal.  This method was used to identify small structural differences between pairs of mols. which are related to changes in Tm.  Anal. shows that the no. of hydrogen bond donors, hydrogen bond acceptors and rotatable bonds has a significant effect on the Tm of a mol.  Hydrogen bond donors have the most pronounced effect.  Also, the studies reveal that not ClogP but rather the no. of bromine and iodine atoms has a marked effect on the Tm.  The results of MMP anal. are discussed within the context of drug soly. optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxP8780R4L_LVg90H21EOLACvtfcHk0lj3uFnBEH_lGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFart7Y%253D&md5=ce0f5645a6d73788c7d83811fb708167</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1039%2Fc2md00313a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md00313a%26sid%3Dliteratum%253Aachs%26aulast%3DSchultes%26aufirst%3DS.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DH.%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DSteffen%26aufirst%3DA.%26aulast%3DHaaksma%26aufirst%3DE.%2BE.%2BJ.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DO.%26atitle%3DA%2520medicinal%2520chemistry%2520perspective%2520on%2520melting%2520point%253A%2520matched%2520molecular%2520pair%2520analysis%2520of%2520the%2520effects%2520of%2520simple%2520descriptors%2520on%2520the%2520melting%2520point%2520of%2520drug-like%2520compounds%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D584%26epage%3D591%26doi%3D10.1039%2Fc2md00313a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Withnall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tetko, I. V.</span></span> <span> </span><span class="NLM_article-title">Matched molecular pair analysis on large melting point datasets: a big data perspective</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1002%2Fcmdc.201700303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=28650584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKmtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=599-606&author=M.+Withnallauthor=H.+Chenauthor=I.+V.+Tetko&title=Matched+molecular+pair+analysis+on+large+melting+point+datasets%3A+a+big+data+perspective&doi=10.1002%2Fcmdc.201700303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pair Analysis on Large Melting Point Datasets: A Big Data Perspective</span></div><div class="casAuthors">Withnall, Michael; Chen, Hongming; Tetko, Igor V.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-606</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A matched mol. pair (MMP) anal. was used to examine the change in m.p. (MP) between pairs of similar mols. in a set of ∼275k compds.  The authors found many cases in which the change in MP (ΔMP) of compds. correlates with changes in functional groups.  In line with the results of a previous study, correlations between ΔMP and simple mol. descriptors, such as the no. of hydrogen bond donors, were identified.  In using a larger dataset, covering a wider chem. space and range of m.ps., the authors obsd. that this method remains stable and scales well with larger datasets.  This MMP-based method could find use as a simple privacy-preserving technique to analyze large proprietary databases and share findings between participating research groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7U9HkXCnBg7Vg90H21EOLACvtfcHk0lg83opR9c2jUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKmtrbN&md5=1f820decb1057f59ec79a0e55ba9a206</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700303%26sid%3Dliteratum%253Aachs%26aulast%3DWithnall%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTetko%26aufirst%3DI.%2BV.%26atitle%3DMatched%2520molecular%2520pair%2520analysis%2520on%2520large%2520melting%2520point%2520datasets%253A%2520a%2520big%2520data%2520perspective%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D599%26epage%3D606%26doi%3D10.1002%2Fcmdc.201700303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">Aqueous solubilities are determined using a semithermodynamic protocol where a mixture obtained from a 10 mM DMSO solution is diluted in pH 7.4 buffered water and is stirred for 24 h.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">This match pair was an extreme case in our data set. The average ΔpSol<sub>aq</sub> over 4 naphthalene vs quinoxaline matched pairs was 0.08, and the average ΔChromLogD was 1.1. None of matched pairs showed a significantly more aqueous soluble quinoxaline.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">Drug substance color can be a commercial liability in topical products. For this reason, colorless compounds are highly favored.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span>Photocytotoxicity potential was assessed in a
keratinocytes NRU assay adapted from the 3T3 NRU assay described in
the OECD guideline 432. Cells were irradiated with UV daily simulation
at 6 J/cm<sup>2</sup>, and cells viability was determined after 24
h exposure with chemicals. The sensitivity of the 3T3 NRU-PT is high,
and if a compound is negative in this assay, it would have a very
low probability of being phototoxic in humans. However, a positive
result in the 3T3 NRU-PT should not be regarded as indicative of a
likely clinical phototoxic risk but rather a flag for follow-up assessment.
For more details, see the following:<span class="NLM_contrib-group">OECD</span>.  <i>Test No. 432: In Vitro 3T3 NRU Phototoxicity Test</i>; <span class="NLM_publisher-name">OECD Publishing</span>: <span class="NLM_publisher-loc">Paris</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1787%2F9789264071162-en" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=OECD&title=Test+No.+432%3A+In+Vitro+3T3+NRU+Phototoxicity+Test"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1787%2F9789264071162-en&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1787%252F9789264071162-en%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DTest%2520No.%2520432%253A%2520In%2520Vitro%25203T3%2520NRU%2520Phototoxicity%2520Test%26pub%3DOECD%2520Publishing%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span> For a more detailed analysis
of the importance of physicochemical parameters on phototoxicity,
see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouix-Peter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzy, A.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouvry, G.</span></span> <span> </span><span class="NLM_article-title">Intrinsic property forecast (iPFI) as a rule of thumb for medicinal chemist to remove a photo-toxicity liability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3231</span>– <span class="NLM_lpage">3236</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3231-3236&author=J.-F.+Fournierauthor=C.+Bouix-Peterauthor=D.+Duvertauthor=A.-P.+Luzyauthor=G.+Ouvry&title=Intrinsic+property+forecast+%28iPFI%29+as+a+rule+of+thumb+for+medicinal+chemist+to+remove+a+photo-toxicity+liability&doi=10.1021%2Facs.jmedchem.8b00075"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00075%26sid%3Dliteratum%253Aachs%26aulast%3DFournier%26aufirst%3DJ.-F.%26aulast%3DBouix-Peter%26aufirst%3DC.%26aulast%3DDuvert%26aufirst%3DD.%26aulast%3DLuzy%26aufirst%3DA.-P.%26aulast%3DOuvry%26aufirst%3DG.%26atitle%3DIntrinsic%2520property%2520forecast%2520%2528iPFI%2529%2520as%2520a%2520rule%2520of%2520thumb%2520for%2520medicinal%2520chemist%2520to%2520remove%2520a%2520photo-toxicity%2520liability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3231%26epage%3D3236%26doi%3D10.1021%2Facs.jmedchem.8b00075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span> For the role of conjugated π
electrons in phototoxicity, see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Haranosono, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaki, H.</span></span> <span> </span><span class="NLM_article-title">Establishment of an <i>in silico</i> phototoxicity prediction method by combining descriptors related to photo-absorption and photo-reaction</span>. <i>J. Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.2131/jts.39.655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.2131%2Fjts.39.655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=25056790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVentrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=655-664&author=Y.+Haranosonoauthor=M.+Kurataauthor=H.+Sakaki&title=Establishment+of+an+in+silico+phototoxicity+prediction+method+by+combining+descriptors+related+to+photo-absorption+and+photo-reaction&doi=10.2131%2Fjts.39.655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Establishment of an in silico phototoxicity prediction method by combining descriptors related to photo-absorption and photo-reaction</span></div><div class="casAuthors">Haranosono, Yu; Kurata, Masaaki; Sakaki, Hideyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Toxicological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">655-664</span>CODEN:
                <span class="NLM_cas:coden">JTSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0388-1350</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society of Toxicology</span>)
        </div><div class="casAbstract">One of the mechanisms of phototoxicity is photo-reaction, such as reactive oxygen species (ROS) generation following photo-absorption.  We focused on ROS generation and photo-absorption as key-steps, because these key-steps are able to be described by photochem. properties, and these properties are dependent on chem. structure.  Photo-reactivity of a compd. is described by HOMO-LUMO Gap (HLG), generally.  Herein, we showed that HLG can be used as a descriptor of the generation of reactive oxygen species.  Moreover, the max.-conjugated π electron no. (PENMC), which we found as a descriptor of photo-absorption, could also predict in vitro phototoxicity.  Each descriptor could predict in vitro phototoxicity with 70.0% concordance, but there was un-predicted area found (gray zone).  Interestingly, some compds. in each gray zone were not common, indicating that the combination of two descriptors could improve prediction potential.  We reset the cut-off lines to define pos. zone, neg. zone and gray zone for each descriptor.  Thereby we overlapped HLG and PENMC in a graph, and divided the total area to nine zones with cut-off lines of each descriptor.  The rules to prediction were decided to achieve the best concordance, and the concordances were improved up to 82.8% for self-validation, 81.6% for cross-validation.  We found common properties among false pos. or neg. compds., photo-reactive structure and photo-allergenic, resp.  In addn., our method could be adapted to compds. rich in structural diversity using only chem. structure without any statistical anal. and complicated calcn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6-LipbO6LOLVg90H21EOLACvtfcHk0lg83opR9c2jUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVentrjF&md5=4ef07067c76343efcfd2a5f5d0f7d6f0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2131%2Fjts.39.655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2131%252Fjts.39.655%26sid%3Dliteratum%253Aachs%26aulast%3DHaranosono%26aufirst%3DY.%26aulast%3DKurata%26aufirst%3DM.%26aulast%3DSakaki%26aufirst%3DH.%26atitle%3DEstablishment%2520of%2520an%2520in%2520silico%2520phototoxicity%2520prediction%2520method%2520by%2520combining%2520descriptors%2520related%2520to%2520photo-absorption%2520and%2520photo-reaction%26jtitle%3DJ.%2520Toxicol.%2520Sci.%26date%3D2014%26volume%3D39%26spage%3D655%26epage%3D664%26doi%3D10.2131%2Fjts.39.655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="note"><p class="first last">Topical programs resemble inhalation ones in that inhibitors should be rapidly cleared once they reach systemic distribution to prevent toxicity issues. However they still need to be stable in skin in order to achieve efficacy. For a review on skin metabolism, see the following:</p></div><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, C. K.</span></span> <span> </span><span class="NLM_article-title">Minireview: biotransformation of drugs in human skin</span>. <i>Drug</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1124/dmd.108.024794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1124%2Fdmd.108.024794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Krs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=247-253&author=C.+K.+Svensson&title=Minireview%3A+biotransformation+of+drugs+in+human+skin&doi=10.1124%2Fdmd.108.024794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation of drugs in human skin</span></div><div class="casAuthors">Svensson, Craig K.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-253</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Although it is the largest organ of the human body, skin is often not considered in discussions of drug metab.  However, there is growing evidence that most common drug-metabolizing enzymes are expressed in the skin.  Evidence for expression of cytochromes P 450, flavin monooxygenases, glutathione-S-transferases, N-acetyltransferases, and sulfotransferases in human skin and skin cells are presented.  Addnl. discussion is focused on the evidence of actual metab. of drugs.  Finally, the potential clin. implications of metab. within the skin are discussed briefly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2GNsGESefO7Vg90H21EOLACvtfcHk0ljfSNhSby08rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Krs7k%253D&md5=c7bb178e9cfcd22a11dee43b9c396ff8</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024794%26sid%3Dliteratum%253Aachs%26aulast%3DSvensson%26aufirst%3DC.%2BK.%26atitle%3DMinireview%253A%2520biotransformation%2520of%2520drugs%2520in%2520human%2520skin%26jtitle%3DDrug%26date%3D2009%26volume%3D37%26spage%3D247%26epage%3D253%26doi%3D10.1124%2Fdmd.108.024794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oesch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oesch-Bartlomowicz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landsiedel, R.</span></span> <span> </span><span class="NLM_article-title">Drug-metabolizing enzymes in the skin of man, rat, and pig</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1080/03602530701690366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1080%2F03602530701690366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=18058329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlyitbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=659-698&author=F.+Oeschauthor=E.+Fabianauthor=B.+Oesch-Bartlomowiczauthor=C.+Wernerauthor=R.+Landsiedel&title=Drug-metabolizing+enzymes+in+the+skin+of+man%2C+rat%2C+and+pig&doi=10.1080%2F03602530701690366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-Metabolizing Enzymes in the Skin of Man, Rat, and Pig</span></div><div class="casAuthors">Oesch, Franz; Fabian, Eric; Oesch-Bartlomowicz, Barbara; Werner, Christoph; Landsiedel, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">659-698</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The mammalian skin has long been considered to be poor in drug metab.  However, many reports clearly show that most drug metabolizing enzymes also occur in the mammalian skin albeit at relatively low specific activities.  This review summarizes the current state of knowledge on drug metabolizing enzymes in the skin of human, rat, and pig, the latter, because it is often taken as a model for human skin on grounds of anatomical similarities.  However only little is known about drug metabolizing enzymes in pig skin.  Interestingly, some cytochromes P 450 (CYP) have been obsd. in the rat skin which are not expressed in the rat liver, such as CYP 2B12 and CYP2D4.  As far as investigated most drug metabolizing enzymes occur in the suprabasal (i.e. differentiating) layers of the epidermis, but the rat CYP1A1 rather in the basal layer and human UDP-glucuronosyltransferase rather in the stratum corneum.  The pattern of drug metabolizing enzymes and their localization will impact not only the beneficial as well as detrimental properties of drugs for the skin but also dictate whether a drug reaches the blood flow unchanged or as activated or inactivated metabolite(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofhs_tmoLY7bVg90H21EOLACvtfcHk0ljfSNhSby08rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlyitbnO&md5=43dcf77be2bd31c8a5629321f959bc10</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1080%2F03602530701690366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03602530701690366%26sid%3Dliteratum%253Aachs%26aulast%3DOesch%26aufirst%3DF.%26aulast%3DFabian%26aufirst%3DE.%26aulast%3DOesch-Bartlomowicz%26aufirst%3DB.%26aulast%3DWerner%26aufirst%3DC.%26aulast%3DLandsiedel%26aufirst%3DR.%26atitle%3DDrug-metabolizing%2520enzymes%2520in%2520the%2520skin%2520of%2520man%252C%2520rat%252C%2520and%2520pig%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2007%26volume%3D39%26spage%3D659%26epage%3D698%26doi%3D10.1080%2F03602530701690366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">Stability of compounds with the aspartylaldehyde warhead was first evaluated in a few common excipients as well as a simple mixture at 40 °C for 1 month. Results showed compounds were more prone to decomposition when PG was present, possibly because of acetal formation following addition of the diol. Ethanol was therefore selected as excipient of choice for this assay. See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_001.pdf" class="ext-link">Figure 2S in Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">Average absolute error between extrapolation and measured value was 6.9% with a median of 3.5%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span>For simplicity, all tautomers and potential stereoisomers were assimilated
to parent. Stereochemical stability was evaluated in separate assays
which could not be evaluated in a high throughput fashion. A detailed
discussion on the chemical and stereochemical stability of different
caspase-1 inhibitor series and warheads is in preparation:<span class="NLM_contrib-group"><span class="NLM_string-name">Chambon, S.</span>; <span class="NLM_string-name">Talano, S.</span>; <span class="NLM_string-name">Millois, C.</span>; <span class="NLM_string-name">Dumais, L.</span>; <span class="NLM_string-name">Pierre, R.</span>; <span class="NLM_string-name">Mathieu, C.</span>; <span class="NLM_string-name">Ghilini, A.-L.</span>; <span class="NLM_string-name">Vanthuyne, N.</span>; <span class="NLM_string-name">Reverse, K.</span>; <span class="NLM_string-name">Brethon, A.</span>; <span class="NLM_string-name">Rodeschini, V.</span>; <span class="NLM_string-name">Comino, C.</span>; <span class="NLM_string-name">Mouis, G.</span>; <span class="NLM_string-name">El-Bazbouz, G.</span>; <span class="NLM_string-name">Clary, L.</span>; <span class="NLM_string-name">Fournier, J.-F.</span>; <span class="NLM_string-name">Bouix-Peter, C.</span>; <span class="NLM_string-name">Tomas, L.</span>; <span class="NLM_string-name">Hennequin, L. F.</span>; <span class="NLM_string-name">Harris, C. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and stability evaluation of novel caspase 1 inhibitors for topical application</span>. Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+simplicity%2C+all+tautomers+and+potential+stereoisomers+were+assimilated%0Ato+parent.+Stereochemical+stability+was+evaluated+in+separate+assays%0Awhich+could+not+be+evaluated+in+a+high+throughput+fashion.+A+detailed%0Adiscussion+on+the+chemical+and+stereochemical+stability+of+different%0Acaspase-1+inhibitor+series+and+warheads+is+in+preparation%3AChambon%2C+S.%3B+Talano%2C+S.%3B+Millois%2C+C.%3B+Dumais%2C+L.%3B+Pierre%2C+R.%3B+Mathieu%2C+C.%3B+Ghilini%2C+A.-L.%3B+Vanthuyne%2C+N.%3B+Reverse%2C+K.%3B+Brethon%2C+A.%3B+Rodeschini%2C+V.%3B+Comino%2C+C.%3B+Mouis%2C+G.%3B+El-Bazbouz%2C+G.%3B+Clary%2C+L.%3B+Fournier%2C+J.-F.%3B+Bouix-Peter%2C+C.%3B+Tomas%2C+L.%3B+Hennequin%2C+L.+F.%3B+Harris%2C+C.+S.+Synthesis+and+stability+evaluation+of+novel+caspase+1+inhibitors+for+topical+application.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DChambon%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520stability%2520evaluation%2520of%2520novel%2520caspase%25201%2520inhibitors%2520for%2520topical%2520application" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span> For a recent discussion on cysteine
protease warheads design, see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, J. F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddad Franco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitas-Junior, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burtoloso, A. C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitão, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span> <span> </span><span class="NLM_article-title">A comparative study of warheads for design of cysteine protease inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5031</span>– <span class="NLM_lpage">5035</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.bmcl.2017.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=29054358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yjsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5031-5035&author=D.+G.+Silvaauthor=J.+F.+R.+Ribeiroauthor=D.+De+Vitaauthor=L.+Cianniauthor=C.+Haddad+Francoauthor=L.+H.+Freitas-Juniorauthor=C.+B.+Moraesauthor=J.+R.+Rochaauthor=A.+C.+B.+Burtolosoauthor=P.+W.+Kennyauthor=A.+Leit%C3%A3oauthor=C.+A.+Montanari&title=A+comparative+study+of+warheads+for+design+of+cysteine+protease+inhibitors&doi=10.1016%2Fj.bmcl.2017.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of warheads for design of cysteine protease inhibitors</span></div><div class="casAuthors">Silva, Daniel G.; Ribeiro, Jean F. R.; De Vita, Daniela; Cianni, Lorenzo; Franco, Caio Haddad; Freitas-Junior, Lucio H.; Moraes, Carolina Borsoi; Rocha, Josmar R.; Burtoloso, Antonio C. B.; Kenny, Peter W.; Leitao, Andrei; Montanari, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5031-5035</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The effects on potency of cruzain inhibition of replacing a nitrile group with alternative warheads were explored.  The oxime was almost an order of magnitude more potent than the corresponding nitrile and has the potential to provide access to the prime side of the catalytic site.  Dipeptide aldehydes and azadipeptide nitriles were found to be two orders of magnitude more potent cruzain inhibitors than the corresponding dipeptide nitriles although potency differences were modulated by substitution at P1 and P3.  Replacement of the α methylene of a dipeptide aldehyde with cyclopropane led to a loss of potency of almost three orders of magnitude.  The vinyl esters and amides that were characterized as reversible inhibitors were less potent than the corresponding nitrile by between one and two orders of magnitude.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1EsVPrEhve7Vg90H21EOLACvtfcHk0ljfSNhSby08rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yjsL%252FI&md5=0e2c0c2f3bc188bd43e05c14a1b8d963</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DD.%2BG.%26aulast%3DRibeiro%26aufirst%3DJ.%2BF.%2BR.%26aulast%3DDe%2BVita%26aufirst%3DD.%26aulast%3DCianni%26aufirst%3DL.%26aulast%3DHaddad%2BFranco%26aufirst%3DC.%26aulast%3DFreitas-Junior%26aufirst%3DL.%2BH.%26aulast%3DMoraes%26aufirst%3DC.%2BB.%26aulast%3DRocha%26aufirst%3DJ.%2BR.%26aulast%3DBurtoloso%26aufirst%3DA.%2BC.%2BB.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DLeit%25C3%25A3o%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DA%2520comparative%2520study%2520of%2520warheads%2520for%2520design%2520of%2520cysteine%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5031%26epage%3D5035%26doi%3D10.1016%2Fj.bmcl.2017.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Free, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. W.</span></span> <span> </span><span class="NLM_article-title">A mathematical contribution to structure-activity studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1021/jm00334a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00334a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADyaF2cXkt1OltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1964&pages=395-399&author=S.+M.+Freeauthor=J.+W.+Wilson&title=A+mathematical+contribution+to+structure-activity+studies&doi=10.1021%2Fjm00334a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A mathematical contribution to structure-activity studies</span></div><div class="casAuthors">Free, Spencer M., Jr.; Wilson, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A math. technique is suggested as a means of describing structure-activity relation of a series of chem. analogs.  The data requirements included specific side chain arrangements and performance characteristics of all analogs tested.  Two examples illustrate the use of the additive math. model where the performance characteristics are measures of biol. activity.  The results rank the structural changes per position by estg. the amt. of biol. response attributed to each change.  The estimates are both pos. and neg.  Several uses for the math. soln. are suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRyTj3xI-aH7Vg90H21EOLACvtfcHk0lguF5HKH65Uug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXkt1OltbY%253D&md5=88fabb64d7a5635506a11418a2744bd6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm00334a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00334a001%26sid%3Dliteratum%253Aachs%26aulast%3DFree%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26atitle%3DA%2520mathematical%2520contribution%2520to%2520structure-activity%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1964%26volume%3D7%26spage%3D395%26epage%3D399%26doi%3D10.1021%2Fjm00334a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="note"><p class="first last">No stability data were generated for the active warheads B (oxopentanoate), C (acrylamide), and F (nitrile) as they showed a significant shift in the cellular assay to lower potencies. As a general rule, compounds were shifted about 5-fold. Roughly 25% were shifted more than 10-fold, and none were shifted more than 100-fold. The reasons behind this shift could be due to usual factors such as difference in serum and substrate content but also to kinetics.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="note"><p class="first last">Stability SPR was not always additive. For this reason, caution was used when constituting the data set and interpreting the analysis.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="note"><p class="first last">Albeit counterintuitive at first, picolinamide was, in our hands, generally more lipophilic than their benzamide counterpart in part due to the intramolecular H-bond between the pyridine lone pair and the carboxamide NH. In the case of our uracils, this can then lead to a higher risk of phototoxicity even in the case of the ortho-substituted <b>17</b> since conjugation of the π systems is then restored. For discussions on the role of IMHB in medicinal chemistry, see, for example, the following:</p></div><div class="NLM_citation" id="cit41a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2601</span>– <span class="NLM_lpage">2611</span>, <span class="refDoi"> DOI: 10.1021/jm100087s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry&doi=10.1021%2Fjm100087s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0lguF5HKH65Uug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611%26doi%3D10.1021%2Fjm100087s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit41b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tardia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolfa, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangiatordi, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolotti, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lattanzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berardi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzariti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colabufo, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellamare, S.</span></span> <span> </span><span class="NLM_article-title">Trimethoxybenzanilide-Based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6403</span>– <span class="NLM_lpage">6418</span>, <span class="refDoi"> DOI: 10.1021/jm500697c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500697c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6403-6418&author=P.+Tardiaauthor=A.+Stefanachiauthor=M.+Nisoauthor=D.+A.+Stolfaauthor=G.+F.+Mangiatordiauthor=D.+Albergaauthor=O.+Nicolottiauthor=G.+Lattanziauthor=A.+Carottiauthor=F.+Leonettiauthor=R.+Perroneauthor=F.+Berardiauthor=A.+Azzaritiauthor=N.+A.+Colabufoauthor=S.+Cellamare&title=Trimethoxybenzanilide-Based+P-glycoprotein+modulators%3A+an+interesting+case+of+lipophilicity+tuning+by+intramolecular+hydrogen+bonding&doi=10.1021%2Fjm500697c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1021%2Fjm500697c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500697c%26sid%3Dliteratum%253Aachs%26aulast%3DTardia%26aufirst%3DP.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DStolfa%26aufirst%3DD.%2BA.%26aulast%3DMangiatordi%26aufirst%3DG.%2BF.%26aulast%3DAlberga%26aufirst%3DD.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLattanzi%26aufirst%3DG.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DAzzariti%26aufirst%3DA.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DCellamare%26aufirst%3DS.%26atitle%3DTrimethoxybenzanilide-Based%2520P-glycoprotein%2520modulators%253A%2520an%2520interesting%2520case%2520of%2520lipophilicity%2520tuning%2520by%2520intramolecular%2520hydrogen%2520bonding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6403%26epage%3D6418%26doi%3D10.1021%2Fjm500697c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="note"><p class="first last">The impact of the cyclopropyl moiety on chemical stability was not general as other molecular matched pairs showed the reverse impact.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">South, M. S.</span>; <span class="NLM_string-name">Rueppel, M. L.</span>; <span class="NLM_string-name">Jones, D.</span></span> <span> </span><span class="NLM_article-title">Substituted Polycyclic Aryl and Heteroaryl Uracils Useful for Selective Inhibition of the Coagulation Cascade</span>. PCT Int. Appl. <span class="NLM_patent">WO2001087852</span>, <span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=M.+S.+South&author=M.+L.+Rueppel&author=D.+Jones&title=Substituted+Polycyclic+Aryl+and+Heteroaryl+Uracils+Useful+for+Selective+Inhibition+of+the+Coagulation+Cascade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSouth%26aufirst%3DM.%2BS.%26atitle%3DSubstituted%2520Polycyclic%2520Aryl%2520and%2520Heteroaryl%2520Uracils%2520Useful%2520for%2520Selective%2520Inhibition%2520of%2520the%2520Coagulation%2520Cascade%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit43b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhendwa, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, D. F.</span></span> <span> </span><span class="NLM_article-title">Benzhydryl as an efficient selective nitrogen protecting group for uracils</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">9307</span>– <span class="NLM_lpage">9309</span>, <span class="refDoi"> DOI: 10.1021/jo0485076</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0485076" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=9307-9309&author=F.+Wuauthor=M.+G.+Buhendwaauthor=D.+F.+Weaver&title=Benzhydryl+as+an+efficient+selective+nitrogen+protecting+group+for+uracils&doi=10.1021%2Fjo0485076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1021%2Fjo0485076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0485076%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DF.%26aulast%3DBuhendwa%26aufirst%3DM.%2BG.%26aulast%3DWeaver%26aufirst%3DD.%2BF.%26atitle%3DBenzhydryl%2520as%2520an%2520efficient%2520selective%2520nitrogen%2520protecting%2520group%2520for%2520uracils%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D9307%26epage%3D9309%26doi%3D10.1021%2Fjo0485076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boiteau, J.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouix-Peter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clary, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daver, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumais, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mebrouk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millois, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodeville, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas, L.</span></span> <span> </span><span class="NLM_article-title">An efficient multi-component synthesis of <i>N</i>-1-alkylated 5-nitrouracils from α-amino acids</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2367</span>– <span class="NLM_lpage">2371</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2016.04.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.tetlet.2016.04.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=2367-2371&author=J.-G.+Boiteauauthor=C.+Bouix-Peterauthor=S.+Chambonauthor=L.+Claryauthor=S.+Daverauthor=L.+Dumaisauthor=J.-F.+Fournierauthor=C.+S.+Harrisauthor=K.+Mebroukauthor=C.+Milloisauthor=R.+Pierreauthor=N.+Rodevilleauthor=S.+Talanoauthor=L.+Tomas&title=An+efficient+multi-component+synthesis+of+N-1-alkylated+5-nitrouracils+from+%CE%B1-amino+acids&doi=10.1016%2Fj.tetlet.2016.04.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2016.04.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2016.04.039%26sid%3Dliteratum%253Aachs%26aulast%3DBoiteau%26aufirst%3DJ.-G.%26aulast%3DBouix-Peter%26aufirst%3DC.%26aulast%3DChambon%26aufirst%3DS.%26aulast%3DClary%26aufirst%3DL.%26aulast%3DDaver%26aufirst%3DS.%26aulast%3DDumais%26aufirst%3DL.%26aulast%3DFournier%26aufirst%3DJ.-F.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DMebrouk%26aufirst%3DK.%26aulast%3DMillois%26aufirst%3DC.%26aulast%3DPierre%26aufirst%3DR.%26aulast%3DRodeville%26aufirst%3DN.%26aulast%3DTalano%26aufirst%3DS.%26aulast%3DTomas%26aufirst%3DL.%26atitle%3DAn%2520efficient%2520multi-component%2520synthesis%2520of%2520N-1-alkylated%25205-nitrouracils%2520from%2520%25CE%25B1-amino%2520acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2016%26volume%3D57%26spage%3D2367%26epage%3D2371%26doi%3D10.1016%2Fj.tetlet.2016.04.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maligres, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcoux, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillier, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabowski, E. J. J.</span></span> <span> </span><span class="NLM_article-title">Practical, Highly convergent, asymmetric synthesis of a selective PPARγ modulator</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1021/op8002882</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op8002882" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=525-534&author=P.+E.+Maligresauthor=G.+R.+Humphreyauthor=J.-F.+Marcouxauthor=M.+C.+Hillierauthor=D.+Zhaoauthor=S.+Krskaauthor=E.+J.+J.+Grabowski&title=Practical%2C+Highly+convergent%2C+asymmetric+synthesis+of+a+selective+PPAR%CE%B3+modulator&doi=10.1021%2Fop8002882"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fop8002882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop8002882%26sid%3Dliteratum%253Aachs%26aulast%3DMaligres%26aufirst%3DP.%2BE.%26aulast%3DHumphrey%26aufirst%3DG.%2BR.%26aulast%3DMarcoux%26aufirst%3DJ.-F.%26aulast%3DHillier%26aufirst%3DM.%2BC.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DKrska%26aufirst%3DS.%26aulast%3DGrabowski%26aufirst%3DE.%2BJ.%2BJ.%26atitle%3DPractical%252C%2520Highly%2520convergent%252C%2520asymmetric%2520synthesis%2520of%2520a%2520selective%2520PPAR%25CE%25B3%2520modulator%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2009%26volume%3D13%26spage%3D525%26epage%3D534%26doi%3D10.1021%2Fop8002882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Faham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subirós-Funosas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prohens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albericio, F.</span></span> <span> </span><span class="NLM_article-title">COMU: A Safer and More Effective replacement for benzotriazole-based uronium coupling reagents</span>. <i>Chem.—Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">9404</span>– <span class="NLM_lpage">9416</span>, <span class="refDoi"> DOI: 10.1002/chem.200900615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1002%2Fchem.200900615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=19621394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGlu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=9404-9416&author=A.+El-Fahamauthor=R.+Subir%C3%B3s-Funosasauthor=R.+Prohensauthor=F.+Albericio&title=COMU%3A+A+Safer+and+More+Effective+replacement+for+benzotriazole-based+uronium+coupling+reagents&doi=10.1002%2Fchem.200900615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">COMU: A Safer and More Effective Replacement for Benzotriazole-Based Uronium Coupling Reagents</span></div><div class="casAuthors">El-Faham, Ayman; Funosas, Ramon Subiros; Prohens, Rafel; Albericio, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">9404-9416, S9404/1-S9404/34</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors describe a new family of uronium-type coupling reagents that differ in their iminium moieties and leaving groups.  The presence of the morpholino group in conjunction with an oxime deriv., esp. Et 2-cyano-2-(hydroxyimino)acetate (Oxyma), had a marked influence on the solubilities, stabilities, and reactivities of the reagents.  Finally, the new uronium salt I (COMU) derived from Oxyma performed extremely well in the presence of only 1 equiv of base, thereby confirming the effect of the hydrogen bond acceptor in the reaction.  I also showed a less hazardous safety profile than the benzotriazole-based HDMA and HDMB, which exhibited unpredictable autocatalytic decompns.  Furthermore, the Oxyma moiety contained in I suggests a lower risk of explosion than in the case of the benzotriazole derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFM_Djmx8l9rVg90H21EOLACvtfcHk0lhLQW9Lq8-3jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGlu7fO&md5=9f415ba22d4414a93226d741b0cbfd30</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fchem.200900615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200900615%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Faham%26aufirst%3DA.%26aulast%3DSubir%25C3%25B3s-Funosas%26aufirst%3DR.%26aulast%3DProhens%26aufirst%3DR.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DCOMU%253A%2520A%2520Safer%2520and%2520More%2520Effective%2520replacement%2520for%2520benzotriazole-based%2520uronium%2520coupling%2520reagents%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2009%26volume%3D15%26spage%3D9404%26epage%3D9416%26doi%3D10.1002%2Fchem.200900615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="note"><p class="first last">Unfortunately, chiral analogs of <b>44</b> prepared using this strategy underwent partial epimerization during the saponification step.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.
T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a Potent, Reversible inhibitor of interleukin-1β converting enzyme</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)81209-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2FS0960-894X%2801%2981209-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=613-618&author=K.%0AT.+Chapman&title=Synthesis+of+a+Potent%2C+Reversible+inhibitor+of+interleukin-1%CE%B2+converting+enzyme&doi=10.1016%2FS0960-894X%2801%2981209-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2981209-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252981209-9%26sid%3Dliteratum%253Aachs%26aulast%3DChapman%26aufirst%3DK.%2BT.%26atitle%3DSynthesis%2520of%2520a%2520Potent%252C%2520Reversible%2520inhibitor%2520of%2520interleukin-1%25CE%25B2%2520converting%2520enzyme%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1992%26volume%3D2%26spage%3D613%26epage%3D618%26doi%3D10.1016%2FS0960-894X%2801%2981209-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunetz, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringling, J.</span></span> <span> </span><span class="NLM_article-title">General and scalable amide bond formation with epimerization-prone substrates using T3P and pyridine</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">5048</span>– <span class="NLM_lpage">5051</span>, <span class="refDoi"> DOI: 10.1021/ol201875q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol201875q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2isbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=5048-5051&author=J.+R.+Dunetzauthor=Y.+Xiangauthor=A.+Baldwinauthor=J.+Ringling&title=General+and+scalable+amide+bond+formation+with+epimerization-prone+substrates+using+T3P+and+pyridine&doi=10.1021%2Fol201875q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">General and Scalable Amide Bond Formation with Epimerization-Prone Substrates Using T3P and Pyridine</span></div><div class="casAuthors">Dunetz, Joshua R.; Xiang, Yanqiao; Baldwin, Aaron; Ringling, Justin</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5048-5051</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The mild combination of T3P (n-propanephosphonic acid anhydride) and pyridine has been developed for low-epimerization amide bond formation and implemented for the synthesis of a key intermediate to a glucokinase activator.  This robust method is general for the coupling of various racemization-prone acid substrates and amines, including relatively non-nucleophilic anilines, and provides amides in high yields with very low epimerization.  With easy reaction setup and product isolation, this protocol offers several practical and exptl. benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMpm-IixCiDLVg90H21EOLACvtfcHk0lhLQW9Lq8-3jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2isbbJ&md5=d7137a2564e69031af69208dde5e6f30</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fol201875q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol201875q%26sid%3Dliteratum%253Aachs%26aulast%3DDunetz%26aufirst%3DJ.%2BR.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DBaldwin%26aufirst%3DA.%26aulast%3DRingling%26aufirst%3DJ.%26atitle%3DGeneral%2520and%2520scalable%2520amide%2520bond%2520formation%2520with%2520epimerization-prone%2520substrates%2520using%2520T3P%2520and%2520pyridine%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D5048%26epage%3D5051%26doi%3D10.1021%2Fol201875q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span>For a recent discussion on the pharmacokinetics
of topical drugs, see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Trottet, L.</span>; <span class="NLM_string-name">Maibach, H.</span></span> <i>Dermal Drug Selection and Development: An Industrial Perspective</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">93</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1007%2F978-3-319-59504-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=41-93&author=L.+Trottet&author=H.+Maibach&title=Dermal+Drug+Selection+and+Development%3A+An+Industrial+Perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-59504-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-59504-7%26sid%3Dliteratum%253Aachs%26aulast%3DTrottet%26aufirst%3DL.%26btitle%3DDermal%2520Drug%2520Selection%2520and%2520Development%253A%2520An%2520Industrial%2520Perspective%26pub%3DSpringer%26date%3D2017%26spage%3D41%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potts, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, R. H.</span></span> <span> </span><span class="NLM_article-title">Predicting skin permeability</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1023/A:1015810312465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1023%2FA%3A1015810312465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1608900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADyaK38XktF2rs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1992&pages=663-669&author=R.+O.+Pottsauthor=R.+H.+Guy&title=Predicting+skin+permeability&doi=10.1023%2FA%3A1015810312465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting skin permeability</span></div><div class="casAuthors">Potts, Russell O.; Guy, Richard H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">663-9</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    </div><div class="casAbstract">Published permeability coeff. (Kp) data for the transport of a large group of compds. through mammalian epidermis were analyzed by a simple model based upon permeant size [mol. vol. (MV) or mol. wt. (MW)] and octanol/water partition coeff. (Koct).  The anal. presented is a facile means to predict the percutaneous flux of pharmacol. and toxic compds. solely on the basis of their physicochem. properties.  Furthermore, the derived parameters of the model have assignable biophys. significance, and they provide insight into the mechanism of mol. transport through the stratum corneum (SC).  For the very diverse group of chems. considered, the results demonstrate that SC intercellular lipid properties alone are sufficient to account for the dependence of Kp upon MV (or MW) and Koct.  The existence of an "aq.-polar (pore) pathway" across the SC is not necessary to explain the Kp values of small, polar nonelectrolytes.  Rather, their small size, and consequently high diffusivity, accounts for their apparently larger-than-expected Kp.  Finally, despite the size and breadth of the data set (more than 90 compds. with MW ranging from 18 to >750, and log Koct ranging from -3 to +6), the postulated upper limiting value of Kp for permeants of very high lipophilicity cannot be detd.  However, the anal. is able to define the physicochem. characteristics of mols. which should exhibit these maximal Kp values.  Overall, then, we present a facile interpretation of a considerable body of skin permeability measurements that (a) very adequately describes the dependence of Kp upon permeant size and lipophilicity, (b) generates parameters of considerable physicochem. and mechanistic relevance, and (c) implies that the SC lipids alone can fully characterize the barrier properties of mammalian skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod7Y5vdr1_q7Vg90H21EOLACvtfcHk0lg81pDIft6kHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktF2rs7c%253D&md5=b8884dfc56bdcbfc32972d155b399cdc</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015810312465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015810312465%26sid%3Dliteratum%253Aachs%26aulast%3DPotts%26aufirst%3DR.%2BO.%26aulast%3DGuy%26aufirst%3DR.%2BH.%26atitle%3DPredicting%2520skin%2520permeability%26jtitle%3DPharm.%2520Res.%26date%3D1992%26volume%3D9%26spage%3D663%26epage%3D669%26doi%3D10.1023%2FA%3A1015810312465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rey-Giraud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ries, C. H.</span></span> <span> </span><span class="NLM_article-title">In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">e42656</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0042656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1371%2Fjournal.pone.0042656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=22880072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOlt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e42656&issue=8&author=F.+Rey-Giraudauthor=M.+Hafnerauthor=C.+H.+Ries&title=In+vitro+generation+of+monocyte-derived+macrophages+under+serum-free+conditions+improves+their+tumor+promoting+functions&doi=10.1371%2Fjournal.pone.0042656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions</span></div><div class="casAuthors">Rey-Giraud, Flora; Hafner, Mathias; Ries, Carola H.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e42656</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The tumor promoting role of M2 macrophages has been described in in vivo models and the presence of macrophages in certain tumor types has been linked to a poor clin. outcome.  In light of burgeoning activities to clin. develop new therapies targeting tumor-assocd. macrophages (TAMs), reliable in vitro models faithfully mimicking the tumor promoting functions of TAMs are required.  Generation and activation of human monocyte-derived macrophages (MDM) in vitro, described as M1 or M2 macrophages attributed with tumoricidal or tumor-promoting functions, resp., has been widely reported using mainly serum contg. culture methods.  In this study, we compared the properties of macrophages originating from monocytes cultured either in media contg. serum together with M-CSF for M2 and GM-CSF for M1 macrophages or in serum-free media supplemented with M-CSF or GM-CSF and cytokines such as IL-4, IL-10 to induce activated M2 or LPS together with IFN-γ to generate activated M1 phenotype.  We obsd. differences in cell morphol. as well as increased surface receptor expression levels in serum-contg. culture whereas similar or higher cytokine prodn. levels were detected under serum-free culture conditions.  More importantly, MDM differentiated under serum-free conditions displayed enhanced tumoricidal activity for M1 and tumor promoting property for M2 macrophages in contrast to MDM differentiated in the presence of serum.  Moreover, evaluation of MDM phagocytic activity in serum free condition resulted in greater phagocytic properties of M2 compared to M1.  Our data therefore confirm the tumor promoting properties of M2 macrophages in vitro and encourage the targeting of TAMs for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkse7HP0vKCLVg90H21EOLACvtfcHk0lg81pDIft6kHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOlt77J&md5=6320b00e43ab6f503d6d873a28528738</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0042656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0042656%26sid%3Dliteratum%253Aachs%26aulast%3DRey-Giraud%26aufirst%3DF.%26aulast%3DHafner%26aufirst%3DM.%26aulast%3DRies%26aufirst%3DC.%2BH.%26atitle%3DIn%2520vitro%2520generation%2520of%2520monocyte-derived%2520macrophages%2520under%2520serum-free%2520conditions%2520improves%2520their%2520tumor%2520promoting%2520functions%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D8%26spage%3De42656%26doi%3D10.1371%2Fjournal.pone.0042656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':[],'ref11':['cit11'],'ref12':['cit12'],'ref13':[],'ref14':['cit14a','cit14b','cit14c.0','cit14c'],'ref15':[],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25a','cit25b'],'ref26':['cit26a','cit26b'],'ref27':[],'ref28':[],'ref29':[],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b'],'ref34':[],'ref35':[],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':[],'ref40':[],'ref41':['cit41a','cit41b'],'ref42':[],'ref43':['cit43a','cit43b'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':[],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Feng Qin, Cai Yi Wang, Donghwa Kim, Heng-Shan Wang, Yan-Kui Zhu, Sang Kook Lee, Gui-Yang Yao, <span class="NLM_string-name hlFld-ContribAuthor">Dong Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Nitidumpeptins A and B, Cyclohexapeptides Isolated from Zanthoxylum nitidum var. tomentosum: Structural Elucidation, Total Synthesis, and Antiproliferative Activity in Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (2)
                                     , 1462-1470. <a href="https://doi.org/10.1021/acs.joc.0c02057" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02057%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DNitidumpeptins%252BA%252Band%252BB%25252C%252BCyclohexapeptides%252BIsolated%252Bfrom%252BZanthoxylum%252Bnitidum%252Bvar.%252Btomentosum%25253A%252BStructural%252BElucidation%25252C%252BTotal%252BSynthesis%25252C%252Band%252BAntiproliferative%252BActivity%252Bin%252BCancer%252BCells%26aulast%3DQin%26aufirst%3DFeng%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D12092020%26date%3D07012021%26volume%3D86%26issue%3D2%26spage%3D1462%26epage%3D1470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leandro L.  Santos</span>, <span class="hlFld-ContribAuthor ">Eva L.  Wu</span>, <span class="hlFld-ContribAuthor ">Kaitlin M.  Grinias</span>, <span class="hlFld-ContribAuthor ">Michael C.  Koetting</span>, <span class="hlFld-ContribAuthor ">Piyush  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Developability profile framework for lead candidate selection in topical dermatology. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Pharmaceutics</span><span> <strong>2021,</strong> <em>604 </em>, 120750. <a href="https://doi.org/10.1016/j.ijpharm.2021.120750" title="DOI URL">https://doi.org/10.1016/j.ijpharm.2021.120750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpharm.2021.120750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpharm.2021.120750%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Pharmaceutics%26atitle%3DDevelopability%252Bprofile%252Bframework%252Bfor%252Blead%252Bcandidate%252Bselection%252Bin%252Btopical%252Bdermatology%26aulast%3DSantos%26aufirst%3DLeandro%2BL.%26date%3D2021%26volume%3D604%26spage%3D120750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela Carmen  Oniciu</span>. </span><span class="cited-content_cbyCitation_article-title">Eight-membered Rings With One Nitrogen. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00011-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00011-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00011-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00011-1%26sid%3Dliteratum%253Aachs%26atitle%3DEight-membered%252BRings%252BWith%252BOne%252BNitrogen%26aulast%3DOniciu%26aufirst%3DDaniela%2BCarmen%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%25207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvio  Aprile</span>, <span class="hlFld-ContribAuthor ">Marta  Serafini</span>, <span class="hlFld-ContribAuthor ">Tracey  Pirali</span>. </span><span class="cited-content_cbyCitation_article-title">Soft drugs for dermatological applications: recent trends. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (12)
                                     , 2234-2246. <a href="https://doi.org/10.1016/j.drudis.2019.08.007" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.08.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.08.007%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DSoft%252Bdrugs%252Bfor%252Bdermatological%252Bapplications%25253A%252Brecent%252Btrends%26aulast%3DAprile%26aufirst%3DSilvio%26date%3D2019%26volume%3D24%26issue%3D12%26spage%3D2234%26epage%3D2246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiasi  Wu</span>, <span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Qing  Jiang</span>, <span class="hlFld-ContribAuthor ">Sheng  Li</span>, <span class="hlFld-ContribAuthor ">Wenge  Huang</span>, <span class="hlFld-ContribAuthor ">Li  Xiang</span>, <span class="hlFld-ContribAuthor ">Deming  Liu</span>, <span class="hlFld-ContribAuthor ">Yingfan  Hu</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Lu</span>, <span class="hlFld-ContribAuthor ">Guolin  Zhang</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Xianli  Meng</span>. </span><span class="cited-content_cbyCitation_article-title">Coptisine from Coptis chinensis blocks NLRP3 inflammasome activation by inhibiting caspase-1. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>147 </em>, 104348. <a href="https://doi.org/10.1016/j.phrs.2019.104348" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104348%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DCoptisine%252Bfrom%252BCoptis%252Bchinensis%252Bblocks%252BNLRP3%252Binflammasome%252Bactivation%252Bby%252Binhibiting%252Bcaspase-1%26aulast%3DWu%26aufirst%3DJiasi%26date%3D2019%26volume%3D147%26spage%3D104348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlos A.  Ramos-Guzmán</span>, <span class="hlFld-ContribAuthor ">Kirill  Zinovjev</span>, <span class="hlFld-ContribAuthor ">Iñaki  Tuñón</span>. </span><span class="cited-content_cbyCitation_article-title">Modeling caspase-1 inhibition: Implications for catalytic mechanism and drug design. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>169 </em>, 159-167. <a href="https://doi.org/10.1016/j.ejmech.2019.02.064" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.064%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModeling%252Bcaspase-1%252Binhibition%25253A%252BImplications%252Bfor%252Bcatalytic%252Bmechanism%252Band%252Bdrug%252Bdesign%26aulast%3DRamos-Guzm%25C3%25A1n%26aufirst%3DCarlos%2BA.%26date%3D2019%26volume%3D169%26spage%3D159%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-François  Fournier</span>, <span class="hlFld-ContribAuthor ">Yushma  Bhurruth-Alcor</span>, <span class="hlFld-ContribAuthor ">Branislav  Musicki</span>, <span class="hlFld-ContribAuthor ">Jérome  Aubert</span>, <span class="hlFld-ContribAuthor ">Michèle  Aurelly</span>, <span class="hlFld-ContribAuthor ">Claire  Bouix-Peter</span>, <span class="hlFld-ContribAuthor ">Karinne  Bouquet</span>, <span class="hlFld-ContribAuthor ">Laurent  Chantalat</span>, <span class="hlFld-ContribAuthor ">Marion  Delorme</span>, <span class="hlFld-ContribAuthor ">Bénédicte  Drean</span>, <span class="hlFld-ContribAuthor ">Gwenaelle  Duvert</span>, <span class="hlFld-ContribAuthor ">Nicolas  Fleury-Bregeot</span>, <span class="hlFld-ContribAuthor ">Blanche  Gauthier</span>, <span class="hlFld-ContribAuthor ">Karine  Grisendi</span>, <span class="hlFld-ContribAuthor ">Craig S.  Harris</span>, <span class="hlFld-ContribAuthor ">Laurent F.  Hennequin</span>, <span class="hlFld-ContribAuthor ">Tatiana  Isabet</span>, <span class="hlFld-ContribAuthor ">Florence  Joly</span>, <span class="hlFld-ContribAuthor ">Guillaume  Lafitte</span>, <span class="hlFld-ContribAuthor ">Corinne  Millois</span>, <span class="hlFld-ContribAuthor ">Rémy  Morgentin</span>, <span class="hlFld-ContribAuthor ">Jonathan  Pascau</span>, <span class="hlFld-ContribAuthor ">David  Piwnica</span>, <span class="hlFld-ContribAuthor ">Yves  Rival</span>, <span class="hlFld-ContribAuthor ">Catherine  Soulet</span>, <span class="hlFld-ContribAuthor ">Étienne  Thoreau</span>, <span class="hlFld-ContribAuthor ">Loïc  Tomas</span>. </span><span class="cited-content_cbyCitation_article-title">Squaramides as novel class I and IIB histone deacetylase inhibitors for topical treatment of cutaneous t-cell lymphoma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (17)
                                     , 2985-2992. <a href="https://doi.org/10.1016/j.bmcl.2018.06.029" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.06.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.06.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.06.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSquaramides%252Bas%252Bnovel%252Bclass%252BI%252Band%252BIIB%252Bhistone%252Bdeacetylase%252Binhibitors%252Bfor%252Btopical%252Btreatment%252Bof%252Bcutaneous%252Bt-cell%252Blymphoma%26aulast%3DFournier%26aufirst%3DJean-Fran%25C3%25A7ois%26date%3D2018%26volume%3D28%26issue%3D17%26spage%3D2985%26epage%3D2992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandrine  Chambon</span>, <span class="hlFld-ContribAuthor ">Sandrine  Talano</span>, <span class="hlFld-ContribAuthor ">Corinne  Millois</span>, <span class="hlFld-ContribAuthor ">Laurence  Dumais</span>, <span class="hlFld-ContribAuthor ">Romain  Pierre</span>, <span class="hlFld-ContribAuthor ">Loic  Tomas</span>, <span class="hlFld-ContribAuthor ">Céline  Mathieu</span>, <span class="hlFld-ContribAuthor ">Anne-Laurence  Ghilini</span>, <span class="hlFld-ContribAuthor ">Nicolas  Vanthuyne</span>, <span class="hlFld-ContribAuthor ">Kevin  Reverse</span>, <span class="hlFld-ContribAuthor ">Anne  Brethon</span>, <span class="hlFld-ContribAuthor ">Vincent  Rodeschini</span>, <span class="hlFld-ContribAuthor ">Catherine  Comino</span>, <span class="hlFld-ContribAuthor ">Grégoire  Mouis</span>, <span class="hlFld-ContribAuthor ">Ghizlane  El-Bazbouz</span>, <span class="hlFld-ContribAuthor ">Laurence  Clary</span>, <span class="hlFld-ContribAuthor ">Jean-François  Fournier</span>, <span class="hlFld-ContribAuthor ">Claire  Bouix-Peter</span>, <span class="hlFld-ContribAuthor ">Craig S.  Harris</span>, <span class="hlFld-ContribAuthor ">Laurent F.  Hennequin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and stability evaluation of novel peptidomimetic Caspase-1 inhibitors for topical application. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (37)
                                     , 4805-4822. <a href="https://doi.org/10.1016/j.tet.2018.07.029" title="DOI URL">https://doi.org/10.1016/j.tet.2018.07.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.07.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.07.029%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Band%252Bstability%252Bevaluation%252Bof%252Bnovel%252Bpeptidomimetic%252BCaspase-1%252Binhibitors%252Bfor%252Btopical%252Bapplication%26aulast%3DChambon%26aufirst%3DSandrine%26date%3D2018%26volume%3D74%26issue%3D37%26spage%3D4805%26epage%3D4822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) ZVAD-CHO bound to caspase-1 shows the key binding elements that need to be reproduced in novel scaffolds: covalent bond with CYS285, ionic interactions with ARG179, GLN283, and ARG341, H-bonds with SER339’s carbonyl and ARG341’s carbonyl and NH. (b) Some examples of novel scaffolds designed to reproduce key binding elements with caspase-1 and tested for inhibitory activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Correlation between the pIC<sub>50</sub> measured at <i>K</i><sub>M</sub> vs 20<i>K</i><sub>M</sub> substrate concentration for early compounds. For competitive inhibition following Michaelis–Menten kinetics, a 1 log unit difference in pIC<sub>50</sub> values would be expected (green line). (b) Reversibility profiles as evaluated by the recovery of enzymatic reaction rate in a kinetic dilution experiment. Results from both graphs suggest that reversibility of the inhibition (under the condition of the assay) can be quickly evaluated using the ratio of IC<sub>50</sub> values: fully reversible inhibitors (green line/bars) have a 10-fold difference, whereas pseudoirreversible inhibitors (red line/bars) have equal IC<sub>50</sub> values irrespective of the substrate concentration. Under this assumption, uracil compound <b>8</b> is fully reversible.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding efficiency index plot of the H2L phase of the uracil series. Starting from hit <b>8</b>, a 10-fold improvement in potency can be achieved by the addition of 48 amu. Potency gains that come at the cost of larger molecular weight contributions should be rejected.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Solubility in PG/EtOH is a function of the melting point in the uracil series with no positive impact from lowering ChromLogD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking studies of <b>14</b> (brown) vs X-ray structure of <b>10</b> (green; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F6R">6F6R</a>) suggest the cyclopropyl moiety in S2 optimally fits a small lipophilic pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Molecular matched pairs on the R1 substituents (connected dots) vs celluar potency: cyclopropyl unit gives a consistent increase in potency vs nonsubstituted, monomethyl, monoethyl, and <i>gem</i>-dimethyl substituents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0007.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Phototoxicity in the uracil series is highly dependent on ChromLogD: 100% of the compounds with ChromLogD lower than 2 were photosafe vs only 18% when it was higher than 4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0008.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (a) Stability<sup>a</sup> vs potency<sup>b</sup> of various electrophilic warheads. <sup>a</sup>Numbers in boxes represent the Free–Wilson contribution on chemical stability in ethanol at 23 °C after 3 months as compared to the standard aspartyl aldehyde warhead <b>A</b>. For example, molecular matched pairs with warhead <b>J</b> give, on average, analogs with 33% less parent product after 3 months. Gray boxes: no stability measurements were made. <sup>b</sup>The <i>y</i>-coordinate of boxes represent the binned Free–Wilson contribution on enzymatic pIC<sub>50</sub> (at <i>K</i><sub>M</sub> concentration of substrate) as compared to the standard aspartyl aldehyde warhead <b>A</b>. For example, molecular matched pairs with warheads <b>F</b> through <b>H</b> give, on average, analogs that are 10- to 30-fold less potent compounds (−1 to −1.5 log unit). (b) Structures of warheads used in Free–Wilson plot. Aspartylaldehyde warhead <b>A</b> is the optimal warhead when taking into account both potency and chemical stability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis Strategy Employed for Our Uracil-Based P2/P3 Peptidomimetic Fragments Building Blocks Exemplified by the Synthesis of <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Ph<sub>2</sub>CHBr, <i>N</i>,<i>O</i>-bis(trimethylsilyl)acetamide, cat. I<sub>2</sub>, acetonitrile, reflux, yield 85%; (b) K<sub>2</sub>CO<sub>3</sub>, acetonitrile, 23 °C, yield 64%; (c) TFA–TfOH (1:1), 23 °C, yield 98%.</p></p></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of P2/P3 Uracil Peptidomimetic Fragments Building Blocks with Quaternary C Centers at N-1<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) KOCN, water, reflux, yield 78%; (b) allyl bromide, DIPEA, THF/H<sub>2</sub>O (10:1), 60 °C, 18 h, yield 80%; (c) ethyl nitroacetate, triethyl orthoformate, toluene, reflux, yield 92%; (d) Cs<sub>2</sub>CO<sub>3</sub>, MeCN, reflux, yield 81%.</p></p></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. General Synthesis Strategy Employed for Our Uracil-Based Caspase-1 Inhibitors: (a) P1 and P4 Building Blocks and (b) Final Assembly<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaHCO<sub>3</sub>, allyl chloroformate, THF/H<sub>2</sub>O (1:3), 23 °C, yield 80%; (b) MeONHMe·HCl, NMM, EDCI, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, yield 86%; (c) LiAlH<sub>4</sub>, THF, −78 °C, yield 83%; (d) (EtO)<sub>3</sub>CH, 3 Å molecular sieves, <i>p</i>-TsOH, EtOH, 23 °C, yield 92%; (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, yield 71%; (f) MeONHMe·HCl, NMM, EDCI, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, yield quantitative; (g) DBU, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, yield 68%; (h) NaHCO<sub>3</sub>, allyl chloroformate, THF/H<sub>2</sub>O (1:3), 23 °C, yield 88%; (i) LiAlH<sub>4</sub>, THF, −78 °C, yield 95%; (j) (EtO)<sub>3</sub>CH, 3 Å molecular sieves, <i>p</i>-TsOH, EtOH, 23 °C, yield 81%; (k) 2-aminonaphthalene, Pd(OAc)<sub>2</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, μwave 120 °C, yield 89%; (l) LiOH<sub>(aq)</sub>, MeOH, 50 °C, yield 92%; (m) 2-iodopropane, K<sub>2</sub>CO<sub>3</sub>, DMF, 23 °C, yield 46%; (n) Fe(s), NH<sub>4</sub>Cl, THF/EtOH/H<sub>2</sub>O (1:1:1), 70 °C, yield 98%; (o) <b>40</b>, COMU, NMM, DMF, 23 °C, yield 90%; (p) Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,3-dimethylbarbituric acid, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, yield 60%; (q) (i) HATU, CH<sub>2</sub>Cl<sub>2</sub>/DMF (1:1), 23 °C; (ii) <b>33</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,3-dimethylbarbituric acid, CH<sub>2</sub>Cl<sub>2</sub>/DMF (1.4:1), 23 °C, yield quantitative; (r) HCl<sub>(aq)</sub>, acetonitrile, 23 °C, yield 65%; (s) (i) HATU, CH<sub>2</sub>Cl<sub>2</sub>/DMF (0.7:1), 23 °C; (ii) <b>38</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,3-dimethylbarbituric acid, CH<sub>2</sub>Cl<sub>2</sub>/DMF (1.4:1), 23 °C, yield 95%; (t) TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0–23 °C, yield 80%.</p></p></figure><figure data-id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Strategy Employed for N-3 Alkylation Exploration Based on a Late-Stage Mitsunobu Alkylation<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>, Pd–C, EtOAc, 23 °C, yield 32%; (b) <b>40</b>, COMU, NMM, DMF, 80 °C, yield 79%; (c) 4 M HCl in dioxane, 23 °C, yield 78%; (d) (i) DIPEA, T3P, DMF, 23 °C; (ii) <b>33</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,3-dimethylbarbituric acid, CH<sub>2</sub>Cl<sub>2</sub>/DMF (1:1), 23 °C, yield 73%; (e) <i>i</i>-PrOH, DIAD, PPh<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0–23 °C, yield 11%; (f) 1 M HCl (aq), MeCN, 23 °C, 65%.</p></p></figure><figure data-id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/medium/jm-2018-000673_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Strategy Employed for the P4 Region Exploration Based on a Late-Stage Amide Coupling Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.8b00067/20180504/images/large/jm-2018-000673_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00067&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Me-I, K<sub>2</sub>CO<sub>3</sub>, DMF, 23 °C, yield 88%; (b) LiOH, THF/MeOH (10:1), 50 °C, yield 92% (<i>S</i>/<i>R</i>, 86:14); (c) (i) Pfp-OH, EDCI, CH<sub>2</sub>Cl<sub>2</sub>/DMF (4:1), 23 °C; (ii) <b>33</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,3-dimethylbarbituric acid, CH<sub>2</sub>Cl<sub>2</sub>/DMF (2:1), 23 °C, yield 60%; (d) H<sub>2</sub>, Pd–C, EtOAc, 23 °C, yield 80%; (e) RCOCl, DIEA, THF or RCOOH, HATU, NMM, THF, 23 °C or RCOOH, COMU, NMM, DMF, 80 °C, yield 34–95%; (f) AcOH/H<sub>2</sub>O (1:1), 40 °C or 1 M HCl<sub>(aq)</sub>, acetonitrile, 23 °C, yield >70%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74278" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74278" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, E.
B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimball, A. B.</span></span> <span> </span><span class="NLM_article-title">Meta-analysis comparing efficacy versus oral of antibiotics contraceptives in acne vulgaris</span>. <i>J. Am. Acad. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1016/j.jaad.2014.03.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.jaad.2014.03.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=24880665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFCjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=450-459&author=E.%0AB.+Kooauthor=T.+D.+Petersenauthor=A.+B.+Kimball&title=Meta-analysis+comparing+efficacy+versus+oral+of+antibiotics+contraceptives+in+acne+vulgaris&doi=10.1016%2Fj.jaad.2014.03.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris</span></div><div class="casAuthors">Koo, Eubee Baughn; Petersen, Tyler Daniel; Kimball, Alexandra Boer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Academy of Dermatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">450-459</span>CODEN:
                <span class="NLM_cas:coden">JAADDB</span>;
        ISSN:<span class="NLM_cas:issn">0190-9622</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Both antibiotics and oral contraceptive pills (OCPs) have been found to be effective in managing acne vulgaris.  Despite widespread use, few direct comparisons of efficacy between the 2 modalities have been published.We compared the efficacy of antibiotics and OCPs in managing acne.A meta-anal. was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Cochrane collaboration guidelines.A review of 226 publications yielded 32 randomized controlled trials that met our inclusion criteria.  At 3 and 6 mo, compared with placebo, both antibiotics and OCPs effected greater percent redn. in inflammatory, noninflammatory, and total lesions; the 2 modalities at each time point demonstrated statistical parity, except that antibiotics were superior to OCPs in percent redn. of total lesions at 3 mo (weighted mean inflammatory lesion redn.: 3-mo course of oral antibiotic treatment = 53.2%, 3-mo course of OCPs = 35.6%, 3-mo course of placebo treatment = 26.4%, 6-mo course of oral antibiotic treatment = 57.9%, 6-mo course of OCPs = 61.9%, 6-mo course of placebo treatment = 34.2%; weighted mean noninflammatory lesion redn.: 3-mo course of oral antibiotic treatment = 41.9%, 3-mo course of OCPs = 32.6%, 3-mo course of placebo treatment = 17.1%, 6-mo course of oral antibiotic treatment = 56.4%, 6-mo course of OCPs = 49.1%, 6-mo course of placebo treatment = 23.4%; weighted mean total lesion redn.: 3-mo course of oral antibiotic treatment = 48.0%, 3-mo course of OCPs = 37.3%, 3-mo course of placebo treatment = 24.5%, 6-mo course of oral antibiotic treatment = 52.8%, 6-mo course of OCPs = 55.0%, 6-mo course of placebo treatment = 28.6%).Investigative treatment heterogeneity and publication bias are limitations.Although antibiotics may be superior at 3 mo, OCPs are equiv. to antibiotics at 6 mo in reducing acne lesions and, thus, may be a better first-line alternative to systemic antibiotics for long-term acne management in women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqikbHL8QtvcbVg90H21EOLACvtfcHk0lgnDyjyeLQOvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFCjsL4%253D&md5=6e7b4c5fb1caf34fb2f7497e70637648</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2014.03.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2014.03.051%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DE.%2BB.%26aulast%3DPetersen%26aufirst%3DT.%2BD.%26aulast%3DKimball%26aufirst%3DA.%2BB.%26atitle%3DMeta-analysis%2520comparing%2520efficacy%2520versus%2520oral%2520of%2520antibiotics%2520contraceptives%2520in%2520acne%2520vulgaris%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2014%26volume%3D71%26spage%3D450%26epage%3D459%26doi%3D10.1016%2Fj.jaad.2014.03.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaxman, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naghavi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdalla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboyans, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">AlMazroa, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baddour, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahalim, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker-Collo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrero, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartels, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basáñez, M.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benjamin, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernabé, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhalla, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhandari, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikbov, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdulhak, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birbeck, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blencowe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blore, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blyth, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolliger, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boufous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boussinesq, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braithwaite, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brayne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridgett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brugha, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryan-Hancock, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucello, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchbinder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budke, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burstein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabria, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canter, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carabin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carapetis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chugh, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffeng, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colan, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colquhoun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corriere, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortinovis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vaccaro, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couser, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowie, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criqui, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabhadkar, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahodwala, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damsere-Derry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danaei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Leo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degenhardt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dellavalle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delossantos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derrett, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Des Jarlais, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmaratne, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dherani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Torne, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driscoll, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duber, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmond, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elbaz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erskine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erwin, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espindola, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewoigbokhan, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farzadfar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feigin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felson, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferri, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fèvre, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finucane, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaxman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flood, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foreman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forouzanfar, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowkes, F. G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fransen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabbe, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gakidou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganatra, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillum, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grainger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groeger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunnell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haagsma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halasa, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haring, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Havmoeller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotez, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibeanusi, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarvis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasrasaria, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johns, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karthikeyan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassebaum, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoo, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knowlton, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobusingye, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koranteng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalloo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laslett, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lathlean, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leasher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leigh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipnick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipshultz, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mabweijano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malekzadeh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manivannan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcenes, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolis, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzopoulos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayosi, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAnulty, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGill, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina-Mora, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meltzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memish, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mensah, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merriman, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miglioli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocumbi, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffitt, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokdad, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monasta, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montico, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moradi-Lakeh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawska, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdoch, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mwaniki, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidoo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naldi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayan, K. M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevitt, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O'Donnell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O'Hanlon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olives, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omer, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortblad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozgediz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pahari, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandian, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivero, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patten, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padilla, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Ruiz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perico, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesudovs, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pion, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polanczyk, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polinder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pope, C. A.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porrini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourmalek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullan, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranganathan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razavi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehm, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rein, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remuzzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Leòn, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronfani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Room, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenfeld, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rushton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacco, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Riera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwebel, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segui-Gomez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahraz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepard, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivakoti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silberberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singleton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleet, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sliwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stapelberg, N. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolk, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stovner, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudfeld, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburlini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavakkoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomson, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurston, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tleyjeh, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towbin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truelsen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsilimbaris, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubeda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Undurraga, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Werf, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Os, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vavilala, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venketasubramanian, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weatherall, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weintraub, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisskopf, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiteford, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiersma, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaidi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonies, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">AlMazroa, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memish, Z. A.</span></span> <span> </span><span class="NLM_article-title">Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the global burden of disease study 2010</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>380</i></span>,  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2196</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(12)61729-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2FS0140-6736%2812%2961729-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=23245607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A280%3ADC%252BC3s3isFCltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2012&pages=2163-2196&author=T.+Vosauthor=A.+D.+Flaxmanauthor=M.+Naghaviauthor=R.+Lozanoauthor=C.+Michaudauthor=M.+Ezzatiauthor=K.+Shibuyaauthor=J.+A.+Salomonauthor=S.+Abdallaauthor=V.+Aboyansauthor=J.+Abrahamauthor=I.+Ackermanauthor=R.+Aggarwalauthor=S.+Y.+Ahnauthor=M.+K.+Aliauthor=M.+A.+AlMazroaauthor=M.+Alvaradoauthor=H.+R.+Andersonauthor=L.+M.+Andersonauthor=K.+G.+Andrewsauthor=C.+Atkinsonauthor=L.+M.+Baddourauthor=A.+N.+Bahalimauthor=S.+Barker-Colloauthor=L.+H.+Barreroauthor=D.+H.+Bartelsauthor=M.-G.+Bas%C3%A1%C3%B1ezauthor=A.+Baxterauthor=M.+L.+Bellauthor=E.+J.+Benjaminauthor=D.+Bennettauthor=E.+Bernab%C3%A9author=K.+Bhallaauthor=B.+Bhandariauthor=B.+Bikbovauthor=A.+B.+Abdulhakauthor=G.+Birbeckauthor=J.+A.+Blackauthor=H.+Blencoweauthor=J.+D.+Bloreauthor=F.+Blythauthor=I.+Bolligerauthor=A.+Bonaventureauthor=S.+Boufousauthor=R.+Bourneauthor=M.+Boussinesqauthor=T.+Braithwaiteauthor=C.+Brayneauthor=L.+Bridgettauthor=S.+Brookerauthor=P.+Brooksauthor=T.+S.+Brughaauthor=C.+Bryan-Hancockauthor=C.+Bucelloauthor=R.+Buchbinderauthor=G.+Buckleauthor=C.+M.+Budkeauthor=M.+Burchauthor=P.+Burneyauthor=R.+Bursteinauthor=B.+Calabriaauthor=B.+Campbellauthor=C.+E.+Canterauthor=H.+Carabinauthor=J.+Carapetisauthor=L.+Carmonaauthor=C.+Cellaauthor=F.+Charlsonauthor=H.+Chenauthor=A.+T.+Chengauthor=D.+Chouauthor=S.+S.+Chughauthor=L.+E.+Coffengauthor=S.+D.+Colanauthor=S.+Colquhounauthor=K.+E.+Colsonauthor=J.+Condonauthor=M.+D.+Connorauthor=L.+T.+Cooperauthor=M.+Corriereauthor=M.+Cortinovisauthor=K.+C.+de+Vaccaroauthor=W.+Couserauthor=B.+C.+Cowieauthor=M.+H.+Criquiauthor=M.+Crossauthor=K.+C.+Dabhadkarauthor=M.+Dahiyaauthor=N.+Dahodwalaauthor=J.+Damsere-Derryauthor=G.+Danaeiauthor=A.+Davisauthor=D.+De+Leoauthor=L.+Degenhardtauthor=R.+Dellavalleauthor=A.+Delossantosauthor=J.+Denenbergauthor=S.+Derrettauthor=D.+C.+Des+Jarlaisauthor=S.+D.+Dharmaratneauthor=M.+Dheraniauthor=C.+Diaz-Torneauthor=H.+Dolkauthor=E.+R.+Dorseyauthor=T.+Driscollauthor=H.+Duberauthor=B.+Ebelauthor=K.+Edmondauthor=A.+Elbazauthor=S.+E.+Aliauthor=H.+Erskineauthor=P.+J.+Erwinauthor=P.+Espindolaauthor=S.+E.+Ewoigbokhanauthor=F.+Farzadfarauthor=V.+Feiginauthor=D.+T.+Felsonauthor=A.+Ferrariauthor=C.+P.+Ferriauthor=E.+M.+F%C3%A8vreauthor=M.+M.+Finucaneauthor=S.+Flaxmanauthor=L.+Floodauthor=K.+Foremanauthor=M.+H.+Forouzanfarauthor=F.+G.+R.+Fowkesauthor=R.+Franklinauthor=M.+Fransenauthor=M.+K.+Freemanauthor=B.+J.+Gabbeauthor=S.+E.+Gabrielauthor=E.+Gakidouauthor=H.+A.+Ganatraauthor=B.+Garciaauthor=F.+Gaspariauthor=R.+F.+Gillumauthor=G.+Gmelauthor=R.+Gosselinauthor=R.+Graingerauthor=J.+Groegerauthor=F.+Guilleminauthor=D.+Gunnellauthor=R.+Guptaauthor=J.+Haagsmaauthor=H.+Haganauthor=Y.+A.+Halasaauthor=W.+Hallauthor=D.+Haringauthor=J.+M.+Haroauthor=J.+E.+Harrisonauthor=R.+Havmoellerauthor=R.+J.+Hayauthor=H.+Higashiauthor=C.+Hillauthor=B.+Hoenauthor=H.+Hoffmanauthor=P.+J.+Hotezauthor=D.+Hoyauthor=J.+J.+Huangauthor=S.+E.+Ibeanusiauthor=K.+H.+Jacobsenauthor=S.+L.+Jamesauthor=D.+Jarvisauthor=R.+Jasrasariaauthor=S.+Jayaramanauthor=N.+Johnsauthor=J.+B.+Jonasauthor=G.+Karthikeyanauthor=N.+Kassebaumauthor=N.+Kawakamiauthor=A.+Kerenauthor=J.-P.+Khooauthor=C.+H.+Kingauthor=L.+M.+Knowltonauthor=O.+Kobusingyeauthor=A.+Korantengauthor=R.+Krishnamurthiauthor=R.+Lallooauthor=L.+L.+Laslettauthor=T.+Lathleanauthor=J.+L.+Leasherauthor=Y.+Y.+Leeauthor=J.+Leighauthor=S.+S.+Limauthor=E.+Limbauthor=J.+K.+Linauthor=M.+Lipnickauthor=S.+E.+Lipshultzauthor=W.+Liuauthor=M.+Loaneauthor=S.+L.+Ohnoauthor=R.+Lyonsauthor=J.+Maauthor=J.+Mabweijanoauthor=M.+F.+MacIntyreauthor=R.+Malekzadehauthor=L.+Mallingerauthor=S.+Manivannanauthor=W.+Marcenesauthor=L.+Marchauthor=D.+J.+Margolisauthor=G.+B.+Marksauthor=R.+Marksauthor=A.+Matsumoriauthor=R.+Matzopoulosauthor=B.+M.+Mayosiauthor=J.+H.+McAnultyauthor=M.+M.+McDermottauthor=N.+McGillauthor=J.+McGrathauthor=M.+E.+Medina-Moraauthor=M.+Meltzerauthor=Z.+A.+Memishauthor=G.+A.+Mensahauthor=T.+R.+Merrimanauthor=A.-C.+Meyerauthor=V.+Miglioliauthor=M.+Millerauthor=T.+R.+Millerauthor=P.+B.+Mitchellauthor=A.+O.+Mocumbiauthor=T.+E.+Moffittauthor=A.+A.+Mokdadauthor=L.+Monastaauthor=M.+Monticoauthor=M.+Moradi-Lakehauthor=A.+Moranauthor=L.+Morawskaauthor=R.+Moriauthor=M.+E.+Murdochauthor=M.+K.+Mwanikiauthor=K.+Naidooauthor=M.+N.+Nairauthor=L.+Naldiauthor=K.+M.+V.+Narayanauthor=P.+K.+Nelsonauthor=R.+G.+Nelsonauthor=M.+C.+Nevittauthor=C.+R.+Newtonauthor=S.+Nolteauthor=P.+Normanauthor=R.+Normanauthor=M.+O%27Donnellauthor=S.+O%27Hanlonauthor=C.+Olivesauthor=S.+B.+Omerauthor=K.+Ortbladauthor=R.+Osborneauthor=D.+Ozgedizauthor=A.+Pageauthor=B.+Pahariauthor=J.+D.+Pandianauthor=A.+P.+Riveroauthor=S.+B.+Pattenauthor=N.+Pearceauthor=R.+P.+Padillaauthor=F.+Perez-Ruizauthor=N.+Pericoauthor=K.+Pesudovsauthor=D.+Phillipsauthor=M.+R.+Phillipsauthor=K.+Pierceauthor=S.+Pionauthor=G.+V.+Polanczykauthor=S.+Polinderauthor=C.+A.+Popeauthor=S.+Popovaauthor=E.+Porriniauthor=F.+Pourmalekauthor=M.+Princeauthor=R.+L.+Pullanauthor=K.+D.+Ramaiahauthor=D.+Ranganathanauthor=H.+Razaviauthor=M.+Reganauthor=J.+T.+Rehmauthor=D.+B.+Reinauthor=G.+Remuzziauthor=K.+Richardsonauthor=F.+P.+Rivaraauthor=T.+Robertsauthor=C.+Robinsonauthor=F.+R.+De+Le%C3%B2nauthor=L.+Ronfaniauthor=R.+Roomauthor=L.+C.+Rosenfeldauthor=L.+Rushtonauthor=R.+L.+Saccoauthor=S.+Sahaauthor=U.+Sampsonauthor=L.+Sanchez-Rieraauthor=E.+Sanmanauthor=D.+C.+Schwebelauthor=J.+G.+Scottauthor=M.+Segui-Gomezauthor=S.+Shahrazauthor=D.+S.+Shepardauthor=H.+Shinauthor=R.+Shivakotiauthor=D.+Silberbergauthor=D.+Singhauthor=G.+M.+Singhauthor=J.+A.+Singhauthor=J.+Singletonauthor=D.+A.+Sleetauthor=K.+Sliwaauthor=E.+Smithauthor=J.+L.+Smithauthor=N.+J.+C.+Stapelbergauthor=A.+Steerauthor=T.+Steinerauthor=W.+A.+Stolkauthor=L.+J.+Stovnerauthor=C.+Sudfeldauthor=S.+Syedauthor=G.+Tamburliniauthor=M.+Tavakkoliauthor=H.+R.+Taylorauthor=J.+A.+Taylorauthor=W.+J.+Taylorauthor=B.+Thomasauthor=W.+M.+Thomsonauthor=G.+D.+Thurstonauthor=I.+M.+Tleyjehauthor=M.+Tonelliauthor=J.+A.+Towbinauthor=T.+Truelsenauthor=M.+K.+Tsilimbarisauthor=C.+Ubedaauthor=E.+A.+Undurragaauthor=M.+J.+van+der+Werfauthor=J.+van+Osauthor=M.+S.+Vavilalaauthor=N.+Venketasubramanianauthor=M.+Wangauthor=W.+Wangauthor=K.+Wattauthor=D.+J.+Weatherallauthor=M.+A.+Weinstockauthor=R.+Weintraubauthor=M.+G.+Weisskopfauthor=M.+M.+Weissmanauthor=R.+A.+Whiteauthor=H.+Whitefordauthor=S.+T.+Wiersmaauthor=J.+D.+Wilkinsonauthor=H.+C.+Williamsauthor=S.+R.+Williamsauthor=E.+Wittauthor=F.+Wolfeauthor=A.+D.+Woolfauthor=S.+Wulfauthor=P.-H.+Yehauthor=A.+K.+Zaidiauthor=Z.-J.+Zhengauthor=D.+Zoniesauthor=A.+D.+Lopezauthor=C.+J.+L.+Murrayauthor=M.+A.+AlMazroaauthor=Z.+A.+Memish&title=Years+lived+with+disability+%28YLDs%29+for+1160+sequelae+of+289+diseases+and+injuries+1990%E2%80%932010%3A+A+systematic+analysis+for+the+global+burden+of+disease+study+2010&doi=10.1016%2FS0140-6736%2812%2961729-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010</span></div><div class="casAuthors">Vos Theo; Flaxman Abraham D; Naghavi Mohsen; Lozano Rafael; Michaud Catherine; Ezzati Majid; Shibuya Kenji; Salomon Joshua A; Abdalla Safa; Aboyans Victor; Abraham Jerry; Ackerman Ilana; Aggarwal Rakesh; Ahn Stephanie Y; Ali Mohammed K; Alvarado Miriam; Anderson H Ross; Anderson Laurie M; Andrews Kathryn G; Atkinson Charles; Baddour Larry M; Bahalim Adil N; Barker-Collo Suzanne; Barrero Lope H; Bartels David H; Basanez Maria-Gloria; Baxter Amanda; Bell Michelle L; Benjamin Emelia J; Bennett Derrick; Bernabe Eduardo; Bhalla Kavi; Bhandari Bishal; Bikbov Boris; Bin Abdulhak Aref; Birbeck Gretchen; Black James A; Blencowe Hannah; Blore Jed D; Blyth Fiona; Bolliger Ian; Bonaventure Audrey; Boufous Soufiane; Bourne Rupert; Boussinesq Michel; Braithwaite Tasanee; Brayne Carol; Bridgett Lisa; Brooker Simon; Brooks Peter; Brugha Traolach S; Bryan-Hancock Claire; Bucello Chiara; Buchbinder Rachelle; Buckle Geoffrey; Budke Christine M; Burch Michael; Burney Peter; Burstein Roy; Calabria Bianca; Campbell Benjamin; Canter Charles E; Carabin Helene; Carapetis Jonathan; Carmona Loreto; Cella Claudia; Charlson Fiona; Chen Honglei; Cheng Andrew Tai-Ann; Chou David; Chugh Sumeet S; Coffeng Luc E; Colan Steven D; Colquhoun Samantha; Colson K Ellicott; Condon John; Connor Myles D; Cooper Leslie T; Corriere Matthew; Cortinovis Monica; de Vaccaro Karen Courville; Couser William; Cowie Benjamin C; Criqui Michael H; Cross Marita; Dabhadkar Kaustubh C; Dahiya Manu; Dahodwala Nabila; Damsere-Derry James; Danaei Goodarz; Davis Adrian; De Leo Diego; Degenhardt Louisa; Dellavalle Robert; Delossantos Allyne; Denenberg Julie; Derrett Sarah; Des Jarlais Don C; Dharmaratne Samath D; Dherani Mukesh; Diaz-Torne Cesar; Dolk Helen; Dorsey E Ray; Driscoll Tim; Duber Herbert; Ebel Beth; Edmond Karen; Elbaz Alexis; Ali Suad Eltahir; Erskine Holly; Erwin Patricia J; Espindola Patricia; Ewoigbokhan Stalin E; Farzadfar Farshad; Feigin Valery; Felson David T; Ferrari Alize; Ferri Cleusa P; Fevre Eric M; Finucane Mariel M; Flaxman Seth; Flood Louise; Foreman Kyle; Forouzanfar Mohammad H; Fowkes Francis Gerry R; Franklin Richard; Fransen Marlene; Freeman Michael K; Gabbe Belinda J; Gabriel Sherine E; Gakidou Emmanuela; Ganatra Hammad A; Garcia Bianca; Gaspari Flavio; Gillum Richard F; Gmel Gerhard; Gosselin Richard; Grainger Rebecca; Groeger Justina; Guillemin Francis; Gunnell David; Gupta Ramyani; Haagsma Juanita; Hagan Holly; Halasa Yara A; Hall Wayne; Haring Diana; Haro Josep Maria; Harrison James E; Havmoeller Rasmus; Hay Roderick J; Higashi Hideki; Hill Catherine; Hoen Bruno; Hoffman Howard; Hotez Peter J; Hoy Damian; Huang John J; Ibeanusi Sydney E; Jacobsen Kathryn H; James Spencer L; Jarvis Deborah; Jasrasaria Rashmi; Jayaraman Sudha; Johns Nicole; Jonas Jost B; Karthikeyan Ganesan; Kassebaum Nicholas; Kawakami Norito; Keren Andre; Khoo Jon-Paul; King Charles H; Knowlton Lisa Marie; Kobusingye Olive; Koranteng Adofo; Krishnamurthi Rita; Lalloo Ratilal; Laslett Laura L; Lathlean Tim; Leasher Janet L; Lee Yong Yi; Leigh James; Lim Stephen S; Limb Elizabeth; Lin John Kent; Lipnick Michael; Lipshultz Steven E; Liu Wei; Loane Maria; Ohno Summer Lockett; Lyons Ronan; Ma Jixiang; Mabweijano Jacqueline; MacIntyre Michael F; Malekzadeh Reza; Mallinger Leslie; Manivannan Sivabalan; Marcenes Wagner; March Lyn; Margolis David J; Marks Guy B; Marks Robin; Matsumori Akira; Matzopoulos Richard; Mayosi Bongani M; McAnulty John H; McDermott Mary M; McGill Neil; McGrath John; Medina-Mora Maria Elena; Meltzer Michele; Mensah George A; Merriman Tony R; Meyer Ana-Claire; Miglioli Valeria; Miller Matthew; Miller Ted R; Mitchell Philip B; Mocumbi Ana Olga; Moffitt Terrie E; Mokdad Ali A; Monasta Lorenzo; Montico Marcella; Moradi-Lakeh Maziar; Moran Andrew; Morawska Lidia; Mori Rintaro; Murdoch Michele E; Mwaniki Michael K; Naidoo Kovin; Nair M Nathan; Naldi Luigi; Narayan K M Venkat; Nelson Paul K; Nelson Robert G; Nevitt Michael C; Newton Charles R; Nolte Sandra; Norman Paul; Norman Rosana; O'Donnell Martin; O'Hanlon Simon; Olives Casey; Omer Saad B; Ortblad Katrina; Osborne Richard; Ozgediz Doruk; Page Andrew; Pahari Bishnu; Pandian Jeyaraj Durai; Rivero Andrea Panozo; Patten Scott B; Pearce Neil; Padilla Rogelio Perez; Perez-Ruiz Fernando; Perico Norberto; Pesudovs Konrad; Phillips David; Phillips Michael R; Pierce Kelsey; Pion Sebastien; Polanczyk Guilherme V; Polinder Suzanne; Pope C Arden 3rd; Popova Svetlana; Porrini Esteban; Pourmalek Farshad; Prince Martin; Pullan Rachel L; Ramaiah Kapa D; Ranganathan Dharani; Razavi Homie; Regan Mathilda; Rehm Jurgen T; Rein David B; Remuzzi Guiseppe; Richardson Kathryn; Rivara Frederick P; Roberts Thomas; Robinson Carolyn; De Leon Felipe Rodriguez; Ronfani Luca; Room Robin; Rosenfeld Lisa C; Rushton Lesley; Sacco Ralph L; Saha Sukanta; Sampson Uchechukwu; Sanchez-Riera Lidia; Sanman Ella; Schwebel David C; Scott James Graham; Segui-Gomez Maria; Shahraz Saeid; Shepard Donald S; Shin Hwashin; Shivakoti Rupak; Singh David; Singh Gitanjali M; Singh Jasvinder A; Singleton Jessica; Sleet David A; Sliwa Karen; Smith Emma; Smith Jennifer L; Stapelberg Nicolas J C; Steer Andrew; Steiner Timothy; Stolk Wilma A; Stovner Lars Jacob; Sudfeld Christopher; Syed Sana; Tamburlini Giorgio; Tavakkoli Mohammad; Taylor Hugh R; Taylor Jennifer A; Taylor William J; Thomas Bernadette; Thomson W Murray; Thurston George D; Tleyjeh Imad M; Tonelli Marcello; Towbin Jeffrey A; Truelsen Thomas; Tsilimbaris Miltiadis K; Ubeda Clotilde; Undurraga Eduardo A; van der Werf Marieke J; van Os Jim; Vavilala Monica S; Venketasubramanian N; Wang Mengru; Wang Wenzhi; Watt Kerrianne; Weatherall David J; Weinstock Martin A; Weintraub Robert; Weisskopf Marc G; Weissman Myrna M; White Richard A; Whiteford Harvey; Wiersma Steven T; Wilkinson James D; Williams Hywel C; Williams Sean R M; Witt Emma; Wolfe Frederick; Woolf Anthony D; Wulf Sarah; Yeh Pon-Hsiu; Zaidi Anita K M; Zheng Zhi-Jie; Zonies David; Lopez Alan D; Murray Christopher J L; AlMazroa Mohammad A; Memish Ziad A</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">380</span>
        (<span class="NLM_cas:issue">9859</span>),
    <span class="NLM_cas:pages">2163-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Non-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health.  The Global Burden of Disease (GBD) studies done in 1990 and 2000 have been the only studies to quantify non-fatal health outcomes across an exhaustive set of disorders at the global and regional level.  Neither effort quantified uncertainty in prevalence or years lived with disability (YLDs).  METHODS:  Of the 291 diseases and injuries in the GBD cause list, 289 cause disability.  For 1160 sequelae of the 289 diseases and injuries, we undertook a systematic analysis of prevalence, incidence, remission, duration, and excess mortality.  Sources included published studies, case notification, population-based cancer registries, other disease registries, antenatal clinic serosurveillance, hospital discharge data, ambulatory care data, household surveys, other surveys, and cohort studies.  For most sequelae, we used a Bayesian meta-regression method, DisMod-MR, designed to address key limitations in descriptive epidemiological data, including missing data, inconsistency, and large methodological variation between data sources.  For some disorders, we used natural history models, geospatial models, back-calculation models (models calculating incidence from population mortality rates and case fatality), or registration completeness models (models adjusting for incomplete registration with health-system access and other covariates).  Disability weights for 220 unique health states were used to capture the severity of health loss.  YLDs by cause at age, sex, country, and year levels were adjusted for comorbidity with simulation methods.  We included uncertainty estimates at all stages of the analysis.  FINDINGS:  Global prevalence for all ages combined in 2010 across the 1160 sequelae ranged from fewer than one case per 1 million people to 350,000 cases per 1 million people.  Prevalence and severity of health loss were weakly correlated (correlation coefficient -0·37).  In 2010, there were 777 million YLDs from all causes, up from 583 million in 1990.  The main contributors to global YLDs were mental and behavioural disorders, musculoskeletal disorders, and diabetes or endocrine diseases.  The leading specific causes of YLDs were much the same in 2010 as they were in 1990: low back pain, major depressive disorder, iron-deficiency anaemia, neck pain, chronic obstructive pulmonary disease, anxiety disorders, migraine, diabetes, and falls.  Age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010.  Regional patterns of the leading causes of YLDs were more similar compared with years of life lost due to premature mortality.  Neglected tropical diseases, HIV/AIDS, tuberculosis, malaria, and anaemia were important causes of YLDs in sub-Saharan Africa.  INTERPRETATION:  Rates of YLDs per 100,000 people have remained largely constant over time but rise steadily with age.  Population growth and ageing have increased YLD numbers and crude rates over the past two decades.  Prevalences of the most common causes of YLDs, such as mental and behavioural disorders and musculoskeletal disorders, have not decreased.  Health systems will need to address the needs of the rising numbers of individuals with a range of disorders that largely cause disability but not mortality.  Quantification of the burden of non-fatal health outcomes will be crucial to understand how well health systems are responding to these challenges.  Effective and affordable strategies to deal with this rising burden are an urgent priority for health systems in most parts of the world.  FUNDING:  Bill & Melinda Gates Foundation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqOG_wjVrF_5NiNltV31zlfW6udTcc2ea_rIlYRadF7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3isFCltA%253D%253D&md5=e23ef644cc0998b536d2d988807654a1</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2812%2961729-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252812%252961729-2%26sid%3Dliteratum%253Aachs%26aulast%3DVos%26aufirst%3DT.%26aulast%3DFlaxman%26aufirst%3DA.%2BD.%26aulast%3DNaghavi%26aufirst%3DM.%26aulast%3DLozano%26aufirst%3DR.%26aulast%3DMichaud%26aufirst%3DC.%26aulast%3DEzzati%26aufirst%3DM.%26aulast%3DShibuya%26aufirst%3DK.%26aulast%3DSalomon%26aufirst%3DJ.%2BA.%26aulast%3DAbdalla%26aufirst%3DS.%26aulast%3DAboyans%26aufirst%3DV.%26aulast%3DAbraham%26aufirst%3DJ.%26aulast%3DAckerman%26aufirst%3DI.%26aulast%3DAggarwal%26aufirst%3DR.%26aulast%3DAhn%26aufirst%3DS.%2BY.%26aulast%3DAli%26aufirst%3DM.%2BK.%26aulast%3DAlMazroa%26aufirst%3DM.%2BA.%26aulast%3DAlvarado%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DH.%2BR.%26aulast%3DAnderson%26aufirst%3DL.%2BM.%26aulast%3DAndrews%26aufirst%3DK.%2BG.%26aulast%3DAtkinson%26aufirst%3DC.%26aulast%3DBaddour%26aufirst%3DL.%2BM.%26aulast%3DBahalim%26aufirst%3DA.%2BN.%26aulast%3DBarker-Collo%26aufirst%3DS.%26aulast%3DBarrero%26aufirst%3DL.%2BH.%26aulast%3DBartels%26aufirst%3DD.%2BH.%26aulast%3DBas%25C3%25A1%25C3%25B1ez%26aufirst%3DM.-G.%26aulast%3DBaxter%26aufirst%3DA.%26aulast%3DBell%26aufirst%3DM.%2BL.%26aulast%3DBenjamin%26aufirst%3DE.%2BJ.%26aulast%3DBennett%26aufirst%3DD.%26aulast%3DBernab%25C3%25A9%26aufirst%3DE.%26aulast%3DBhalla%26aufirst%3DK.%26aulast%3DBhandari%26aufirst%3DB.%26aulast%3DBikbov%26aufirst%3DB.%26aulast%3DAbdulhak%26aufirst%3DA.%2BB.%26aulast%3DBirbeck%26aufirst%3DG.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DBlencowe%26aufirst%3DH.%26aulast%3DBlore%26aufirst%3DJ.%2BD.%26aulast%3DBlyth%26aufirst%3DF.%26aulast%3DBolliger%26aufirst%3DI.%26aulast%3DBonaventure%26aufirst%3DA.%26aulast%3DBoufous%26aufirst%3DS.%26aulast%3DBourne%26aufirst%3DR.%26aulast%3DBoussinesq%26aufirst%3DM.%26aulast%3DBraithwaite%26aufirst%3DT.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DBridgett%26aufirst%3DL.%26aulast%3DBrooker%26aufirst%3DS.%26aulast%3DBrooks%26aufirst%3DP.%26aulast%3DBrugha%26aufirst%3DT.%2BS.%26aulast%3DBryan-Hancock%26aufirst%3DC.%26aulast%3DBucello%26aufirst%3DC.%26aulast%3DBuchbinder%26aufirst%3DR.%26aulast%3DBuckle%26aufirst%3DG.%26aulast%3DBudke%26aufirst%3DC.%2BM.%26aulast%3DBurch%26aufirst%3DM.%26aulast%3DBurney%26aufirst%3DP.%26aulast%3DBurstein%26aufirst%3DR.%26aulast%3DCalabria%26aufirst%3DB.%26aulast%3DCampbell%26aufirst%3DB.%26aulast%3DCanter%26aufirst%3DC.%2BE.%26aulast%3DCarabin%26aufirst%3DH.%26aulast%3DCarapetis%26aufirst%3DJ.%26aulast%3DCarmona%26aufirst%3DL.%26aulast%3DCella%26aufirst%3DC.%26aulast%3DCharlson%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DA.%2BT.%26aulast%3DChou%26aufirst%3DD.%26aulast%3DChugh%26aufirst%3DS.%2BS.%26aulast%3DCoffeng%26aufirst%3DL.%2BE.%26aulast%3DColan%26aufirst%3DS.%2BD.%26aulast%3DColquhoun%26aufirst%3DS.%26aulast%3DColson%26aufirst%3DK.%2BE.%26aulast%3DCondon%26aufirst%3DJ.%26aulast%3DConnor%26aufirst%3DM.%2BD.%26aulast%3DCooper%26aufirst%3DL.%2BT.%26aulast%3DCorriere%26aufirst%3DM.%26aulast%3DCortinovis%26aufirst%3DM.%26aulast%3Dde%2BVaccaro%26aufirst%3DK.%2BC.%26aulast%3DCouser%26aufirst%3DW.%26aulast%3DCowie%26aufirst%3DB.%2BC.%26aulast%3DCriqui%26aufirst%3DM.%2BH.%26aulast%3DCross%26aufirst%3DM.%26aulast%3DDabhadkar%26aufirst%3DK.%2BC.%26aulast%3DDahiya%26aufirst%3DM.%26aulast%3DDahodwala%26aufirst%3DN.%26aulast%3DDamsere-Derry%26aufirst%3DJ.%26aulast%3DDanaei%26aufirst%3DG.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DDe%2BLeo%26aufirst%3DD.%26aulast%3DDegenhardt%26aufirst%3DL.%26aulast%3DDellavalle%26aufirst%3DR.%26aulast%3DDelossantos%26aufirst%3DA.%26aulast%3DDenenberg%26aufirst%3DJ.%26aulast%3DDerrett%26aufirst%3DS.%26aulast%3DDes%2BJarlais%26aufirst%3DD.%2BC.%26aulast%3DDharmaratne%26aufirst%3DS.%2BD.%26aulast%3DDherani%26aufirst%3DM.%26aulast%3DDiaz-Torne%26aufirst%3DC.%26aulast%3DDolk%26aufirst%3DH.%26aulast%3DDorsey%26aufirst%3DE.%2BR.%26aulast%3DDriscoll%26aufirst%3DT.%26aulast%3DDuber%26aufirst%3DH.%26aulast%3DEbel%26aufirst%3DB.%26aulast%3DEdmond%26aufirst%3DK.%26aulast%3DElbaz%26aufirst%3DA.%26aulast%3DAli%26aufirst%3DS.%2BE.%26aulast%3DErskine%26aufirst%3DH.%26aulast%3DErwin%26aufirst%3DP.%2BJ.%26aulast%3DEspindola%26aufirst%3DP.%26aulast%3DEwoigbokhan%26aufirst%3DS.%2BE.%26aulast%3DFarzadfar%26aufirst%3DF.%26aulast%3DFeigin%26aufirst%3DV.%26aulast%3DFelson%26aufirst%3DD.%2BT.%26aulast%3DFerrari%26aufirst%3DA.%26aulast%3DFerri%26aufirst%3DC.%2BP.%26aulast%3DF%25C3%25A8vre%26aufirst%3DE.%2BM.%26aulast%3DFinucane%26aufirst%3DM.%2BM.%26aulast%3DFlaxman%26aufirst%3DS.%26aulast%3DFlood%26aufirst%3DL.%26aulast%3DForeman%26aufirst%3DK.%26aulast%3DForouzanfar%26aufirst%3DM.%2BH.%26aulast%3DFowkes%26aufirst%3DF.%2BG.%2BR.%26aulast%3DFranklin%26aufirst%3DR.%26aulast%3DFransen%26aufirst%3DM.%26aulast%3DFreeman%26aufirst%3DM.%2BK.%26aulast%3DGabbe%26aufirst%3DB.%2BJ.%26aulast%3DGabriel%26aufirst%3DS.%2BE.%26aulast%3DGakidou%26aufirst%3DE.%26aulast%3DGanatra%26aufirst%3DH.%2BA.%26aulast%3DGarcia%26aufirst%3DB.%26aulast%3DGaspari%26aufirst%3DF.%26aulast%3DGillum%26aufirst%3DR.%2BF.%26aulast%3DGmel%26aufirst%3DG.%26aulast%3DGosselin%26aufirst%3DR.%26aulast%3DGrainger%26aufirst%3DR.%26aulast%3DGroeger%26aufirst%3DJ.%26aulast%3DGuillemin%26aufirst%3DF.%26aulast%3DGunnell%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DHaagsma%26aufirst%3DJ.%26aulast%3DHagan%26aufirst%3DH.%26aulast%3DHalasa%26aufirst%3DY.%2BA.%26aulast%3DHall%26aufirst%3DW.%26aulast%3DHaring%26aufirst%3DD.%26aulast%3DHaro%26aufirst%3DJ.%2BM.%26aulast%3DHarrison%26aufirst%3DJ.%2BE.%26aulast%3DHavmoeller%26aufirst%3DR.%26aulast%3DHay%26aufirst%3DR.%2BJ.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DHill%26aufirst%3DC.%26aulast%3DHoen%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DH.%26aulast%3DHotez%26aufirst%3DP.%2BJ.%26aulast%3DHoy%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DJ.%2BJ.%26aulast%3DIbeanusi%26aufirst%3DS.%2BE.%26aulast%3DJacobsen%26aufirst%3DK.%2BH.%26aulast%3DJames%26aufirst%3DS.%2BL.%26aulast%3DJarvis%26aufirst%3DD.%26aulast%3DJasrasaria%26aufirst%3DR.%26aulast%3DJayaraman%26aufirst%3DS.%26aulast%3DJohns%26aufirst%3DN.%26aulast%3DJonas%26aufirst%3DJ.%2BB.%26aulast%3DKarthikeyan%26aufirst%3DG.%26aulast%3DKassebaum%26aufirst%3DN.%26aulast%3DKawakami%26aufirst%3DN.%26aulast%3DKeren%26aufirst%3DA.%26aulast%3DKhoo%26aufirst%3DJ.-P.%26aulast%3DKing%26aufirst%3DC.%2BH.%26aulast%3DKnowlton%26aufirst%3DL.%2BM.%26aulast%3DKobusingye%26aufirst%3DO.%26aulast%3DKoranteng%26aufirst%3DA.%26aulast%3DKrishnamurthi%26aufirst%3DR.%26aulast%3DLalloo%26aufirst%3DR.%26aulast%3DLaslett%26aufirst%3DL.%2BL.%26aulast%3DLathlean%26aufirst%3DT.%26aulast%3DLeasher%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DY.%2BY.%26aulast%3DLeigh%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BS.%26aulast%3DLimb%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DJ.%2BK.%26aulast%3DLipnick%26aufirst%3DM.%26aulast%3DLipshultz%26aufirst%3DS.%2BE.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLoane%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DS.%2BL.%26aulast%3DLyons%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DMabweijano%26aufirst%3DJ.%26aulast%3DMacIntyre%26aufirst%3DM.%2BF.%26aulast%3DMalekzadeh%26aufirst%3DR.%26aulast%3DMallinger%26aufirst%3DL.%26aulast%3DManivannan%26aufirst%3DS.%26aulast%3DMarcenes%26aufirst%3DW.%26aulast%3DMarch%26aufirst%3DL.%26aulast%3DMargolis%26aufirst%3DD.%2BJ.%26aulast%3DMarks%26aufirst%3DG.%2BB.%26aulast%3DMarks%26aufirst%3DR.%26aulast%3DMatsumori%26aufirst%3DA.%26aulast%3DMatzopoulos%26aufirst%3DR.%26aulast%3DMayosi%26aufirst%3DB.%2BM.%26aulast%3DMcAnulty%26aufirst%3DJ.%2BH.%26aulast%3DMcDermott%26aufirst%3DM.%2BM.%26aulast%3DMcGill%26aufirst%3DN.%26aulast%3DMcGrath%26aufirst%3DJ.%26aulast%3DMedina-Mora%26aufirst%3DM.%2BE.%26aulast%3DMeltzer%26aufirst%3DM.%26aulast%3DMemish%26aufirst%3DZ.%2BA.%26aulast%3DMensah%26aufirst%3DG.%2BA.%26aulast%3DMerriman%26aufirst%3DT.%2BR.%26aulast%3DMeyer%26aufirst%3DA.-C.%26aulast%3DMiglioli%26aufirst%3DV.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DT.%2BR.%26aulast%3DMitchell%26aufirst%3DP.%2BB.%26aulast%3DMocumbi%26aufirst%3DA.%2BO.%26aulast%3DMoffitt%26aufirst%3DT.%2BE.%26aulast%3DMokdad%26aufirst%3DA.%2BA.%26aulast%3DMonasta%26aufirst%3DL.%26aulast%3DMontico%26aufirst%3DM.%26aulast%3DMoradi-Lakeh%26aufirst%3DM.%26aulast%3DMoran%26aufirst%3DA.%26aulast%3DMorawska%26aufirst%3DL.%26aulast%3DMori%26aufirst%3DR.%26aulast%3DMurdoch%26aufirst%3DM.%2BE.%26aulast%3DMwaniki%26aufirst%3DM.%2BK.%26aulast%3DNaidoo%26aufirst%3DK.%26aulast%3DNair%26aufirst%3DM.%2BN.%26aulast%3DNaldi%26aufirst%3DL.%26aulast%3DNarayan%26aufirst%3DK.%2BM.%2BV.%26aulast%3DNelson%26aufirst%3DP.%2BK.%26aulast%3DNelson%26aufirst%3DR.%2BG.%26aulast%3DNevitt%26aufirst%3DM.%2BC.%26aulast%3DNewton%26aufirst%3DC.%2BR.%26aulast%3DNolte%26aufirst%3DS.%26aulast%3DNorman%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DR.%26aulast%3DO%2527Donnell%26aufirst%3DM.%26aulast%3DO%2527Hanlon%26aufirst%3DS.%26aulast%3DOlives%26aufirst%3DC.%26aulast%3DOmer%26aufirst%3DS.%2BB.%26aulast%3DOrtblad%26aufirst%3DK.%26aulast%3DOsborne%26aufirst%3DR.%26aulast%3DOzgediz%26aufirst%3DD.%26aulast%3DPage%26aufirst%3DA.%26aulast%3DPahari%26aufirst%3DB.%26aulast%3DPandian%26aufirst%3DJ.%2BD.%26aulast%3DRivero%26aufirst%3DA.%2BP.%26aulast%3DPatten%26aufirst%3DS.%2BB.%26aulast%3DPearce%26aufirst%3DN.%26aulast%3DPadilla%26aufirst%3DR.%2BP.%26aulast%3DPerez-Ruiz%26aufirst%3DF.%26aulast%3DPerico%26aufirst%3DN.%26aulast%3DPesudovs%26aufirst%3DK.%26aulast%3DPhillips%26aufirst%3DD.%26aulast%3DPhillips%26aufirst%3DM.%2BR.%26aulast%3DPierce%26aufirst%3DK.%26aulast%3DPion%26aufirst%3DS.%26aulast%3DPolanczyk%26aufirst%3DG.%2BV.%26aulast%3DPolinder%26aufirst%3DS.%26aulast%3DPope%26aufirst%3DC.%2BA.%26aulast%3DPopova%26aufirst%3DS.%26aulast%3DPorrini%26aufirst%3DE.%26aulast%3DPourmalek%26aufirst%3DF.%26aulast%3DPrince%26aufirst%3DM.%26aulast%3DPullan%26aufirst%3DR.%2BL.%26aulast%3DRamaiah%26aufirst%3DK.%2BD.%26aulast%3DRanganathan%26aufirst%3DD.%26aulast%3DRazavi%26aufirst%3DH.%26aulast%3DRegan%26aufirst%3DM.%26aulast%3DRehm%26aufirst%3DJ.%2BT.%26aulast%3DRein%26aufirst%3DD.%2BB.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DRichardson%26aufirst%3DK.%26aulast%3DRivara%26aufirst%3DF.%2BP.%26aulast%3DRoberts%26aufirst%3DT.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DDe%2BLe%25C3%25B2n%26aufirst%3DF.%2BR.%26aulast%3DRonfani%26aufirst%3DL.%26aulast%3DRoom%26aufirst%3DR.%26aulast%3DRosenfeld%26aufirst%3DL.%2BC.%26aulast%3DRushton%26aufirst%3DL.%26aulast%3DSacco%26aufirst%3DR.%2BL.%26aulast%3DSaha%26aufirst%3DS.%26aulast%3DSampson%26aufirst%3DU.%26aulast%3DSanchez-Riera%26aufirst%3DL.%26aulast%3DSanman%26aufirst%3DE.%26aulast%3DSchwebel%26aufirst%3DD.%2BC.%26aulast%3DScott%26aufirst%3DJ.%2BG.%26aulast%3DSegui-Gomez%26aufirst%3DM.%26aulast%3DShahraz%26aufirst%3DS.%26aulast%3DShepard%26aufirst%3DD.%2BS.%26aulast%3DShin%26aufirst%3DH.%26aulast%3DShivakoti%26aufirst%3DR.%26aulast%3DSilberberg%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DG.%2BM.%26aulast%3DSingh%26aufirst%3DJ.%2BA.%26aulast%3DSingleton%26aufirst%3DJ.%26aulast%3DSleet%26aufirst%3DD.%2BA.%26aulast%3DSliwa%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DStapelberg%26aufirst%3DN.%2BJ.%2BC.%26aulast%3DSteer%26aufirst%3DA.%26aulast%3DSteiner%26aufirst%3DT.%26aulast%3DStolk%26aufirst%3DW.%2BA.%26aulast%3DStovner%26aufirst%3DL.%2BJ.%26aulast%3DSudfeld%26aufirst%3DC.%26aulast%3DSyed%26aufirst%3DS.%26aulast%3DTamburlini%26aufirst%3DG.%26aulast%3DTavakkoli%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DH.%2BR.%26aulast%3DTaylor%26aufirst%3DJ.%2BA.%26aulast%3DTaylor%26aufirst%3DW.%2BJ.%26aulast%3DThomas%26aufirst%3DB.%26aulast%3DThomson%26aufirst%3DW.%2BM.%26aulast%3DThurston%26aufirst%3DG.%2BD.%26aulast%3DTleyjeh%26aufirst%3DI.%2BM.%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DTowbin%26aufirst%3DJ.%2BA.%26aulast%3DTruelsen%26aufirst%3DT.%26aulast%3DTsilimbaris%26aufirst%3DM.%2BK.%26aulast%3DUbeda%26aufirst%3DC.%26aulast%3DUndurraga%26aufirst%3DE.%2BA.%26aulast%3Dvan%2Bder%2BWerf%26aufirst%3DM.%2BJ.%26aulast%3Dvan%2BOs%26aufirst%3DJ.%26aulast%3DVavilala%26aufirst%3DM.%2BS.%26aulast%3DVenketasubramanian%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWatt%26aufirst%3DK.%26aulast%3DWeatherall%26aufirst%3DD.%2BJ.%26aulast%3DWeinstock%26aufirst%3DM.%2BA.%26aulast%3DWeintraub%26aufirst%3DR.%26aulast%3DWeisskopf%26aufirst%3DM.%2BG.%26aulast%3DWeissman%26aufirst%3DM.%2BM.%26aulast%3DWhite%26aufirst%3DR.%2BA.%26aulast%3DWhiteford%26aufirst%3DH.%26aulast%3DWiersma%26aufirst%3DS.%2BT.%26aulast%3DWilkinson%26aufirst%3DJ.%2BD.%26aulast%3DWilliams%26aufirst%3DH.%2BC.%26aulast%3DWilliams%26aufirst%3DS.%2BR.%26aulast%3DWitt%26aufirst%3DE.%26aulast%3DWolfe%26aufirst%3DF.%26aulast%3DWoolf%26aufirst%3DA.%2BD.%26aulast%3DWulf%26aufirst%3DS.%26aulast%3DYeh%26aufirst%3DP.-H.%26aulast%3DZaidi%26aufirst%3DA.%2BK.%26aulast%3DZheng%26aufirst%3DZ.-J.%26aulast%3DZonies%26aufirst%3DD.%26aulast%3DLopez%26aufirst%3DA.%2BD.%26aulast%3DMurray%26aufirst%3DC.%2BJ.%2BL.%26aulast%3DAlMazroa%26aufirst%3DM.%2BA.%26aulast%3DMemish%26aufirst%3DZ.%2BA.%26atitle%3DYears%2520lived%2520with%2520disability%2520%2528YLDs%2529%2520for%25201160%2520sequelae%2520of%2520289%2520diseases%2520and%2520injuries%25201990%25E2%2580%25932010%253A%2520A%2520systematic%2520analysis%2520for%2520the%2520global%2520burden%2520of%2520disease%2520study%25202010%26jtitle%3DLancet%26date%3D2012%26volume%3D380%26spage%3D2163%26epage%3D2196%26doi%3D10.1016%2FS0140-6736%2812%2961729-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thiboutot, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dréno, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abanmi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexis, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araviiskaia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barona Cabal, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettoli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casintahan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Costa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Ouazzani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollnick, H. P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herane, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honeyman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemeny, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubba, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyden, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Estebaranz, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noppakun, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochsendorf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprica, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piquero-Martin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozada, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troielli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, L. F.</span></span> <span> </span><span class="NLM_article-title">Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne</span>. <i>J. Am. Acad. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">S1</span>– <span class="NLM_lpage">S23</span>, <span class="refDoi"> DOI: 10.1016/j.jaad.2017.09.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.jaad.2017.09.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=29127053" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=S1-S23&author=D.+M.+Thiboutotauthor=B.+Dr%C3%A9noauthor=A.+Abanmiauthor=A.+F.+Alexisauthor=E.+Araviiskaiaauthor=M.+I.+Barona+Cabalauthor=V.+Bettoliauthor=F.+Casintahanauthor=S.+Chowauthor=A.+da+Costaauthor=T.+El+Ouazzaniauthor=C.+L.+Gohauthor=H.+P.+M.+Gollnickauthor=M.+Gomezauthor=N.+Hayashiauthor=M.+I.+Heraneauthor=J.+Honeymanauthor=S.+Kangauthor=L.+Kemenyauthor=R.+Kubbaauthor=J.+Lambertauthor=A.+M.+Laytonauthor=J.+J.+Leydenauthor=J.+L.+L%C3%B3pez-Estebaranzauthor=N.+Noppakunauthor=F.+Ochsendorfauthor=C.+Opricaauthor=B.+Orozcoauthor=M.+Perezauthor=J.+Piquero-Martinauthor=J.+A.+Seeauthor=D.+H.+Suhauthor=J.+Tanauthor=V.+T.+Lozadaauthor=P.+Troielliauthor=L.+F.+Xiang&title=Practical+management+of+acne+for+clinicians%3A+An+international+consensus+from+the+Global+Alliance+to+Improve+Outcomes+in+Acne&doi=10.1016%2Fj.jaad.2017.09.078"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2017.09.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2017.09.078%26sid%3Dliteratum%253Aachs%26aulast%3DThiboutot%26aufirst%3DD.%2BM.%26aulast%3DDr%25C3%25A9no%26aufirst%3DB.%26aulast%3DAbanmi%26aufirst%3DA.%26aulast%3DAlexis%26aufirst%3DA.%2BF.%26aulast%3DAraviiskaia%26aufirst%3DE.%26aulast%3DBarona%2BCabal%26aufirst%3DM.%2BI.%26aulast%3DBettoli%26aufirst%3DV.%26aulast%3DCasintahan%26aufirst%3DF.%26aulast%3DChow%26aufirst%3DS.%26aulast%3Dda%2BCosta%26aufirst%3DA.%26aulast%3DEl%2BOuazzani%26aufirst%3DT.%26aulast%3DGoh%26aufirst%3DC.%2BL.%26aulast%3DGollnick%26aufirst%3DH.%2BP.%2BM.%26aulast%3DGomez%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DN.%26aulast%3DHerane%26aufirst%3DM.%2BI.%26aulast%3DHoneyman%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DKemeny%26aufirst%3DL.%26aulast%3DKubba%26aufirst%3DR.%26aulast%3DLambert%26aufirst%3DJ.%26aulast%3DLayton%26aufirst%3DA.%2BM.%26aulast%3DLeyden%26aufirst%3DJ.%2BJ.%26aulast%3DL%25C3%25B3pez-Estebaranz%26aufirst%3DJ.%2BL.%26aulast%3DNoppakun%26aufirst%3DN.%26aulast%3DOchsendorf%26aufirst%3DF.%26aulast%3DOprica%26aufirst%3DC.%26aulast%3DOrozco%26aufirst%3DB.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DPiquero-Martin%26aufirst%3DJ.%26aulast%3DSee%26aufirst%3DJ.%2BA.%26aulast%3DSuh%26aufirst%3DD.%2BH.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DLozada%26aufirst%3DV.%2BT.%26aulast%3DTroielli%26aufirst%3DP.%26aulast%3DXiang%26aufirst%3DL.%2BF.%26atitle%3DPractical%2520management%2520of%2520acne%2520for%2520clinicians%253A%2520An%2520international%2520consensus%2520from%2520the%2520Global%2520Alliance%2520to%2520Improve%2520Outcomes%2520in%2520Acne%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2018%26volume%3D78%26spage%3DS1%26epage%3DS23%26doi%3D10.1016%2Fj.jaad.2017.09.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dréno, B.</span></span> <span> </span><span class="NLM_article-title">What is new in the pathophysiology of acne, an overview</span>. <i>J. Eur. Acad. Dermatol. Venereol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1111/jdv.14374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1111%2Fjdv.14374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=28805938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlakt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=8-12&author=B.+Dr%C3%A9no&title=What+is+new+in+the+pathophysiology+of+acne%2C+an+overview&doi=10.1111%2Fjdv.14374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">What is new in the pathophysiology of acne, an overview</span></div><div class="casAuthors">Dreno, B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the European Academy of Dermatology and Venereology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">S5</span>),
    <span class="NLM_cas:pages">8-12</span>CODEN:
                <span class="NLM_cas:coden">JEAVEQ</span>;
        ISSN:<span class="NLM_cas:issn">1468-3083</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Acne is a chronic inflammatory disease of the pilosebaceous unit.  Its pathophysiol. includes hyperseborrhoea, abnormal follicular keratinization and Propionibacterium acnes proliferation in the pilosebaceous unit.  Recent research has shed some new light on the involvement of the sebaceous gland, as well as on the pro-inflammatory activity of the cutaneous microbiome.  During puberty, alteration of the sebaceous lipid profile, called dysseborrhoea, stress, irritation, cosmetics and potential dietary factors lead to inflammation and formation of different types of acne lesions.  Dysbiosis, the process leading to a disturbed skin barrier and disequil. of the cutaneous microbiome, resulting in the proliferation of P. acnes strains, is another important process that triggers acne.  P. acnes activates the innate immunity via the expression of protease activated receptors (PARs), tumor necrosis factor (TNF) α and toll-like receptors (TLRs), and the prodn. of interferon (INF) γ, interleukins (IL-8, IL12, IL-1), TNF, and matrix metalloproteinases (MMPs) by keratinocytes, resulting in the hyperkeratinization of the pilosebaceous unit.  Rebalancing the natural microbiome of the skin by restoring the natural skin barrier, limiting the proliferation of P. acnes on the skin by using topical antibacterials which do not cause resistance and regulating quantity and quality of sebum will be the main acne treatment challenges in the future.  The aim of this article to provide an update on the involvement of the sebaceous gland, the innate immunity and the cutaneous microbiome, how all of these factors promote acne and to illustrate their links with current and future treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotFmLmMfcPMbVg90H21EOLACvtfcHk0lj2fna7qkQ1Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlakt73P&md5=a0175785c47fea2f7f7f621847381fd5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fjdv.14374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjdv.14374%26sid%3Dliteratum%253Aachs%26aulast%3DDr%25C3%25A9no%26aufirst%3DB.%26atitle%3DWhat%2520is%2520new%2520in%2520the%2520pathophysiology%2520of%2520acne%252C%2520an%2520overview%26jtitle%3DJ.%2520Eur.%2520Acad.%2520Dermatol.%2520Venereol.%26date%3D2017%26volume%3D31%26spage%3D8%26epage%3D12%26doi%3D10.1111%2Fjdv.14374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moecking, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, S. L.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of NLRP1-mediated autoinflammatory disease in humans and mice</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>430</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2017.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.jmb.2017.07.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2018&pages=142-152&author=C.+H.+Yuauthor=J.+Moeckingauthor=M.+Geyerauthor=S.+L.+Masters&title=Mechanisms+of+NLRP1-mediated+autoinflammatory+disease+in+humans+and+mice&doi=10.1016%2Fj.jmb.2017.07.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2017.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2017.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DC.%2BH.%26aulast%3DMoecking%26aufirst%3DJ.%26aulast%3DGeyer%26aufirst%3DM.%26aulast%3DMasters%26aufirst%3DS.%2BL.%26atitle%3DMechanisms%2520of%2520NLRP1-mediated%2520autoinflammatory%2520disease%2520in%2520humans%2520and%2520mice%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2018%26volume%3D430%26spage%3D142%26epage%3D152%26doi%3D10.1016%2Fj.jmb.2017.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kistowska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehrke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jankovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fettelschoss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmeyer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenini, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolios, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganceviciene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schauber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contassot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, L. E.</span></span> <span> </span><span class="NLM_article-title">IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">677</span>– <span class="NLM_lpage">685</span>, <span class="refDoi"> DOI: 10.1038/jid.2013.438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1038%2Fjid.2013.438" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2014&pages=677-685&author=M.+Kistowskaauthor=S.+Gehrkeauthor=D.+Jankovicauthor=K.+Kerlauthor=A.+Fettelschossauthor=L.+Feldmeyerauthor=G.+Feniniauthor=A.+Koliosauthor=A.+Navariniauthor=R.+Gancevicieneauthor=J.+Schauberauthor=E.+Contassotauthor=L.+E.+French&title=IL-1%CE%B2+drives+inflammatory+responses+to+propionibacterium+acnes+in+vitro+and+in+vivo&doi=10.1038%2Fjid.2013.438"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fjid.2013.438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjid.2013.438%26sid%3Dliteratum%253Aachs%26aulast%3DKistowska%26aufirst%3DM.%26aulast%3DGehrke%26aufirst%3DS.%26aulast%3DJankovic%26aufirst%3DD.%26aulast%3DKerl%26aufirst%3DK.%26aulast%3DFettelschoss%26aufirst%3DA.%26aulast%3DFeldmeyer%26aufirst%3DL.%26aulast%3DFenini%26aufirst%3DG.%26aulast%3DKolios%26aufirst%3DA.%26aulast%3DNavarini%26aufirst%3DA.%26aulast%3DGanceviciene%26aufirst%3DR.%26aulast%3DSchauber%26aufirst%3DJ.%26aulast%3DContassot%26aufirst%3DE.%26aulast%3DFrench%26aufirst%3DL.%2BE.%26atitle%3DIL-1%25CE%25B2%2520drives%2520inflammatory%2520responses%2520to%2520propionibacterium%2520acnes%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2014%26volume%3D134%26spage%3D677%26epage%3D685%26doi%3D10.1038%2Fjid.2013.438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span> Assuming
equilibrium can be reached, then the free drug concentration in skin
should be comparable to that in blood at steady state. For a more
detailed explanation, see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span> <span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1038/nrd3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery&doi=10.1038%2Fnrd3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0lhOuJAGxZvYJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D929%26epage%3D939%26doi%3D10.1038%2Fnrd3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchwald, P.</span></span> <span> </span><span class="NLM_article-title">Soft drug design: general principles and recent applications</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10608921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFWqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=58-101&author=N.+Bodorauthor=P.+Buchwald&title=Soft+drug+design%3A+general+principles+and+recent+applications&doi=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Soft drug design: general principles and recent applications</span></div><div class="casAuthors">Bodor, Nicholas; Buchwald, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-101</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 208 refs.  Soft drug design represents a new approach aimed to design safer drugs with an increased therapeutic index by integrating metab. considerations into the drug design process.  Soft drugs are new therapeutic agents that undergo predictable metab. to inactive metabolites after exerting their therapeutic effect.  Hence, they are obtained by building into the mol., in addn. to the activity, the most desired way in which the mol. is to be deactivated and detoxified.  In an attempt to systematize and summarize the related work done in a no. of labs., including ours, the present review presents an overview of the general soft drug design principles and provides a variety of specific examples to illustrate the concepts.  A no. of already marketed drugs, such as esmolol, remifentanil, or loteprednol etabonate, resulted from the successful application of such design principles.  Many other promising drug candidates are currently under investigation in a variety of fields including possible soft antimicrobials, anticholinergics, corticosteroids, β-blockers, analgetics, ACE inhibitors, antiarrhythmics, and others.  Whenever possible, pharmacokinetic and pharmacodynamic properties are briefly summarized and compared to those of other compds. used in the same field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphV1vhXwTl8LVg90H21EOLACvtfcHk0lhOuJAGxZvYJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFWqsg%253D%253D&md5=e0ca493ba31d001e62a759be0fc4bcc8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528200001%252920%253A1%253C58%253A%253AAID-MED3%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DBodor%26aufirst%3DN.%26aulast%3DBuchwald%26aufirst%3DP.%26atitle%3DSoft%2520drug%2520design%253A%2520general%2520principles%2520and%2520recent%2520applications%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2000%26volume%3D20%26spage%3D58%26epage%3D101%26doi%3D10.1002%2F%28SICI%291098-1128%28200001%2920%3A1%3C58%3A%3AAID-MED3%3E3.0.CO%3B2-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsumi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakusa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, O.</span></span> <span> </span><span class="NLM_article-title">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1977</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.027797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1124%2Fdmd.109.027797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=19487250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1970-1977&author=S.+Nakayamaauthor=R.+Atsumiauthor=H.+Takakusaauthor=Y.+Kobayashiauthor=A.+Kuriharaauthor=Y.+Nagaiauthor=D.+Nakaiauthor=O.+Okazaki&title=A+zone+classification+system+for+risk+assessment+of+idiosyncratic+drug+toxicity+using+daily+dose+and+covalent+binding&doi=10.1124%2Fdmd.109.027797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding</span></div><div class="casAuthors">Nakayama, Shintaro; Atsumi, Ryo; Takakusa, Hideo; Kobayashi, Yoshimasa; Kurihara, Atsushi; Nagai, Yoko; Nakai, Daisuke; Okazaki, Osamu</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1970-1977</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The risk of idiosyncratic drug toxicity (IDT) is of great concern to the pharmaceutical industry.  Current hypotheses based on retrospective studies suggest that the occurrence of IDT is related to covalent binding and daily dose.  The authors detd. the covalent binding of 42 radiolabeled drugs in three test systems (human liver microsomes and hepatocytes in vitro and rat liver in vivo) to assess the risk of IDT.  On the basis of safety profiles given in official documentation, tested drugs were classified into the safety categories of safe, warning, black box warning, and withdrawn.  The covalent binding in each of the three test systems did not distinguish the safety categories clearly.  However, when the log-normalized covalent binding was plotted against the log-normalized daily dose, the distribution of the plot in the safety categories became clear.  An ordinal logistic regression anal. indicated that both covalent binding and daily dose were significantly correlated with safety category and that covalent binding in hepatocytes was the best predictor among the three systems.  When two sepn. lines were drawn on the correlation graph between covalent binding in human hepatocytes and daily dose by a regression anal. to create three zones, 30 of 37 tested drugs were located in zones corresponding to their resp. classified safety categories.  In conclusion, the authors established a zone classification system using covalent binding in human hepatocytes and daily dose for the risk assessment of IDTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtahZPkNJ3JbVg90H21EOLACvtfcHk0li8gQwLc0L12A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOrsrfO&md5=425119e0451fc50ec6ca95d5e3fe5fd3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.027797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.027797%26sid%3Dliteratum%253Aachs%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DAtsumi%26aufirst%3DR.%26aulast%3DTakakusa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKurihara%26aufirst%3DA.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DNakai%26aufirst%3DD.%26aulast%3DOkazaki%26aufirst%3DO.%26atitle%3DA%2520zone%2520classification%2520system%2520for%2520risk%2520assessment%2520of%2520idiosyncratic%2520drug%2520toxicity%2520using%2520daily%2520dose%2520and%2520covalent%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1970%26epage%3D1977%26doi%3D10.1124%2Fdmd.109.027797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Howley, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearnhead, H. O.</span></span> <span> </span><span class="NLM_article-title">Caspases as therapeutic targets</span>. <i>J. Cell. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1502</span>– <span class="NLM_lpage">1516</span>, <span class="refDoi"> DOI: 10.1111/j.1582-4934.2008.00292.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1111%2Fj.1582-4934.2008.00292.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=18298652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVarsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1502-1516&author=B.+Howleyauthor=H.+O.+Fearnhead&title=Caspases+as+therapeutic+targets&doi=10.1111%2Fj.1582-4934.2008.00292.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Caspases as therapeutic targets</span></div><div class="casAuthors">Howley, B.; Fearnhead, H. O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5A</span>),
    <span class="NLM_cas:pages">1502-1516</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The development of small mols. to modulate caspase activity offers a novel therapeutic strategy in the treatment of apoptosis-related and inflammatory diseases.  Caspases are key mediators of apoptosis and inflammation; deregulation of their activation or expression can lead to the development of conditions such as neurodegenerative and autoinflammatory disorders.  This review details the different caspase-assocd. disorders while focusing on caspase-1 inhibition as a potential therapeutic strategy.  Problems facing the development of effective and safe caspase therapeutics will also be addressed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocysVbrR7n4bVg90H21EOLACvtfcHk0li8gQwLc0L12A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVarsbbI&md5=f439705c22843fdc973a71e3218ec3ad</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00292.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00292.x%26sid%3Dliteratum%253Aachs%26aulast%3DHowley%26aufirst%3DB.%26aulast%3DFearnhead%26aufirst%3DH.%2BO.%26atitle%3DCaspases%2520as%2520therapeutic%2520targets%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2008%26volume%3D12%26spage%3D1502%26epage%3D1516%26doi%3D10.1111%2Fj.1582-4934.2008.00292.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schipper, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. C.</span></span> <span> </span><span class="NLM_article-title">The potential for caspases in drug discovery</span>. <i>Curr. Opin. Drug Discovery Devel.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=568-576&author=S.+H.+MacKenzieauthor=J.+L.+Schipperauthor=A.+C.+Clark&title=The+potential+for+caspases+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DS.%2BH.%26aulast%3DSchipper%26aufirst%3DJ.%2BL.%26aulast%3DClark%26aufirst%3DA.%2BC.%26atitle%3DThe%2520potential%2520for%2520caspases%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Devel.%26date%3D2010%26volume%3D13%26spage%3D568%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="note"><p class="first last">In our experience, the hepatic stability of compounds designed for the systemic route often leads to difficulties in development.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T.</span>; <span class="NLM_string-name">Linton, S. D.</span></span> <i>Design of Caspase Inhibitors as Potential Clinical Agents</i>; <span class="NLM_publisher-name">CRC Press/Taylor & Francis Group</span>: <span class="NLM_publisher-loc">Boca Raton, FL</span>, <span class="NLM_year">2009</span>; pp  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">132</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=82-132&author=T.+O%E2%80%99Brien&author=S.+D.+Linton&title=Design+of+Caspase+Inhibitors+as+Potential+Clinical+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26btitle%3DDesign%2520of%2520Caspase%2520Inhibitors%2520as%2520Potential%2520Clinical%2520Agents%26pub%3DCRC%2520Press%252FTaylor%2520%2526%2520Francis%2520Group%26date%3D2009%26spage%3D82%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span> <i>Evaluation of Enzyme Inhibition in Drug Discovery: A Guide to Medicinal Chemists and Pharmacologists</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Wiley-Interscience</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2013</span>; 294 pp.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1002%2F9781118540398" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+A.+Copeland&title=Evaluation+of+Enzyme+Inhibition+in+Drug+Discovery%3A+A+Guide+to+Medicinal+Chemists+and+Pharmacologists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2F9781118540398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118540398%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26btitle%3DEvaluation%2520of%2520Enzyme%2520Inhibition%2520in%2520Drug%2520Discovery%253A%2520A%2520Guide%2520to%2520Medicinal%2520Chemists%2520and%2520Pharmacologists%26pub%3DWiley-Interscience%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">General mechanism of reversible covalent bond formation between catalytic cysteine and reactive warhead occurs through general base catalysis via histidine 237 and concomitant attack of cysteine 285 on an electrophilic center, usually a carbonyl.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_001.pdf" class="ext-link">Scheme 1S in Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">PGE-3935199 (<b>5</b>):</p></div><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Soper, D. L.</span>; <span class="NLM_string-name">O’Neil, S. V.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Oppong, K. A.</span>; <span class="NLM_string-name">Ellis, C. D.</span>; <span class="NLM_string-name">Laufersweiler, M. C.</span>; <span class="NLM_string-name">Demuth, T. P.</span>; <span class="NLM_string-name">Fancher, A. N.</span>; <span class="NLM_string-name">Lu, W.</span>; <span class="NLM_string-name">Wang, R. L.</span>; <span class="NLM_string-name">Schwecke, W. P.</span>; <span class="NLM_string-name">Cruze, C. A.</span>; <span class="NLM_string-name">Buchalova, M.</span>; <span class="NLM_string-name">Belkin, M.</span>; <span class="NLM_string-name">Wos, J. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and discovery of PGE-527667, an orally bioavailable caspase-1 inhibitor</span>.  <i>Abstracts of Papers</i>, 228th National Meeting of the American Chemical Society, Philadelphia, PA, U.S., 2004; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>, <span class="NLM_year">2004</span>; MEDI-268.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=D.+L.+Soper&author=S.+V.+O%E2%80%99Neil&author=Y.+Wang&author=K.+A.+Oppong&author=C.+D.+Ellis&author=M.+C.+Laufersweiler&author=T.+P.+Demuth&author=A.+N.+Fancher&author=W.+Lu&author=R.+L.+Wang&author=W.+P.+Schwecke&author=C.+A.+Cruze&author=M.+Buchalova&author=M.+Belkin&author=J.+A.+Wos&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSoper%26aufirst%3DD.%2BL.%26atitle%3DSynthesis%2520and%2520discovery%2520of%2520PGE-527667%252C%2520an%2520orally%2520bioavailable%2520caspase-1%2520inhibitor%26btitle%3DAbstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Soper, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheville, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufersweiler, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppong, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baize, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fancher, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suchanek, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwecke, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruze, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchalova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belkin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wireko, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, T. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of novel 8,5-fused bicyclic peptidomimetic compounds as interleukin-1β converting enzyme (ICE) inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7880</span>– <span class="NLM_lpage">7892</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.07.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.bmc.2006.07.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=7880-7892&author=D.+L.+Soperauthor=J.+X.+Shevilleauthor=S.+V.+O%E2%80%99Neilauthor=Y.+Wangauthor=M.+C.+Laufersweilerauthor=K.+A.+Oppongauthor=J.+A.+Wosauthor=C.+D.+Ellisauthor=M.+W.+Baizeauthor=J.+J.+Chenauthor=A.+N.+Fancherauthor=W.+Luauthor=M.+K.+Suchanekauthor=R.+L.+Wangauthor=W.+P.+Schweckeauthor=C.+A.+Cruzeauthor=M.+Buchalovaauthor=M.+Belkinauthor=F.+Wirekoauthor=A.+Ritterauthor=B.+Deauthor=D.+Wangauthor=T.+P.+Demuth&title=Synthesis+and+evaluation+of+novel+8%2C5-fused+bicyclic+peptidomimetic+compounds+as+interleukin-1%CE%B2+converting+enzyme+%28ICE%29+inhibitors&doi=10.1016%2Fj.bmc.2006.07.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.07.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.07.056%26sid%3Dliteratum%253Aachs%26aulast%3DSoper%26aufirst%3DD.%2BL.%26aulast%3DSheville%26aufirst%3DJ.%2BX.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DS.%2BV.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLaufersweiler%26aufirst%3DM.%2BC.%26aulast%3DOppong%26aufirst%3DK.%2BA.%26aulast%3DWos%26aufirst%3DJ.%2BA.%26aulast%3DEllis%26aufirst%3DC.%2BD.%26aulast%3DBaize%26aufirst%3DM.%2BW.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DFancher%26aufirst%3DA.%2BN.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DSuchanek%26aufirst%3DM.%2BK.%26aulast%3DWang%26aufirst%3DR.%2BL.%26aulast%3DSchwecke%26aufirst%3DW.%2BP.%26aulast%3DCruze%26aufirst%3DC.%2BA.%26aulast%3DBuchalova%26aufirst%3DM.%26aulast%3DBelkin%26aufirst%3DM.%26aulast%3DWireko%26aufirst%3DF.%26aulast%3DRitter%26aufirst%3DA.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DDemuth%26aufirst%3DT.%2BP.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%25208%252C5-fused%2520bicyclic%2520peptidomimetic%2520compounds%2520as%2520interleukin-1%25CE%25B2%2520converting%2520enzyme%2520%2528ICE%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D7880%26epage%3D7892%26doi%3D10.1016%2Fj.bmc.2006.07.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14c.0"><span>ZYVAD-FMK (<b>7</b>):</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ZYVAD-FMK+%287%29%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c.0&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochevar, I. E.</span></span> <span> </span><span class="NLM_article-title">Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 Cells</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>250</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1006/excr.1999.4501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1006%2Fexcr.1999.4501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10388534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADyaK1MXktV2ksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=250&publication_year=1999&pages=203-212&author=S.+Zhuangauthor=M.+C.+Lynchauthor=I.+E.+Kochevar&title=Caspase-8+mediates+caspase-3+activation+and+cytochrome+c+release+during+singlet+oxygen-induced+apoptosis+of+HL-60+Cells&doi=10.1006%2Fexcr.1999.4501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-8 Mediates Caspase-3 Activation and Cytochrome c Release during Singlet Oxygen-Induced Apoptosis of HL-60 Cells</span></div><div class="casAuthors">Zhuang, Shougang; Lynch, Mary C.; Kochevar, Irene E.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">250</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">203-212</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">We reported previously that singlet oxygen, generated by irradn. of rose bengal with visible light, induced apoptosis in human promyelocytic leukemia HL-60 cells.  However, the mechanism of apoptosis caused by this reactive oxygen species is unclear.  In this study, we demonstrate that singlet oxygen induced caspase-3 activation and Z-DEVD-FMK, a caspase-3 inhibitor, blocked apoptosis induction, while caspase-1 activity was not detectable and the caspase-1 inhibitor Z-YVAD-FMK had a very limited effect on apoptosis.  This suggests that the activation of caspase-3 by singlet oxygen is essential for the commitment of cells to undergo apoptosis.  Further studies showed that singlet oxygen induced an increase in caspase-8 activity and a redn. in mitochondrial cytochrome c.  Time course anal. indicated that the cleavage of caspase-8 precedes that of caspase-3.  In addn., blockade of caspase-8 by Z-IETD-FMK inhibited cleavage of pro-caspase-3 and prevented loss of mitochondrial cytochrome c.  These results suggest that caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis in HL-60 cells.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXafrd6x_Y97Vg90H21EOLACvtfcHk0lgALvGHInUHHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktV2ksbg%253D&md5=9826a2faf5c8dd9b78eb8753acfa1a50</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1999.4501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1999.4501%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DS.%26aulast%3DLynch%26aufirst%3DM.%2BC.%26aulast%3DKochevar%26aufirst%3DI.%2BE.%26atitle%3DCaspase-8%2520mediates%2520caspase-3%2520activation%2520and%2520cytochrome%2520c%2520release%2520during%2520singlet%2520oxygen-induced%2520apoptosis%2520of%2520HL-60%2520Cells%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D250%26spage%3D203%26epage%3D212%26doi%3D10.1006%2Fexcr.1999.4501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">This is also corroborated by preincubating caspase-1 with the inhibitors before the addition of substrate to allow slow equilibrium to take place. Indeed, a linear relationship was found between the log ratios of the IC<sub>50</sub> values measured with the two incubation periods (0 and 1 h) vs the two substrate concentrations. Thus, these two different sets of two experimental conditions are affected in a similar fashion by compounds that are slow to reach Michaelis–Menten equilibrium. See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_001.pdf" class="ext-link">Figure 1S in Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">Because the half-life of caspase-1 was shown to be below 10 min, we did not attempt to optimize this variable as a longer residence time would not translate into prolonged efficacy. See, for example, the following:</p></div><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logue, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lüthi, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. J.</span></span> <span> </span><span class="NLM_article-title">Caspase-1 promiscuity is counterbalanced by rapid inactivation of processed enzyme</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">32513</span>– <span class="NLM_lpage">32524</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.225862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1074%2Fjbc.M111.225862" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=32513-32524&author=J.+G.+Walshauthor=S.+E.+Logueauthor=A.+U.+L%C3%BCthiauthor=S.+J.+Martin&title=Caspase-1+promiscuity+is+counterbalanced+by+rapid+inactivation+of+processed+enzyme&doi=10.1074%2Fjbc.M111.225862"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.225862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.225862%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DJ.%2BG.%26aulast%3DLogue%26aufirst%3DS.%2BE.%26aulast%3DL%25C3%25BCthi%26aufirst%3DA.%2BU.%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26atitle%3DCaspase-1%2520promiscuity%2520is%2520counterbalanced%2520by%2520rapid%2520inactivation%2520of%2520processed%2520enzyme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D32513%26epage%3D32524%26doi%3D10.1074%2Fjbc.M111.225862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Núñez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venhorst, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, C. G.</span></span> <span> </span><span class="NLM_article-title">Target-drug interactions: first principles and their application to drug discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.drudis.2011.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=21777691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns12gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=10-22&author=S.+N%C3%BA%C3%B1ezauthor=J.+Venhorstauthor=C.+G.+Kruse&title=Target-drug+interactions%3A+first+principles+and+their+application+to+drug+discovery&doi=10.1016%2Fj.drudis.2011.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Target-drug interactions: first principles and their application to drug discovery</span></div><div class="casAuthors">Nunez, Sara; Venhorst, Jennifer; Kruse, Chris G.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">10-22</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this review, we begin by introducing the basic principles of kinetics and thermodn. of target-drug binding within the context of drug discovery.  In addn., we present a meta-anal. of the recent literature describing the kinetic and thermodn. resoln. of successful clin. candidates with diverse mechanisms of action.  We finish by discussing the best practices in the triage and chem. optimization towards clin. candidates with maximal in vivo efficacy devoid of adverse events.  The utilization of the kinetic and thermodn. signatures of preclin. leads is proving pivotal in their triage and rational optimization towards clin. candidates with maximal in vivo efficacy devoid of adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-KD3TmQ_PbbVg90H21EOLACvtfcHk0lgALvGHInUHHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns12gsQ%253D%253D&md5=9656faef61159898077def9fbe502360</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DS.%26aulast%3DVenhorst%26aufirst%3DJ.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26atitle%3DTarget-drug%2520interactions%253A%2520first%2520principles%2520and%2520their%2520application%2520to%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D10%26epage%3D22%26doi%3D10.1016%2Fj.drudis.2011.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span> The azabicyclooctane
is the object of another communication; see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Rodeschini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brethon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantalat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clary, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastreich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isabet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreau, E.</span></span> <span> </span><span class="NLM_article-title">New Caspase-1 inhibitor by scaffold hopping into bio-inspired 3D-fragment space</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5373</span>– <span class="NLM_lpage">5377</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.bmcl.2017.11.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5373-5377&author=V.+Rodeschiniauthor=A.+Brethonauthor=L.+Chantalatauthor=O.+Christinauthor=L.+Claryauthor=J.-F.+Fournierauthor=M.+Gastreichauthor=C.+S.+Harrisauthor=T.+Isabetauthor=D.+Rocheauthor=J.+Pascauauthor=E.+Thoreau&title=New+Caspase-1+inhibitor+by+scaffold+hopping+into+bio-inspired+3D-fragment+space&doi=10.1016%2Fj.bmcl.2017.11.015"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DRodeschini%26aufirst%3DV.%26aulast%3DBrethon%26aufirst%3DA.%26aulast%3DChantalat%26aufirst%3DL.%26aulast%3DChristin%26aufirst%3DO.%26aulast%3DClary%26aufirst%3DL.%26aulast%3DFournier%26aufirst%3DJ.-F.%26aulast%3DGastreich%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DIsabet%26aufirst%3DT.%26aulast%3DRoche%26aufirst%3DD.%26aulast%3DPascau%26aufirst%3DJ.%26aulast%3DThoreau%26aufirst%3DE.%26atitle%3DNew%2520Caspase-1%2520inhibitor%2520by%2520scaffold%2520hopping%2520into%2520bio-inspired%25203D-fragment%2520space%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5373%26epage%3D5377%26doi%3D10.1016%2Fj.bmcl.2017.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahr, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopko, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waal, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimundo, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purkey, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romanowski, M.</span></span> <span> </span><span class="NLM_article-title">Structural analysis of caspase-1 inhibitors derived from Tethering</span>. <i>Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">451</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1107/S1744309105010109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1107%2FS1744309105010109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=16511067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=451-458&author=T.+O%E2%80%99Brienauthor=B.+T.+Fahrauthor=M.+M.+Sopkoauthor=J.+W.+Lamauthor=N.+D.+Waalauthor=B.+C.+Raimundoauthor=H.+E.+Purkeyauthor=P.+Phamauthor=M.+Romanowski&title=Structural+analysis+of+caspase-1+inhibitors+derived+from+Tethering&doi=10.1107%2FS1744309105010109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analysis of caspase-1 inhibitors derived from tethering</span></div><div class="casAuthors">O'Brien, Tom; Fahr, Bruce T.; Sopko, Michelle M.; Lam, Joni W.; Waal, Nathan D.; Raimundo, Brian C.; Purkey, Hans E.; Pham, Phuongly; Romanowski, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">451-458</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Caspase-1 is a key endopeptidase responsible for the post-translational processing of the IL-1β and IL-18 cytokines and small-mol. inhibitors that modulate the activity of this enzyme are predicted to be important therapeutic treatments for many inflammatory diseases.  A fragment-assembly approach, accompanied by structural anal., was employed to generate caspase-1 inhibitors.  With the aid of Tethering with extenders (small mols. that bind to the active-site cysteine and contain a free thiol), two novel fragments that bound to the active site and made a disulfide bond with the extender were identified by mass spectrometry.  Direct linking of each fragment to the extender generated submicromolar reversible inhibitors that significantly reduced secretion of IL-1β but not IL-6 from human peripheral blood mononuclear cells.  Thus, Tethering with extenders facilitated rapid identification and synthesis of caspase-1 inhibitors with cell-based activity and subsequent structural analyses provided insights into the enzyme's ability to accommodate different inhibitor-binding modes in the active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMkYqntJ_HZLVg90H21EOLACvtfcHk0lgsOACSUhMe_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVehsb8%253D&md5=2fa16fde66c84a35d8fe97c8a0931af6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1107%2FS1744309105010109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309105010109%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26aulast%3DFahr%26aufirst%3DB.%2BT.%26aulast%3DSopko%26aufirst%3DM.%2BM.%26aulast%3DLam%26aufirst%3DJ.%2BW.%26aulast%3DWaal%26aufirst%3DN.%2BD.%26aulast%3DRaimundo%26aufirst%3DB.%2BC.%26aulast%3DPurkey%26aufirst%3DH.%2BE.%26aulast%3DPham%26aufirst%3DP.%26aulast%3DRomanowski%26aufirst%3DM.%26atitle%3DStructural%2520analysis%2520of%2520caspase-1%2520inhibitors%2520derived%2520from%2520Tethering%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2005%26volume%3D61%26spage%3D451%26epage%3D458%26doi%3D10.1107%2FS1744309105010109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abad-Zapatero, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metz, J. T.</span></span> <span> </span><span class="NLM_article-title">Ligand efficiency indices as guideposts for drug discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(05)03386-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2FS1359-6446%2805%2903386-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=15809192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=464-469&author=C.+Abad-Zapateroauthor=J.+T.+Metz&title=Ligand+efficiency+indices+as+guideposts+for+drug+discovery&doi=10.1016%2FS1359-6446%2805%2903386-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency indices as guideposts for drug discovery</span></div><div class="casAuthors">Abad-Zapatero Cele; Metz James T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">464-9</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHqVfZXUq224qdXsLcGTEUfW6udTcc2eYn09PeGg1vRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7nsF2iug%253D%253D&md5=1720f263a306122c86a57463e5a39287</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2805%2903386-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252805%252903386-6%26sid%3Dliteratum%253Aachs%26aulast%3DAbad-Zapatero%26aufirst%3DC.%26aulast%3DMetz%26aufirst%3DJ.%2BT.%26atitle%3DLigand%2520efficiency%2520indices%2520as%2520guideposts%2520for%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2005%26volume%3D10%26spage%3D464%26epage%3D469%26doi%3D10.1016%2FS1359-6446%2805%2903386-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P. J.</span></span> <span> </span><span class="NLM_article-title">Fragment-based drug design: How big is too big?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6972</span>– <span class="NLM_lpage">6976</span>, <span class="refDoi"> DOI: 10.1021/jm060511h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060511h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6972-6976&author=P.+J.+Hajduk&title=Fragment-based+drug+design%3A+How+big+is+too+big%3F&doi=10.1021%2Fjm060511h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Design: How Big Is Too Big?</span></div><div class="casAuthors">Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6972-6976</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Much has been discussed about the proper physicochem. properties (e.g., mol. wt., hydrophobicity, etc.) that should be considered when utilizing fragment leads in drug design.  However, little has been reported as to what emphasis, if any, should be placed on the potency of the resulting fragment leads.  In this report, a retrospective anal. of 18 highly optimized inhibitors is described in which the compds. were systematically deconstructed until the minimal binding elements could be identified.  An anal. of the potency changes that were obsd. as the leads were reduced in size indicate that a nearly linear relationship exists between mol. wt. and binding affinity over the entire range of sizes and potencies represented in the dataset.  On the basis of these observations, prediction maps can be constructed that enable crit. and quant. assessments of the process of lead identification and optimization.  These data place well-defined limits on the ideal size and potency of fragment leads that are being considered for use in fragment-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfCz9NMtBgNrVg90H21EOLACvtfcHk0lgmqzIEdZ5fOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLbJ&md5=b27d4ca6446a033b82e0ea223da5e6de</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm060511h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060511h%26sid%3Dliteratum%253Aachs%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DFragment-based%2520drug%2520design%253A%2520How%2520big%2520is%2520too%2520big%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6972%26epage%3D6976%26doi%3D10.1021%2Fjm060511h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span> <span> </span><span class="NLM_article-title">Drug-like properties and the causes of poor solubility and poor permeability</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1016/S1056-8719(00)00107-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2FS1056-8719%2800%2900107-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=11274893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2000&pages=235-249&author=C.+A.+Lipinski&title=Drug-like+properties+and+the+causes+of+poor+solubility+and+poor+permeability&doi=10.1016%2FS1056-8719%2800%2900107-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-like properties and the causes of poor solubility and poor permeability</span></div><div class="casAuthors">Lipinski C A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of pharmacological and toxicological methods</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-49</span>
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">There are currently about 10000 drug-like compounds.  These are sparsely, rather than uniformly, distributed through chemistry space.  True diversity does not exist in experimental combinatorial chemistry screening libraries.  Absorption, distribution, metabolism, and excretion (ADME) and chemical reactivity-related toxicity is low, while biological receptor activity is higher dimensional in chemistry space, and this is partly explainable by evolutionary pressures on ADME to deal with endobiotics and exobiotics.  ADME is hard to predict for large data sets because current ADME experimental screens are multi-mechanisms, and predictions get worse as more data accumulates.  Currently, screening for biological receptor activity precedes or is concurrent with screening for properties related to "drugability." In the future, "drugability" screening may precede biological receptor activity screening.  The level of permeability or solubility needed for oral absorption is related to potency.  The relative importance of poor solubility and poor permeability towards the problem of poor oral absorption depends on the research approach used for lead generation.  A "rational drug design" approach as exemplified by Merck advanced clinical candidates leads to time-dependent higher molecular weight, higher H-bonding properties, unchanged lipophilicity, and, hence, poorer permeability.  A high throughput screening (HTS)-based approach as exemplified by unpublished data on Pfizer (Groton, CT) early candidates leads to higher molecular weight, unchanged H-bonding properties, higher lipophilicity, and, hence, poorer aqueous solubility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmUcEou3dTa_EeosoOnpOLfW6udTcc2eZUkgAbVcqRN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7os1OjsQ%253D%253D&md5=aeb705afe1eccaceaf441c7a19f13ecc</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2800%2900107-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252800%252900107-6%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DDrug-like%2520properties%2520and%2520the%2520causes%2520of%2520poor%2520solubility%2520and%2520poor%2520permeability%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2000%26volume%3D44%26spage%3D235%26epage%3D249%26doi%3D10.1016%2FS1056-8719%2800%2900107-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalkowsky, S. H.</span></span> <span> </span><span class="NLM_article-title">Estimation of the aqueous solubility i: application to organic nonelectrolytes</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1002/1520-6017(200102)90:2<234::AID-JPS14>3.0.CO;2-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1002%2F1520-6017%28200102%2990%3A2%3C234%3A%3AAID-JPS14%3E3.0.CO%3B2-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=11169540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1yktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2001&pages=234-252&author=N.+Jainauthor=S.+H.+Yalkowsky&title=Estimation+of+the+aqueous+solubility+i%3A+application+to+organic+nonelectrolytes&doi=10.1002%2F1520-6017%28200102%2990%3A2%3C234%3A%3AAID-JPS14%3E3.0.CO%3B2-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of the aqueous solubility I: Application to organic nonelectrolytes</span></div><div class="casAuthors">Jain, Neera; Yalkowsky, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">234-252</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The estn. of aq. solubilities of org. nonelectrolytes by the General Soly. Equation (GSE) as proposed by Valvani and Yalkowsky (1980) is used.  The data and assumptions on which the GSE are based are reevaluated, and the equation is revised.  The revised GSE is validated on a set of 580 pharmaceutically, environmentally, and industrially relevant nonelectrolytes.  The revised equation has a stronger theor. background and provides a more accurate estn. of aq. soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokht7kvEZSF7Vg90H21EOLACvtfcHk0lgmqzIEdZ5fOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1yktbo%253D&md5=d0ff887aeb74953499706b49598277f4</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1002%2F1520-6017%28200102%2990%3A2%3C234%3A%3AAID-JPS14%3E3.0.CO%3B2-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1520-6017%2528200102%252990%253A2%253C234%253A%253AAID-JPS14%253E3.0.CO%253B2-V%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DN.%26aulast%3DYalkowsky%26aufirst%3DS.%2BH.%26atitle%3DEstimation%2520of%2520the%2520aqueous%2520solubility%2520i%253A%2520application%2520to%2520organic%2520nonelectrolytes%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2001%26volume%3D90%26spage%3D234%26epage%3D252%26doi%3D10.1002%2F1520-6017%28200102%2990%3A2%3C234%3A%3AAID-JPS14%3E3.0.CO%3B2-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalkowsky, S. H.</span></span> <span> </span><span class="NLM_article-title">Prediction of drug solubility by the general solubility equation (GSE)</span>. <i>J. Chem. Inf. Comput. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">354</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1021/ci000338c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci000338c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislKntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=354-357&author=Y.+Ranauthor=S.+H.+Yalkowsky&title=Prediction+of+drug+solubility+by+the+general+solubility+equation+%28GSE%29&doi=10.1021%2Fci000338c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Drug Solubility by the General Solubility Equation (GSE)</span></div><div class="casAuthors">Ran, Yingqing; Yalkowsky, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">354-357</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The revised GSE proposed by Jain and Yalkowsky is used to est. the aq. soly. of a set of org. nonelectrolytes studied by Jorgensen and Duffy.  The only inputs used in the GSE are the Celsius m.p. (MP) and the octanol water partition coeff. (Kow).  These are generally known, easily measured, or easily calcd.  The GSE does not utilize any fitted parameters.  The av. abs. error for the 150 compds. is 0.43 compared to 0.56 with Jorgensen and Duffy's computational method, which utilizes 5 fitted parameters.  Thus, the revised GSE is simpler and provides a more accurate estn. of aq. soly. of the same set of org. compds.  It is also more accurate than the original version of the GSE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC0cl3QciSf7Vg90H21EOLACvtfcHk0lgmqzIEdZ5fOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislKntA%253D%253D&md5=c15ffefdf6aacf5fdafd95e5adad7017</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1021%2Fci000338c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci000338c%26sid%3Dliteratum%253Aachs%26aulast%3DRan%26aufirst%3DY.%26aulast%3DYalkowsky%26aufirst%3DS.%2BH.%26atitle%3DPrediction%2520of%2520drug%2520solubility%2520by%2520the%2520general%2520solubility%2520equation%2520%2528GSE%2529%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2001%26volume%3D41%26spage%3D354%26epage%3D357%26doi%3D10.1021%2Fci000338c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span>Furthermore,
the importance of good organic and aqueous solubility for skin permeation
has been demonstrated by Sloan and co-workers.<span class="NLM_contrib-group"><span class="NLM_string-name">Sloan, K. B.</span>; <span class="NLM_string-name">Wasdo, S. C.</span></span> In  <i>Prodrugs: Challenges and Rewards Part 1</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, V. J.</span>, <span class="NLM_string-name">Borchardt, R. T.</span>, <span class="NLM_string-name">Hageman, M. J.</span>, <span class="NLM_string-name">Oliyai, R.</span>, <span class="NLM_string-name">Maag, H.</span>; <span class="NLM_string-name">Tilley, J. W.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">123</span> and references cited therein..</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=86-123&author=K.+B.+Sloan&author=S.+C.+Wasdoauthor=V.+J.+Stella&author=R.+T.+Borchardt&author=M.+J.+Hageman&author=R.+Oliyai&author=H.+Maag&author=J.+W.+Tilley&title=Prodrugs%3A+Challenges+and+Rewards+Part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSloan%26aufirst%3DK.%2BB.%26btitle%3DProdrugs%253A%2520Challenges%2520and%2520Rewards%2520Part%25201%26aulast%3DStella%26aufirst%3DV.%2BJ.%26pub%3DSpringer%26date%3D2007%26spage%3D86%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sepassi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yalkowsky, S. H.</span></span> <span> </span><span class="NLM_article-title">Solubility prediction in octanol: A technical note</span>. <i>AAPS PharmSciTech</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">E184</span>– <span class="NLM_lpage">E191</span>, <span class="refDoi"> DOI: 10.1208/pt070126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1208%2Fpt070126" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=E184-E191&issue=1&author=K.+Sepassiauthor=S.+H.+Yalkowsky&title=Solubility+prediction+in+octanol%3A+A+technical+note&doi=10.1208%2Fpt070126"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1208%2Fpt070126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fpt070126%26sid%3Dliteratum%253Aachs%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DYalkowsky%26aufirst%3DS.%2BH.%26atitle%3DSolubility%2520prediction%2520in%2520octanol%253A%2520A%2520technical%2520note%26jtitle%3DAAPS%2520PharmSciTech%26date%3D2006%26volume%3D7%26issue%3D1%26spage%3DE184%26epage%3DE191%26doi%3D10.1208%2Fpt070126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">Compound lipophilicity is evaluated at pH 6.5 by the chromatographic method described by Valko and then expressed as ChromLogD using the equation described by Young: ChromLogD = CHI × 0.0857 – 2.</p></div><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Valko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, D.</span></span> <span> </span><span class="NLM_article-title">Chromatographic hydrophobicity index by fast-gradient RP-HPLC: A high-throughput alternative to logP/logD</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">2022</span>– <span class="NLM_lpage">2029</span>, <span class="refDoi"> DOI: 10.1021/ac961242d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac961242d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1997&pages=2022-2029&author=K.+Valkoauthor=C.+Bevanauthor=D.+Reynolds&title=Chromatographic+hydrophobicity+index+by+fast-gradient+RP-HPLC%3A+A+high-throughput+alternative+to+logP%2FlogD&doi=10.1021%2Fac961242d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Fac961242d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac961242d%26sid%3Dliteratum%253Aachs%26aulast%3DValko%26aufirst%3DK.%26aulast%3DBevan%26aufirst%3DC.%26aulast%3DReynolds%26aufirst%3DD.%26atitle%3DChromatographic%2520hydrophobicity%2520index%2520by%2520fast-gradient%2520RP-HPLC%253A%2520A%2520high-throughput%2520alternative%2520to%2520logP%252FlogD%26jtitle%3DAnal.%2520Chem.%26date%3D1997%26volume%3D69%26spage%3D2022%26epage%3D2029%26doi%3D10.1021%2Fac961242d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span> <span> </span><span class="NLM_article-title">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">822</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.drudis.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=21704184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=822-830&author=R.+J.+Youngauthor=D.+V.+S.+Greenauthor=C.+N.+Luscombeauthor=A.+P.+Hill&title=Getting+physical+in+drug+discovery+II%3A+the+impact+of+chromatographic+hydrophobicity+measurements+and+aromaticity&doi=10.1016%2Fj.drudis.2011.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span></div><div class="casAuthors">Young, Robert J.; Green, Darren V. S.; Luscombe, Christopher N.; Hill, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17/18</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here, we review the performance of chromatog. hydrophobicity measurements in a data set of 100 000 GlaxoSmithKline compds., demonstrating the advantages of the method over octanol-water partitioning and highlighting new insights for drug discovery.  The value of chromatog. measurements, vs. other hydrophobicity ests., was supported by improved relationships with soly., permeation, cytochrome P450s, intrinsic clearance, hERG binding and promiscuity.  We also obsd. marked differentiation of the relative influence of intrinsic and effective hydrophobicity.  The summing of hydrophobicity values plus arom. ring count [log D pH7.4 (or log P) + #Ar], indicated a wide relevance for simplistic property forecast indexes' in developability assays, clearly enhanced by chromatog. values; therefore establishing new foundations for enriching property-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmIJyWi-DBW7Vg90H21EOLACvtfcHk0ljAyxOl8c6rsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF&md5=22788603a45aa77537e8666433473d14</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DGreen%26aufirst%3DD.%2BV.%2BS.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DHill%26aufirst%3DA.%2BP.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%2520II%253A%2520the%2520impact%2520of%2520chromatographic%2520hydrophobicity%2520measurements%2520and%2520aromaticity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D822%26epage%3D830%26doi%3D10.1016%2Fj.drudis.2011.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schultes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haaksma, E. E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Esch, I. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krämer, O.</span></span> <span> </span><span class="NLM_article-title">A medicinal chemistry perspective on melting point: matched molecular pair analysis of the effects of simple descriptors on the melting point of drug-like compounds</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">584</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1039/c2md00313a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1039%2Fc2md00313a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFart7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=584-591&author=S.+Schultesauthor=C.+de+Graafauthor=H.+Bergerauthor=M.+Mayerauthor=A.+Steffenauthor=E.+E.+J.+Haaksmaauthor=I.+J.+P.+de+Eschauthor=R.+Leursauthor=O.+Kr%C3%A4mer&title=A+medicinal+chemistry+perspective+on+melting+point%3A+matched+molecular+pair+analysis+of+the+effects+of+simple+descriptors+on+the+melting+point+of+drug-like+compounds&doi=10.1039%2Fc2md00313a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">A medicinal chemistry perspective on melting point: matched molecular pair analysis of the effects of simple descriptors on the melting point of drug-like compounds</span></div><div class="casAuthors">Schultes, Sabine; de Graaf, Chris; Berger, Helmut; Mayer, Moriz; Steffen, Andreas; Haaksma, Eric E. J.; de Esch, Iwan J. P.; Leurs, Rob; Kraemer, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">584-591</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The influence of simple mol. descriptors on the m.p. temp. (Tm) was studied using a matched mol. pair (MMP) anal.  This method was used to identify small structural differences between pairs of mols. which are related to changes in Tm.  Anal. shows that the no. of hydrogen bond donors, hydrogen bond acceptors and rotatable bonds has a significant effect on the Tm of a mol.  Hydrogen bond donors have the most pronounced effect.  Also, the studies reveal that not ClogP but rather the no. of bromine and iodine atoms has a marked effect on the Tm.  The results of MMP anal. are discussed within the context of drug soly. optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxP8780R4L_LVg90H21EOLACvtfcHk0ljAyxOl8c6rsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFart7Y%253D&md5=ce0f5645a6d73788c7d83811fb708167</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1039%2Fc2md00313a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md00313a%26sid%3Dliteratum%253Aachs%26aulast%3DSchultes%26aufirst%3DS.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DH.%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DSteffen%26aufirst%3DA.%26aulast%3DHaaksma%26aufirst%3DE.%2BE.%2BJ.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DO.%26atitle%3DA%2520medicinal%2520chemistry%2520perspective%2520on%2520melting%2520point%253A%2520matched%2520molecular%2520pair%2520analysis%2520of%2520the%2520effects%2520of%2520simple%2520descriptors%2520on%2520the%2520melting%2520point%2520of%2520drug-like%2520compounds%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D584%26epage%3D591%26doi%3D10.1039%2Fc2md00313a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Withnall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tetko, I. V.</span></span> <span> </span><span class="NLM_article-title">Matched molecular pair analysis on large melting point datasets: a big data perspective</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1002%2Fcmdc.201700303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=28650584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKmtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=599-606&author=M.+Withnallauthor=H.+Chenauthor=I.+V.+Tetko&title=Matched+molecular+pair+analysis+on+large+melting+point+datasets%3A+a+big+data+perspective&doi=10.1002%2Fcmdc.201700303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pair Analysis on Large Melting Point Datasets: A Big Data Perspective</span></div><div class="casAuthors">Withnall, Michael; Chen, Hongming; Tetko, Igor V.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-606</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A matched mol. pair (MMP) anal. was used to examine the change in m.p. (MP) between pairs of similar mols. in a set of ∼275k compds.  The authors found many cases in which the change in MP (ΔMP) of compds. correlates with changes in functional groups.  In line with the results of a previous study, correlations between ΔMP and simple mol. descriptors, such as the no. of hydrogen bond donors, were identified.  In using a larger dataset, covering a wider chem. space and range of m.ps., the authors obsd. that this method remains stable and scales well with larger datasets.  This MMP-based method could find use as a simple privacy-preserving technique to analyze large proprietary databases and share findings between participating research groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7U9HkXCnBg7Vg90H21EOLACvtfcHk0ljl4sKm_OfKiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKmtrbN&md5=1f820decb1057f59ec79a0e55ba9a206</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700303%26sid%3Dliteratum%253Aachs%26aulast%3DWithnall%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTetko%26aufirst%3DI.%2BV.%26atitle%3DMatched%2520molecular%2520pair%2520analysis%2520on%2520large%2520melting%2520point%2520datasets%253A%2520a%2520big%2520data%2520perspective%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D599%26epage%3D606%26doi%3D10.1002%2Fcmdc.201700303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">Aqueous solubilities are determined using a semithermodynamic protocol where a mixture obtained from a 10 mM DMSO solution is diluted in pH 7.4 buffered water and is stirred for 24 h.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">This match pair was an extreme case in our data set. The average ΔpSol<sub>aq</sub> over 4 naphthalene vs quinoxaline matched pairs was 0.08, and the average ΔChromLogD was 1.1. None of matched pairs showed a significantly more aqueous soluble quinoxaline.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">Drug substance color can be a commercial liability in topical products. For this reason, colorless compounds are highly favored.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span>Photocytotoxicity potential was assessed in a
keratinocytes NRU assay adapted from the 3T3 NRU assay described in
the OECD guideline 432. Cells were irradiated with UV daily simulation
at 6 J/cm<sup>2</sup>, and cells viability was determined after 24
h exposure with chemicals. The sensitivity of the 3T3 NRU-PT is high,
and if a compound is negative in this assay, it would have a very
low probability of being phototoxic in humans. However, a positive
result in the 3T3 NRU-PT should not be regarded as indicative of a
likely clinical phototoxic risk but rather a flag for follow-up assessment.
For more details, see the following:<span class="NLM_contrib-group">OECD</span>.  <i>Test No. 432: In Vitro 3T3 NRU Phototoxicity Test</i>; <span class="NLM_publisher-name">OECD Publishing</span>: <span class="NLM_publisher-loc">Paris</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1787%2F9789264071162-en" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=OECD&title=Test+No.+432%3A+In+Vitro+3T3+NRU+Phototoxicity+Test"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1787%2F9789264071162-en&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1787%252F9789264071162-en%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DTest%2520No.%2520432%253A%2520In%2520Vitro%25203T3%2520NRU%2520Phototoxicity%2520Test%26pub%3DOECD%2520Publishing%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span> For a more detailed analysis
of the importance of physicochemical parameters on phototoxicity,
see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouix-Peter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzy, A.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouvry, G.</span></span> <span> </span><span class="NLM_article-title">Intrinsic property forecast (iPFI) as a rule of thumb for medicinal chemist to remove a photo-toxicity liability</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3231</span>– <span class="NLM_lpage">3236</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3231-3236&author=J.-F.+Fournierauthor=C.+Bouix-Peterauthor=D.+Duvertauthor=A.-P.+Luzyauthor=G.+Ouvry&title=Intrinsic+property+forecast+%28iPFI%29+as+a+rule+of+thumb+for+medicinal+chemist+to+remove+a+photo-toxicity+liability&doi=10.1021%2Facs.jmedchem.8b00075"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00075%26sid%3Dliteratum%253Aachs%26aulast%3DFournier%26aufirst%3DJ.-F.%26aulast%3DBouix-Peter%26aufirst%3DC.%26aulast%3DDuvert%26aufirst%3DD.%26aulast%3DLuzy%26aufirst%3DA.-P.%26aulast%3DOuvry%26aufirst%3DG.%26atitle%3DIntrinsic%2520property%2520forecast%2520%2528iPFI%2529%2520as%2520a%2520rule%2520of%2520thumb%2520for%2520medicinal%2520chemist%2520to%2520remove%2520a%2520photo-toxicity%2520liability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3231%26epage%3D3236%26doi%3D10.1021%2Facs.jmedchem.8b00075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span> For the role of conjugated π
electrons in phototoxicity, see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Haranosono, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaki, H.</span></span> <span> </span><span class="NLM_article-title">Establishment of an <i>in silico</i> phototoxicity prediction method by combining descriptors related to photo-absorption and photo-reaction</span>. <i>J. Toxicol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.2131/jts.39.655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.2131%2Fjts.39.655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=25056790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVentrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=655-664&author=Y.+Haranosonoauthor=M.+Kurataauthor=H.+Sakaki&title=Establishment+of+an+in+silico+phototoxicity+prediction+method+by+combining+descriptors+related+to+photo-absorption+and+photo-reaction&doi=10.2131%2Fjts.39.655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Establishment of an in silico phototoxicity prediction method by combining descriptors related to photo-absorption and photo-reaction</span></div><div class="casAuthors">Haranosono, Yu; Kurata, Masaaki; Sakaki, Hideyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Toxicological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">655-664</span>CODEN:
                <span class="NLM_cas:coden">JTSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0388-1350</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society of Toxicology</span>)
        </div><div class="casAbstract">One of the mechanisms of phototoxicity is photo-reaction, such as reactive oxygen species (ROS) generation following photo-absorption.  We focused on ROS generation and photo-absorption as key-steps, because these key-steps are able to be described by photochem. properties, and these properties are dependent on chem. structure.  Photo-reactivity of a compd. is described by HOMO-LUMO Gap (HLG), generally.  Herein, we showed that HLG can be used as a descriptor of the generation of reactive oxygen species.  Moreover, the max.-conjugated π electron no. (PENMC), which we found as a descriptor of photo-absorption, could also predict in vitro phototoxicity.  Each descriptor could predict in vitro phototoxicity with 70.0% concordance, but there was un-predicted area found (gray zone).  Interestingly, some compds. in each gray zone were not common, indicating that the combination of two descriptors could improve prediction potential.  We reset the cut-off lines to define pos. zone, neg. zone and gray zone for each descriptor.  Thereby we overlapped HLG and PENMC in a graph, and divided the total area to nine zones with cut-off lines of each descriptor.  The rules to prediction were decided to achieve the best concordance, and the concordances were improved up to 82.8% for self-validation, 81.6% for cross-validation.  We found common properties among false pos. or neg. compds., photo-reactive structure and photo-allergenic, resp.  In addn., our method could be adapted to compds. rich in structural diversity using only chem. structure without any statistical anal. and complicated calcn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6-LipbO6LOLVg90H21EOLACvtfcHk0ljl4sKm_OfKiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVentrjF&md5=4ef07067c76343efcfd2a5f5d0f7d6f0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2131%2Fjts.39.655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2131%252Fjts.39.655%26sid%3Dliteratum%253Aachs%26aulast%3DHaranosono%26aufirst%3DY.%26aulast%3DKurata%26aufirst%3DM.%26aulast%3DSakaki%26aufirst%3DH.%26atitle%3DEstablishment%2520of%2520an%2520in%2520silico%2520phototoxicity%2520prediction%2520method%2520by%2520combining%2520descriptors%2520related%2520to%2520photo-absorption%2520and%2520photo-reaction%26jtitle%3DJ.%2520Toxicol.%2520Sci.%26date%3D2014%26volume%3D39%26spage%3D655%26epage%3D664%26doi%3D10.2131%2Fjts.39.655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="note"><p class="first last">Topical programs resemble inhalation ones in that inhibitors should be rapidly cleared once they reach systemic distribution to prevent toxicity issues. However they still need to be stable in skin in order to achieve efficacy. For a review on skin metabolism, see the following:</p></div><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, C. K.</span></span> <span> </span><span class="NLM_article-title">Minireview: biotransformation of drugs in human skin</span>. <i>Drug</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1124/dmd.108.024794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1124%2Fdmd.108.024794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Krs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=247-253&author=C.+K.+Svensson&title=Minireview%3A+biotransformation+of+drugs+in+human+skin&doi=10.1124%2Fdmd.108.024794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation of drugs in human skin</span></div><div class="casAuthors">Svensson, Craig K.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-253</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Although it is the largest organ of the human body, skin is often not considered in discussions of drug metab.  However, there is growing evidence that most common drug-metabolizing enzymes are expressed in the skin.  Evidence for expression of cytochromes P 450, flavin monooxygenases, glutathione-S-transferases, N-acetyltransferases, and sulfotransferases in human skin and skin cells are presented.  Addnl. discussion is focused on the evidence of actual metab. of drugs.  Finally, the potential clin. implications of metab. within the skin are discussed briefly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2GNsGESefO7Vg90H21EOLACvtfcHk0lhMVnSfAQ0OwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Krs7k%253D&md5=c7bb178e9cfcd22a11dee43b9c396ff8</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024794%26sid%3Dliteratum%253Aachs%26aulast%3DSvensson%26aufirst%3DC.%2BK.%26atitle%3DMinireview%253A%2520biotransformation%2520of%2520drugs%2520in%2520human%2520skin%26jtitle%3DDrug%26date%3D2009%26volume%3D37%26spage%3D247%26epage%3D253%26doi%3D10.1124%2Fdmd.108.024794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oesch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oesch-Bartlomowicz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landsiedel, R.</span></span> <span> </span><span class="NLM_article-title">Drug-metabolizing enzymes in the skin of man, rat, and pig</span>. <i>Drug Metab. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1080/03602530701690366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1080%2F03602530701690366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=18058329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlyitbnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=659-698&author=F.+Oeschauthor=E.+Fabianauthor=B.+Oesch-Bartlomowiczauthor=C.+Wernerauthor=R.+Landsiedel&title=Drug-metabolizing+enzymes+in+the+skin+of+man%2C+rat%2C+and+pig&doi=10.1080%2F03602530701690366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-Metabolizing Enzymes in the Skin of Man, Rat, and Pig</span></div><div class="casAuthors">Oesch, Franz; Fabian, Eric; Oesch-Bartlomowicz, Barbara; Werner, Christoph; Landsiedel, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">659-698</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The mammalian skin has long been considered to be poor in drug metab.  However, many reports clearly show that most drug metabolizing enzymes also occur in the mammalian skin albeit at relatively low specific activities.  This review summarizes the current state of knowledge on drug metabolizing enzymes in the skin of human, rat, and pig, the latter, because it is often taken as a model for human skin on grounds of anatomical similarities.  However only little is known about drug metabolizing enzymes in pig skin.  Interestingly, some cytochromes P 450 (CYP) have been obsd. in the rat skin which are not expressed in the rat liver, such as CYP 2B12 and CYP2D4.  As far as investigated most drug metabolizing enzymes occur in the suprabasal (i.e. differentiating) layers of the epidermis, but the rat CYP1A1 rather in the basal layer and human UDP-glucuronosyltransferase rather in the stratum corneum.  The pattern of drug metabolizing enzymes and their localization will impact not only the beneficial as well as detrimental properties of drugs for the skin but also dictate whether a drug reaches the blood flow unchanged or as activated or inactivated metabolite(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofhs_tmoLY7bVg90H21EOLACvtfcHk0lhMVnSfAQ0OwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlyitbnO&md5=43dcf77be2bd31c8a5629321f959bc10</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1080%2F03602530701690366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F03602530701690366%26sid%3Dliteratum%253Aachs%26aulast%3DOesch%26aufirst%3DF.%26aulast%3DFabian%26aufirst%3DE.%26aulast%3DOesch-Bartlomowicz%26aufirst%3DB.%26aulast%3DWerner%26aufirst%3DC.%26aulast%3DLandsiedel%26aufirst%3DR.%26atitle%3DDrug-metabolizing%2520enzymes%2520in%2520the%2520skin%2520of%2520man%252C%2520rat%252C%2520and%2520pig%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2007%26volume%3D39%26spage%3D659%26epage%3D698%26doi%3D10.1080%2F03602530701690366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">Stability of compounds with the aspartylaldehyde warhead was first evaluated in a few common excipients as well as a simple mixture at 40 °C for 1 month. Results showed compounds were more prone to decomposition when PG was present, possibly because of acetal formation following addition of the diol. Ethanol was therefore selected as excipient of choice for this assay. See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_001.pdf" class="ext-link">Figure 2S in Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">Average absolute error between extrapolation and measured value was 6.9% with a median of 3.5%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span>For simplicity, all tautomers and potential stereoisomers were assimilated
to parent. Stereochemical stability was evaluated in separate assays
which could not be evaluated in a high throughput fashion. A detailed
discussion on the chemical and stereochemical stability of different
caspase-1 inhibitor series and warheads is in preparation:<span class="NLM_contrib-group"><span class="NLM_string-name">Chambon, S.</span>; <span class="NLM_string-name">Talano, S.</span>; <span class="NLM_string-name">Millois, C.</span>; <span class="NLM_string-name">Dumais, L.</span>; <span class="NLM_string-name">Pierre, R.</span>; <span class="NLM_string-name">Mathieu, C.</span>; <span class="NLM_string-name">Ghilini, A.-L.</span>; <span class="NLM_string-name">Vanthuyne, N.</span>; <span class="NLM_string-name">Reverse, K.</span>; <span class="NLM_string-name">Brethon, A.</span>; <span class="NLM_string-name">Rodeschini, V.</span>; <span class="NLM_string-name">Comino, C.</span>; <span class="NLM_string-name">Mouis, G.</span>; <span class="NLM_string-name">El-Bazbouz, G.</span>; <span class="NLM_string-name">Clary, L.</span>; <span class="NLM_string-name">Fournier, J.-F.</span>; <span class="NLM_string-name">Bouix-Peter, C.</span>; <span class="NLM_string-name">Tomas, L.</span>; <span class="NLM_string-name">Hennequin, L. F.</span>; <span class="NLM_string-name">Harris, C. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and stability evaluation of novel caspase 1 inhibitors for topical application</span>. Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+simplicity%2C+all+tautomers+and+potential+stereoisomers+were+assimilated%0Ato+parent.+Stereochemical+stability+was+evaluated+in+separate+assays%0Awhich+could+not+be+evaluated+in+a+high+throughput+fashion.+A+detailed%0Adiscussion+on+the+chemical+and+stereochemical+stability+of+different%0Acaspase-1+inhibitor+series+and+warheads+is+in+preparation%3AChambon%2C+S.%3B+Talano%2C+S.%3B+Millois%2C+C.%3B+Dumais%2C+L.%3B+Pierre%2C+R.%3B+Mathieu%2C+C.%3B+Ghilini%2C+A.-L.%3B+Vanthuyne%2C+N.%3B+Reverse%2C+K.%3B+Brethon%2C+A.%3B+Rodeschini%2C+V.%3B+Comino%2C+C.%3B+Mouis%2C+G.%3B+El-Bazbouz%2C+G.%3B+Clary%2C+L.%3B+Fournier%2C+J.-F.%3B+Bouix-Peter%2C+C.%3B+Tomas%2C+L.%3B+Hennequin%2C+L.+F.%3B+Harris%2C+C.+S.+Synthesis+and+stability+evaluation+of+novel+caspase+1+inhibitors+for+topical+application.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DChambon%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520stability%2520evaluation%2520of%2520novel%2520caspase%25201%2520inhibitors%2520for%2520topical%2520application" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span> For a recent discussion on cysteine
protease warheads design, see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, J. F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vita, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddad Franco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freitas-Junior, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burtoloso, A. C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leitão, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, C. A.</span></span> <span> </span><span class="NLM_article-title">A comparative study of warheads for design of cysteine protease inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5031</span>– <span class="NLM_lpage">5035</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.bmcl.2017.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=29054358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yjsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5031-5035&author=D.+G.+Silvaauthor=J.+F.+R.+Ribeiroauthor=D.+De+Vitaauthor=L.+Cianniauthor=C.+Haddad+Francoauthor=L.+H.+Freitas-Juniorauthor=C.+B.+Moraesauthor=J.+R.+Rochaauthor=A.+C.+B.+Burtolosoauthor=P.+W.+Kennyauthor=A.+Leit%C3%A3oauthor=C.+A.+Montanari&title=A+comparative+study+of+warheads+for+design+of+cysteine+protease+inhibitors&doi=10.1016%2Fj.bmcl.2017.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of warheads for design of cysteine protease inhibitors</span></div><div class="casAuthors">Silva, Daniel G.; Ribeiro, Jean F. R.; De Vita, Daniela; Cianni, Lorenzo; Franco, Caio Haddad; Freitas-Junior, Lucio H.; Moraes, Carolina Borsoi; Rocha, Josmar R.; Burtoloso, Antonio C. B.; Kenny, Peter W.; Leitao, Andrei; Montanari, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5031-5035</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The effects on potency of cruzain inhibition of replacing a nitrile group with alternative warheads were explored.  The oxime was almost an order of magnitude more potent than the corresponding nitrile and has the potential to provide access to the prime side of the catalytic site.  Dipeptide aldehydes and azadipeptide nitriles were found to be two orders of magnitude more potent cruzain inhibitors than the corresponding dipeptide nitriles although potency differences were modulated by substitution at P1 and P3.  Replacement of the α methylene of a dipeptide aldehyde with cyclopropane led to a loss of potency of almost three orders of magnitude.  The vinyl esters and amides that were characterized as reversible inhibitors were less potent than the corresponding nitrile by between one and two orders of magnitude.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1EsVPrEhve7Vg90H21EOLACvtfcHk0lhMVnSfAQ0OwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yjsL%252FI&md5=0e2c0c2f3bc188bd43e05c14a1b8d963</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DD.%2BG.%26aulast%3DRibeiro%26aufirst%3DJ.%2BF.%2BR.%26aulast%3DDe%2BVita%26aufirst%3DD.%26aulast%3DCianni%26aufirst%3DL.%26aulast%3DHaddad%2BFranco%26aufirst%3DC.%26aulast%3DFreitas-Junior%26aufirst%3DL.%2BH.%26aulast%3DMoraes%26aufirst%3DC.%2BB.%26aulast%3DRocha%26aufirst%3DJ.%2BR.%26aulast%3DBurtoloso%26aufirst%3DA.%2BC.%2BB.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DLeit%25C3%25A3o%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DC.%2BA.%26atitle%3DA%2520comparative%2520study%2520of%2520warheads%2520for%2520design%2520of%2520cysteine%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5031%26epage%3D5035%26doi%3D10.1016%2Fj.bmcl.2017.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Free, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. W.</span></span> <span> </span><span class="NLM_article-title">A mathematical contribution to structure-activity studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1021/jm00334a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00334a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADyaF2cXkt1OltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1964&pages=395-399&author=S.+M.+Freeauthor=J.+W.+Wilson&title=A+mathematical+contribution+to+structure-activity+studies&doi=10.1021%2Fjm00334a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A mathematical contribution to structure-activity studies</span></div><div class="casAuthors">Free, Spencer M., Jr.; Wilson, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A math. technique is suggested as a means of describing structure-activity relation of a series of chem. analogs.  The data requirements included specific side chain arrangements and performance characteristics of all analogs tested.  Two examples illustrate the use of the additive math. model where the performance characteristics are measures of biol. activity.  The results rank the structural changes per position by estg. the amt. of biol. response attributed to each change.  The estimates are both pos. and neg.  Several uses for the math. soln. are suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRyTj3xI-aH7Vg90H21EOLACvtfcHk0ljZof77L5eRRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXkt1OltbY%253D&md5=88fabb64d7a5635506a11418a2744bd6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm00334a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00334a001%26sid%3Dliteratum%253Aachs%26aulast%3DFree%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26atitle%3DA%2520mathematical%2520contribution%2520to%2520structure-activity%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1964%26volume%3D7%26spage%3D395%26epage%3D399%26doi%3D10.1021%2Fjm00334a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="note"><p class="first last">No stability data were generated for the active warheads B (oxopentanoate), C (acrylamide), and F (nitrile) as they showed a significant shift in the cellular assay to lower potencies. As a general rule, compounds were shifted about 5-fold. Roughly 25% were shifted more than 10-fold, and none were shifted more than 100-fold. The reasons behind this shift could be due to usual factors such as difference in serum and substrate content but also to kinetics.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="note"><p class="first last">Stability SPR was not always additive. For this reason, caution was used when constituting the data set and interpreting the analysis.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="note"><p class="first last">Albeit counterintuitive at first, picolinamide was, in our hands, generally more lipophilic than their benzamide counterpart in part due to the intramolecular H-bond between the pyridine lone pair and the carboxamide NH. In the case of our uracils, this can then lead to a higher risk of phototoxicity even in the case of the ortho-substituted <b>17</b> since conjugation of the π systems is then restored. For discussions on the role of IMHB in medicinal chemistry, see, for example, the following:</p></div><div class="NLM_citation" id="rightTab-cit41a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2601</span>– <span class="NLM_lpage">2611</span>, <span class="refDoi"> DOI: 10.1021/jm100087s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry&doi=10.1021%2Fjm100087s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0ljZof77L5eRRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611%26doi%3D10.1021%2Fjm100087s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit41b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tardia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolfa, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangiatordi, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolotti, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lattanzi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berardi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzariti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colabufo, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellamare, S.</span></span> <span> </span><span class="NLM_article-title">Trimethoxybenzanilide-Based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6403</span>– <span class="NLM_lpage">6418</span>, <span class="refDoi"> DOI: 10.1021/jm500697c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500697c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6403-6418&author=P.+Tardiaauthor=A.+Stefanachiauthor=M.+Nisoauthor=D.+A.+Stolfaauthor=G.+F.+Mangiatordiauthor=D.+Albergaauthor=O.+Nicolottiauthor=G.+Lattanziauthor=A.+Carottiauthor=F.+Leonettiauthor=R.+Perroneauthor=F.+Berardiauthor=A.+Azzaritiauthor=N.+A.+Colabufoauthor=S.+Cellamare&title=Trimethoxybenzanilide-Based+P-glycoprotein+modulators%3A+an+interesting+case+of+lipophilicity+tuning+by+intramolecular+hydrogen+bonding&doi=10.1021%2Fjm500697c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1021%2Fjm500697c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500697c%26sid%3Dliteratum%253Aachs%26aulast%3DTardia%26aufirst%3DP.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DStolfa%26aufirst%3DD.%2BA.%26aulast%3DMangiatordi%26aufirst%3DG.%2BF.%26aulast%3DAlberga%26aufirst%3DD.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLattanzi%26aufirst%3DG.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DAzzariti%26aufirst%3DA.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26aulast%3DCellamare%26aufirst%3DS.%26atitle%3DTrimethoxybenzanilide-Based%2520P-glycoprotein%2520modulators%253A%2520an%2520interesting%2520case%2520of%2520lipophilicity%2520tuning%2520by%2520intramolecular%2520hydrogen%2520bonding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6403%26epage%3D6418%26doi%3D10.1021%2Fjm500697c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="note"><p class="first last">The impact of the cyclopropyl moiety on chemical stability was not general as other molecular matched pairs showed the reverse impact.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">South, M. S.</span>; <span class="NLM_string-name">Rueppel, M. L.</span>; <span class="NLM_string-name">Jones, D.</span></span> <span> </span><span class="NLM_article-title">Substituted Polycyclic Aryl and Heteroaryl Uracils Useful for Selective Inhibition of the Coagulation Cascade</span>. PCT Int. Appl. <span class="NLM_patent">WO2001087852</span>, <span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=M.+S.+South&author=M.+L.+Rueppel&author=D.+Jones&title=Substituted+Polycyclic+Aryl+and+Heteroaryl+Uracils+Useful+for+Selective+Inhibition+of+the+Coagulation+Cascade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSouth%26aufirst%3DM.%2BS.%26atitle%3DSubstituted%2520Polycyclic%2520Aryl%2520and%2520Heteroaryl%2520Uracils%2520Useful%2520for%2520Selective%2520Inhibition%2520of%2520the%2520Coagulation%2520Cascade%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit43b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhendwa, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, D. F.</span></span> <span> </span><span class="NLM_article-title">Benzhydryl as an efficient selective nitrogen protecting group for uracils</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">9307</span>– <span class="NLM_lpage">9309</span>, <span class="refDoi"> DOI: 10.1021/jo0485076</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0485076" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=9307-9309&author=F.+Wuauthor=M.+G.+Buhendwaauthor=D.+F.+Weaver&title=Benzhydryl+as+an+efficient+selective+nitrogen+protecting+group+for+uracils&doi=10.1021%2Fjo0485076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1021%2Fjo0485076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0485076%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DF.%26aulast%3DBuhendwa%26aufirst%3DM.%2BG.%26aulast%3DWeaver%26aufirst%3DD.%2BF.%26atitle%3DBenzhydryl%2520as%2520an%2520efficient%2520selective%2520nitrogen%2520protecting%2520group%2520for%2520uracils%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D9307%26epage%3D9309%26doi%3D10.1021%2Fjo0485076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boiteau, J.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouix-Peter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clary, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daver, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumais, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mebrouk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millois, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodeville, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas, L.</span></span> <span> </span><span class="NLM_article-title">An efficient multi-component synthesis of <i>N</i>-1-alkylated 5-nitrouracils from α-amino acids</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2367</span>– <span class="NLM_lpage">2371</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2016.04.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2Fj.tetlet.2016.04.039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=2367-2371&author=J.-G.+Boiteauauthor=C.+Bouix-Peterauthor=S.+Chambonauthor=L.+Claryauthor=S.+Daverauthor=L.+Dumaisauthor=J.-F.+Fournierauthor=C.+S.+Harrisauthor=K.+Mebroukauthor=C.+Milloisauthor=R.+Pierreauthor=N.+Rodevilleauthor=S.+Talanoauthor=L.+Tomas&title=An+efficient+multi-component+synthesis+of+N-1-alkylated+5-nitrouracils+from+%CE%B1-amino+acids&doi=10.1016%2Fj.tetlet.2016.04.039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2016.04.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2016.04.039%26sid%3Dliteratum%253Aachs%26aulast%3DBoiteau%26aufirst%3DJ.-G.%26aulast%3DBouix-Peter%26aufirst%3DC.%26aulast%3DChambon%26aufirst%3DS.%26aulast%3DClary%26aufirst%3DL.%26aulast%3DDaver%26aufirst%3DS.%26aulast%3DDumais%26aufirst%3DL.%26aulast%3DFournier%26aufirst%3DJ.-F.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DMebrouk%26aufirst%3DK.%26aulast%3DMillois%26aufirst%3DC.%26aulast%3DPierre%26aufirst%3DR.%26aulast%3DRodeville%26aufirst%3DN.%26aulast%3DTalano%26aufirst%3DS.%26aulast%3DTomas%26aufirst%3DL.%26atitle%3DAn%2520efficient%2520multi-component%2520synthesis%2520of%2520N-1-alkylated%25205-nitrouracils%2520from%2520%25CE%25B1-amino%2520acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2016%26volume%3D57%26spage%3D2367%26epage%3D2371%26doi%3D10.1016%2Fj.tetlet.2016.04.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maligres, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcoux, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillier, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krska, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabowski, E. J. J.</span></span> <span> </span><span class="NLM_article-title">Practical, Highly convergent, asymmetric synthesis of a selective PPARγ modulator</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">534</span>, <span class="refDoi"> DOI: 10.1021/op8002882</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op8002882" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=525-534&author=P.+E.+Maligresauthor=G.+R.+Humphreyauthor=J.-F.+Marcouxauthor=M.+C.+Hillierauthor=D.+Zhaoauthor=S.+Krskaauthor=E.+J.+J.+Grabowski&title=Practical%2C+Highly+convergent%2C+asymmetric+synthesis+of+a+selective+PPAR%CE%B3+modulator&doi=10.1021%2Fop8002882"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fop8002882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop8002882%26sid%3Dliteratum%253Aachs%26aulast%3DMaligres%26aufirst%3DP.%2BE.%26aulast%3DHumphrey%26aufirst%3DG.%2BR.%26aulast%3DMarcoux%26aufirst%3DJ.-F.%26aulast%3DHillier%26aufirst%3DM.%2BC.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DKrska%26aufirst%3DS.%26aulast%3DGrabowski%26aufirst%3DE.%2BJ.%2BJ.%26atitle%3DPractical%252C%2520Highly%2520convergent%252C%2520asymmetric%2520synthesis%2520of%2520a%2520selective%2520PPAR%25CE%25B3%2520modulator%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2009%26volume%3D13%26spage%3D525%26epage%3D534%26doi%3D10.1021%2Fop8002882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Faham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subirós-Funosas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prohens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albericio, F.</span></span> <span> </span><span class="NLM_article-title">COMU: A Safer and More Effective replacement for benzotriazole-based uronium coupling reagents</span>. <i>Chem.—Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">9404</span>– <span class="NLM_lpage">9416</span>, <span class="refDoi"> DOI: 10.1002/chem.200900615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1002%2Fchem.200900615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=19621394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGlu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=9404-9416&author=A.+El-Fahamauthor=R.+Subir%C3%B3s-Funosasauthor=R.+Prohensauthor=F.+Albericio&title=COMU%3A+A+Safer+and+More+Effective+replacement+for+benzotriazole-based+uronium+coupling+reagents&doi=10.1002%2Fchem.200900615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">COMU: A Safer and More Effective Replacement for Benzotriazole-Based Uronium Coupling Reagents</span></div><div class="casAuthors">El-Faham, Ayman; Funosas, Ramon Subiros; Prohens, Rafel; Albericio, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">9404-9416, S9404/1-S9404/34</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors describe a new family of uronium-type coupling reagents that differ in their iminium moieties and leaving groups.  The presence of the morpholino group in conjunction with an oxime deriv., esp. Et 2-cyano-2-(hydroxyimino)acetate (Oxyma), had a marked influence on the solubilities, stabilities, and reactivities of the reagents.  Finally, the new uronium salt I (COMU) derived from Oxyma performed extremely well in the presence of only 1 equiv of base, thereby confirming the effect of the hydrogen bond acceptor in the reaction.  I also showed a less hazardous safety profile than the benzotriazole-based HDMA and HDMB, which exhibited unpredictable autocatalytic decompns.  Furthermore, the Oxyma moiety contained in I suggests a lower risk of explosion than in the case of the benzotriazole derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFM_Djmx8l9rVg90H21EOLACvtfcHk0li_SKevlXuMng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGlu7fO&md5=9f415ba22d4414a93226d741b0cbfd30</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fchem.200900615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200900615%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Faham%26aufirst%3DA.%26aulast%3DSubir%25C3%25B3s-Funosas%26aufirst%3DR.%26aulast%3DProhens%26aufirst%3DR.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DCOMU%253A%2520A%2520Safer%2520and%2520More%2520Effective%2520replacement%2520for%2520benzotriazole-based%2520uronium%2520coupling%2520reagents%26jtitle%3DChem.%25E2%2580%2594Eur.%2520J.%26date%3D2009%26volume%3D15%26spage%3D9404%26epage%3D9416%26doi%3D10.1002%2Fchem.200900615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="note"><p class="first last">Unfortunately, chiral analogs of <b>44</b> prepared using this strategy underwent partial epimerization during the saponification step.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.
T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a Potent, Reversible inhibitor of interleukin-1β converting enzyme</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)81209-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1016%2FS0960-894X%2801%2981209-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1992&pages=613-618&author=K.%0AT.+Chapman&title=Synthesis+of+a+Potent%2C+Reversible+inhibitor+of+interleukin-1%CE%B2+converting+enzyme&doi=10.1016%2FS0960-894X%2801%2981209-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2981209-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252981209-9%26sid%3Dliteratum%253Aachs%26aulast%3DChapman%26aufirst%3DK.%2BT.%26atitle%3DSynthesis%2520of%2520a%2520Potent%252C%2520Reversible%2520inhibitor%2520of%2520interleukin-1%25CE%25B2%2520converting%2520enzyme%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1992%26volume%3D2%26spage%3D613%26epage%3D618%26doi%3D10.1016%2FS0960-894X%2801%2981209-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunetz, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringling, J.</span></span> <span> </span><span class="NLM_article-title">General and scalable amide bond formation with epimerization-prone substrates using T3P and pyridine</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">5048</span>– <span class="NLM_lpage">5051</span>, <span class="refDoi"> DOI: 10.1021/ol201875q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol201875q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2isbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=5048-5051&author=J.+R.+Dunetzauthor=Y.+Xiangauthor=A.+Baldwinauthor=J.+Ringling&title=General+and+scalable+amide+bond+formation+with+epimerization-prone+substrates+using+T3P+and+pyridine&doi=10.1021%2Fol201875q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">General and Scalable Amide Bond Formation with Epimerization-Prone Substrates Using T3P and Pyridine</span></div><div class="casAuthors">Dunetz, Joshua R.; Xiang, Yanqiao; Baldwin, Aaron; Ringling, Justin</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5048-5051</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The mild combination of T3P (n-propanephosphonic acid anhydride) and pyridine has been developed for low-epimerization amide bond formation and implemented for the synthesis of a key intermediate to a glucokinase activator.  This robust method is general for the coupling of various racemization-prone acid substrates and amines, including relatively non-nucleophilic anilines, and provides amides in high yields with very low epimerization.  With easy reaction setup and product isolation, this protocol offers several practical and exptl. benefits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMpm-IixCiDLVg90H21EOLACvtfcHk0li_SKevlXuMng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2isbbJ&md5=d7137a2564e69031af69208dde5e6f30</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fol201875q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol201875q%26sid%3Dliteratum%253Aachs%26aulast%3DDunetz%26aufirst%3DJ.%2BR.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DBaldwin%26aufirst%3DA.%26aulast%3DRingling%26aufirst%3DJ.%26atitle%3DGeneral%2520and%2520scalable%2520amide%2520bond%2520formation%2520with%2520epimerization-prone%2520substrates%2520using%2520T3P%2520and%2520pyridine%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D5048%26epage%3D5051%26doi%3D10.1021%2Fol201875q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span>For a recent discussion on the pharmacokinetics
of topical drugs, see the following:<span class="NLM_contrib-group"><span class="NLM_string-name">Trottet, L.</span>; <span class="NLM_string-name">Maibach, H.</span></span> <i>Dermal Drug Selection and Development: An Industrial Perspective</i>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">93</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1007%2F978-3-319-59504-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=41-93&author=L.+Trottet&author=H.+Maibach&title=Dermal+Drug+Selection+and+Development%3A+An+Industrial+Perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-59504-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-59504-7%26sid%3Dliteratum%253Aachs%26aulast%3DTrottet%26aufirst%3DL.%26btitle%3DDermal%2520Drug%2520Selection%2520and%2520Development%253A%2520An%2520Industrial%2520Perspective%26pub%3DSpringer%26date%3D2017%26spage%3D41%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Potts, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, R. H.</span></span> <span> </span><span class="NLM_article-title">Predicting skin permeability</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1023/A:1015810312465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1023%2FA%3A1015810312465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1608900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADyaK38XktF2rs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1992&pages=663-669&author=R.+O.+Pottsauthor=R.+H.+Guy&title=Predicting+skin+permeability&doi=10.1023%2FA%3A1015810312465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting skin permeability</span></div><div class="casAuthors">Potts, Russell O.; Guy, Richard H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">663-9</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    </div><div class="casAbstract">Published permeability coeff. (Kp) data for the transport of a large group of compds. through mammalian epidermis were analyzed by a simple model based upon permeant size [mol. vol. (MV) or mol. wt. (MW)] and octanol/water partition coeff. (Koct).  The anal. presented is a facile means to predict the percutaneous flux of pharmacol. and toxic compds. solely on the basis of their physicochem. properties.  Furthermore, the derived parameters of the model have assignable biophys. significance, and they provide insight into the mechanism of mol. transport through the stratum corneum (SC).  For the very diverse group of chems. considered, the results demonstrate that SC intercellular lipid properties alone are sufficient to account for the dependence of Kp upon MV (or MW) and Koct.  The existence of an "aq.-polar (pore) pathway" across the SC is not necessary to explain the Kp values of small, polar nonelectrolytes.  Rather, their small size, and consequently high diffusivity, accounts for their apparently larger-than-expected Kp.  Finally, despite the size and breadth of the data set (more than 90 compds. with MW ranging from 18 to >750, and log Koct ranging from -3 to +6), the postulated upper limiting value of Kp for permeants of very high lipophilicity cannot be detd.  However, the anal. is able to define the physicochem. characteristics of mols. which should exhibit these maximal Kp values.  Overall, then, we present a facile interpretation of a considerable body of skin permeability measurements that (a) very adequately describes the dependence of Kp upon permeant size and lipophilicity, (b) generates parameters of considerable physicochem. and mechanistic relevance, and (c) implies that the SC lipids alone can fully characterize the barrier properties of mammalian skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod7Y5vdr1_q7Vg90H21EOLACvtfcHk0ligdas2_YFZSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktF2rs7c%253D&md5=b8884dfc56bdcbfc32972d155b399cdc</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015810312465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015810312465%26sid%3Dliteratum%253Aachs%26aulast%3DPotts%26aufirst%3DR.%2BO.%26aulast%3DGuy%26aufirst%3DR.%2BH.%26atitle%3DPredicting%2520skin%2520permeability%26jtitle%3DPharm.%2520Res.%26date%3D1992%26volume%3D9%26spage%3D663%26epage%3D669%26doi%3D10.1023%2FA%3A1015810312465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rey-Giraud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ries, C. H.</span></span> <span> </span><span class="NLM_article-title">In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">e42656</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0042656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=10.1371%2Fjournal.pone.0042656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=22880072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOlt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e42656&issue=8&author=F.+Rey-Giraudauthor=M.+Hafnerauthor=C.+H.+Ries&title=In+vitro+generation+of+monocyte-derived+macrophages+under+serum-free+conditions+improves+their+tumor+promoting+functions&doi=10.1371%2Fjournal.pone.0042656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions</span></div><div class="casAuthors">Rey-Giraud, Flora; Hafner, Mathias; Ries, Carola H.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e42656</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The tumor promoting role of M2 macrophages has been described in in vivo models and the presence of macrophages in certain tumor types has been linked to a poor clin. outcome.  In light of burgeoning activities to clin. develop new therapies targeting tumor-assocd. macrophages (TAMs), reliable in vitro models faithfully mimicking the tumor promoting functions of TAMs are required.  Generation and activation of human monocyte-derived macrophages (MDM) in vitro, described as M1 or M2 macrophages attributed with tumoricidal or tumor-promoting functions, resp., has been widely reported using mainly serum contg. culture methods.  In this study, we compared the properties of macrophages originating from monocytes cultured either in media contg. serum together with M-CSF for M2 and GM-CSF for M1 macrophages or in serum-free media supplemented with M-CSF or GM-CSF and cytokines such as IL-4, IL-10 to induce activated M2 or LPS together with IFN-γ to generate activated M1 phenotype.  We obsd. differences in cell morphol. as well as increased surface receptor expression levels in serum-contg. culture whereas similar or higher cytokine prodn. levels were detected under serum-free culture conditions.  More importantly, MDM differentiated under serum-free conditions displayed enhanced tumoricidal activity for M1 and tumor promoting property for M2 macrophages in contrast to MDM differentiated in the presence of serum.  Moreover, evaluation of MDM phagocytic activity in serum free condition resulted in greater phagocytic properties of M2 compared to M1.  Our data therefore confirm the tumor promoting properties of M2 macrophages in vitro and encourage the targeting of TAMs for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkse7HP0vKCLVg90H21EOLACvtfcHk0ligdas2_YFZSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOlt77J&md5=6320b00e43ab6f503d6d873a28528738</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0042656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0042656%26sid%3Dliteratum%253Aachs%26aulast%3DRey-Giraud%26aufirst%3DF.%26aulast%3DHafner%26aufirst%3DM.%26aulast%3DRies%26aufirst%3DC.%2BH.%26atitle%3DIn%2520vitro%2520generation%2520of%2520monocyte-derived%2520macrophages%2520under%2520serum-free%2520conditions%2520improves%2520their%2520tumor%2520promoting%2520functions%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D8%26spage%3De42656%26doi%3D10.1371%2Fjournal.pone.0042656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F6R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F6R','PDB','6F6R'); return false;">PDB: 6F6R</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i80"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00067">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_01657"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00067">10.1021/acs.jmedchem.8b00067</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional chemical and biological figures and tables (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Additional experimental information (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_001.pdf">jm8b00067_si_001.pdf (374.97 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_002.pdf">jm8b00067_si_002.pdf (1.4 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00067/suppl_file/jm8b00067_si_003.csv">jm8b00067_si_003.csv (3.98 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">X-ray crystal structures have been deposited in the Protein Data Bank as follows: compound <b>6</b> bound to human caspase-1, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F6R">6F6R</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00067&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-9%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00067" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00067" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799941138d53ce2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
